/*! For license information please see main.1e442e01.js.LICENSE.txt */
!function(){var e={76:function(e,t,n){"use strict";n.d(t,{Z:function(){return ae}});var r=function(){function e(e){var t=this;this._insertTag=function(e){var n;n=0===t.tags.length?t.insertionPoint?t.insertionPoint.nextSibling:t.prepend?t.container.firstChild:t.before:t.tags[t.tags.length-1].nextSibling,t.container.insertBefore(e,n),t.tags.push(e)},this.isSpeedy=void 0===e.speedy||e.speedy,this.tags=[],this.ctr=0,this.nonce=e.nonce,this.key=e.key,this.container=e.container,this.prepend=e.prepend,this.insertionPoint=e.insertionPoint,this.before=null}var t=e.prototype;return t.hydrate=function(e){e.forEach(this._insertTag)},t.insert=function(e){this.ctr%(this.isSpeedy?65e3:1)===0&&this._insertTag(function(e){var t=document.createElement("style");return t.setAttribute("data-emotion",e.key),void 0!==e.nonce&&t.setAttribute("nonce",e.nonce),t.appendChild(document.createTextNode("")),t.setAttribute("data-s",""),t}(this));var t=this.tags[this.tags.length-1];if(this.isSpeedy){var n=function(e){if(e.sheet)return e.sheet;for(var t=0;t<document.styleSheets.length;t++)if(document.styleSheets[t].ownerNode===e)return document.styleSheets[t]}(t);try{n.insertRule(e,n.cssRules.length)}catch(r){0}}else t.appendChild(document.createTextNode(e));this.ctr++},t.flush=function(){this.tags.forEach((function(e){return e.parentNode&&e.parentNode.removeChild(e)})),this.tags=[],this.ctr=0},e}(),a=Math.abs,o=String.fromCharCode,i=Object.assign;function s(e){return e.trim()}function l(e,t,n){return e.replace(t,n)}function u(e,t){return e.indexOf(t)}function c(e,t){return 0|e.charCodeAt(t)}function d(e,t,n){return e.slice(t,n)}function f(e){return e.length}function p(e){return e.length}function m(e,t){return t.push(e),e}var h=1,v=1,b=0,y=0,g=0,_="";function w(e,t,n,r,a,o,i){return{value:e,root:t,parent:n,type:r,props:a,children:o,line:h,column:v,length:i,return:""}}function k(e,t){return i(w("",null,null,"",null,null,0),e,{length:-e.length},t)}function S(){return g=y>0?c(_,--y):0,v--,10===g&&(v=1,h--),g}function T(){return g=y<b?c(_,y++):0,v++,10===g&&(v=1,h++),g}function C(){return c(_,y)}function x(){return y}function A(e,t){return d(_,e,t)}function F(e){switch(e){case 0:case 9:case 10:case 13:case 32:return 5;case 33:case 43:case 44:case 47:case 62:case 64:case 126:case 59:case 123:case 125:return 4;case 58:return 3;case 34:case 39:case 40:case 91:return 2;case 41:case 93:return 1}return 0}function E(e){return h=v=1,b=f(_=e),y=0,[]}function P(e){return _="",e}function O(e){return s(A(y-1,R(91===e?e+2:40===e?e+1:e)))}function N(e){for(;(g=C())&&g<33;)T();return F(e)>2||F(g)>3?"":" "}function M(e,t){for(;--t&&T()&&!(g<48||g>102||g>57&&g<65||g>70&&g<97););return A(e,x()+(t<6&&32==C()&&32==T()))}function R(e){for(;T();)switch(g){case e:return y;case 34:case 39:34!==e&&39!==e&&R(g);break;case 40:41===e&&R(e);break;case 92:T()}return y}function D(e,t){for(;T()&&e+g!==57&&(e+g!==84||47!==C()););return"/*"+A(t,y-1)+"*"+o(47===e?e:T())}function L(e){for(;!F(C());)T();return A(e,y)}var I="-ms-",z="-moz-",j="-webkit-",Z="comm",B="rule",V="decl",W="@keyframes";function G(e,t){for(var n="",r=p(e),a=0;a<r;a++)n+=t(e[a],a,e,t)||"";return n}function U(e,t,n,r){switch(e.type){case"@import":case V:return e.return=e.return||e.value;case Z:return"";case W:return e.return=e.value+"{"+G(e.children,r)+"}";case B:e.value=e.props.join(",")}return f(n=G(e.children,r))?e.return=e.value+"{"+n+"}":""}function H(e,t){switch(function(e,t){return(((t<<2^c(e,0))<<2^c(e,1))<<2^c(e,2))<<2^c(e,3)}(e,t)){case 5103:return j+"print-"+e+e;case 5737:case 4201:case 3177:case 3433:case 1641:case 4457:case 2921:case 5572:case 6356:case 5844:case 3191:case 6645:case 3005:case 6391:case 5879:case 5623:case 6135:case 4599:case 4855:case 4215:case 6389:case 5109:case 5365:case 5621:case 3829:return j+e+e;case 5349:case 4246:case 4810:case 6968:case 2756:return j+e+z+e+I+e+e;case 6828:case 4268:return j+e+I+e+e;case 6165:return j+e+I+"flex-"+e+e;case 5187:return j+e+l(e,/(\w+).+(:[^]+)/,"-webkit-box-$1$2-ms-flex-$1$2")+e;case 5443:return j+e+I+"flex-item-"+l(e,/flex-|-self/,"")+e;case 4675:return j+e+I+"flex-line-pack"+l(e,/align-content|flex-|-self/,"")+e;case 5548:return j+e+I+l(e,"shrink","negative")+e;case 5292:return j+e+I+l(e,"basis","preferred-size")+e;case 6060:return j+"box-"+l(e,"-grow","")+j+e+I+l(e,"grow","positive")+e;case 4554:return j+l(e,/([^-])(transform)/g,"$1-webkit-$2")+e;case 6187:return l(l(l(e,/(zoom-|grab)/,j+"$1"),/(image-set)/,j+"$1"),e,"")+e;case 5495:case 3959:return l(e,/(image-set\([^]*)/,j+"$1$`$1");case 4968:return l(l(e,/(.+:)(flex-)?(.*)/,"-webkit-box-pack:$3-ms-flex-pack:$3"),/s.+-b[^;]+/,"justify")+j+e+e;case 4095:case 3583:case 4068:case 2532:return l(e,/(.+)-inline(.+)/,j+"$1$2")+e;case 8116:case 7059:case 5753:case 5535:case 5445:case 5701:case 4933:case 4677:case 5533:case 5789:case 5021:case 4765:if(f(e)-1-t>6)switch(c(e,t+1)){case 109:if(45!==c(e,t+4))break;case 102:return l(e,/(.+:)(.+)-([^]+)/,"$1-webkit-$2-$3$1"+z+(108==c(e,t+3)?"$3":"$2-$3"))+e;case 115:return~u(e,"stretch")?H(l(e,"stretch","fill-available"),t)+e:e}break;case 4949:if(115!==c(e,t+1))break;case 6444:switch(c(e,f(e)-3-(~u(e,"!important")&&10))){case 107:return l(e,":",":"+j)+e;case 101:return l(e,/(.+:)([^;!]+)(;|!.+)?/,"$1"+j+(45===c(e,14)?"inline-":"")+"box$3$1"+j+"$2$3$1"+I+"$2box$3")+e}break;case 5936:switch(c(e,t+11)){case 114:return j+e+I+l(e,/[svh]\w+-[tblr]{2}/,"tb")+e;case 108:return j+e+I+l(e,/[svh]\w+-[tblr]{2}/,"tb-rl")+e;case 45:return j+e+I+l(e,/[svh]\w+-[tblr]{2}/,"lr")+e}return j+e+I+e+e}return e}function $(e){return P(J("",null,null,null,[""],e=E(e),0,[0],e))}function J(e,t,n,r,a,i,s,c,d){for(var p=0,h=0,v=s,b=0,y=0,g=0,_=1,w=1,k=1,A=0,F="",E=a,P=i,R=r,I=F;w;)switch(g=A,A=T()){case 40:if(108!=g&&58==I.charCodeAt(v-1)){-1!=u(I+=l(O(A),"&","&\f"),"&\f")&&(k=-1);break}case 34:case 39:case 91:I+=O(A);break;case 9:case 10:case 13:case 32:I+=N(g);break;case 92:I+=M(x()-1,7);continue;case 47:switch(C()){case 42:case 47:m(Q(D(T(),x()),t,n),d);break;default:I+="/"}break;case 123*_:c[p++]=f(I)*k;case 125*_:case 59:case 0:switch(A){case 0:case 125:w=0;case 59+h:y>0&&f(I)-v&&m(y>32?K(I+";",r,n,v-1):K(l(I," ","")+";",r,n,v-2),d);break;case 59:I+=";";default:if(m(R=q(I,t,n,p,h,a,c,F,E=[],P=[],v),i),123===A)if(0===h)J(I,t,R,R,E,i,v,c,P);else switch(b){case 100:case 109:case 115:J(e,R,R,r&&m(q(e,R,R,0,0,a,c,F,a,E=[],v),P),a,P,v,c,r?E:P);break;default:J(I,R,R,R,[""],P,0,c,P)}}p=h=y=0,_=k=1,F=I="",v=s;break;case 58:v=1+f(I),y=g;default:if(_<1)if(123==A)--_;else if(125==A&&0==_++&&125==S())continue;switch(I+=o(A),A*_){case 38:k=h>0?1:(I+="\f",-1);break;case 44:c[p++]=(f(I)-1)*k,k=1;break;case 64:45===C()&&(I+=O(T())),b=C(),h=v=f(F=I+=L(x())),A++;break;case 45:45===g&&2==f(I)&&(_=0)}}return i}function q(e,t,n,r,o,i,u,c,f,m,h){for(var v=o-1,b=0===o?i:[""],y=p(b),g=0,_=0,k=0;g<r;++g)for(var S=0,T=d(e,v+1,v=a(_=u[g])),C=e;S<y;++S)(C=s(_>0?b[S]+" "+T:l(T,/&\f/g,b[S])))&&(f[k++]=C);return w(e,t,n,0===o?B:c,f,m,h)}function Q(e,t,n){return w(e,t,n,Z,o(g),d(e,2,-2),0)}function K(e,t,n,r){return w(e,t,n,V,d(e,0,r),d(e,r+1,-1),r)}var Y=function(e,t,n){for(var r=0,a=0;r=a,a=C(),38===r&&12===a&&(t[n]=1),!F(a);)T();return A(e,y)},X=function(e,t){return P(function(e,t){var n=-1,r=44;do{switch(F(r)){case 0:38===r&&12===C()&&(t[n]=1),e[n]+=Y(y-1,t,n);break;case 2:e[n]+=O(r);break;case 4:if(44===r){e[++n]=58===C()?"&\f":"",t[n]=e[n].length;break}default:e[n]+=o(r)}}while(r=T());return e}(E(e),t))},ee=new WeakMap,te=function(e){if("rule"===e.type&&e.parent&&!(e.length<1)){for(var t=e.value,n=e.parent,r=e.column===n.column&&e.line===n.line;"rule"!==n.type;)if(!(n=n.parent))return;if((1!==e.props.length||58===t.charCodeAt(0)||ee.get(n))&&!r){ee.set(e,!0);for(var a=[],o=X(t,a),i=n.props,s=0,l=0;s<o.length;s++)for(var u=0;u<i.length;u++,l++)e.props[l]=a[s]?o[s].replace(/&\f/g,i[u]):i[u]+" "+o[s]}}},ne=function(e){if("decl"===e.type){var t=e.value;108===t.charCodeAt(0)&&98===t.charCodeAt(2)&&(e.return="",e.value="")}},re=[function(e,t,n,r){if(e.length>-1&&!e.return)switch(e.type){case V:e.return=H(e.value,e.length);break;case W:return G([k(e,{value:l(e.value,"@","@"+j)})],r);case B:if(e.length)return function(e,t){return e.map(t).join("")}(e.props,(function(t){switch(function(e,t){return(e=t.exec(e))?e[0]:e}(t,/(::plac\w+|:read-\w+)/)){case":read-only":case":read-write":return G([k(e,{props:[l(t,/:(read-\w+)/,":-moz-$1")]})],r);case"::placeholder":return G([k(e,{props:[l(t,/:(plac\w+)/,":-webkit-input-$1")]}),k(e,{props:[l(t,/:(plac\w+)/,":-moz-$1")]}),k(e,{props:[l(t,/:(plac\w+)/,I+"input-$1")]})],r)}return""}))}}],ae=function(e){var t=e.key;if("css"===t){var n=document.querySelectorAll("style[data-emotion]:not([data-s])");Array.prototype.forEach.call(n,(function(e){-1!==e.getAttribute("data-emotion").indexOf(" ")&&(document.head.appendChild(e),e.setAttribute("data-s",""))}))}var a=e.stylisPlugins||re;var o,i,s={},l=[];o=e.container||document.head,Array.prototype.forEach.call(document.querySelectorAll('style[data-emotion^="'+t+' "]'),(function(e){for(var t=e.getAttribute("data-emotion").split(" "),n=1;n<t.length;n++)s[t[n]]=!0;l.push(e)}));var u,c,d=[U,(c=function(e){u.insert(e)},function(e){e.root||(e=e.return)&&c(e)})],f=function(e){var t=p(e);return function(n,r,a,o){for(var i="",s=0;s<t;s++)i+=e[s](n,r,a,o)||"";return i}}([te,ne].concat(a,d));i=function(e,t,n,r){u=n,G($(e?e+"{"+t.styles+"}":t.styles),f),r&&(m.inserted[t.name]=!0)};var m={key:t,sheet:new r({key:t,container:o,nonce:e.nonce,speedy:e.speedy,prepend:e.prepend,insertionPoint:e.insertionPoint}),nonce:e.nonce,inserted:s,registered:{},insert:i};return m.sheet.hydrate(l),m}},9797:function(e,t){"use strict";t.Z=function(e){var t=Object.create(null);return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}}},9886:function(e,t,n){"use strict";n.d(t,{T:function(){return s},w:function(){return i}});var r=n(2791),a=n(76),o=(n(9140),n(2561),(0,r.createContext)("undefined"!==typeof HTMLElement?(0,a.Z)({key:"css"}):null));o.Provider;var i=function(e){return(0,r.forwardRef)((function(t,n){var a=(0,r.useContext)(o);return e(t,a,n)}))},s=(0,r.createContext)({})},9140:function(e,t,n){"use strict";n.d(t,{O:function(){return h}});var r=function(e){for(var t,n=0,r=0,a=e.length;a>=4;++r,a-=4)t=1540483477*(65535&(t=255&e.charCodeAt(r)|(255&e.charCodeAt(++r))<<8|(255&e.charCodeAt(++r))<<16|(255&e.charCodeAt(++r))<<24))+(59797*(t>>>16)<<16),n=1540483477*(65535&(t^=t>>>24))+(59797*(t>>>16)<<16)^1540483477*(65535&n)+(59797*(n>>>16)<<16);switch(a){case 3:n^=(255&e.charCodeAt(r+2))<<16;case 2:n^=(255&e.charCodeAt(r+1))<<8;case 1:n=1540483477*(65535&(n^=255&e.charCodeAt(r)))+(59797*(n>>>16)<<16)}return(((n=1540483477*(65535&(n^=n>>>13))+(59797*(n>>>16)<<16))^n>>>15)>>>0).toString(36)},a={animationIterationCount:1,borderImageOutset:1,borderImageSlice:1,borderImageWidth:1,boxFlex:1,boxFlexGroup:1,boxOrdinalGroup:1,columnCount:1,columns:1,flex:1,flexGrow:1,flexPositive:1,flexShrink:1,flexNegative:1,flexOrder:1,gridRow:1,gridRowEnd:1,gridRowSpan:1,gridRowStart:1,gridColumn:1,gridColumnEnd:1,gridColumnSpan:1,gridColumnStart:1,msGridRow:1,msGridRowSpan:1,msGridColumn:1,msGridColumnSpan:1,fontWeight:1,lineHeight:1,opacity:1,order:1,orphans:1,tabSize:1,widows:1,zIndex:1,zoom:1,WebkitLineClamp:1,fillOpacity:1,floodOpacity:1,stopOpacity:1,strokeDasharray:1,strokeDashoffset:1,strokeMiterlimit:1,strokeOpacity:1,strokeWidth:1},o=n(9797),i=/[A-Z]|^ms/g,s=/_EMO_([^_]+?)_([^]*?)_EMO_/g,l=function(e){return 45===e.charCodeAt(1)},u=function(e){return null!=e&&"boolean"!==typeof e},c=(0,o.Z)((function(e){return l(e)?e:e.replace(i,"-$&").toLowerCase()})),d=function(e,t){switch(e){case"animation":case"animationName":if("string"===typeof t)return t.replace(s,(function(e,t,n){return p={name:t,styles:n,next:p},t}))}return 1===a[e]||l(e)||"number"!==typeof t||0===t?t:t+"px"};function f(e,t,n){if(null==n)return"";if(void 0!==n.__emotion_styles)return n;switch(typeof n){case"boolean":return"";case"object":if(1===n.anim)return p={name:n.name,styles:n.styles,next:p},n.name;if(void 0!==n.styles){var r=n.next;if(void 0!==r)for(;void 0!==r;)p={name:r.name,styles:r.styles,next:p},r=r.next;return n.styles+";"}return function(e,t,n){var r="";if(Array.isArray(n))for(var a=0;a<n.length;a++)r+=f(e,t,n[a])+";";else for(var o in n){var i=n[o];if("object"!==typeof i)null!=t&&void 0!==t[i]?r+=o+"{"+t[i]+"}":u(i)&&(r+=c(o)+":"+d(o,i)+";");else if(!Array.isArray(i)||"string"!==typeof i[0]||null!=t&&void 0!==t[i[0]]){var s=f(e,t,i);switch(o){case"animation":case"animationName":r+=c(o)+":"+s+";";break;default:r+=o+"{"+s+"}"}}else for(var l=0;l<i.length;l++)u(i[l])&&(r+=c(o)+":"+d(o,i[l])+";")}return r}(e,t,n);case"function":if(void 0!==e){var a=p,o=n(e);return p=a,f(e,t,o)}}if(null==t)return n;var i=t[n];return void 0!==i?i:n}var p,m=/label:\s*([^\s;\n{]+)\s*(;|$)/g;var h=function(e,t,n){if(1===e.length&&"object"===typeof e[0]&&null!==e[0]&&void 0!==e[0].styles)return e[0];var a=!0,o="";p=void 0;var i=e[0];null==i||void 0===i.raw?(a=!1,o+=f(n,t,i)):o+=i[0];for(var s=1;s<e.length;s++)o+=f(n,t,e[s]),a&&(o+=i[s]);m.lastIndex=0;for(var l,u="";null!==(l=m.exec(o));)u+="-"+l[1];return{name:r(o)+u,styles:o,next:p}}},2561:function(e,t,n){"use strict";var r;n.d(t,{L:function(){return i},j:function(){return s}});var a=n(2791),o=!!(r||(r=n.t(a,2))).useInsertionEffect&&(r||(r=n.t(a,2))).useInsertionEffect,i=o||function(e){return e()},s=o||a.useLayoutEffect},5438:function(e,t,n){"use strict";n.d(t,{My:function(){return o},fp:function(){return r},hC:function(){return a}});function r(e,t,n){var r="";return n.split(" ").forEach((function(n){void 0!==e[n]?t.push(e[n]+";"):r+=n+" "})),r}var a=function(e,t,n){var r=e.key+"-"+t.name;!1===n&&void 0===e.registered[r]&&(e.registered[r]=t.styles)},o=function(e,t,n){a(e,t,n);var r=e.key+"-"+t.name;if(void 0===e.inserted[t.name]){var o=t;do{e.insert(t===o?"."+r:"",o,e.sheet,!0);o=o.next}while(void 0!==o)}}},2156:function(e,t,n){"use strict";var r=n(4836);t.Z=void 0;var a=r(n(5649)),o=n(184),i=(0,a.default)((0,o.jsx)("path",{d:"M15.41 7.41 14 6l-6 6 6 6 1.41-1.41L10.83 12z"}),"NavigateBefore");t.Z=i},5129:function(e,t,n){"use strict";var r=n(4836);t.Z=void 0;var a=r(n(5649)),o=n(184),i=(0,a.default)((0,o.jsx)("path",{d:"M10 6 8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z"}),"NavigateNext");t.Z=i},5649:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0}),Object.defineProperty(t,"default",{enumerable:!0,get:function(){return r.createSvgIcon}});var r=n(3111)},4360:function(e,t,n){"use strict";n.d(t,{Z:function(){return j}});var r=n(7462),a=n(3366),o=n(6189),i=n(2466),s=n(5080),l=n(4942);function u(e,t){var n;return(0,r.Z)({toolbar:(n={minHeight:56},(0,l.Z)(n,e.up("xs"),{"@media (orientation: landscape)":{minHeight:48}}),(0,l.Z)(n,e.up("sm"),{minHeight:64}),n)},t)}var c=n(2065),d={black:"#000",white:"#fff"},f={50:"#fafafa",100:"#f5f5f5",200:"#eeeeee",300:"#e0e0e0",400:"#bdbdbd",500:"#9e9e9e",600:"#757575",700:"#616161",800:"#424242",900:"#212121",A100:"#f5f5f5",A200:"#eeeeee",A400:"#bdbdbd",A700:"#616161"},p={50:"#f3e5f5",100:"#e1bee7",200:"#ce93d8",300:"#ba68c8",400:"#ab47bc",500:"#9c27b0",600:"#8e24aa",700:"#7b1fa2",800:"#6a1b9a",900:"#4a148c",A100:"#ea80fc",A200:"#e040fb",A400:"#d500f9",A700:"#aa00ff"},m={50:"#ffebee",100:"#ffcdd2",200:"#ef9a9a",300:"#e57373",400:"#ef5350",500:"#f44336",600:"#e53935",700:"#d32f2f",800:"#c62828",900:"#b71c1c",A100:"#ff8a80",A200:"#ff5252",A400:"#ff1744",A700:"#d50000"},h={50:"#fff3e0",100:"#ffe0b2",200:"#ffcc80",300:"#ffb74d",400:"#ffa726",500:"#ff9800",600:"#fb8c00",700:"#f57c00",800:"#ef6c00",900:"#e65100",A100:"#ffd180",A200:"#ffab40",A400:"#ff9100",A700:"#ff6d00"},v={50:"#e3f2fd",100:"#bbdefb",200:"#90caf9",300:"#64b5f6",400:"#42a5f5",500:"#2196f3",600:"#1e88e5",700:"#1976d2",800:"#1565c0",900:"#0d47a1",A100:"#82b1ff",A200:"#448aff",A400:"#2979ff",A700:"#2962ff"},b={50:"#e1f5fe",100:"#b3e5fc",200:"#81d4fa",300:"#4fc3f7",400:"#29b6f6",500:"#03a9f4",600:"#039be5",700:"#0288d1",800:"#0277bd",900:"#01579b",A100:"#80d8ff",A200:"#40c4ff",A400:"#00b0ff",A700:"#0091ea"},y={50:"#e8f5e9",100:"#c8e6c9",200:"#a5d6a7",300:"#81c784",400:"#66bb6a",500:"#4caf50",600:"#43a047",700:"#388e3c",800:"#2e7d32",900:"#1b5e20",A100:"#b9f6ca",A200:"#69f0ae",A400:"#00e676",A700:"#00c853"},g=["mode","contrastThreshold","tonalOffset"],_={text:{primary:"rgba(0, 0, 0, 0.87)",secondary:"rgba(0, 0, 0, 0.6)",disabled:"rgba(0, 0, 0, 0.38)"},divider:"rgba(0, 0, 0, 0.12)",background:{paper:d.white,default:d.white},action:{active:"rgba(0, 0, 0, 0.54)",hover:"rgba(0, 0, 0, 0.04)",hoverOpacity:.04,selected:"rgba(0, 0, 0, 0.08)",selectedOpacity:.08,disabled:"rgba(0, 0, 0, 0.26)",disabledBackground:"rgba(0, 0, 0, 0.12)",disabledOpacity:.38,focus:"rgba(0, 0, 0, 0.12)",focusOpacity:.12,activatedOpacity:.12}},w={text:{primary:d.white,secondary:"rgba(255, 255, 255, 0.7)",disabled:"rgba(255, 255, 255, 0.5)",icon:"rgba(255, 255, 255, 0.5)"},divider:"rgba(255, 255, 255, 0.12)",background:{paper:"#121212",default:"#121212"},action:{active:d.white,hover:"rgba(255, 255, 255, 0.08)",hoverOpacity:.08,selected:"rgba(255, 255, 255, 0.16)",selectedOpacity:.16,disabled:"rgba(255, 255, 255, 0.3)",disabledBackground:"rgba(255, 255, 255, 0.12)",disabledOpacity:.38,focus:"rgba(255, 255, 255, 0.12)",focusOpacity:.12,activatedOpacity:.24}};function k(e,t,n,r){var a=r.light||r,o=r.dark||1.5*r;e[t]||(e.hasOwnProperty(n)?e[t]=e[n]:"light"===t?e.light=(0,c.$n)(e.main,a):"dark"===t&&(e.dark=(0,c._j)(e.main,o)))}function S(e){var t=e.mode,n=void 0===t?"light":t,s=e.contrastThreshold,l=void 0===s?3:s,u=e.tonalOffset,S=void 0===u?.2:u,T=(0,a.Z)(e,g),C=e.primary||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:v[200],light:v[50],dark:v[400]}:{main:v[700],light:v[400],dark:v[800]}}(n),x=e.secondary||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:p[200],light:p[50],dark:p[400]}:{main:p[500],light:p[300],dark:p[700]}}(n),A=e.error||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:m[500],light:m[300],dark:m[700]}:{main:m[700],light:m[400],dark:m[800]}}(n),F=e.info||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:b[400],light:b[300],dark:b[700]}:{main:b[700],light:b[500],dark:b[900]}}(n),E=e.success||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:y[400],light:y[300],dark:y[700]}:{main:y[800],light:y[500],dark:y[900]}}(n),P=e.warning||function(){return"dark"===(arguments.length>0&&void 0!==arguments[0]?arguments[0]:"light")?{main:h[400],light:h[300],dark:h[700]}:{main:"#ed6c02",light:h[500],dark:h[900]}}(n);function O(e){return(0,c.mi)(e,w.text.primary)>=l?w.text.primary:_.text.primary}var N=function(e){var t=e.color,n=e.name,a=e.mainShade,i=void 0===a?500:a,s=e.lightShade,l=void 0===s?300:s,u=e.darkShade,c=void 0===u?700:u;if(!(t=(0,r.Z)({},t)).main&&t[i]&&(t.main=t[i]),!t.hasOwnProperty("main"))throw new Error((0,o.Z)(11,n?" (".concat(n,")"):"",i));if("string"!==typeof t.main)throw new Error((0,o.Z)(12,n?" (".concat(n,")"):"",JSON.stringify(t.main)));return k(t,"light",l,S),k(t,"dark",c,S),t.contrastText||(t.contrastText=O(t.main)),t},M={dark:w,light:_};return(0,i.Z)((0,r.Z)({common:(0,r.Z)({},d),mode:n,primary:N({color:C,name:"primary"}),secondary:N({color:x,name:"secondary",mainShade:"A400",lightShade:"A200",darkShade:"A700"}),error:N({color:A,name:"error"}),warning:N({color:P,name:"warning"}),info:N({color:F,name:"info"}),success:N({color:E,name:"success"}),grey:f,contrastThreshold:l,getContrastText:O,augmentColor:N,tonalOffset:S},M[n]),T)}var T=["fontFamily","fontSize","fontWeightLight","fontWeightRegular","fontWeightMedium","fontWeightBold","htmlFontSize","allVariants","pxToRem"];var C={textTransform:"uppercase"},x='"Roboto", "Helvetica", "Arial", sans-serif';function A(e,t){var n="function"===typeof t?t(e):t,o=n.fontFamily,s=void 0===o?x:o,l=n.fontSize,u=void 0===l?14:l,c=n.fontWeightLight,d=void 0===c?300:c,f=n.fontWeightRegular,p=void 0===f?400:f,m=n.fontWeightMedium,h=void 0===m?500:m,v=n.fontWeightBold,b=void 0===v?700:v,y=n.htmlFontSize,g=void 0===y?16:y,_=n.allVariants,w=n.pxToRem,k=(0,a.Z)(n,T);var S=u/14,A=w||function(e){return"".concat(e/g*S,"rem")},F=function(e,t,n,a,o){return(0,r.Z)({fontFamily:s,fontWeight:e,fontSize:A(t),lineHeight:n},s===x?{letterSpacing:"".concat((i=a/t,Math.round(1e5*i)/1e5),"em")}:{},o,_);var i},E={h1:F(d,96,1.167,-1.5),h2:F(d,60,1.2,-.5),h3:F(p,48,1.167,0),h4:F(p,34,1.235,.25),h5:F(p,24,1.334,0),h6:F(h,20,1.6,.15),subtitle1:F(p,16,1.75,.15),subtitle2:F(h,14,1.57,.1),body1:F(p,16,1.5,.15),body2:F(p,14,1.43,.15),button:F(h,14,1.75,.4,C),caption:F(p,12,1.66,.4),overline:F(p,12,2.66,1,C)};return(0,i.Z)((0,r.Z)({htmlFontSize:g,pxToRem:A,fontFamily:s,fontSize:u,fontWeightLight:d,fontWeightRegular:p,fontWeightMedium:h,fontWeightBold:b},E),k,{clone:!1})}function F(){return["".concat(arguments.length<=0?void 0:arguments[0],"px ").concat(arguments.length<=1?void 0:arguments[1],"px ").concat(arguments.length<=2?void 0:arguments[2],"px ").concat(arguments.length<=3?void 0:arguments[3],"px rgba(0,0,0,").concat(.2,")"),"".concat(arguments.length<=4?void 0:arguments[4],"px ").concat(arguments.length<=5?void 0:arguments[5],"px ").concat(arguments.length<=6?void 0:arguments[6],"px ").concat(arguments.length<=7?void 0:arguments[7],"px rgba(0,0,0,").concat(.14,")"),"".concat(arguments.length<=8?void 0:arguments[8],"px ").concat(arguments.length<=9?void 0:arguments[9],"px ").concat(arguments.length<=10?void 0:arguments[10],"px ").concat(arguments.length<=11?void 0:arguments[11],"px rgba(0,0,0,").concat(.12,")")].join(",")}var E=["none",F(0,2,1,-1,0,1,1,0,0,1,3,0),F(0,3,1,-2,0,2,2,0,0,1,5,0),F(0,3,3,-2,0,3,4,0,0,1,8,0),F(0,2,4,-1,0,4,5,0,0,1,10,0),F(0,3,5,-1,0,5,8,0,0,1,14,0),F(0,3,5,-1,0,6,10,0,0,1,18,0),F(0,4,5,-2,0,7,10,1,0,2,16,1),F(0,5,5,-3,0,8,10,1,0,3,14,2),F(0,5,6,-3,0,9,12,1,0,3,16,2),F(0,6,6,-3,0,10,14,1,0,4,18,3),F(0,6,7,-4,0,11,15,1,0,4,20,3),F(0,7,8,-4,0,12,17,2,0,5,22,4),F(0,7,8,-4,0,13,19,2,0,5,24,4),F(0,7,9,-4,0,14,21,2,0,5,26,4),F(0,8,9,-5,0,15,22,2,0,6,28,5),F(0,8,10,-5,0,16,24,2,0,6,30,5),F(0,8,11,-5,0,17,26,2,0,6,32,5),F(0,9,11,-5,0,18,28,2,0,7,34,6),F(0,9,12,-6,0,19,29,2,0,7,36,6),F(0,10,13,-6,0,20,31,3,0,8,38,7),F(0,10,13,-6,0,21,33,3,0,8,40,7),F(0,10,14,-6,0,22,35,3,0,8,42,7),F(0,11,14,-7,0,23,36,3,0,9,44,8),F(0,11,15,-7,0,24,38,3,0,9,46,8)],P=["duration","easing","delay"],O={easeInOut:"cubic-bezier(0.4, 0, 0.2, 1)",easeOut:"cubic-bezier(0.0, 0, 0.2, 1)",easeIn:"cubic-bezier(0.4, 0, 1, 1)",sharp:"cubic-bezier(0.4, 0, 0.6, 1)"},N={shortest:150,shorter:200,short:250,standard:300,complex:375,enteringScreen:225,leavingScreen:195};function M(e){return"".concat(Math.round(e),"ms")}function R(e){if(!e)return 0;var t=e/36;return Math.round(10*(4+15*Math.pow(t,.25)+t/5))}function D(e){var t=(0,r.Z)({},O,e.easing),n=(0,r.Z)({},N,e.duration);return(0,r.Z)({getAutoHeightDuration:R,create:function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:["all"],r=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},o=r.duration,i=void 0===o?n.standard:o,s=r.easing,l=void 0===s?t.easeInOut:s,u=r.delay,c=void 0===u?0:u;(0,a.Z)(r,P);return(Array.isArray(e)?e:[e]).map((function(e){return"".concat(e," ").concat("string"===typeof i?i:M(i)," ").concat(l," ").concat("string"===typeof c?c:M(c))})).join(",")}},e,{easing:t,duration:n})}var L={mobileStepper:1e3,fab:1050,speedDial:1050,appBar:1100,drawer:1200,modal:1300,snackbar:1400,tooltip:1500},I=["breakpoints","mixins","spacing","palette","transitions","typography","shape"];function z(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.mixins,n=void 0===t?{}:t,l=e.palette,c=void 0===l?{}:l,d=e.transitions,f=void 0===d?{}:d,p=e.typography,m=void 0===p?{}:p,h=(0,a.Z)(e,I);if(e.vars)throw new Error((0,o.Z)(18));var v=S(c),b=(0,s.Z)(e),y=(0,i.Z)(b,{mixins:u(b.breakpoints,n),palette:v,shadows:E.slice(),typography:A(v,m),transitions:D(f),zIndex:(0,r.Z)({},L)});y=(0,i.Z)(y,h);for(var g=arguments.length,_=new Array(g>1?g-1:0),w=1;w<g;w++)_[w-1]=arguments[w];return y=_.reduce((function(e,t){return(0,i.Z)(e,t)}),y)}var j=z},4205:function(e,t,n){"use strict";var r=(0,n(4360).Z)();t.Z=r},277:function(e,t,n){"use strict";var r=n(4046),a=n(4205),o=(0,r.ZP)({defaultTheme:a.Z,rootShouldForwardProp:function(e){return(0,r.x9)(e)&&"classes"!==e}});t.ZP=o},5513:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(8691),a=n(4205);function o(e){var t=e.props,n=e.name;return(0,r.Z)({props:t,name:n,defaultTheme:a.Z})}},9853:function(e,t,n){"use strict";var r=n(7312);t.Z=r.Z},3111:function(e,t,n){"use strict";n.r(t),n.d(t,{capitalize:function(){return a.Z},createChainedFunction:function(){return o},createSvgIcon:function(){return w},debounce:function(){return k},deprecatedPropType:function(){return S},isMuiElement:function(){return T},ownerDocument:function(){return x},ownerWindow:function(){return A},requirePropFactory:function(){return F},setRef:function(){return E},unstable_ClassNameGenerator:function(){return Z},unstable_useEnhancedEffect:function(){return P},unstable_useId:function(){return R},unsupportedProp:function(){return D},useControlled:function(){return L},useEventCallback:function(){return I.Z},useForkRef:function(){return z.Z},useIsFocusVisible:function(){return j.Z}});var r=n(5902),a=n(9853);var o=function(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];return t.reduce((function(e,t){return null==t?e:function(){for(var n=arguments.length,r=new Array(n),a=0;a<n;a++)r[a]=arguments[a];e.apply(this,r),t.apply(this,r)}}),(function(){}))},i=n(7462),s=n(2791),l=n.t(s,2),u=n(3366),c=n(8182),d=n(4419),f=n(5513),p=n(277),m=n(1217);function h(e){return(0,m.Z)("MuiSvgIcon",e)}(0,n(5878).Z)("MuiSvgIcon",["root","colorPrimary","colorSecondary","colorAction","colorError","colorDisabled","fontSizeInherit","fontSizeSmall","fontSizeMedium","fontSizeLarge"]);var v=n(184),b=["children","className","color","component","fontSize","htmlColor","inheritViewBox","titleAccess","viewBox"],y=(0,p.ZP)("svg",{name:"MuiSvgIcon",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,"inherit"!==n.color&&t["color".concat((0,a.Z)(n.color))],t["fontSize".concat((0,a.Z)(n.fontSize))]]}})((function(e){var t,n,r,a,o,i,s,l,u,c,d,f,p,m,h,v,b,y=e.theme,g=e.ownerState;return{userSelect:"none",width:"1em",height:"1em",display:"inline-block",fill:"currentColor",flexShrink:0,transition:null==(t=y.transitions)||null==(n=t.create)?void 0:n.call(t,"fill",{duration:null==(r=y.transitions)||null==(a=r.duration)?void 0:a.shorter}),fontSize:{inherit:"inherit",small:(null==(o=y.typography)||null==(i=o.pxToRem)?void 0:i.call(o,20))||"1.25rem",medium:(null==(s=y.typography)||null==(l=s.pxToRem)?void 0:l.call(s,24))||"1.5rem",large:(null==(u=y.typography)||null==(c=u.pxToRem)?void 0:c.call(u,35))||"2.1875rem"}[g.fontSize],color:null!=(d=null==(f=(y.vars||y).palette)||null==(p=f[g.color])?void 0:p.main)?d:{action:null==(m=(y.vars||y).palette)||null==(h=m.action)?void 0:h.active,disabled:null==(v=(y.vars||y).palette)||null==(b=v.action)?void 0:b.disabled,inherit:void 0}[g.color]}})),g=s.forwardRef((function(e,t){var n=(0,f.Z)({props:e,name:"MuiSvgIcon"}),r=n.children,o=n.className,s=n.color,l=void 0===s?"inherit":s,p=n.component,m=void 0===p?"svg":p,g=n.fontSize,_=void 0===g?"medium":g,w=n.htmlColor,k=n.inheritViewBox,S=void 0!==k&&k,T=n.titleAccess,C=n.viewBox,x=void 0===C?"0 0 24 24":C,A=(0,u.Z)(n,b),F=(0,i.Z)({},n,{color:l,component:m,fontSize:_,instanceFontSize:e.fontSize,inheritViewBox:S,viewBox:x}),E={};S||(E.viewBox=x);var P=function(e){var t=e.color,n=e.fontSize,r=e.classes,o={root:["root","inherit"!==t&&"color".concat((0,a.Z)(t)),"fontSize".concat((0,a.Z)(n))]};return(0,d.Z)(o,h,r)}(F);return(0,v.jsxs)(y,(0,i.Z)({as:m,className:(0,c.Z)(P.root,o),focusable:"false",color:w,"aria-hidden":!T||void 0,role:T?"img":void 0,ref:t},E,A,{ownerState:F,children:[r,T?(0,v.jsx)("title",{children:T}):null]}))}));g.muiName="SvgIcon";var _=g;function w(e,t){var n=function(n,r){return(0,v.jsx)(_,(0,i.Z)({"data-testid":"".concat(t,"Icon"),ref:r},n,{children:e}))};return n.muiName=_.muiName,s.memo(s.forwardRef(n))}var k=function(e){var t,n=arguments.length>1&&void 0!==arguments[1]?arguments[1]:166;function r(){for(var r=this,a=arguments.length,o=new Array(a),i=0;i<a;i++)o[i]=arguments[i];var s=function(){e.apply(r,o)};clearTimeout(t),t=setTimeout(s,n)}return r.clear=function(){clearTimeout(t)},r};var S=function(e,t){return function(){return null}};var T=function(e,t){return s.isValidElement(e)&&-1!==t.indexOf(e.type.muiName)};function C(e){return e&&e.ownerDocument||document}var x=C;var A=function(e){return C(e).defaultView||window};var F=function(e,t){return function(){return null}},E=n(2971).Z,P=n(5721).Z,O=n(885),N=0;var M=l.useId;var R=function(e){if(void 0!==M){var t=M();return null!=e?e:t}return function(e){var t=s.useState(e),n=(0,O.Z)(t,2),r=n[0],a=n[1],o=e||r;return s.useEffect((function(){null==r&&a("mui-".concat(N+=1))}),[r]),o}(e)};var D=function(e,t,n,r,a){return null};var L=function(e){var t=e.controlled,n=e.default,r=(e.name,e.state,s.useRef(void 0!==t).current),a=s.useState(n),o=(0,O.Z)(a,2),i=o[0],l=o[1];return[r?t:i,s.useCallback((function(e){r||l(e)}),[])]},I=n(6702),z=n(792),j=n(2763),Z={configure:function(e){console.warn(["MUI: `ClassNameGenerator` import from `@mui/material/utils` is outdated and might cause unexpected issues.","","You should use `import { unstable_ClassNameGenerator } from '@mui/material/className'` instead","","The detail of the issue: https://github.com/mui/material-ui/issues/30011#issuecomment-1024993401","","The updated documentation: https://mui.com/guides/classname-generator/"].join("\n")),r.Z.configure(e)}}},6702:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(2791),a=n(5721);var o=function(e){var t=r.useRef(e);return(0,a.Z)((function(){t.current=e})),r.useCallback((function(){return t.current.apply(void 0,arguments)}),[])}},792:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(2791),a=n(2971);var o=function(e,t){return r.useMemo((function(){return null==e&&null==t?null:function(n){(0,a.Z)(e,n),(0,a.Z)(t,n)}}),[e,t])}},2763:function(e,t,n){"use strict";n.d(t,{Z:function(){return f}});var r,a=n(2791),o=!0,i=!1,s={text:!0,search:!0,url:!0,tel:!0,email:!0,password:!0,number:!0,date:!0,month:!0,week:!0,time:!0,datetime:!0,"datetime-local":!0};function l(e){e.metaKey||e.altKey||e.ctrlKey||(o=!0)}function u(){o=!1}function c(){"hidden"===this.visibilityState&&i&&(o=!0)}function d(e){var t=e.target;try{return t.matches(":focus-visible")}catch(n){}return o||function(e){var t=e.type,n=e.tagName;return!("INPUT"!==n||!s[t]||e.readOnly)||"TEXTAREA"===n&&!e.readOnly||!!e.isContentEditable}(t)}var f=function(){var e=a.useCallback((function(e){var t;null!=e&&((t=e.ownerDocument).addEventListener("keydown",l,!0),t.addEventListener("mousedown",u,!0),t.addEventListener("pointerdown",u,!0),t.addEventListener("touchstart",u,!0),t.addEventListener("visibilitychange",c,!0))}),[]),t=a.useRef(!1);return{isFocusVisibleRef:t,onFocus:function(e){return!!d(e)&&(t.current=!0,!0)},onBlur:function(){return!!t.current&&(i=!0,window.clearTimeout(r),r=window.setTimeout((function(){i=!1}),100),t.current=!1,!0)},ref:e}}},2421:function(e,t,n){"use strict";n.d(t,{ZP:function(){return _},Co:function(){return w}});var r=n(2791),a=n(7462),o=n(9797),i=/^((children|dangerouslySetInnerHTML|key|ref|autoFocus|defaultValue|defaultChecked|innerHTML|suppressContentEditableWarning|suppressHydrationWarning|valueLink|abbr|accept|acceptCharset|accessKey|action|allow|allowUserMedia|allowPaymentRequest|allowFullScreen|allowTransparency|alt|async|autoComplete|autoPlay|capture|cellPadding|cellSpacing|challenge|charSet|checked|cite|classID|className|cols|colSpan|content|contentEditable|contextMenu|controls|controlsList|coords|crossOrigin|data|dateTime|decoding|default|defer|dir|disabled|disablePictureInPicture|download|draggable|encType|enterKeyHint|form|formAction|formEncType|formMethod|formNoValidate|formTarget|frameBorder|headers|height|hidden|high|href|hrefLang|htmlFor|httpEquiv|id|inputMode|integrity|is|keyParams|keyType|kind|label|lang|list|loading|loop|low|marginHeight|marginWidth|max|maxLength|media|mediaGroup|method|min|minLength|multiple|muted|name|nonce|noValidate|open|optimum|pattern|placeholder|playsInline|poster|preload|profile|radioGroup|readOnly|referrerPolicy|rel|required|reversed|role|rows|rowSpan|sandbox|scope|scoped|scrolling|seamless|selected|shape|size|sizes|slot|span|spellCheck|src|srcDoc|srcLang|srcSet|start|step|style|summary|tabIndex|target|title|translate|type|useMap|value|width|wmode|wrap|about|datatype|inlist|prefix|property|resource|typeof|vocab|autoCapitalize|autoCorrect|autoSave|color|incremental|fallback|inert|itemProp|itemScope|itemType|itemID|itemRef|on|option|results|security|unselectable|accentHeight|accumulate|additive|alignmentBaseline|allowReorder|alphabetic|amplitude|arabicForm|ascent|attributeName|attributeType|autoReverse|azimuth|baseFrequency|baselineShift|baseProfile|bbox|begin|bias|by|calcMode|capHeight|clip|clipPathUnits|clipPath|clipRule|colorInterpolation|colorInterpolationFilters|colorProfile|colorRendering|contentScriptType|contentStyleType|cursor|cx|cy|d|decelerate|descent|diffuseConstant|direction|display|divisor|dominantBaseline|dur|dx|dy|edgeMode|elevation|enableBackground|end|exponent|externalResourcesRequired|fill|fillOpacity|fillRule|filter|filterRes|filterUnits|floodColor|floodOpacity|focusable|fontFamily|fontSize|fontSizeAdjust|fontStretch|fontStyle|fontVariant|fontWeight|format|from|fr|fx|fy|g1|g2|glyphName|glyphOrientationHorizontal|glyphOrientationVertical|glyphRef|gradientTransform|gradientUnits|hanging|horizAdvX|horizOriginX|ideographic|imageRendering|in|in2|intercept|k|k1|k2|k3|k4|kernelMatrix|kernelUnitLength|kerning|keyPoints|keySplines|keyTimes|lengthAdjust|letterSpacing|lightingColor|limitingConeAngle|local|markerEnd|markerMid|markerStart|markerHeight|markerUnits|markerWidth|mask|maskContentUnits|maskUnits|mathematical|mode|numOctaves|offset|opacity|operator|order|orient|orientation|origin|overflow|overlinePosition|overlineThickness|panose1|paintOrder|pathLength|patternContentUnits|patternTransform|patternUnits|pointerEvents|points|pointsAtX|pointsAtY|pointsAtZ|preserveAlpha|preserveAspectRatio|primitiveUnits|r|radius|refX|refY|renderingIntent|repeatCount|repeatDur|requiredExtensions|requiredFeatures|restart|result|rotate|rx|ry|scale|seed|shapeRendering|slope|spacing|specularConstant|specularExponent|speed|spreadMethod|startOffset|stdDeviation|stemh|stemv|stitchTiles|stopColor|stopOpacity|strikethroughPosition|strikethroughThickness|string|stroke|strokeDasharray|strokeDashoffset|strokeLinecap|strokeLinejoin|strokeMiterlimit|strokeOpacity|strokeWidth|surfaceScale|systemLanguage|tableValues|targetX|targetY|textAnchor|textDecoration|textRendering|textLength|to|transform|u1|u2|underlinePosition|underlineThickness|unicode|unicodeBidi|unicodeRange|unitsPerEm|vAlphabetic|vHanging|vIdeographic|vMathematical|values|vectorEffect|version|vertAdvY|vertOriginX|vertOriginY|viewBox|viewTarget|visibility|widths|wordSpacing|writingMode|x|xHeight|x1|x2|xChannelSelector|xlinkActuate|xlinkArcrole|xlinkHref|xlinkRole|xlinkShow|xlinkTitle|xlinkType|xmlBase|xmlns|xmlnsXlink|xmlLang|xmlSpace|y|y1|y2|yChannelSelector|z|zoomAndPan|for|class|autofocus)|(([Dd][Aa][Tt][Aa]|[Aa][Rr][Ii][Aa]|x)-.*))$/,s=(0,o.Z)((function(e){return i.test(e)||111===e.charCodeAt(0)&&110===e.charCodeAt(1)&&e.charCodeAt(2)<91})),l=n(9886),u=n(5438),c=n(9140),d=n(2561),f=s,p=function(e){return"theme"!==e},m=function(e){return"string"===typeof e&&e.charCodeAt(0)>96?f:p},h=function(e,t,n){var r;if(t){var a=t.shouldForwardProp;r=e.__emotion_forwardProp&&a?function(t){return e.__emotion_forwardProp(t)&&a(t)}:a}return"function"!==typeof r&&n&&(r=e.__emotion_forwardProp),r},v=function(e){var t=e.cache,n=e.serialized,r=e.isStringTag;(0,u.hC)(t,n,r);(0,d.L)((function(){return(0,u.My)(t,n,r)}));return null},b=function e(t,n){var o,i,s=t.__emotion_real===t,d=s&&t.__emotion_base||t;void 0!==n&&(o=n.label,i=n.target);var f=h(t,n,s),p=f||m(d),b=!p("as");return function(){var y=arguments,g=s&&void 0!==t.__emotion_styles?t.__emotion_styles.slice(0):[];if(void 0!==o&&g.push("label:"+o+";"),null==y[0]||void 0===y[0].raw)g.push.apply(g,y);else{0,g.push(y[0][0]);for(var _=y.length,w=1;w<_;w++)g.push(y[w],y[0][w])}var k=(0,l.w)((function(e,t,n){var a=b&&e.as||d,o="",s=[],h=e;if(null==e.theme){for(var y in h={},e)h[y]=e[y];h.theme=(0,r.useContext)(l.T)}"string"===typeof e.className?o=(0,u.fp)(t.registered,s,e.className):null!=e.className&&(o=e.className+" ");var _=(0,c.O)(g.concat(s),t.registered,h);o+=t.key+"-"+_.name,void 0!==i&&(o+=" "+i);var w=b&&void 0===f?m(a):p,k={};for(var S in e)b&&"as"===S||w(S)&&(k[S]=e[S]);return k.className=o,k.ref=n,(0,r.createElement)(r.Fragment,null,(0,r.createElement)(v,{cache:t,serialized:_,isStringTag:"string"===typeof a}),(0,r.createElement)(a,k))}));return k.displayName=void 0!==o?o:"Styled("+("string"===typeof d?d:d.displayName||d.name||"Component")+")",k.defaultProps=t.defaultProps,k.__emotion_real=k,k.__emotion_base=d,k.__emotion_styles=g,k.__emotion_forwardProp=f,Object.defineProperty(k,"toString",{value:function(){return"."+i}}),k.withComponent=function(t,r){return e(t,(0,a.Z)({},n,r,{shouldForwardProp:h(k,r,!0)})).apply(void 0,g)},k}},y=b.bind();["a","abbr","address","area","article","aside","audio","b","base","bdi","bdo","big","blockquote","body","br","button","canvas","caption","cite","code","col","colgroup","data","datalist","dd","del","details","dfn","dialog","div","dl","dt","em","embed","fieldset","figcaption","figure","footer","form","h1","h2","h3","h4","h5","h6","head","header","hgroup","hr","html","i","iframe","img","input","ins","kbd","keygen","label","legend","li","link","main","map","mark","marquee","menu","menuitem","meta","meter","nav","noscript","object","ol","optgroup","option","output","p","param","picture","pre","progress","q","rp","rt","ruby","s","samp","script","section","select","small","source","span","strong","style","sub","summary","sup","table","tbody","td","textarea","tfoot","th","thead","time","title","tr","track","u","ul","var","video","wbr","circle","clipPath","defs","ellipse","foreignObject","g","image","line","linearGradient","mask","path","pattern","polygon","polyline","radialGradient","rect","stop","svg","text","tspan"].forEach((function(e){y[e]=y(e)}));var g=y;function _(e,t){return g(e,t)}var w=function(e,t){Array.isArray(e.__emotion_styles)&&(e.__emotion_styles=t(e.__emotion_styles))}},1184:function(e,t,n){"use strict";n.d(t,{L7:function(){return l},P$:function(){return c},VO:function(){return a},W8:function(){return s},dt:function(){return u},k9:function(){return i}});var r=n(2466),a={xs:0,sm:600,md:900,lg:1200,xl:1536},o={keys:["xs","sm","md","lg","xl"],up:function(e){return"@media (min-width:".concat(a[e],"px)")}};function i(e,t,n){var r=e.theme||{};if(Array.isArray(t)){var i=r.breakpoints||o;return t.reduce((function(e,r,a){return e[i.up(i.keys[a])]=n(t[a]),e}),{})}if("object"===typeof t){var s=r.breakpoints||o;return Object.keys(t).reduce((function(e,r){if(-1!==Object.keys(s.values||a).indexOf(r)){e[s.up(r)]=n(t[r],r)}else{var o=r;e[o]=t[o]}return e}),{})}return n(t)}function s(){var e,t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=null==(e=t.keys)?void 0:e.reduce((function(e,n){return e[t.up(n)]={},e}),{});return n||{}}function l(e,t){return e.reduce((function(e,t){var n=e[t];return(!n||0===Object.keys(n).length)&&delete e[t],e}),t)}function u(e){for(var t=s(e),n=arguments.length,a=new Array(n>1?n-1:0),o=1;o<n;o++)a[o-1]=arguments[o];var i=[t].concat(a).reduce((function(e,t){return(0,r.Z)(e,t)}),{});return l(Object.keys(t),i)}function c(e){var t,n=e.values,r=e.breakpoints,a=e.base||function(e,t){if("object"!==typeof e)return{};var n={},r=Object.keys(t);return Array.isArray(e)?r.forEach((function(t,r){r<e.length&&(n[t]=!0)})):r.forEach((function(t){null!=e[t]&&(n[t]=!0)})),n}(n,r),o=Object.keys(a);return 0===o.length?n:o.reduce((function(e,r,a){return Array.isArray(n)?(e[r]=null!=n[a]?n[a]:n[t],t=a):"object"===typeof n?(e[r]=null!=n[r]?n[r]:n[t],t=r):e[r]=n,e}),{})}},2065:function(e,t,n){"use strict";n.d(t,{$n:function(){return d},Fq:function(){return u},_j:function(){return c},mi:function(){return l}});var r=n(6189);function a(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:0,n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:1;return Math.min(Math.max(t,e),n)}function o(e){if(e.type)return e;if("#"===e.charAt(0))return o(function(e){e=e.slice(1);var t=new RegExp(".{1,".concat(e.length>=6?2:1,"}"),"g"),n=e.match(t);return n&&1===n[0].length&&(n=n.map((function(e){return e+e}))),n?"rgb".concat(4===n.length?"a":"","(").concat(n.map((function(e,t){return t<3?parseInt(e,16):Math.round(parseInt(e,16)/255*1e3)/1e3})).join(", "),")"):""}(e));var t=e.indexOf("("),n=e.substring(0,t);if(-1===["rgb","rgba","hsl","hsla","color"].indexOf(n))throw new Error((0,r.Z)(9,e));var a,i=e.substring(t+1,e.length-1);if("color"===n){if(a=(i=i.split(" ")).shift(),4===i.length&&"/"===i[3].charAt(0)&&(i[3]=i[3].slice(1)),-1===["srgb","display-p3","a98-rgb","prophoto-rgb","rec-2020"].indexOf(a))throw new Error((0,r.Z)(10,a))}else i=i.split(",");return{type:n,values:i=i.map((function(e){return parseFloat(e)})),colorSpace:a}}function i(e){var t=e.type,n=e.colorSpace,r=e.values;return-1!==t.indexOf("rgb")?r=r.map((function(e,t){return t<3?parseInt(e,10):e})):-1!==t.indexOf("hsl")&&(r[1]="".concat(r[1],"%"),r[2]="".concat(r[2],"%")),r=-1!==t.indexOf("color")?"".concat(n," ").concat(r.join(" ")):"".concat(r.join(", ")),"".concat(t,"(").concat(r,")")}function s(e){var t="hsl"===(e=o(e)).type||"hsla"===e.type?o(function(e){var t=(e=o(e)).values,n=t[0],r=t[1]/100,a=t[2]/100,s=r*Math.min(a,1-a),l=function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(e+n/30)%12;return a-s*Math.max(Math.min(t-3,9-t,1),-1)},u="rgb",c=[Math.round(255*l(0)),Math.round(255*l(8)),Math.round(255*l(4))];return"hsla"===e.type&&(u+="a",c.push(t[3])),i({type:u,values:c})}(e)).values:e.values;return t=t.map((function(t){return"color"!==e.type&&(t/=255),t<=.03928?t/12.92:Math.pow((t+.055)/1.055,2.4)})),Number((.2126*t[0]+.7152*t[1]+.0722*t[2]).toFixed(3))}function l(e,t){var n=s(e),r=s(t);return(Math.max(n,r)+.05)/(Math.min(n,r)+.05)}function u(e,t){return e=o(e),t=a(t),"rgb"!==e.type&&"hsl"!==e.type||(e.type+="a"),"color"===e.type?e.values[3]="/".concat(t):e.values[3]=t,i(e)}function c(e,t){if(e=o(e),t=a(t),-1!==e.type.indexOf("hsl"))e.values[2]*=1-t;else if(-1!==e.type.indexOf("rgb")||-1!==e.type.indexOf("color"))for(var n=0;n<3;n+=1)e.values[n]*=1-t;return i(e)}function d(e,t){if(e=o(e),t=a(t),-1!==e.type.indexOf("hsl"))e.values[2]+=(100-e.values[2])*t;else if(-1!==e.type.indexOf("rgb"))for(var n=0;n<3;n+=1)e.values[n]+=(255-e.values[n])*t;else if(-1!==e.type.indexOf("color"))for(var r=0;r<3;r+=1)e.values[r]+=(1-e.values[r])*t;return i(e)}},4046:function(e,t,n){"use strict";n.d(t,{ZP:function(){return T},x9:function(){return k}});var r=n(2982),a=n(885),o=n(3366),i=n(7462),s=n(2421),l=n(5080),u=n(7312),c=["variant"];function d(e){return 0===e.length}function f(e){var t=e.variant,n=(0,o.Z)(e,c),r=t||"";return Object.keys(n).sort().forEach((function(t){r+="color"===t?d(r)?e[t]:(0,u.Z)(e[t]):"".concat(d(r)?t:(0,u.Z)(t)).concat((0,u.Z)(e[t].toString()))})),r}var p=n(104),m=["name","slot","skipVariantsResolver","skipSx","overridesResolver"],h=["theme"],v=["theme"];function b(e){return 0===Object.keys(e).length}function y(e){return"string"===typeof e&&e.charCodeAt(0)>96}var g=function(e,t){return t.components&&t.components[e]&&t.components[e].styleOverrides?t.components[e].styleOverrides:null},_=function(e,t){var n=[];t&&t.components&&t.components[e]&&t.components[e].variants&&(n=t.components[e].variants);var r={};return n.forEach((function(e){var t=f(e.props);r[t]=e.style})),r},w=function(e,t,n,r){var a,o,i=e.ownerState,s=void 0===i?{}:i,l=[],u=null==n||null==(a=n.components)||null==(o=a[r])?void 0:o.variants;return u&&u.forEach((function(n){var r=!0;Object.keys(n.props).forEach((function(t){s[t]!==n.props[t]&&e[t]!==n.props[t]&&(r=!1)})),r&&l.push(t[f(n.props)])})),l};function k(e){return"ownerState"!==e&&"theme"!==e&&"sx"!==e&&"as"!==e}var S=(0,l.Z)();function T(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.defaultTheme,n=void 0===t?S:t,l=e.rootShouldForwardProp,u=void 0===l?k:l,c=e.slotShouldForwardProp,d=void 0===c?k:c,f=e.styleFunctionSx,T=void 0===f?p.Z:f,C=function(e){var t=b(e.theme)?n:e.theme;return T((0,i.Z)({},e,{theme:t}))};return C.__mui_systemSx=!0,function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{};(0,s.Co)(e,(function(e){return e.filter((function(e){return!(null!=e&&e.__mui_systemSx)}))}));var l,c=t.name,f=t.slot,p=t.skipVariantsResolver,S=t.skipSx,T=t.overridesResolver,x=(0,o.Z)(t,m),A=void 0!==p?p:f&&"Root"!==f||!1,F=S||!1;var E=k;"Root"===f?E=u:f?E=d:y(e)&&(E=void 0);var P=(0,s.ZP)(e,(0,i.Z)({shouldForwardProp:E,label:l},x)),O=function(e){for(var t=arguments.length,s=new Array(t>1?t-1:0),l=1;l<t;l++)s[l-1]=arguments[l];var u=s?s.map((function(e){return"function"===typeof e&&e.__emotion_real!==e?function(t){var r=t.theme,a=(0,o.Z)(t,h);return e((0,i.Z)({theme:b(r)?n:r},a))}:e})):[],d=e;c&&T&&u.push((function(e){var t=b(e.theme)?n:e.theme,r=g(c,t);if(r){var o={};return Object.entries(r).forEach((function(n){var r=(0,a.Z)(n,2),s=r[0],l=r[1];o[s]="function"===typeof l?l((0,i.Z)({},e,{theme:t})):l})),T(e,o)}return null})),c&&!A&&u.push((function(e){var t=b(e.theme)?n:e.theme;return w(e,_(c,t),t,c)})),F||u.push(C);var f=u.length-s.length;if(Array.isArray(e)&&f>0){var p=new Array(f).fill("");(d=[].concat((0,r.Z)(e),(0,r.Z)(p))).raw=[].concat((0,r.Z)(e.raw),(0,r.Z)(p))}else"function"===typeof e&&e.__emotion_real!==e&&(d=function(t){var r=t.theme,a=(0,o.Z)(t,v);return e((0,i.Z)({theme:b(r)?n:r},a))});var m=P.apply(void 0,[d].concat((0,r.Z)(u)));return m};return P.withConfig&&(O.withConfig=P.withConfig),O}}},5080:function(e,t,n){"use strict";n.d(t,{Z:function(){return p}});var r=n(7462),a=n(3366),o=n(2466),i=n(4942),s=["values","unit","step"];function l(e){var t=e.values,n=void 0===t?{xs:0,sm:600,md:900,lg:1200,xl:1536}:t,o=e.unit,l=void 0===o?"px":o,u=e.step,c=void 0===u?5:u,d=(0,a.Z)(e,s),f=function(e){var t=Object.keys(e).map((function(t){return{key:t,val:e[t]}}))||[];return t.sort((function(e,t){return e.val-t.val})),t.reduce((function(e,t){return(0,r.Z)({},e,(0,i.Z)({},t.key,t.val))}),{})}(n),p=Object.keys(f);function m(e){var t="number"===typeof n[e]?n[e]:e;return"@media (min-width:".concat(t).concat(l,")")}function h(e){var t="number"===typeof n[e]?n[e]:e;return"@media (max-width:".concat(t-c/100).concat(l,")")}function v(e,t){var r=p.indexOf(t);return"@media (min-width:".concat("number"===typeof n[e]?n[e]:e).concat(l,") and ")+"(max-width:".concat((-1!==r&&"number"===typeof n[p[r]]?n[p[r]]:t)-c/100).concat(l,")")}return(0,r.Z)({keys:p,values:f,up:m,down:h,between:v,only:function(e){return p.indexOf(e)+1<p.length?v(e,p[p.indexOf(e)+1]):m(e)},not:function(e){var t=p.indexOf(e);return 0===t?m(p[1]):t===p.length-1?h(p[t]):v(e,p[p.indexOf(e)+1]).replace("@media","@media not all and")},unit:l},d)}var u={borderRadius:4},c=n(5682);function d(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:8;if(e.mui)return e;var t=(0,c.hB)({spacing:e}),n=function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=0===n.length?[1]:n;return a.map((function(e){var n=t(e);return"number"===typeof n?"".concat(n,"px"):n})).join(" ")};return n.mui=!0,n}var f=["breakpoints","palette","spacing","shape"];var p=function(){for(var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=e.breakpoints,n=void 0===t?{}:t,i=e.palette,s=void 0===i?{}:i,c=e.spacing,p=e.shape,m=void 0===p?{}:p,h=(0,a.Z)(e,f),v=l(n),b=d(c),y=(0,o.Z)({breakpoints:v,direction:"ltr",components:{},palette:(0,r.Z)({mode:"light"},s),spacing:b,shape:(0,r.Z)({},u,m)},h),g=arguments.length,_=new Array(g>1?g-1:0),w=1;w<g;w++)_[w-1]=arguments[w];return y=_.reduce((function(e,t){return(0,o.Z)(e,t)}),y)}},114:function(e,t,n){"use strict";n.d(t,{Gc:function(){return q},G$:function(){return J}});var r=n(8529),a=n(8247);var o=function(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];var r=t.reduce((function(e,t){return t.filterProps.forEach((function(n){e[n]=t})),e}),{}),o=function(e){return Object.keys(e).reduce((function(t,n){return r[n]?(0,a.Z)(t,r[n](e)):t}),{})};return o.propTypes={},o.filterProps=t.reduce((function(e,t){return e.concat(t.filterProps)}),[]),o},i=n(5682),s=n(1184);function l(e){return"number"!==typeof e?e:"".concat(e,"px solid")}var u=(0,r.Z)({prop:"border",themeKey:"borders",transform:l}),c=(0,r.Z)({prop:"borderTop",themeKey:"borders",transform:l}),d=(0,r.Z)({prop:"borderRight",themeKey:"borders",transform:l}),f=(0,r.Z)({prop:"borderBottom",themeKey:"borders",transform:l}),p=(0,r.Z)({prop:"borderLeft",themeKey:"borders",transform:l}),m=(0,r.Z)({prop:"borderColor",themeKey:"palette"}),h=(0,r.Z)({prop:"borderTopColor",themeKey:"palette"}),v=(0,r.Z)({prop:"borderRightColor",themeKey:"palette"}),b=(0,r.Z)({prop:"borderBottomColor",themeKey:"palette"}),y=(0,r.Z)({prop:"borderLeftColor",themeKey:"palette"}),g=function(e){if(void 0!==e.borderRadius&&null!==e.borderRadius){var t=(0,i.eI)(e.theme,"shape.borderRadius",4,"borderRadius");return(0,s.k9)(e,e.borderRadius,(function(e){return{borderRadius:(0,i.NA)(t,e)}}))}return null};g.propTypes={},g.filterProps=["borderRadius"];var _=o(u,c,d,f,p,m,h,v,b,y,g),w=o((0,r.Z)({prop:"displayPrint",cssProperty:!1,transform:function(e){return{"@media print":{display:e}}}}),(0,r.Z)({prop:"display"}),(0,r.Z)({prop:"overflow"}),(0,r.Z)({prop:"textOverflow"}),(0,r.Z)({prop:"visibility"}),(0,r.Z)({prop:"whiteSpace"})),k=o((0,r.Z)({prop:"flexBasis"}),(0,r.Z)({prop:"flexDirection"}),(0,r.Z)({prop:"flexWrap"}),(0,r.Z)({prop:"justifyContent"}),(0,r.Z)({prop:"alignItems"}),(0,r.Z)({prop:"alignContent"}),(0,r.Z)({prop:"order"}),(0,r.Z)({prop:"flex"}),(0,r.Z)({prop:"flexGrow"}),(0,r.Z)({prop:"flexShrink"}),(0,r.Z)({prop:"alignSelf"}),(0,r.Z)({prop:"justifyItems"}),(0,r.Z)({prop:"justifySelf"})),S=function(e){if(void 0!==e.gap&&null!==e.gap){var t=(0,i.eI)(e.theme,"spacing",8,"gap");return(0,s.k9)(e,e.gap,(function(e){return{gap:(0,i.NA)(t,e)}}))}return null};S.propTypes={},S.filterProps=["gap"];var T=function(e){if(void 0!==e.columnGap&&null!==e.columnGap){var t=(0,i.eI)(e.theme,"spacing",8,"columnGap");return(0,s.k9)(e,e.columnGap,(function(e){return{columnGap:(0,i.NA)(t,e)}}))}return null};T.propTypes={},T.filterProps=["columnGap"];var C=function(e){if(void 0!==e.rowGap&&null!==e.rowGap){var t=(0,i.eI)(e.theme,"spacing",8,"rowGap");return(0,s.k9)(e,e.rowGap,(function(e){return{rowGap:(0,i.NA)(t,e)}}))}return null};C.propTypes={},C.filterProps=["rowGap"];var x=o(S,T,C,(0,r.Z)({prop:"gridColumn"}),(0,r.Z)({prop:"gridRow"}),(0,r.Z)({prop:"gridAutoFlow"}),(0,r.Z)({prop:"gridAutoColumns"}),(0,r.Z)({prop:"gridAutoRows"}),(0,r.Z)({prop:"gridTemplateColumns"}),(0,r.Z)({prop:"gridTemplateRows"}),(0,r.Z)({prop:"gridTemplateAreas"}),(0,r.Z)({prop:"gridArea"})),A=o((0,r.Z)({prop:"position"}),(0,r.Z)({prop:"zIndex",themeKey:"zIndex"}),(0,r.Z)({prop:"top"}),(0,r.Z)({prop:"right"}),(0,r.Z)({prop:"bottom"}),(0,r.Z)({prop:"left"})),F=o((0,r.Z)({prop:"color",themeKey:"palette"}),(0,r.Z)({prop:"bgcolor",cssProperty:"backgroundColor",themeKey:"palette"}),(0,r.Z)({prop:"backgroundColor",themeKey:"palette"})),E=(0,r.Z)({prop:"boxShadow",themeKey:"shadows"});function P(e){return e<=1&&0!==e?"".concat(100*e,"%"):e}var O=(0,r.Z)({prop:"width",transform:P}),N=function(e){if(void 0!==e.maxWidth&&null!==e.maxWidth){return(0,s.k9)(e,e.maxWidth,(function(t){var n,r,a;return{maxWidth:(null==(n=e.theme)||null==(r=n.breakpoints)||null==(a=r.values)?void 0:a[t])||s.VO[t]||P(t)}}))}return null};N.filterProps=["maxWidth"];var M=(0,r.Z)({prop:"minWidth",transform:P}),R=(0,r.Z)({prop:"height",transform:P}),D=(0,r.Z)({prop:"maxHeight",transform:P}),L=(0,r.Z)({prop:"minHeight",transform:P}),I=((0,r.Z)({prop:"size",cssProperty:"width",transform:P}),(0,r.Z)({prop:"size",cssProperty:"height",transform:P}),o(O,N,M,R,D,L,(0,r.Z)({prop:"boxSizing"}))),z=(0,r.Z)({prop:"fontFamily",themeKey:"typography"}),j=(0,r.Z)({prop:"fontSize",themeKey:"typography"}),Z=(0,r.Z)({prop:"fontStyle",themeKey:"typography"}),B=(0,r.Z)({prop:"fontWeight",themeKey:"typography"}),V=(0,r.Z)({prop:"letterSpacing"}),W=(0,r.Z)({prop:"textTransform"}),G=(0,r.Z)({prop:"lineHeight"}),U=(0,r.Z)({prop:"textAlign"}),H=o((0,r.Z)({prop:"typography",cssProperty:!1,themeKey:"typography"}),z,j,Z,B,V,G,U,W),$={borders:_.filterProps,display:w.filterProps,flexbox:k.filterProps,grid:x.filterProps,positions:A.filterProps,palette:F.filterProps,shadows:E.filterProps,sizing:I.filterProps,spacing:i.ZP.filterProps,typography:H.filterProps},J={borders:_,display:w,flexbox:k,grid:x,positions:A,palette:F,shadows:E,sizing:I,spacing:i.ZP,typography:H},q=Object.keys($).reduce((function(e,t){return $[t].forEach((function(n){e[n]=J[t]})),e}),{})},8247:function(e,t,n){"use strict";var r=n(2466);t.Z=function(e,t){return t?(0,r.Z)(e,t,{clone:!1}):e}},5682:function(e,t,n){"use strict";n.d(t,{hB:function(){return h},eI:function(){return m},ZP:function(){return k},NA:function(){return v}});var r=n(885),a=n(1184),o=n(8529),i=n(8247);var s={m:"margin",p:"padding"},l={t:"Top",r:"Right",b:"Bottom",l:"Left",x:["Left","Right"],y:["Top","Bottom"]},u={marginX:"mx",marginY:"my",paddingX:"px",paddingY:"py"},c=function(e){var t={};return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}}((function(e){if(e.length>2){if(!u[e])return[e];e=u[e]}var t=e.split(""),n=(0,r.Z)(t,2),a=n[0],o=n[1],i=s[a],c=l[o]||"";return Array.isArray(c)?c.map((function(e){return i+e})):[i+c]})),d=["m","mt","mr","mb","ml","mx","my","margin","marginTop","marginRight","marginBottom","marginLeft","marginX","marginY","marginInline","marginInlineStart","marginInlineEnd","marginBlock","marginBlockStart","marginBlockEnd"],f=["p","pt","pr","pb","pl","px","py","padding","paddingTop","paddingRight","paddingBottom","paddingLeft","paddingX","paddingY","paddingInline","paddingInlineStart","paddingInlineEnd","paddingBlock","paddingBlockStart","paddingBlockEnd"],p=[].concat(d,f);function m(e,t,n,r){var a,i=null!=(a=(0,o.D)(e,t,!1))?a:n;return"number"===typeof i?function(e){return"string"===typeof e?e:i*e}:Array.isArray(i)?function(e){return"string"===typeof e?e:i[e]}:"function"===typeof i?i:function(){}}function h(e){return m(e,"spacing",8)}function v(e,t){if("string"===typeof t||null==t)return t;var n=e(Math.abs(t));return t>=0?n:"number"===typeof n?-n:"-".concat(n)}function b(e,t,n,r){if(-1===t.indexOf(n))return null;var o=function(e,t){return function(n){return e.reduce((function(e,r){return e[r]=v(t,n),e}),{})}}(c(n),r),i=e[n];return(0,a.k9)(e,i,o)}function y(e,t){var n=h(e.theme);return Object.keys(e).map((function(r){return b(e,t,r,n)})).reduce(i.Z,{})}function g(e){return y(e,d)}function _(e){return y(e,f)}function w(e){return y(e,p)}g.propTypes={},g.filterProps=d,_.propTypes={},_.filterProps=f,w.propTypes={},w.filterProps=p;var k=w},8529:function(e,t,n){"use strict";n.d(t,{D:function(){return i}});var r=n(4942),a=n(7312),o=n(1184);function i(e,t){var n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(!t||"string"!==typeof t)return null;if(e&&e.vars&&n){var r="vars.".concat(t).split(".").reduce((function(e,t){return e&&e[t]?e[t]:null}),e);if(null!=r)return r}return t.split(".").reduce((function(e,t){return e&&null!=e[t]?e[t]:null}),e)}function s(e,t,n){var r,a=arguments.length>3&&void 0!==arguments[3]?arguments[3]:n;return r="function"===typeof e?e(n):Array.isArray(e)?e[n]||a:i(e,n)||a,t&&(r=t(r)),r}t.Z=function(e){var t=e.prop,n=e.cssProperty,l=void 0===n?e.prop:n,u=e.themeKey,c=e.transform,d=function(e){if(null==e[t])return null;var n=e[t],d=i(e.theme,u)||{};return(0,o.k9)(e,n,(function(e){var n=s(d,c,e);return e===n&&"string"===typeof e&&(n=s(d,c,"".concat(t).concat("default"===e?"":(0,a.Z)(e)),e)),!1===l?n:(0,r.Z)({},l,n)}))};return d.propTypes={},d.filterProps=[t],d}},104:function(e,t,n){"use strict";var r=n(4942),a=n(8247),o=n(114),i=n(1184);function s(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];var r=t.reduce((function(e,t){return e.concat(Object.keys(t))}),[]),a=new Set(r);return t.every((function(e){return a.size===Object.keys(e).length}))}function l(e,t){return"function"===typeof e?e(t):e}var u=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:o.G$,t=Object.keys(e).reduce((function(t,n){return e[n].filterProps.forEach((function(r){t[r]=e[n]})),t}),{});function n(e,n,a){var o,i=(o={},(0,r.Z)(o,e,n),(0,r.Z)(o,"theme",a),o),s=t[e];return s?s(i):(0,r.Z)({},e,n)}function u(e){var o=e||{},c=o.sx,d=o.theme,f=void 0===d?{}:d;if(!c)return null;function p(e){var o=e;if("function"===typeof e)o=e(f);else if("object"!==typeof e)return e;if(!o)return null;var c=(0,i.W8)(f.breakpoints),d=Object.keys(c),p=c;return Object.keys(o).forEach((function(e){var c=l(o[e],f);if(null!==c&&void 0!==c)if("object"===typeof c)if(t[e])p=(0,a.Z)(p,n(e,c,f));else{var d=(0,i.k9)({theme:f},c,(function(t){return(0,r.Z)({},e,t)}));s(d,c)?p[e]=u({sx:c,theme:f}):p=(0,a.Z)(p,d)}else p=(0,a.Z)(p,n(e,c,f))})),(0,i.L7)(d,p)}return Array.isArray(c)?c.map(p):p(c)}return u}();u.filterProps=["sx"],t.Z=u},886:function(e,t,n){"use strict";n.d(t,{Z:function(){return c}});var r=n(5080),a=n(2791);var o=a.createContext(null);function i(){return a.useContext(o)}function s(e){return 0===Object.keys(e).length}var l=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:null,t=i();return!t||s(t)?e:t},u=(0,r.Z)();var c=function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:u;return l(e)}},8691:function(e,t,n){"use strict";n.d(t,{Z:function(){return i}});var r=n(7462);function a(e){var t=e.theme,n=e.name,a=e.props;return t&&t.components&&t.components[n]&&t.components[n].defaultProps?function(e,t){var n=(0,r.Z)({},t);return Object.keys(e).forEach((function(t){void 0===n[t]&&(n[t]=e[t])})),n}(t.components[n].defaultProps,a):a}var o=n(886);function i(e){var t=e.props,n=e.name,r=e.defaultTheme;return a({theme:(0,o.Z)(r),name:n,props:t})}},5902:function(e,t){"use strict";var n=function(e){return e},r=function(){var e=n;return{configure:function(t){e=t},generate:function(t){return e(t)},reset:function(){e=n}}}();t.Z=r},7312:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(6189);function a(e){if("string"!==typeof e)throw new Error((0,r.Z)(7));return e.charAt(0).toUpperCase()+e.slice(1)}},4419:function(e,t,n){"use strict";function r(e,t,n){var r={};return Object.keys(e).forEach((function(a){r[a]=e[a].reduce((function(e,r){return r&&(e.push(t(r)),n&&n[r]&&e.push(n[r])),e}),[]).join(" ")})),r}n.d(t,{Z:function(){return r}})},2466:function(e,t,n){"use strict";n.d(t,{P:function(){return a},Z:function(){return o}});var r=n(7462);function a(e){return null!==e&&"object"===typeof e&&e.constructor===Object}function o(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{clone:!0},i=n.clone?(0,r.Z)({},e):e;return a(e)&&a(t)&&Object.keys(t).forEach((function(r){"__proto__"!==r&&(a(t[r])&&r in e&&a(e[r])?i[r]=o(e[r],t[r],n):i[r]=t[r])})),i}},6189:function(e,t,n){"use strict";function r(e){for(var t="https://mui.com/production-error/?code="+e,n=1;n<arguments.length;n+=1)t+="&args[]="+encodeURIComponent(arguments[n]);return"Minified MUI error #"+e+"; visit "+t+" for the full message."}n.d(t,{Z:function(){return r}})},1217:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(5902),a={active:"active",checked:"checked",completed:"completed",disabled:"disabled",error:"error",expanded:"expanded",focused:"focused",focusVisible:"focusVisible",required:"required",selected:"selected"};function o(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"Mui",o=a[t];return o?"".concat(n,"-").concat(o):"".concat(r.Z.generate(e),"-").concat(t)}},5878:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(1217);function a(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"Mui",a={};return t.forEach((function(t){a[t]=(0,r.Z)(e,t,n)})),a}},2971:function(e,t,n){"use strict";function r(e,t){"function"===typeof e?e(t):e&&(e.current=t)}n.d(t,{Z:function(){return r}})},5721:function(e,t,n){"use strict";var r=n(2791),a="undefined"!==typeof window?r.useLayoutEffect:r.useEffect;t.Z=a},1694:function(e,t){var n;!function(){"use strict";var r={}.hasOwnProperty;function a(){for(var e=[],t=0;t<arguments.length;t++){var n=arguments[t];if(n){var o=typeof n;if("string"===o||"number"===o)e.push(n);else if(Array.isArray(n)){if(n.length){var i=a.apply(null,n);i&&e.push(i)}}else if("object"===o){if(n.toString!==Object.prototype.toString&&!n.toString.toString().includes("[native code]")){e.push(n.toString());continue}for(var s in n)r.call(n,s)&&n[s]&&e.push(s)}}}return e.join(" ")}e.exports?(a.default=a,e.exports=a):void 0===(n=function(){return a}.apply(t,[]))||(e.exports=n)}()},8182:function(e,t,n){"use strict";function r(e){var t,n,a="";if("string"==typeof e||"number"==typeof e)a+=e;else if("object"==typeof e)if(Array.isArray(e))for(t=0;t<e.length;t++)e[t]&&(n=r(e[t]))&&(a&&(a+=" "),a+=n);else for(t in e)e[t]&&(a&&(a+=" "),a+=t);return a}t.Z=function(){for(var e,t,n=0,a="";n<arguments.length;)(e=arguments[n++])&&(t=r(e))&&(a&&(a+=" "),a+=t);return a}},4173:function(e,t){!function(e){"use strict";function t(){}function n(e,t,n,r,a){for(var o=0,i=t.length,s=0,l=0;o<i;o++){var u=t[o];if(u.removed){if(u.value=e.join(r.slice(l,l+u.count)),l+=u.count,o&&t[o-1].added){var c=t[o-1];t[o-1]=t[o],t[o]=c}}else{if(!u.added&&a){var d=n.slice(s,s+u.count);d=d.map((function(e,t){var n=r[l+t];return n.length>e.length?n:e})),u.value=e.join(d)}else u.value=e.join(n.slice(s,s+u.count));s+=u.count,u.added||(l+=u.count)}}var f=t[i-1];return i>1&&"string"===typeof f.value&&(f.added||f.removed)&&e.equals("",f.value)&&(t[i-2].value+=f.value,t.pop()),t}function r(e){return{newPos:e.newPos,components:e.components.slice(0)}}t.prototype={diff:function(e,t){var a=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{},o=a.callback;"function"===typeof a&&(o=a,a={}),this.options=a;var i=this;function s(e){return o?(setTimeout((function(){o(void 0,e)}),0),!0):e}e=this.castInput(e),t=this.castInput(t),e=this.removeEmpty(this.tokenize(e));var l=(t=this.removeEmpty(this.tokenize(t))).length,u=e.length,c=1,d=l+u,f=[{newPos:-1,components:[]}],p=this.extractCommon(f[0],t,e,0);if(f[0].newPos+1>=l&&p+1>=u)return s([{value:this.join(t),count:t.length}]);function m(){for(var a=-1*c;a<=c;a+=2){var o=void 0,d=f[a-1],p=f[a+1],m=(p?p.newPos:0)-a;d&&(f[a-1]=void 0);var h=d&&d.newPos+1<l,v=p&&0<=m&&m<u;if(h||v){if(!h||v&&d.newPos<p.newPos?(o=r(p),i.pushComponent(o.components,void 0,!0)):((o=d).newPos++,i.pushComponent(o.components,!0,void 0)),m=i.extractCommon(o,t,e,a),o.newPos+1>=l&&m+1>=u)return s(n(i,o.components,t,e,i.useLongestToken));f[a]=o}else f[a]=void 0}c++}if(o)!function e(){setTimeout((function(){if(c>d)return o();m()||e()}),0)}();else for(;c<=d;){var h=m();if(h)return h}},pushComponent:function(e,t,n){var r=e[e.length-1];r&&r.added===t&&r.removed===n?e[e.length-1]={count:r.count+1,added:t,removed:n}:e.push({count:1,added:t,removed:n})},extractCommon:function(e,t,n,r){for(var a=t.length,o=n.length,i=e.newPos,s=i-r,l=0;i+1<a&&s+1<o&&this.equals(t[i+1],n[s+1]);)i++,s++,l++;return l&&e.components.push({count:l}),e.newPos=i,s},equals:function(e,t){return this.options.comparator?this.options.comparator(e,t):e===t||this.options.ignoreCase&&e.toLowerCase()===t.toLowerCase()},removeEmpty:function(e){for(var t=[],n=0;n<e.length;n++)e[n]&&t.push(e[n]);return t},castInput:function(e){return e},tokenize:function(e){return e.split("")},join:function(e){return e.join("")}};var a=new t;function o(e,t,n){return a.diff(e,t,n)}function i(e,t){if("function"===typeof e)t.callback=e;else if(e)for(var n in e)e.hasOwnProperty(n)&&(t[n]=e[n]);return t}var s=/^[A-Za-z\xC0-\u02C6\u02C8-\u02D7\u02DE-\u02FF\u1E00-\u1EFF]+$/,l=/\S/,u=new t;function c(e,t,n){return n=i(n,{ignoreWhitespace:!0}),u.diff(e,t,n)}function d(e,t,n){return u.diff(e,t,n)}u.equals=function(e,t){return this.options.ignoreCase&&(e=e.toLowerCase(),t=t.toLowerCase()),e===t||this.options.ignoreWhitespace&&!l.test(e)&&!l.test(t)},u.tokenize=function(e){for(var t=e.split(/(\s+|[()[\]{}'"]|\b)/),n=0;n<t.length-1;n++)!t[n+1]&&t[n+2]&&s.test(t[n])&&s.test(t[n+2])&&(t[n]+=t[n+2],t.splice(n+1,2),n--);return t};var f=new t;function p(e,t,n){return f.diff(e,t,n)}function m(e,t,n){var r=i(n,{ignoreWhitespace:!0});return f.diff(e,t,r)}f.tokenize=function(e){var t=[],n=e.split(/(\n|\r\n)/);n[n.length-1]||n.pop();for(var r=0;r<n.length;r++){var a=n[r];r%2&&!this.options.newlineIsToken?t[t.length-1]+=a:(this.options.ignoreWhitespace&&(a=a.trim()),t.push(a))}return t};var h=new t;function v(e,t,n){return h.diff(e,t,n)}h.tokenize=function(e){return e.split(/(\S.+?[.!?])(?=\s+|$)/)};var b=new t;function y(e,t,n){return b.diff(e,t,n)}function g(e){return g="function"===typeof Symbol&&"symbol"===typeof Symbol.iterator?function(e){return typeof e}:function(e){return e&&"function"===typeof Symbol&&e.constructor===Symbol&&e!==Symbol.prototype?"symbol":typeof e},g(e)}function _(e){return w(e)||k(e)||S()}function w(e){if(Array.isArray(e)){for(var t=0,n=new Array(e.length);t<e.length;t++)n[t]=e[t];return n}}function k(e){if(Symbol.iterator in Object(e)||"[object Arguments]"===Object.prototype.toString.call(e))return Array.from(e)}function S(){throw new TypeError("Invalid attempt to spread non-iterable instance")}b.tokenize=function(e){return e.split(/([{}:;,]|\s+)/)};var T=Object.prototype.toString,C=new t;function x(e,t,n){return C.diff(e,t,n)}function A(e,t,n,r,a){var o,i;for(t=t||[],n=n||[],r&&(e=r(a,e)),o=0;o<t.length;o+=1)if(t[o]===e)return n[o];if("[object Array]"===T.call(e)){for(t.push(e),i=new Array(e.length),n.push(i),o=0;o<e.length;o+=1)i[o]=A(e[o],t,n,r,a);return t.pop(),n.pop(),i}if(e&&e.toJSON&&(e=e.toJSON()),"object"===g(e)&&null!==e){t.push(e),i={},n.push(i);var s,l=[];for(s in e)e.hasOwnProperty(s)&&l.push(s);for(l.sort(),o=0;o<l.length;o+=1)i[s=l[o]]=A(e[s],t,n,r,s);t.pop(),n.pop()}else i=e;return i}C.useLongestToken=!0,C.tokenize=f.tokenize,C.castInput=function(e){var t=this.options,n=t.undefinedReplacement,r=t.stringifyReplacer,a=void 0===r?function(e,t){return"undefined"===typeof t?n:t}:r;return"string"===typeof e?e:JSON.stringify(A(e,null,null,a),a,"  ")},C.equals=function(e,n){return t.prototype.equals.call(C,e.replace(/,([\r\n])/g,"$1"),n.replace(/,([\r\n])/g,"$1"))};var F=new t;function E(e,t,n){return F.diff(e,t,n)}function P(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},n=e.split(/\r\n|[\n\v\f\r\x85]/),r=e.match(/\r\n|[\n\v\f\r\x85]/g)||[],a=[],o=0;function i(){var e={};for(a.push(e);o<n.length;){var r=n[o];if(/^(\-\-\-|\+\+\+|@@)\s/.test(r))break;var i=/^(?:Index:|diff(?: -r \w+)+)\s+(.+?)\s*$/.exec(r);i&&(e.index=i[1]),o++}for(s(e),s(e),e.hunks=[];o<n.length;){var u=n[o];if(/^(Index:|diff|\-\-\-|\+\+\+)\s/.test(u))break;if(/^@@/.test(u))e.hunks.push(l());else{if(u&&t.strict)throw new Error("Unknown line "+(o+1)+" "+JSON.stringify(u));o++}}}function s(e){var t=/^(---|\+\+\+)\s+(.*)$/.exec(n[o]);if(t){var r="---"===t[1]?"old":"new",a=t[2].split("\t",2),i=a[0].replace(/\\\\/g,"\\");/^".*"$/.test(i)&&(i=i.substr(1,i.length-2)),e[r+"FileName"]=i,e[r+"Header"]=(a[1]||"").trim(),o++}}function l(){for(var e=o,a=n[o++].split(/@@ -(\d+)(?:,(\d+))? \+(\d+)(?:,(\d+))? @@/),i={oldStart:+a[1],oldLines:+a[2]||1,newStart:+a[3],newLines:+a[4]||1,lines:[],linedelimiters:[]},s=0,l=0;o<n.length&&!(0===n[o].indexOf("--- ")&&o+2<n.length&&0===n[o+1].indexOf("+++ ")&&0===n[o+2].indexOf("@@"));o++){var u=0==n[o].length&&o!=n.length-1?" ":n[o][0];if("+"!==u&&"-"!==u&&" "!==u&&"\\"!==u)break;i.lines.push(n[o]),i.linedelimiters.push(r[o]||"\n"),"+"===u?s++:"-"===u?l++:" "===u&&(s++,l++)}if(s||1!==i.newLines||(i.newLines=0),l||1!==i.oldLines||(i.oldLines=0),t.strict){if(s!==i.newLines)throw new Error("Added line count did not match for hunk at line "+(e+1));if(l!==i.oldLines)throw new Error("Removed line count did not match for hunk at line "+(e+1))}return i}for(;o<n.length;)i();return a}function O(e,t,n){var r=!0,a=!1,o=!1,i=1;return function s(){if(r&&!o){if(a?i++:r=!1,e+i<=n)return i;o=!0}if(!a)return o||(r=!0),t<=e-i?-i++:(a=!0,s())}}function N(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{};if("string"===typeof t&&(t=P(t)),Array.isArray(t)){if(t.length>1)throw new Error("applyPatch only works with a single input.");t=t[0]}var r,a,o=e.split(/\r\n|[\n\v\f\r\x85]/),i=e.match(/\r\n|[\n\v\f\r\x85]/g)||[],s=t.hunks,l=n.compareLine||function(e,t,n,r){return t===r},u=0,c=n.fuzzFactor||0,d=0,f=0;function p(e,t){for(var n=0;n<e.lines.length;n++){var r=e.lines[n],a=r.length>0?r[0]:" ",i=r.length>0?r.substr(1):r;if(" "===a||"-"===a){if(!l(t+1,o[t],a,i)&&++u>c)return!1;t++}}return!0}for(var m=0;m<s.length;m++){for(var h=s[m],v=o.length-h.oldLines,b=0,y=f+h.oldStart-1,g=O(y,d,v);void 0!==b;b=g())if(p(h,y+b)){h.offset=f+=b;break}if(void 0===b)return!1;d=h.offset+h.oldStart+h.oldLines}for(var _=0,w=0;w<s.length;w++){var k=s[w],S=k.oldStart+k.offset+_-1;_+=k.newLines-k.oldLines,S<0&&(S=0);for(var T=0;T<k.lines.length;T++){var C=k.lines[T],x=C.length>0?C[0]:" ",A=C.length>0?C.substr(1):C,F=k.linedelimiters[T];if(" "===x)S++;else if("-"===x)o.splice(S,1),i.splice(S,1);else if("+"===x)o.splice(S,0,A),i.splice(S,0,F),S++;else if("\\"===x){var E=k.lines[T-1]?k.lines[T-1][0]:null;"+"===E?r=!0:"-"===E&&(a=!0)}}}if(r)for(;!o[o.length-1];)o.pop(),i.pop();else a&&(o.push(""),i.push("\n"));for(var N=0;N<o.length-1;N++)o[N]=o[N]+i[N];return o.join("")}function M(e,t){"string"===typeof e&&(e=P(e));var n=0;function r(){var a=e[n++];if(!a)return t.complete();t.loadFile(a,(function(e,n){if(e)return t.complete(e);var o=N(n,a,t);t.patched(a,o,(function(e){if(e)return t.complete(e);r()}))}))}r()}function R(e,t,n,r,a,o,i){i||(i={}),"undefined"===typeof i.context&&(i.context=4);var s=p(n,r,i);function l(e){return e.map((function(e){return" "+e}))}s.push({value:"",lines:[]});for(var u=[],c=0,d=0,f=[],m=1,h=1,v=function(e){var t=s[e],a=t.lines||t.value.replace(/\n$/,"").split("\n");if(t.lines=a,t.added||t.removed){var o;if(!c){var p=s[e-1];c=m,d=h,p&&(f=i.context>0?l(p.lines.slice(-i.context)):[],c-=f.length,d-=f.length)}(o=f).push.apply(o,_(a.map((function(e){return(t.added?"+":"-")+e})))),t.added?h+=a.length:m+=a.length}else{if(c)if(a.length<=2*i.context&&e<s.length-2){var v;(v=f).push.apply(v,_(l(a)))}else{var b,y=Math.min(a.length,i.context);(b=f).push.apply(b,_(l(a.slice(0,y))));var g={oldStart:c,oldLines:m-c+y,newStart:d,newLines:h-d+y,lines:f};if(e>=s.length-2&&a.length<=i.context){var w=/\n$/.test(n),k=/\n$/.test(r),S=0==a.length&&f.length>g.oldLines;!w&&S&&f.splice(g.oldLines,0,"\\ No newline at end of file"),(w||S)&&k||f.push("\\ No newline at end of file")}u.push(g),c=0,d=0,f=[]}m+=a.length,h+=a.length}},b=0;b<s.length;b++)v(b);return{oldFileName:e,newFileName:t,oldHeader:a,newHeader:o,hunks:u}}function D(e,t,n,r,a,o,i){var s=R(e,t,n,r,a,o,i),l=[];e==t&&l.push("Index: "+e),l.push("==================================================================="),l.push("--- "+s.oldFileName+("undefined"===typeof s.oldHeader?"":"\t"+s.oldHeader)),l.push("+++ "+s.newFileName+("undefined"===typeof s.newHeader?"":"\t"+s.newHeader));for(var u=0;u<s.hunks.length;u++){var c=s.hunks[u];l.push("@@ -"+c.oldStart+","+c.oldLines+" +"+c.newStart+","+c.newLines+" @@"),l.push.apply(l,c.lines)}return l.join("\n")+"\n"}function L(e,t,n,r,a,o){return D(e,e,t,n,r,a,o)}function I(e,t){return e.length===t.length&&z(e,t)}function z(e,t){if(t.length>e.length)return!1;for(var n=0;n<t.length;n++)if(t[n]!==e[n])return!1;return!0}function j(e){var t=ne(e.lines),n=t.oldLines,r=t.newLines;void 0!==n?e.oldLines=n:delete e.oldLines,void 0!==r?e.newLines=r:delete e.newLines}function Z(e,t,n){e=B(e,n),t=B(t,n);var r={};(e.index||t.index)&&(r.index=e.index||t.index),(e.newFileName||t.newFileName)&&(V(e)?V(t)?(r.oldFileName=W(r,e.oldFileName,t.oldFileName),r.newFileName=W(r,e.newFileName,t.newFileName),r.oldHeader=W(r,e.oldHeader,t.oldHeader),r.newHeader=W(r,e.newHeader,t.newHeader)):(r.oldFileName=e.oldFileName,r.newFileName=e.newFileName,r.oldHeader=e.oldHeader,r.newHeader=e.newHeader):(r.oldFileName=t.oldFileName||e.oldFileName,r.newFileName=t.newFileName||e.newFileName,r.oldHeader=t.oldHeader||e.oldHeader,r.newHeader=t.newHeader||e.newHeader)),r.hunks=[];for(var a=0,o=0,i=0,s=0;a<e.hunks.length||o<t.hunks.length;){var l=e.hunks[a]||{oldStart:1/0},u=t.hunks[o]||{oldStart:1/0};if(G(l,u))r.hunks.push(U(l,i)),a++,s+=l.newLines-l.oldLines;else if(G(u,l))r.hunks.push(U(u,s)),o++,i+=u.newLines-u.oldLines;else{var c={oldStart:Math.min(l.oldStart,u.oldStart),oldLines:0,newStart:Math.min(l.newStart+i,u.oldStart+s),newLines:0,lines:[]};H(c,l.oldStart,l.lines,u.oldStart,u.lines),o++,a++,r.hunks.push(c)}}return r}function B(e,t){if("string"===typeof e){if(/^@@/m.test(e)||/^Index:/m.test(e))return P(e)[0];if(!t)throw new Error("Must provide a base reference or pass in a patch");return R(void 0,void 0,t,e)}return e}function V(e){return e.newFileName&&e.newFileName!==e.oldFileName}function W(e,t,n){return t===n?t:(e.conflict=!0,{mine:t,theirs:n})}function G(e,t){return e.oldStart<t.oldStart&&e.oldStart+e.oldLines<t.oldStart}function U(e,t){return{oldStart:e.oldStart,oldLines:e.oldLines,newStart:e.newStart+t,newLines:e.newLines,lines:e.lines}}function H(e,t,n,r,a){var o={offset:t,lines:n,index:0},i={offset:r,lines:a,index:0};for(Q(e,o,i),Q(e,i,o);o.index<o.lines.length&&i.index<i.lines.length;){var s=o.lines[o.index],l=i.lines[i.index];if("-"!==s[0]&&"+"!==s[0]||"-"!==l[0]&&"+"!==l[0])if("+"===s[0]&&" "===l[0]){var u;(u=e.lines).push.apply(u,_(Y(o)))}else if("+"===l[0]&&" "===s[0]){var c;(c=e.lines).push.apply(c,_(Y(i)))}else"-"===s[0]&&" "===l[0]?J(e,o,i):"-"===l[0]&&" "===s[0]?J(e,i,o,!0):s===l?(e.lines.push(s),o.index++,i.index++):q(e,Y(o),Y(i));else $(e,o,i)}K(e,o),K(e,i),j(e)}function $(e,t,n){var r=Y(t),a=Y(n);if(ee(r)&&ee(a)){var o,i;if(z(r,a)&&te(n,r,r.length-a.length))return void(o=e.lines).push.apply(o,_(r));if(z(a,r)&&te(t,a,a.length-r.length))return void(i=e.lines).push.apply(i,_(a))}else if(I(r,a)){var s;return void(s=e.lines).push.apply(s,_(r))}q(e,r,a)}function J(e,t,n,r){var a,o=Y(t),i=X(n,o);i.merged?(a=e.lines).push.apply(a,_(i.merged)):q(e,r?i:o,r?o:i)}function q(e,t,n){e.conflict=!0,e.lines.push({conflict:!0,mine:t,theirs:n})}function Q(e,t,n){for(;t.offset<n.offset&&t.index<t.lines.length;){var r=t.lines[t.index++];e.lines.push(r),t.offset++}}function K(e,t){for(;t.index<t.lines.length;){var n=t.lines[t.index++];e.lines.push(n)}}function Y(e){for(var t=[],n=e.lines[e.index][0];e.index<e.lines.length;){var r=e.lines[e.index];if("-"===n&&"+"===r[0]&&(n="+"),n!==r[0])break;t.push(r),e.index++}return t}function X(e,t){for(var n=[],r=[],a=0,o=!1,i=!1;a<t.length&&e.index<e.lines.length;){var s=e.lines[e.index],l=t[a];if("+"===l[0])break;if(o=o||" "!==s[0],r.push(l),a++,"+"===s[0])for(i=!0;"+"===s[0];)n.push(s),s=e.lines[++e.index];l.substr(1)===s.substr(1)?(n.push(s),e.index++):i=!0}if("+"===(t[a]||"")[0]&&o&&(i=!0),i)return n;for(;a<t.length;)r.push(t[a++]);return{merged:r,changes:n}}function ee(e){return e.reduce((function(e,t){return e&&"-"===t[0]}),!0)}function te(e,t,n){for(var r=0;r<n;r++){var a=t[t.length-n+r].substr(1);if(e.lines[e.index+r]!==" "+a)return!1}return e.index+=n,!0}function ne(e){var t=0,n=0;return e.forEach((function(e){if("string"!==typeof e){var r=ne(e.mine),a=ne(e.theirs);void 0!==t&&(r.oldLines===a.oldLines?t+=r.oldLines:t=void 0),void 0!==n&&(r.newLines===a.newLines?n+=r.newLines:n=void 0)}else void 0===n||"+"!==e[0]&&" "!==e[0]||n++,void 0===t||"-"!==e[0]&&" "!==e[0]||t++})),{oldLines:t,newLines:n}}function re(e){for(var t,n,r=[],a=0;a<e.length;a++)n=(t=e[a]).added?1:t.removed?-1:0,r.push([n,t.value]);return r}function ae(e){for(var t=[],n=0;n<e.length;n++){var r=e[n];r.added?t.push("<ins>"):r.removed&&t.push("<del>"),t.push(oe(r.value)),r.added?t.push("</ins>"):r.removed&&t.push("</del>")}return t.join("")}function oe(e){var t=e;return t=(t=(t=(t=t.replace(/&/g,"&amp;")).replace(/</g,"&lt;")).replace(/>/g,"&gt;")).replace(/"/g,"&quot;")}F.tokenize=function(e){return e.slice()},F.join=F.removeEmpty=function(e){return e},e.Diff=t,e.diffChars=o,e.diffWords=c,e.diffWordsWithSpace=d,e.diffLines=p,e.diffTrimmedLines=m,e.diffSentences=v,e.diffCss=y,e.diffJson=x,e.diffArrays=E,e.structuredPatch=R,e.createTwoFilesPatch=D,e.createPatch=L,e.applyPatch=N,e.applyPatches=M,e.parsePatch=P,e.merge=Z,e.convertChangesToDMP=re,e.convertChangesToXML=ae,e.canonicalize=A,Object.defineProperty(e,"__esModule",{value:!0})}(t)},6025:function(e,t,n){"use strict";n.r(t),n.d(t,{cache:function(){return j},css:function(){return I},cx:function(){return N},flush:function(){return P},getRegisteredStyles:function(){return R},hydrate:function(){return O},injectGlobal:function(){return D},keyframes:function(){return L},merge:function(){return M},sheet:function(){return z}});var r=function(){function e(e){this.isSpeedy=void 0===e.speedy||e.speedy,this.tags=[],this.ctr=0,this.nonce=e.nonce,this.key=e.key,this.container=e.container,this.before=null}var t=e.prototype;return t.insert=function(e){if(this.ctr%(this.isSpeedy?65e3:1)===0){var t,n=function(e){var t=document.createElement("style");return t.setAttribute("data-emotion",e.key),void 0!==e.nonce&&t.setAttribute("nonce",e.nonce),t.appendChild(document.createTextNode("")),t}(this);t=0===this.tags.length?this.before:this.tags[this.tags.length-1].nextSibling,this.container.insertBefore(n,t),this.tags.push(n)}var r=this.tags[this.tags.length-1];if(this.isSpeedy){var a=function(e){if(e.sheet)return e.sheet;for(var t=0;t<document.styleSheets.length;t++)if(document.styleSheets[t].ownerNode===e)return document.styleSheets[t]}(r);try{var o=105===e.charCodeAt(1)&&64===e.charCodeAt(0);a.insertRule(e,o?0:a.cssRules.length)}catch(i){0}}else r.appendChild(document.createTextNode(e));this.ctr++},t.flush=function(){this.tags.forEach((function(e){return e.parentNode.removeChild(e)})),this.tags=[],this.ctr=0},e}();var a=function(e){function t(e,r,l,u,f){for(var p,m,h,v,_,k=0,S=0,T=0,C=0,x=0,N=0,R=h=p=0,L=0,I=0,z=0,j=0,Z=l.length,B=Z-1,V="",W="",G="",U="";L<Z;){if(m=l.charCodeAt(L),L===B&&0!==S+C+T+k&&(0!==S&&(m=47===S?10:47),C=T=k=0,Z++,B++),0===S+C+T+k){if(L===B&&(0<I&&(V=V.replace(d,"")),0<V.trim().length)){switch(m){case 32:case 9:case 59:case 13:case 10:break;default:V+=l.charAt(L)}m=59}switch(m){case 123:for(p=(V=V.trim()).charCodeAt(0),h=1,j=++L;L<Z;){switch(m=l.charCodeAt(L)){case 123:h++;break;case 125:h--;break;case 47:switch(m=l.charCodeAt(L+1)){case 42:case 47:e:{for(R=L+1;R<B;++R)switch(l.charCodeAt(R)){case 47:if(42===m&&42===l.charCodeAt(R-1)&&L+2!==R){L=R+1;break e}break;case 10:if(47===m){L=R+1;break e}}L=R}}break;case 91:m++;case 40:m++;case 34:case 39:for(;L++<B&&l.charCodeAt(L)!==m;);}if(0===h)break;L++}if(h=l.substring(j,L),0===p&&(p=(V=V.replace(c,"").trim()).charCodeAt(0)),64===p){switch(0<I&&(V=V.replace(d,"")),m=V.charCodeAt(1)){case 100:case 109:case 115:case 45:I=r;break;default:I=O}if(j=(h=t(r,I,h,m,f+1)).length,0<M&&(_=s(3,h,I=n(O,V,z),r,F,A,j,m,f,u),V=I.join(""),void 0!==_&&0===(j=(h=_.trim()).length)&&(m=0,h="")),0<j)switch(m){case 115:V=V.replace(w,i);case 100:case 109:case 45:h=V+"{"+h+"}";break;case 107:h=(V=V.replace(b,"$1 $2"))+"{"+h+"}",h=1===P||2===P&&o("@"+h,3)?"@-webkit-"+h+"@"+h:"@"+h;break;default:h=V+h,112===u&&(W+=h,h="")}else h=""}else h=t(r,n(r,V,z),h,u,f+1);G+=h,h=z=I=R=p=0,V="",m=l.charCodeAt(++L);break;case 125:case 59:if(1<(j=(V=(0<I?V.replace(d,""):V).trim()).length))switch(0===R&&(p=V.charCodeAt(0),45===p||96<p&&123>p)&&(j=(V=V.replace(" ",":")).length),0<M&&void 0!==(_=s(1,V,r,e,F,A,W.length,u,f,u))&&0===(j=(V=_.trim()).length)&&(V="\0\0"),p=V.charCodeAt(0),m=V.charCodeAt(1),p){case 0:break;case 64:if(105===m||99===m){U+=V+l.charAt(L);break}default:58!==V.charCodeAt(j-1)&&(W+=a(V,p,m,V.charCodeAt(2)))}z=I=R=p=0,V="",m=l.charCodeAt(++L)}}switch(m){case 13:case 10:47===S?S=0:0===1+p&&107!==u&&0<V.length&&(I=1,V+="\0"),0<M*D&&s(0,V,r,e,F,A,W.length,u,f,u),A=1,F++;break;case 59:case 125:if(0===S+C+T+k){A++;break}default:switch(A++,v=l.charAt(L),m){case 9:case 32:if(0===C+k+S)switch(x){case 44:case 58:case 9:case 32:v="";break;default:32!==m&&(v=" ")}break;case 0:v="\\0";break;case 12:v="\\f";break;case 11:v="\\v";break;case 38:0===C+S+k&&(I=z=1,v="\f"+v);break;case 108:if(0===C+S+k+E&&0<R)switch(L-R){case 2:112===x&&58===l.charCodeAt(L-3)&&(E=x);case 8:111===N&&(E=N)}break;case 58:0===C+S+k&&(R=L);break;case 44:0===S+T+C+k&&(I=1,v+="\r");break;case 34:case 39:0===S&&(C=C===m?0:0===C?m:C);break;case 91:0===C+S+T&&k++;break;case 93:0===C+S+T&&k--;break;case 41:0===C+S+k&&T--;break;case 40:if(0===C+S+k){if(0===p)if(2*x+3*N===533);else p=1;T++}break;case 64:0===S+T+C+k+R+h&&(h=1);break;case 42:case 47:if(!(0<C+k+T))switch(S){case 0:switch(2*m+3*l.charCodeAt(L+1)){case 235:S=47;break;case 220:j=L,S=42}break;case 42:47===m&&42===x&&j+2!==L&&(33===l.charCodeAt(j+2)&&(W+=l.substring(j,L+1)),v="",S=0)}}0===S&&(V+=v)}N=x,x=m,L++}if(0<(j=W.length)){if(I=r,0<M&&(void 0!==(_=s(2,W,I,e,F,A,j,u,f,u))&&0===(W=_).length))return U+W+G;if(W=I.join(",")+"{"+W+"}",0!==P*E){switch(2!==P||o(W,2)||(E=0),E){case 111:W=W.replace(g,":-moz-$1")+W;break;case 112:W=W.replace(y,"::-webkit-input-$1")+W.replace(y,"::-moz-$1")+W.replace(y,":-ms-input-$1")+W}E=0}}return U+W+G}function n(e,t,n){var a=t.trim().split(h);t=a;var o=a.length,i=e.length;switch(i){case 0:case 1:var s=0;for(e=0===i?"":e[0]+" ";s<o;++s)t[s]=r(e,t[s],n).trim();break;default:var l=s=0;for(t=[];s<o;++s)for(var u=0;u<i;++u)t[l++]=r(e[u]+" ",a[s],n).trim()}return t}function r(e,t,n){var r=t.charCodeAt(0);switch(33>r&&(r=(t=t.trim()).charCodeAt(0)),r){case 38:return t.replace(v,"$1"+e.trim());case 58:return e.trim()+t.replace(v,"$1"+e.trim());default:if(0<1*n&&0<t.indexOf("\f"))return t.replace(v,(58===e.charCodeAt(0)?"":"$1")+e.trim())}return e+t}function a(e,t,n,r){var i=e+";",s=2*t+3*n+4*r;if(944===s){e=i.indexOf(":",9)+1;var l=i.substring(e,i.length-1).trim();return l=i.substring(0,e).trim()+l+";",1===P||2===P&&o(l,1)?"-webkit-"+l+l:l}if(0===P||2===P&&!o(i,1))return i;switch(s){case 1015:return 97===i.charCodeAt(10)?"-webkit-"+i+i:i;case 951:return 116===i.charCodeAt(3)?"-webkit-"+i+i:i;case 963:return 110===i.charCodeAt(5)?"-webkit-"+i+i:i;case 1009:if(100!==i.charCodeAt(4))break;case 969:case 942:return"-webkit-"+i+i;case 978:return"-webkit-"+i+"-moz-"+i+i;case 1019:case 983:return"-webkit-"+i+"-moz-"+i+"-ms-"+i+i;case 883:if(45===i.charCodeAt(8))return"-webkit-"+i+i;if(0<i.indexOf("image-set(",11))return i.replace(x,"$1-webkit-$2")+i;break;case 932:if(45===i.charCodeAt(4))switch(i.charCodeAt(5)){case 103:return"-webkit-box-"+i.replace("-grow","")+"-webkit-"+i+"-ms-"+i.replace("grow","positive")+i;case 115:return"-webkit-"+i+"-ms-"+i.replace("shrink","negative")+i;case 98:return"-webkit-"+i+"-ms-"+i.replace("basis","preferred-size")+i}return"-webkit-"+i+"-ms-"+i+i;case 964:return"-webkit-"+i+"-ms-flex-"+i+i;case 1023:if(99!==i.charCodeAt(8))break;return"-webkit-box-pack"+(l=i.substring(i.indexOf(":",15)).replace("flex-","").replace("space-between","justify"))+"-webkit-"+i+"-ms-flex-pack"+l+i;case 1005:return p.test(i)?i.replace(f,":-webkit-")+i.replace(f,":-moz-")+i:i;case 1e3:switch(t=(l=i.substring(13).trim()).indexOf("-")+1,l.charCodeAt(0)+l.charCodeAt(t)){case 226:l=i.replace(_,"tb");break;case 232:l=i.replace(_,"tb-rl");break;case 220:l=i.replace(_,"lr");break;default:return i}return"-webkit-"+i+"-ms-"+l+i;case 1017:if(-1===i.indexOf("sticky",9))break;case 975:switch(t=(i=e).length-10,s=(l=(33===i.charCodeAt(t)?i.substring(0,t):i).substring(e.indexOf(":",7)+1).trim()).charCodeAt(0)+(0|l.charCodeAt(7))){case 203:if(111>l.charCodeAt(8))break;case 115:i=i.replace(l,"-webkit-"+l)+";"+i;break;case 207:case 102:i=i.replace(l,"-webkit-"+(102<s?"inline-":"")+"box")+";"+i.replace(l,"-webkit-"+l)+";"+i.replace(l,"-ms-"+l+"box")+";"+i}return i+";";case 938:if(45===i.charCodeAt(5))switch(i.charCodeAt(6)){case 105:return l=i.replace("-items",""),"-webkit-"+i+"-webkit-box-"+l+"-ms-flex-"+l+i;case 115:return"-webkit-"+i+"-ms-flex-item-"+i.replace(S,"")+i;default:return"-webkit-"+i+"-ms-flex-line-pack"+i.replace("align-content","").replace(S,"")+i}break;case 973:case 989:if(45!==i.charCodeAt(3)||122===i.charCodeAt(4))break;case 931:case 953:if(!0===C.test(e))return 115===(l=e.substring(e.indexOf(":")+1)).charCodeAt(0)?a(e.replace("stretch","fill-available"),t,n,r).replace(":fill-available",":stretch"):i.replace(l,"-webkit-"+l)+i.replace(l,"-moz-"+l.replace("fill-",""))+i;break;case 962:if(i="-webkit-"+i+(102===i.charCodeAt(5)?"-ms-"+i:"")+i,211===n+r&&105===i.charCodeAt(13)&&0<i.indexOf("transform",10))return i.substring(0,i.indexOf(";",27)+1).replace(m,"$1-webkit-$2")+i}return i}function o(e,t){var n=e.indexOf(1===t?":":"{"),r=e.substring(0,3!==t?n:10);return n=e.substring(n+1,e.length-1),R(2!==t?r:r.replace(T,"$1"),n,t)}function i(e,t){var n=a(t,t.charCodeAt(0),t.charCodeAt(1),t.charCodeAt(2));return n!==t+";"?n.replace(k," or ($1)").substring(4):"("+t+")"}function s(e,t,n,r,a,o,i,s,l,c){for(var d,f=0,p=t;f<M;++f)switch(d=N[f].call(u,e,p,n,r,a,o,i,s,l,c)){case void 0:case!1:case!0:case null:break;default:p=d}if(p!==t)return p}function l(e){return void 0!==(e=e.prefix)&&(R=null,e?"function"!==typeof e?P=1:(P=2,R=e):P=0),l}function u(e,n){var r=e;if(33>r.charCodeAt(0)&&(r=r.trim()),r=[r],0<M){var a=s(-1,n,r,r,F,A,0,0,0,0);void 0!==a&&"string"===typeof a&&(n=a)}var o=t(O,r,n,0,0);return 0<M&&(void 0!==(a=s(-2,o,r,r,F,A,o.length,0,0,0))&&(o=a)),"",E=0,A=F=1,o}var c=/^\0+/g,d=/[\0\r\f]/g,f=/: */g,p=/zoo|gra/,m=/([,: ])(transform)/g,h=/,\r+?/g,v=/([\t\r\n ])*\f?&/g,b=/@(k\w+)\s*(\S*)\s*/,y=/::(place)/g,g=/:(read-only)/g,_=/[svh]\w+-[tblr]{2}/,w=/\(\s*(.*)\s*\)/g,k=/([\s\S]*?);/g,S=/-self|flex-/g,T=/[^]*?(:[rp][el]a[\w-]+)[^]*/,C=/stretch|:\s*\w+\-(?:conte|avail)/,x=/([^-])(image-set\()/,A=1,F=1,E=0,P=1,O=[],N=[],M=0,R=null,D=0;return u.use=function e(t){switch(t){case void 0:case null:M=N.length=0;break;default:if("function"===typeof t)N[M++]=t;else if("object"===typeof t)for(var n=0,r=t.length;n<r;++n)e(t[n]);else D=0|!!t}return e},u.set=l,void 0!==e&&l(e),u},o="/*|*/";function i(e){e&&s.current.insert(e+"}")}var s={current:null},l=function(e,t,n,r,a,l,u,c,d,f){switch(e){case 1:switch(t.charCodeAt(0)){case 64:return s.current.insert(t+";"),"";case 108:if(98===t.charCodeAt(2))return""}break;case 2:if(0===c)return t+o;break;case 3:switch(c){case 102:case 112:return s.current.insert(n[0]+t),"";default:return t+(0===f?o:"")}case-2:t.split("/*|*/}").forEach(i)}},u=function(e){void 0===e&&(e={});var t,n=e.key||"css";void 0!==e.prefix&&(t={prefix:e.prefix});var o=new a(t);var i,u={};i=e.container||document.head;var c,d=document.querySelectorAll("style[data-emotion-"+n+"]");Array.prototype.forEach.call(d,(function(e){e.getAttribute("data-emotion-"+n).split(" ").forEach((function(e){u[e]=!0})),e.parentNode!==i&&i.appendChild(e)})),o.use(e.stylisPlugins)(l),c=function(e,t,n,r){var a=t.name;s.current=n,o(e,t.styles),r&&(f.inserted[a]=!0)};var f={key:n,sheet:new r({key:n,container:i,nonce:e.nonce,speedy:e.speedy}),nonce:e.nonce,inserted:u,registered:{},insert:c};return f};var c=function(e){for(var t,n=0,r=0,a=e.length;a>=4;++r,a-=4)t=1540483477*(65535&(t=255&e.charCodeAt(r)|(255&e.charCodeAt(++r))<<8|(255&e.charCodeAt(++r))<<16|(255&e.charCodeAt(++r))<<24))+(59797*(t>>>16)<<16),n=1540483477*(65535&(t^=t>>>24))+(59797*(t>>>16)<<16)^1540483477*(65535&n)+(59797*(n>>>16)<<16);switch(a){case 3:n^=(255&e.charCodeAt(r+2))<<16;case 2:n^=(255&e.charCodeAt(r+1))<<8;case 1:n=1540483477*(65535&(n^=255&e.charCodeAt(r)))+(59797*(n>>>16)<<16)}return(((n=1540483477*(65535&(n^=n>>>13))+(59797*(n>>>16)<<16))^n>>>15)>>>0).toString(36)},d={animationIterationCount:1,borderImageOutset:1,borderImageSlice:1,borderImageWidth:1,boxFlex:1,boxFlexGroup:1,boxOrdinalGroup:1,columnCount:1,columns:1,flex:1,flexGrow:1,flexPositive:1,flexShrink:1,flexNegative:1,flexOrder:1,gridRow:1,gridRowEnd:1,gridRowSpan:1,gridRowStart:1,gridColumn:1,gridColumnEnd:1,gridColumnSpan:1,gridColumnStart:1,msGridRow:1,msGridRowSpan:1,msGridColumn:1,msGridColumnSpan:1,fontWeight:1,lineHeight:1,opacity:1,order:1,orphans:1,tabSize:1,widows:1,zIndex:1,zoom:1,WebkitLineClamp:1,fillOpacity:1,floodOpacity:1,stopOpacity:1,strokeDasharray:1,strokeDashoffset:1,strokeMiterlimit:1,strokeOpacity:1,strokeWidth:1};var f=function(e){var t={};return function(n){return void 0===t[n]&&(t[n]=e(n)),t[n]}},p=/[A-Z]|^ms/g,m=/_EMO_([^_]+?)_([^]*?)_EMO_/g,h=function(e){return 45===e.charCodeAt(1)},v=function(e){return null!=e&&"boolean"!==typeof e},b=f((function(e){return h(e)?e:e.replace(p,"-$&").toLowerCase()})),y=function(e,t){switch(e){case"animation":case"animationName":if("string"===typeof t)return t.replace(m,(function(e,t,n){return _={name:t,styles:n,next:_},t}))}return 1===d[e]||h(e)||"number"!==typeof t||0===t?t:t+"px"};function g(e,t,n,r){if(null==n)return"";if(void 0!==n.__emotion_styles)return n;switch(typeof n){case"boolean":return"";case"object":if(1===n.anim)return _={name:n.name,styles:n.styles,next:_},n.name;if(void 0!==n.styles){var a=n.next;if(void 0!==a)for(;void 0!==a;)_={name:a.name,styles:a.styles,next:_},a=a.next;return n.styles+";"}return function(e,t,n){var r="";if(Array.isArray(n))for(var a=0;a<n.length;a++)r+=g(e,t,n[a],!1);else for(var o in n){var i=n[o];if("object"!==typeof i)null!=t&&void 0!==t[i]?r+=o+"{"+t[i]+"}":v(i)&&(r+=b(o)+":"+y(o,i)+";");else if(!Array.isArray(i)||"string"!==typeof i[0]||null!=t&&void 0!==t[i[0]]){var s=g(e,t,i,!1);switch(o){case"animation":case"animationName":r+=b(o)+":"+s+";";break;default:r+=o+"{"+s+"}"}}else for(var l=0;l<i.length;l++)v(i[l])&&(r+=b(o)+":"+y(o,i[l])+";")}return r}(e,t,n);case"function":if(void 0!==e){var o=_,i=n(e);return _=o,g(e,t,i,r)}}if(null==t)return n;var s=t[n];return void 0===s||r?n:s}var _,w=/label:\s*([^\s;\n{]+)\s*;/g;var k=function(e,t,n){if(1===e.length&&"object"===typeof e[0]&&null!==e[0]&&void 0!==e[0].styles)return e[0];var r=!0,a="";_=void 0;var o=e[0];null==o||void 0===o.raw?(r=!1,a+=g(n,t,o,!1)):a+=o[0];for(var i=1;i<e.length;i++)a+=g(n,t,e[i],46===a.charCodeAt(a.length-1)),r&&(a+=o[i]);w.lastIndex=0;for(var s,l="";null!==(s=w.exec(a));)l+="-"+s[1];return{name:c(a)+l,styles:a,next:_}};function S(e,t,n){var r="";return n.split(" ").forEach((function(n){void 0!==e[n]?t.push(e[n]):r+=n+" "})),r}var T=function(e,t,n){var r=e.key+"-"+t.name;if(!1===n&&void 0===e.registered[r]&&(e.registered[r]=t.styles),void 0===e.inserted[t.name]){var a=t;do{e.insert("."+r,a,e.sheet,!0);a=a.next}while(void 0!==a)}};function C(e,t){if(void 0===e.inserted[t.name])return e.insert("",t,e.sheet,!0)}function x(e,t,n){var r=[],a=S(e,r,n);return r.length<2?n:a+t(r)}var A=function e(t){for(var n="",r=0;r<t.length;r++){var a=t[r];if(null!=a){var o=void 0;switch(typeof a){case"boolean":break;case"object":if(Array.isArray(a))o=e(a);else for(var i in o="",a)a[i]&&i&&(o&&(o+=" "),o+=i);break;default:o=a}o&&(n&&(n+=" "),n+=o)}}return n},F=function(e){var t=u(e);t.sheet.speedy=function(e){this.isSpeedy=e},t.compat=!0;var n=function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=k(n,t.registered,void 0);return T(t,a,!1),t.key+"-"+a.name};return{css:n,cx:function(){for(var e=arguments.length,r=new Array(e),a=0;a<e;a++)r[a]=arguments[a];return x(t.registered,n,A(r))},injectGlobal:function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=k(n,t.registered);C(t,a)},keyframes:function(){for(var e=arguments.length,n=new Array(e),r=0;r<e;r++)n[r]=arguments[r];var a=k(n,t.registered),o="animation-"+a.name;return C(t,{name:a.name,styles:"@keyframes "+o+"{"+a.styles+"}"}),o},hydrate:function(e){e.forEach((function(e){t.inserted[e]=!0}))},flush:function(){t.registered={},t.inserted={},t.sheet.flush()},sheet:t.sheet,cache:t,getRegisteredStyles:S.bind(null,t.registered),merge:x.bind(null,t.registered,n)}},E=F(),P=E.flush,O=E.hydrate,N=E.cx,M=E.merge,R=E.getRegisteredStyles,D=E.injectGlobal,L=E.keyframes,I=E.css,z=E.sheet,j=E.cache},2110:function(e,t,n){"use strict";var r=n(8309),a={childContextTypes:!0,contextType:!0,contextTypes:!0,defaultProps:!0,displayName:!0,getDefaultProps:!0,getDerivedStateFromError:!0,getDerivedStateFromProps:!0,mixins:!0,propTypes:!0,type:!0},o={name:!0,length:!0,prototype:!0,caller:!0,callee:!0,arguments:!0,arity:!0},i={$$typeof:!0,compare:!0,defaultProps:!0,displayName:!0,propTypes:!0,type:!0},s={};function l(e){return r.isMemo(e)?i:s[e.$$typeof]||a}s[r.ForwardRef]={$$typeof:!0,render:!0,defaultProps:!0,displayName:!0,propTypes:!0},s[r.Memo]=i;var u=Object.defineProperty,c=Object.getOwnPropertyNames,d=Object.getOwnPropertySymbols,f=Object.getOwnPropertyDescriptor,p=Object.getPrototypeOf,m=Object.prototype;e.exports=function e(t,n,r){if("string"!==typeof n){if(m){var a=p(n);a&&a!==m&&e(t,a,r)}var i=c(n);d&&(i=i.concat(d(n)));for(var s=l(t),h=l(n),v=0;v<i.length;++v){var b=i[v];if(!o[b]&&(!r||!r[b])&&(!h||!h[b])&&(!s||!s[b])){var y=f(n,b);try{u(t,b,y)}catch(g){}}}}return t}},746:function(e,t){"use strict";var n="function"===typeof Symbol&&Symbol.for,r=n?Symbol.for("react.element"):60103,a=n?Symbol.for("react.portal"):60106,o=n?Symbol.for("react.fragment"):60107,i=n?Symbol.for("react.strict_mode"):60108,s=n?Symbol.for("react.profiler"):60114,l=n?Symbol.for("react.provider"):60109,u=n?Symbol.for("react.context"):60110,c=n?Symbol.for("react.async_mode"):60111,d=n?Symbol.for("react.concurrent_mode"):60111,f=n?Symbol.for("react.forward_ref"):60112,p=n?Symbol.for("react.suspense"):60113,m=n?Symbol.for("react.suspense_list"):60120,h=n?Symbol.for("react.memo"):60115,v=n?Symbol.for("react.lazy"):60116,b=n?Symbol.for("react.block"):60121,y=n?Symbol.for("react.fundamental"):60117,g=n?Symbol.for("react.responder"):60118,_=n?Symbol.for("react.scope"):60119;function w(e){if("object"===typeof e&&null!==e){var t=e.$$typeof;switch(t){case r:switch(e=e.type){case c:case d:case o:case s:case i:case p:return e;default:switch(e=e&&e.$$typeof){case u:case f:case v:case h:case l:return e;default:return t}}case a:return t}}}function k(e){return w(e)===d}t.AsyncMode=c,t.ConcurrentMode=d,t.ContextConsumer=u,t.ContextProvider=l,t.Element=r,t.ForwardRef=f,t.Fragment=o,t.Lazy=v,t.Memo=h,t.Portal=a,t.Profiler=s,t.StrictMode=i,t.Suspense=p,t.isAsyncMode=function(e){return k(e)||w(e)===c},t.isConcurrentMode=k,t.isContextConsumer=function(e){return w(e)===u},t.isContextProvider=function(e){return w(e)===l},t.isElement=function(e){return"object"===typeof e&&null!==e&&e.$$typeof===r},t.isForwardRef=function(e){return w(e)===f},t.isFragment=function(e){return w(e)===o},t.isLazy=function(e){return w(e)===v},t.isMemo=function(e){return w(e)===h},t.isPortal=function(e){return w(e)===a},t.isProfiler=function(e){return w(e)===s},t.isStrictMode=function(e){return w(e)===i},t.isSuspense=function(e){return w(e)===p},t.isValidElementType=function(e){return"string"===typeof e||"function"===typeof e||e===o||e===d||e===s||e===i||e===p||e===m||"object"===typeof e&&null!==e&&(e.$$typeof===v||e.$$typeof===h||e.$$typeof===l||e.$$typeof===u||e.$$typeof===f||e.$$typeof===y||e.$$typeof===g||e.$$typeof===_||e.$$typeof===b)},t.typeOf=w},8309:function(e,t,n){"use strict";e.exports=n(746)},5781:function(e,t,n){"use strict";n.r(t);var r=Number.isNaN||function(e){return"number"===typeof e&&e!==e};function a(e,t){if(e.length!==t.length)return!1;for(var n=0;n<e.length;n++)if(a=e[n],o=t[n],!(a===o||r(a)&&r(o)))return!1;var a,o;return!0}t.default=function(e,t){var n;void 0===t&&(t=a);var r,o=[],i=!1;return function(){for(var a=[],s=0;s<arguments.length;s++)a[s]=arguments[s];return i&&n===this&&t(a,o)||(r=e.apply(this,a),i=!0,n=this,o=a),r}}},888:function(e,t,n){"use strict";var r=n(9047);function a(){}function o(){}o.resetWarningCache=a,e.exports=function(){function e(e,t,n,a,o,i){if(i!==r){var s=new Error("Calling PropTypes validators directly is not supported by the `prop-types` package. Use PropTypes.checkPropTypes() to call them. Read more at http://fb.me/use-check-prop-types");throw s.name="Invariant Violation",s}}function t(){return e}e.isRequired=e;var n={array:e,bigint:e,bool:e,func:e,number:e,object:e,string:e,symbol:e,any:e,arrayOf:t,element:e,elementType:e,instanceOf:t,node:e,objectOf:t,oneOf:t,oneOfType:t,shape:t,exact:t,checkPropTypes:o,resetWarningCache:a};return n.PropTypes=n,n}},2007:function(e,t,n){e.exports=n(888)()},9047:function(e){"use strict";e.exports="SECRET_DO_NOT_PASS_THIS_OR_YOU_WILL_BE_FIRED"},8472:function(e,t,n){n(3561)},8015:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var r,a=function(){function e(e,t){for(var n=0;n<t.length;n++){var r=t[n];r.enumerable=r.enumerable||!1,r.configurable=!0,"value"in r&&(r.writable=!0),Object.defineProperty(e,r.key,r)}}return function(t,n,r){return n&&e(t.prototype,n),r&&e(t,r),t}}(),o=n(2791),i=(r=o)&&r.__esModule?r:{default:r},s=n(1509),l=n(8333);var u=function(e){function t(e){!function(e,t){if(!(e instanceof t))throw new TypeError("Cannot call a class as a function")}(this,t);var n=function(e,t){if(!e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return!t||"object"!==typeof t&&"function"!==typeof t?e:t}(this,(t.__proto__||Object.getPrototypeOf(t)).call(this,e));return n.state={},n}return function(e,t){if("function"!==typeof t&&null!==t)throw new TypeError("Super expression must either be null or a function, not "+typeof t);e.prototype=Object.create(t&&t.prototype,{constructor:{value:e,enumerable:!1,writable:!0,configurable:!0}}),t&&(Object.setPrototypeOf?Object.setPrototypeOf(e,t):e.__proto__=t)}(t,e),a(t,[{key:"buildURI",value:function(){return s.buildURI.apply(void 0,arguments)}},{key:"componentDidMount",value:function(){var e=this.props,t=e.data,n=e.headers,r=e.separator,a=e.enclosingCharacter,o=e.uFEFF,i=e.target,s=e.specs,l=e.replace;this.state.page=window.open(this.buildURI(t,o,n,r,a),i,s,l)}},{key:"getWindow",value:function(){return this.state.page}},{key:"render",value:function(){return null}}]),t}(i.default.Component);u.defaultProps=Object.assign(l.defaultProps,{target:"_blank"}),u.propTypes=l.propTypes,t.default=u},9088:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var r,a=Object.assign||function(e){for(var t=1;t<arguments.length;t++){var n=arguments[t];for(var r in n)Object.prototype.hasOwnProperty.call(n,r)&&(e[r]=n[r])}return e},o=function(){function e(e,t){for(var n=0;n<t.length;n++){var r=t[n];r.enumerable=r.enumerable||!1,r.configurable=!0,"value"in r&&(r.writable=!0),Object.defineProperty(e,r.key,r)}}return function(t,n,r){return n&&e(t.prototype,n),r&&e(t,r),t}}(),i=n(2791),s=(r=i)&&r.__esModule?r:{default:r},l=n(1509),u=n(8333);var c=function(e){function t(e){!function(e,t){if(!(e instanceof t))throw new TypeError("Cannot call a class as a function")}(this,t);var n=function(e,t){if(!e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return!t||"object"!==typeof t&&"function"!==typeof t?e:t}(this,(t.__proto__||Object.getPrototypeOf(t)).call(this,e));return n.buildURI=n.buildURI.bind(n),n}return function(e,t){if("function"!==typeof t&&null!==t)throw new TypeError("Super expression must either be null or a function, not "+typeof t);e.prototype=Object.create(t&&t.prototype,{constructor:{value:e,enumerable:!1,writable:!0,configurable:!0}}),t&&(Object.setPrototypeOf?Object.setPrototypeOf(e,t):e.__proto__=t)}(t,e),o(t,[{key:"buildURI",value:function(){return l.buildURI.apply(void 0,arguments)}},{key:"handleLegacy",value:function(e){var t=arguments.length>1&&void 0!==arguments[1]&&arguments[1];if(window.navigator.msSaveOrOpenBlob){e.preventDefault();var n=this.props,r=n.data,a=n.headers,o=n.separator,i=n.filename,s=n.enclosingCharacter,u=n.uFEFF,c=t&&"function"===typeof r?r():r,d=new Blob([u?"\ufeff":"",(0,l.toCSV)(c,a,o,s)]);return window.navigator.msSaveBlob(d,i),!1}}},{key:"handleAsyncClick",value:function(e){var t=this;this.props.onClick(e,(function(n){!1!==n?t.handleLegacy(e,!0):e.preventDefault()}))}},{key:"handleSyncClick",value:function(e){!1===this.props.onClick(e)?e.preventDefault():this.handleLegacy(e)}},{key:"handleClick",value:function(){var e=this;return function(t){if("function"===typeof e.props.onClick)return e.props.asyncOnClick?e.handleAsyncClick(t):e.handleSyncClick(t);e.handleLegacy(t)}}},{key:"render",value:function(){var e=this,t=this.props,n=t.data,r=t.headers,o=t.separator,i=t.filename,l=t.uFEFF,u=t.children,c=(t.onClick,t.asyncOnClick,t.enclosingCharacter),d=function(e,t){var n={};for(var r in e)t.indexOf(r)>=0||Object.prototype.hasOwnProperty.call(e,r)&&(n[r]=e[r]);return n}(t,["data","headers","separator","filename","uFEFF","children","onClick","asyncOnClick","enclosingCharacter"]),f="undefined"===typeof window?"":this.buildURI(n,l,r,o,c);return s.default.createElement("a",a({download:i},d,{ref:function(t){return e.link=t},target:"_self",href:f,onClick:this.handleClick()}),u)}}]),t}(s.default.Component);c.defaultProps=u.defaultProps,c.propTypes=u.propTypes,t.default=c},1509:function(e,t){"use strict";Object.defineProperty(t,"__esModule",{value:!0});var n="function"===typeof Symbol&&"symbol"===typeof Symbol.iterator?function(e){return typeof e}:function(e){return e&&"function"===typeof Symbol&&e.constructor===Symbol&&e!==Symbol.prototype?"symbol":typeof e};function r(e){if(Array.isArray(e)){for(var t=0,n=Array(e.length);t<e.length;t++)n[t]=e[t];return n}return Array.from(e)}var a=t.isSafari=function(){return/^((?!chrome|android).)*safari/i.test(navigator.userAgent)},o=t.isJsons=function(e){return Array.isArray(e)&&e.every((function(e){return"object"===("undefined"===typeof e?"undefined":n(e))&&!(e instanceof Array)}))},i=t.isArrays=function(e){return Array.isArray(e)&&e.every((function(e){return Array.isArray(e)}))},s=t.jsonsHeaders=function(e){return Array.from(e.map((function(e){return Object.keys(e)})).reduce((function(e,t){return new Set([].concat(r(e),r(t)))}),[]))},l=t.jsons2arrays=function(e,t){var n=t=t||s(e),a=t;o(t)&&(n=t.map((function(e){return e.label})),a=t.map((function(e){return e.key})));var i=e.map((function(e){return a.map((function(t){return u(t,e)}))}));return[n].concat(r(i))},u=t.getHeaderValue=function(e,t){var n=e.replace(/\[([^\]]+)]/g,".$1").split(".").reduce((function(e,t,n,r){var a=e[t];if(void 0!==a&&null!==a)return a;r.splice(1)}),t);return void 0===n?e in t?t[e]:"":n},c=t.elementOrEmpty=function(e){return"undefined"===typeof e||null===e?"":e},d=t.joiner=function(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:",",n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:'"';return e.filter((function(e){return e})).map((function(e){return e.map((function(e){return c(e)})).map((function(e){return""+n+e+n})).join(t)})).join("\n")},f=t.arrays2csv=function(e,t,n,a){return d(t?[t].concat(r(e)):e,n,a)},p=t.jsons2csv=function(e,t,n,r){return d(l(e,t),n,r)},m=t.string2csv=function(e,t,n,r){return t?t.join(n)+"\n"+e:e.replace(/"/g,'""')},h=t.toCSV=function(e,t,n,r){if(o(e))return p(e,t,n,r);if(i(e))return f(e,t,n,r);if("string"===typeof e)return m(e,t,n);throw new TypeError('Data should be a "String", "Array of arrays" OR "Array of objects" ')};t.buildURI=function(e,t,n,r,o){var i=h(e,n,r,o),s=a()?"application/csv":"text/csv",l=new Blob([t?"\ufeff":"",i],{type:s}),u="data:"+s+";charset=utf-8,"+(t?"\ufeff":"")+i,c=window.URL||window.webkitURL;return"undefined"===typeof c.createObjectURL?u:c.createObjectURL(l)}},3561:function(e,t,n){"use strict";var r=o(n(8015)),a=o(n(9088));function o(e){return e&&e.__esModule?e:{default:e}}r.default,a.default},8333:function(e,t,n){"use strict";Object.defineProperty(t,"__esModule",{value:!0}),t.PropsNotForwarded=t.defaultProps=t.propTypes=void 0;var r,a=n(2791),o=((r=a)&&r.__esModule,n(2007));t.propTypes={data:(0,o.oneOfType)([o.string,o.array,o.func]).isRequired,headers:o.array,target:o.string,separator:o.string,filename:o.string,uFEFF:o.bool,onClick:o.func,asyncOnClick:o.bool,enclosingCharacter:o.string},t.defaultProps={separator:",",filename:"generatedBy_react-csv.csv",uFEFF:!0,asyncOnClick:!1,enclosingCharacter:'"'},t.PropsNotForwarded=["data","headers"]},7786:function(e,t,n){"use strict";var r=this&&this.__read||function(e,t){var n="function"===typeof Symbol&&e[Symbol.iterator];if(!n)return e;var r,a,o=n.call(e),i=[];try{for(;(void 0===t||t-- >0)&&!(r=o.next()).done;)i.push(r.value)}catch(s){a={error:s}}finally{try{r&&!r.done&&(n=o.return)&&n.call(o)}finally{if(a)throw a.error}}return i},a=this&&this.__spread||function(){for(var e=[],t=0;t<arguments.length;t++)e=e.concat(r(arguments[t]));return e};Object.defineProperty(t,"__esModule",{value:!0});var o,i,s=n(4173),l=s;!function(e){e[e.DEFAULT=0]="DEFAULT",e[e.ADDED=1]="ADDED",e[e.REMOVED=2]="REMOVED"}(o=t.DiffType||(t.DiffType={})),function(e){e.CHARS="diffChars",e.WORDS="diffWords",e.WORDS_WITH_SPACE="diffWordsWithSpace",e.LINES="diffLines",e.TRIMMED_LINES="diffTrimmedLines",e.SENTENCES="diffSentences",e.CSS="diffCss"}(i=t.DiffMethod||(t.DiffMethod={}));var u=function(e){var t=e.split("\n");if(t.every((function(e){return!e})))return 2===t.length?[]:(t.pop(),t);var n=t[t.length-1],r=t[0];return n||t.pop(),r||t.shift(),t};t.computeLineInformation=function(e,t,n,r,c){void 0===n&&(n=!1),void 0===r&&(r=i.CHARS),void 0===c&&(c=0);var d=s.diffLines(e.trimRight(),t.trimRight(),{newlineIsToken:!0,ignoreWhitespace:!1,ignoreCase:!1}),f=c,p=c,m=[],h=0,v=[],b=[],y=function e(t,a,s,c,m){return u(t).map((function(t,y){var g={},_={};if(!(b.includes(a+"-"+y)||m&&0!==y)){if(s||c)if(v.includes(h)||v.push(h),c){p+=1,g.lineNumber=p,g.type=o.REMOVED,g.value=t||" ";var w=d[a+1];if(w&&w.added)if(u(w.value)[y]){var k=e(w.value,a,!0,!1,!0)[0].right,S=k.value,T=k.lineNumber,C=k.type;if(b.push(a+1+"-"+y),_.lineNumber=T,_.type=C,n)_.value=S;else{var x=function(e,t,n){void 0===n&&(n=i.CHARS);var r=l[n](e,t),a={left:[],right:[]};return r.forEach((function(e){var t=e.added,n=e.removed,r=e.value,i={};return t&&(i.type=o.ADDED,i.value=r,a.right.push(i)),n&&(i.type=o.REMOVED,i.value=r,a.left.push(i)),n||t||(i.type=o.DEFAULT,i.value=r,a.right.push(i),a.left.push(i)),i})),a}(t,S,r);_.value=x.right,g.value=x.left}}}else f+=1,_.lineNumber=f,_.type=o.ADDED,_.value=t;else p+=1,f+=1,g.lineNumber=p,g.type=o.DEFAULT,g.value=t,_.lineNumber=f,_.type=o.DEFAULT,_.value=t;return h+=1,{right:_,left:g}}})).filter(Boolean)};return d.forEach((function(e,t){var n=e.added,r=e.removed,o=e.value;m=a(m,y(o,t,n,r))})),{lineInformation:m,diffLines:v}}},1774:function(e,t,n){"use strict";var r=this&&this.__extends||function(){var e=function(t,n){return e=Object.setPrototypeOf||{__proto__:[]}instanceof Array&&function(e,t){e.__proto__=t}||function(e,t){for(var n in t)t.hasOwnProperty(n)&&(e[n]=t[n])},e(t,n)};return function(t,n){function r(){this.constructor=t}e(t,n),t.prototype=null===n?Object.create(n):(r.prototype=n.prototype,new r)}}();Object.defineProperty(t,"__esModule",{value:!0});var a=n(2791),o=n(2007),i=n(1694),s=n(7786);t.DiffMethod=s.DiffMethod;var l,u=n(2813),c=n(5781),d=c.default||c;!function(e){e.LEFT="L",e.RIGHT="R"}(l=t.LineNumberPrefix||(t.LineNumberPrefix={}));var f=function(e){function t(t){var n=e.call(this,t)||this;return n.resetCodeBlocks=function(){return n.state.expandedBlocks.length>0&&(n.setState({expandedBlocks:[]}),!0)},n.onBlockExpand=function(e){var t=n.state.expandedBlocks.slice();t.push(e),n.setState({expandedBlocks:t})},n.computeStyles=d(u.default),n.onLineNumberClickProxy=function(e){return n.props.onLineNumberClick?function(t){return n.props.onLineNumberClick(e,t)}:function(){}},n.renderWordDiff=function(e,t){return e.map((function(e,r){var o;return a.createElement("span",{key:r,className:i.default(n.styles.wordDiff,(o={},o[n.styles.wordAdded]=e.type===s.DiffType.ADDED,o[n.styles.wordRemoved]=e.type===s.DiffType.REMOVED,o))},t?t(e.value):e.value)}))},n.renderLine=function(e,t,r,o,l,u){var c,d,f,p,m,h=r+"-"+e,v=u+"-"+l,b=n.props.highlightLines.includes(h)||n.props.highlightLines.includes(v),y=t===s.DiffType.ADDED,g=t===s.DiffType.REMOVED;return m=Array.isArray(o)?n.renderWordDiff(o,n.props.renderContent):n.props.renderContent?n.props.renderContent(o):o,a.createElement(a.Fragment,null,!n.props.hideLineNumbers&&a.createElement("td",{onClick:e&&n.onLineNumberClickProxy(h),className:i.default(n.styles.gutter,(c={},c[n.styles.emptyGutter]=!e,c[n.styles.diffAdded]=y,c[n.styles.diffRemoved]=g,c[n.styles.highlightedGutter]=b,c))},a.createElement("pre",{className:n.styles.lineNumber},e)),!n.props.splitView&&!n.props.hideLineNumbers&&a.createElement("td",{onClick:l&&n.onLineNumberClickProxy(v),className:i.default(n.styles.gutter,(d={},d[n.styles.emptyGutter]=!l,d[n.styles.diffAdded]=y,d[n.styles.diffRemoved]=g,d[n.styles.highlightedGutter]=b,d))},a.createElement("pre",{className:n.styles.lineNumber},l)),a.createElement("td",{className:i.default(n.styles.marker,(f={},f[n.styles.emptyLine]=!m,f[n.styles.diffAdded]=y,f[n.styles.diffRemoved]=g,f[n.styles.highlightedLine]=b,f))},a.createElement("pre",null,y&&"+",g&&"-")),a.createElement("td",{className:i.default(n.styles.content,(p={},p[n.styles.emptyLine]=!m,p[n.styles.diffAdded]=y,p[n.styles.diffRemoved]=g,p[n.styles.highlightedLine]=b,p))},a.createElement("pre",{className:n.styles.contentText},m)))},n.renderSplitView=function(e,t){var r=e.left,o=e.right;return a.createElement("tr",{key:t,className:n.styles.line},n.renderLine(r.lineNumber,r.type,l.LEFT,r.value),n.renderLine(o.lineNumber,o.type,l.RIGHT,o.value))},n.renderInlineView=function(e,t){var r,o=e.left,i=e.right;return o.type===s.DiffType.REMOVED&&i.type===s.DiffType.ADDED?a.createElement(a.Fragment,{key:t},a.createElement("tr",{className:n.styles.line},n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,null)),a.createElement("tr",{className:n.styles.line},n.renderLine(null,i.type,l.RIGHT,i.value,i.lineNumber))):(o.type===s.DiffType.REMOVED&&(r=n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,null)),o.type===s.DiffType.DEFAULT&&(r=n.renderLine(o.lineNumber,o.type,l.LEFT,o.value,i.lineNumber,l.RIGHT)),i.type===s.DiffType.ADDED&&(r=n.renderLine(null,i.type,l.RIGHT,i.value,i.lineNumber)),a.createElement("tr",{key:t,className:n.styles.line},r))},n.onBlockClickProxy=function(e){return function(){return n.onBlockExpand(e)}},n.renderSkippedLineIndicator=function(e,t,r,o){var s,l=n.props,u=l.hideLineNumbers,c=l.splitView,d=n.props.codeFoldMessageRenderer?n.props.codeFoldMessageRenderer(e,r,o):a.createElement("pre",{className:n.styles.codeFoldContent},"Expand ",e," lines ..."),f=a.createElement("td",null,a.createElement("a",{onClick:n.onBlockClickProxy(t),tabIndex:0},d)),p=!c&&!u;return a.createElement("tr",{key:r+"-"+o,className:n.styles.codeFold},!u&&a.createElement("td",{className:n.styles.codeFoldGutter}),a.createElement("td",{className:i.default((s={},s[n.styles.codeFoldGutter]=p,s))}),p?a.createElement(a.Fragment,null,a.createElement("td",null),f):a.createElement(a.Fragment,null,f,a.createElement("td",null)),a.createElement("td",null),a.createElement("td",null))},n.renderDiff=function(){var e=n.props,t=e.oldValue,r=e.newValue,o=e.splitView,i=e.disableWordDiff,l=e.compareMethod,u=e.linesOffset,c=s.computeLineInformation(t,r,i,l,u),d=c.lineInformation,f=c.diffLines,p=n.props.extraLinesSurroundingDiff<0?0:n.props.extraLinesSurroundingDiff,m=[];return d.map((function(e,t){var r=f[0],i=r-t;if(n.props.showDiffOnly&&(i===-p&&(m=[],f.shift()),e.left.type===s.DiffType.DEFAULT&&(i>p||"undefined"===typeof r)&&!n.state.expandedBlocks.includes(r)))return m.push(t+1),t===d.length-1&&m.length>1?n.renderSkippedLineIndicator(m.length,r,e.left.lineNumber,e.right.lineNumber):null;var l=o?n.renderSplitView(e,t):n.renderInlineView(e,t);if(i===p&&m.length>0){var u=m.length;return m=[],a.createElement(a.Fragment,{key:t},n.renderSkippedLineIndicator(u,r,e.left.lineNumber,e.right.lineNumber),l)}return l}))},n.render=function(){var e,t=n.props,r=t.oldValue,o=t.newValue,s=t.useDarkTheme,l=t.leftTitle,u=t.rightTitle,c=t.splitView,d=t.hideLineNumbers;if("string"!==typeof r||"string"!==typeof o)throw Error('"oldValue" and "newValue" should be strings');n.styles=n.computeStyles(n.props.styles,s);var f=n.renderDiff(),p=d?2:3,m=d?2:4,h=(l||u)&&a.createElement("tr",null,a.createElement("td",{colSpan:c?p:m,className:n.styles.titleBlock},a.createElement("pre",{className:n.styles.contentText},l)),c&&a.createElement("td",{colSpan:p,className:n.styles.titleBlock},a.createElement("pre",{className:n.styles.contentText},u)));return a.createElement("table",{className:i.default(n.styles.diffContainer,(e={},e[n.styles.splitView]=c,e))},a.createElement("tbody",null,h,f))},n.state={expandedBlocks:[]},n}return r(t,e),t.defaultProps={oldValue:"",newValue:"",splitView:!0,highlightLines:[],disableWordDiff:!1,compareMethod:s.DiffMethod.CHARS,styles:{},hideLineNumbers:!1,extraLinesSurroundingDiff:3,showDiffOnly:!0,useDarkTheme:!1,linesOffset:0},t.propTypes={oldValue:o.string.isRequired,newValue:o.string.isRequired,splitView:o.bool,disableWordDiff:o.bool,compareMethod:o.oneOf(Object.values(s.DiffMethod)),renderContent:o.func,onLineNumberClick:o.func,extraLinesSurroundingDiff:o.number,styles:o.object,hideLineNumbers:o.bool,showDiffOnly:o.bool,highlightLines:o.arrayOf(o.string),leftTitle:o.oneOfType([o.string,o.element]),rightTitle:o.oneOfType([o.string,o.element]),linesOffset:o.number},t}(a.Component);t.default=f},2813:function(e,t,n){"use strict";var r=this&&this.__assign||function(){return r=Object.assign||function(e){for(var t,n=1,r=arguments.length;n<r;n++)for(var a in t=arguments[n])Object.prototype.hasOwnProperty.call(t,a)&&(e[a]=t[a]);return e},r.apply(this,arguments)},a=this&&this.__rest||function(e,t){var n={};for(var r in e)Object.prototype.hasOwnProperty.call(e,r)&&t.indexOf(r)<0&&(n[r]=e[r]);if(null!=e&&"function"===typeof Object.getOwnPropertySymbols){var a=0;for(r=Object.getOwnPropertySymbols(e);a<r.length;a++)t.indexOf(r[a])<0&&Object.prototype.propertyIsEnumerable.call(e,r[a])&&(n[r[a]]=e[r[a]])}return n};Object.defineProperty(t,"__esModule",{value:!0});var o=n(6025);t.default=function(e,t){var n,i,s,l,u,c,d;void 0===t&&(t=!1);var f=e.variables,p=void 0===f?{}:f,m=a(e,["variables"]),h={light:r({diffViewerBackground:"#fff",diffViewerColor:"212529",addedBackground:"#e6ffed",addedColor:"#24292e",removedBackground:"#ffeef0",removedColor:"#24292e",wordAddedBackground:"#acf2bd",wordRemovedBackground:"#fdb8c0",addedGutterBackground:"#cdffd8",removedGutterBackground:"#ffdce0",gutterBackground:"#f7f7f7",gutterBackgroundDark:"#f3f1f1",highlightBackground:"#fffbdd",highlightGutterBackground:"#fff5b1",codeFoldGutterBackground:"#dbedff",codeFoldBackground:"#f1f8ff",emptyLineBackground:"#fafbfc",gutterColor:"#212529",addedGutterColor:"#212529",removedGutterColor:"#212529",codeFoldContentColor:"#212529",diffViewerTitleBackground:"#fafbfc",diffViewerTitleColor:"#212529",diffViewerTitleBorderColor:"#eee"},p.light||{}),dark:r({diffViewerBackground:"#2e303c",diffViewerColor:"#FFF",addedBackground:"#044B53",addedColor:"white",removedBackground:"#632F34",removedColor:"white",wordAddedBackground:"#055d67",wordRemovedBackground:"#7d383f",addedGutterBackground:"#034148",removedGutterBackground:"#632b30",gutterBackground:"#2c2f3a",gutterBackgroundDark:"#262933",highlightBackground:"#2a3967",highlightGutterBackground:"#2d4077",codeFoldGutterBackground:"#21232b",codeFoldBackground:"#262831",emptyLineBackground:"#363946",gutterColor:"#464c67",addedGutterColor:"#8c8c8c",removedGutterColor:"#8c8c8c",codeFoldContentColor:"#555a7b",diffViewerTitleBackground:"#2f323e",diffViewerTitleColor:"#555a7b",diffViewerTitleBorderColor:"#353846"},p.dark||{})},v=t?h.dark:h.light,b=o.css({width:"100%",label:"content"}),y=o.css(((n={})["."+b]={width:"50%"},n.label="split-view",n)),g=o.css({width:"100%",background:v.diffViewerBackground,pre:{margin:0,whiteSpace:"pre-wrap",lineHeight:"25px"},label:"diff-container",borderCollapse:"collapse"}),_=o.css({color:v.codeFoldContentColor,label:"code-fold-content"}),w=o.css({color:v.diffViewerColor,label:"content-text"}),k=o.css(((i={background:v.diffViewerTitleBackground,padding:10,borderBottom:"1px solid "+v.diffViewerTitleBorderColor,label:"title-block",":last-child":{borderLeft:"1px solid "+v.diffViewerTitleBorderColor}})["."+w]={color:v.diffViewerTitleColor},i)),S=o.css({color:v.gutterColor,label:"line-number"}),T=o.css(((s={background:v.removedBackground,color:v.removedColor,pre:{color:v.removedColor}})["."+S]={color:v.removedGutterColor},s.label="diff-removed",s)),C=o.css(((l={background:v.addedBackground,color:v.addedColor,pre:{color:v.addedColor}})["."+S]={color:v.addedGutterColor},l.label="diff-added",l)),x=o.css({padding:2,display:"inline-flex",borderRadius:1,label:"word-diff"}),A=o.css({background:v.wordAddedBackground,label:"word-added"}),F=o.css({background:v.wordRemovedBackground,label:"word-removed"}),E=o.css({backgroundColor:v.codeFoldGutterBackground,label:"code-fold-gutter"}),P=o.css({backgroundColor:v.codeFoldBackground,height:40,fontSize:14,fontWeight:700,label:"code-fold",a:{textDecoration:"underline !important",cursor:"pointer",pre:{display:"inline"}}}),O=o.css({backgroundColor:v.emptyLineBackground,label:"empty-line"}),N=o.css(((u={width:25,paddingLeft:10,paddingRight:10,userSelect:"none",label:"marker"})["&."+C]={pre:{color:v.addedColor}},u["&."+T]={pre:{color:v.removedColor}},u)),M=o.css(((c={background:v.highlightBackground,label:"highlighted-line"})["."+A+", ."+F]={backgroundColor:"initial"},c)),R=o.css({label:"highlighted-gutter"}),D=o.css(((d={userSelect:"none",minWidth:50,padding:"0 10px",label:"gutter",textAlign:"right",background:v.gutterBackground,"&:hover":{cursor:"pointer",background:v.gutterBackgroundDark,pre:{opacity:1}},pre:{opacity:.5}})["&."+C]={background:v.addedGutterBackground},d["&."+T]={background:v.removedGutterBackground},d["&."+R]={background:v.highlightGutterBackground,"&:hover":{background:v.highlightGutterBackground}},d)),L=o.css({"&:hover":{background:v.gutterBackground,cursor:"initial"},label:"empty-gutter"}),I={diffContainer:g,diffRemoved:T,diffAdded:C,splitView:y,marker:N,highlightedGutter:R,highlightedLine:M,gutter:D,line:o.css({verticalAlign:"baseline",label:"line"}),wordDiff:x,wordAdded:A,wordRemoved:F,codeFoldGutter:E,codeFold:P,emptyGutter:L,emptyLine:O,lineNumber:S,contentText:w,content:b,codeFoldContent:_,titleBlock:k},z=Object.keys(m).reduce((function(e,t){var n;return r({},e,((n={})[t]=o.css(m[t]),n))}),{});return Object.keys(I).reduce((function(e,t){var n;return r({},e,((n={})[t]=z[t]?o.cx(I[t],z[t]):I[t],n))}),{})}},4463:function(e,t,n){"use strict";var r=n(2791),a=n(5296);function o(e){for(var t="https://reactjs.org/docs/error-decoder.html?invariant="+e,n=1;n<arguments.length;n++)t+="&args[]="+encodeURIComponent(arguments[n]);return"Minified React error #"+e+"; visit "+t+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}var i=new Set,s={};function l(e,t){u(e,t),u(e+"Capture",t)}function u(e,t){for(s[e]=t,e=0;e<t.length;e++)i.add(t[e])}var c=!("undefined"===typeof window||"undefined"===typeof window.document||"undefined"===typeof window.document.createElement),d=Object.prototype.hasOwnProperty,f=/^[:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD][:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD\-.0-9\u00B7\u0300-\u036F\u203F-\u2040]*$/,p={},m={};function h(e,t,n,r,a,o,i){this.acceptsBooleans=2===t||3===t||4===t,this.attributeName=r,this.attributeNamespace=a,this.mustUseProperty=n,this.propertyName=e,this.type=t,this.sanitizeURL=o,this.removeEmptyString=i}var v={};"children dangerouslySetInnerHTML defaultValue defaultChecked innerHTML suppressContentEditableWarning suppressHydrationWarning style".split(" ").forEach((function(e){v[e]=new h(e,0,!1,e,null,!1,!1)})),[["acceptCharset","accept-charset"],["className","class"],["htmlFor","for"],["httpEquiv","http-equiv"]].forEach((function(e){var t=e[0];v[t]=new h(t,1,!1,e[1],null,!1,!1)})),["contentEditable","draggable","spellCheck","value"].forEach((function(e){v[e]=new h(e,2,!1,e.toLowerCase(),null,!1,!1)})),["autoReverse","externalResourcesRequired","focusable","preserveAlpha"].forEach((function(e){v[e]=new h(e,2,!1,e,null,!1,!1)})),"allowFullScreen async autoFocus autoPlay controls default defer disabled disablePictureInPicture disableRemotePlayback formNoValidate hidden loop noModule noValidate open playsInline readOnly required reversed scoped seamless itemScope".split(" ").forEach((function(e){v[e]=new h(e,3,!1,e.toLowerCase(),null,!1,!1)})),["checked","multiple","muted","selected"].forEach((function(e){v[e]=new h(e,3,!0,e,null,!1,!1)})),["capture","download"].forEach((function(e){v[e]=new h(e,4,!1,e,null,!1,!1)})),["cols","rows","size","span"].forEach((function(e){v[e]=new h(e,6,!1,e,null,!1,!1)})),["rowSpan","start"].forEach((function(e){v[e]=new h(e,5,!1,e.toLowerCase(),null,!1,!1)}));var b=/[\-:]([a-z])/g;function y(e){return e[1].toUpperCase()}function g(e,t,n,r){var a=v.hasOwnProperty(t)?v[t]:null;(null!==a?0!==a.type:r||!(2<t.length)||"o"!==t[0]&&"O"!==t[0]||"n"!==t[1]&&"N"!==t[1])&&(function(e,t,n,r){if(null===t||"undefined"===typeof t||function(e,t,n,r){if(null!==n&&0===n.type)return!1;switch(typeof t){case"function":case"symbol":return!0;case"boolean":return!r&&(null!==n?!n.acceptsBooleans:"data-"!==(e=e.toLowerCase().slice(0,5))&&"aria-"!==e);default:return!1}}(e,t,n,r))return!0;if(r)return!1;if(null!==n)switch(n.type){case 3:return!t;case 4:return!1===t;case 5:return isNaN(t);case 6:return isNaN(t)||1>t}return!1}(t,n,a,r)&&(n=null),r||null===a?function(e){return!!d.call(m,e)||!d.call(p,e)&&(f.test(e)?m[e]=!0:(p[e]=!0,!1))}(t)&&(null===n?e.removeAttribute(t):e.setAttribute(t,""+n)):a.mustUseProperty?e[a.propertyName]=null===n?3!==a.type&&"":n:(t=a.attributeName,r=a.attributeNamespace,null===n?e.removeAttribute(t):(n=3===(a=a.type)||4===a&&!0===n?"":""+n,r?e.setAttributeNS(r,t,n):e.setAttribute(t,n))))}"accent-height alignment-baseline arabic-form baseline-shift cap-height clip-path clip-rule color-interpolation color-interpolation-filters color-profile color-rendering dominant-baseline enable-background fill-opacity fill-rule flood-color flood-opacity font-family font-size font-size-adjust font-stretch font-style font-variant font-weight glyph-name glyph-orientation-horizontal glyph-orientation-vertical horiz-adv-x horiz-origin-x image-rendering letter-spacing lighting-color marker-end marker-mid marker-start overline-position overline-thickness paint-order panose-1 pointer-events rendering-intent shape-rendering stop-color stop-opacity strikethrough-position strikethrough-thickness stroke-dasharray stroke-dashoffset stroke-linecap stroke-linejoin stroke-miterlimit stroke-opacity stroke-width text-anchor text-decoration text-rendering underline-position underline-thickness unicode-bidi unicode-range units-per-em v-alphabetic v-hanging v-ideographic v-mathematical vector-effect vert-adv-y vert-origin-x vert-origin-y word-spacing writing-mode xmlns:xlink x-height".split(" ").forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,null,!1,!1)})),"xlink:actuate xlink:arcrole xlink:role xlink:show xlink:title xlink:type".split(" ").forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,"http://www.w3.org/1999/xlink",!1,!1)})),["xml:base","xml:lang","xml:space"].forEach((function(e){var t=e.replace(b,y);v[t]=new h(t,1,!1,e,"http://www.w3.org/XML/1998/namespace",!1,!1)})),["tabIndex","crossOrigin"].forEach((function(e){v[e]=new h(e,1,!1,e.toLowerCase(),null,!1,!1)})),v.xlinkHref=new h("xlinkHref",1,!1,"xlink:href","http://www.w3.org/1999/xlink",!0,!1),["src","href","action","formAction"].forEach((function(e){v[e]=new h(e,1,!1,e.toLowerCase(),null,!0,!0)}));var _=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED,w=Symbol.for("react.element"),k=Symbol.for("react.portal"),S=Symbol.for("react.fragment"),T=Symbol.for("react.strict_mode"),C=Symbol.for("react.profiler"),x=Symbol.for("react.provider"),A=Symbol.for("react.context"),F=Symbol.for("react.forward_ref"),E=Symbol.for("react.suspense"),P=Symbol.for("react.suspense_list"),O=Symbol.for("react.memo"),N=Symbol.for("react.lazy");Symbol.for("react.scope"),Symbol.for("react.debug_trace_mode");var M=Symbol.for("react.offscreen");Symbol.for("react.legacy_hidden"),Symbol.for("react.cache"),Symbol.for("react.tracing_marker");var R=Symbol.iterator;function D(e){return null===e||"object"!==typeof e?null:"function"===typeof(e=R&&e[R]||e["@@iterator"])?e:null}var L,I=Object.assign;function z(e){if(void 0===L)try{throw Error()}catch(n){var t=n.stack.trim().match(/\n( *(at )?)/);L=t&&t[1]||""}return"\n"+L+e}var j=!1;function Z(e,t){if(!e||j)return"";j=!0;var n=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{if(t)if(t=function(){throw Error()},Object.defineProperty(t.prototype,"props",{set:function(){throw Error()}}),"object"===typeof Reflect&&Reflect.construct){try{Reflect.construct(t,[])}catch(u){var r=u}Reflect.construct(e,[],t)}else{try{t.call()}catch(u){r=u}e.call(t.prototype)}else{try{throw Error()}catch(u){r=u}e()}}catch(u){if(u&&r&&"string"===typeof u.stack){for(var a=u.stack.split("\n"),o=r.stack.split("\n"),i=a.length-1,s=o.length-1;1<=i&&0<=s&&a[i]!==o[s];)s--;for(;1<=i&&0<=s;i--,s--)if(a[i]!==o[s]){if(1!==i||1!==s)do{if(i--,0>--s||a[i]!==o[s]){var l="\n"+a[i].replace(" at new "," at ");return e.displayName&&l.includes("<anonymous>")&&(l=l.replace("<anonymous>",e.displayName)),l}}while(1<=i&&0<=s);break}}}finally{j=!1,Error.prepareStackTrace=n}return(e=e?e.displayName||e.name:"")?z(e):""}function B(e){switch(e.tag){case 5:return z(e.type);case 16:return z("Lazy");case 13:return z("Suspense");case 19:return z("SuspenseList");case 0:case 2:case 15:return e=Z(e.type,!1);case 11:return e=Z(e.type.render,!1);case 1:return e=Z(e.type,!0);default:return""}}function V(e){if(null==e)return null;if("function"===typeof e)return e.displayName||e.name||null;if("string"===typeof e)return e;switch(e){case S:return"Fragment";case k:return"Portal";case C:return"Profiler";case T:return"StrictMode";case E:return"Suspense";case P:return"SuspenseList"}if("object"===typeof e)switch(e.$$typeof){case A:return(e.displayName||"Context")+".Consumer";case x:return(e._context.displayName||"Context")+".Provider";case F:var t=e.render;return(e=e.displayName)||(e=""!==(e=t.displayName||t.name||"")?"ForwardRef("+e+")":"ForwardRef"),e;case O:return null!==(t=e.displayName||null)?t:V(e.type)||"Memo";case N:t=e._payload,e=e._init;try{return V(e(t))}catch(n){}}return null}function W(e){var t=e.type;switch(e.tag){case 24:return"Cache";case 9:return(t.displayName||"Context")+".Consumer";case 10:return(t._context.displayName||"Context")+".Provider";case 18:return"DehydratedFragment";case 11:return e=(e=t.render).displayName||e.name||"",t.displayName||(""!==e?"ForwardRef("+e+")":"ForwardRef");case 7:return"Fragment";case 5:return t;case 4:return"Portal";case 3:return"Root";case 6:return"Text";case 16:return V(t);case 8:return t===T?"StrictMode":"Mode";case 22:return"Offscreen";case 12:return"Profiler";case 21:return"Scope";case 13:return"Suspense";case 19:return"SuspenseList";case 25:return"TracingMarker";case 1:case 0:case 17:case 2:case 14:case 15:if("function"===typeof t)return t.displayName||t.name||null;if("string"===typeof t)return t}return null}function G(e){switch(typeof e){case"boolean":case"number":case"string":case"undefined":case"object":return e;default:return""}}function U(e){var t=e.type;return(e=e.nodeName)&&"input"===e.toLowerCase()&&("checkbox"===t||"radio"===t)}function H(e){e._valueTracker||(e._valueTracker=function(e){var t=U(e)?"checked":"value",n=Object.getOwnPropertyDescriptor(e.constructor.prototype,t),r=""+e[t];if(!e.hasOwnProperty(t)&&"undefined"!==typeof n&&"function"===typeof n.get&&"function"===typeof n.set){var a=n.get,o=n.set;return Object.defineProperty(e,t,{configurable:!0,get:function(){return a.call(this)},set:function(e){r=""+e,o.call(this,e)}}),Object.defineProperty(e,t,{enumerable:n.enumerable}),{getValue:function(){return r},setValue:function(e){r=""+e},stopTracking:function(){e._valueTracker=null,delete e[t]}}}}(e))}function $(e){if(!e)return!1;var t=e._valueTracker;if(!t)return!0;var n=t.getValue(),r="";return e&&(r=U(e)?e.checked?"true":"false":e.value),(e=r)!==n&&(t.setValue(e),!0)}function J(e){if("undefined"===typeof(e=e||("undefined"!==typeof document?document:void 0)))return null;try{return e.activeElement||e.body}catch(t){return e.body}}function q(e,t){var n=t.checked;return I({},t,{defaultChecked:void 0,defaultValue:void 0,value:void 0,checked:null!=n?n:e._wrapperState.initialChecked})}function Q(e,t){var n=null==t.defaultValue?"":t.defaultValue,r=null!=t.checked?t.checked:t.defaultChecked;n=G(null!=t.value?t.value:n),e._wrapperState={initialChecked:r,initialValue:n,controlled:"checkbox"===t.type||"radio"===t.type?null!=t.checked:null!=t.value}}function K(e,t){null!=(t=t.checked)&&g(e,"checked",t,!1)}function Y(e,t){K(e,t);var n=G(t.value),r=t.type;if(null!=n)"number"===r?(0===n&&""===e.value||e.value!=n)&&(e.value=""+n):e.value!==""+n&&(e.value=""+n);else if("submit"===r||"reset"===r)return void e.removeAttribute("value");t.hasOwnProperty("value")?ee(e,t.type,n):t.hasOwnProperty("defaultValue")&&ee(e,t.type,G(t.defaultValue)),null==t.checked&&null!=t.defaultChecked&&(e.defaultChecked=!!t.defaultChecked)}function X(e,t,n){if(t.hasOwnProperty("value")||t.hasOwnProperty("defaultValue")){var r=t.type;if(!("submit"!==r&&"reset"!==r||void 0!==t.value&&null!==t.value))return;t=""+e._wrapperState.initialValue,n||t===e.value||(e.value=t),e.defaultValue=t}""!==(n=e.name)&&(e.name=""),e.defaultChecked=!!e._wrapperState.initialChecked,""!==n&&(e.name=n)}function ee(e,t,n){"number"===t&&J(e.ownerDocument)===e||(null==n?e.defaultValue=""+e._wrapperState.initialValue:e.defaultValue!==""+n&&(e.defaultValue=""+n))}var te=Array.isArray;function ne(e,t,n,r){if(e=e.options,t){t={};for(var a=0;a<n.length;a++)t["$"+n[a]]=!0;for(n=0;n<e.length;n++)a=t.hasOwnProperty("$"+e[n].value),e[n].selected!==a&&(e[n].selected=a),a&&r&&(e[n].defaultSelected=!0)}else{for(n=""+G(n),t=null,a=0;a<e.length;a++){if(e[a].value===n)return e[a].selected=!0,void(r&&(e[a].defaultSelected=!0));null!==t||e[a].disabled||(t=e[a])}null!==t&&(t.selected=!0)}}function re(e,t){if(null!=t.dangerouslySetInnerHTML)throw Error(o(91));return I({},t,{value:void 0,defaultValue:void 0,children:""+e._wrapperState.initialValue})}function ae(e,t){var n=t.value;if(null==n){if(n=t.children,t=t.defaultValue,null!=n){if(null!=t)throw Error(o(92));if(te(n)){if(1<n.length)throw Error(o(93));n=n[0]}t=n}null==t&&(t=""),n=t}e._wrapperState={initialValue:G(n)}}function oe(e,t){var n=G(t.value),r=G(t.defaultValue);null!=n&&((n=""+n)!==e.value&&(e.value=n),null==t.defaultValue&&e.defaultValue!==n&&(e.defaultValue=n)),null!=r&&(e.defaultValue=""+r)}function ie(e){var t=e.textContent;t===e._wrapperState.initialValue&&""!==t&&null!==t&&(e.value=t)}function se(e){switch(e){case"svg":return"http://www.w3.org/2000/svg";case"math":return"http://www.w3.org/1998/Math/MathML";default:return"http://www.w3.org/1999/xhtml"}}function le(e,t){return null==e||"http://www.w3.org/1999/xhtml"===e?se(t):"http://www.w3.org/2000/svg"===e&&"foreignObject"===t?"http://www.w3.org/1999/xhtml":e}var ue,ce,de=(ce=function(e,t){if("http://www.w3.org/2000/svg"!==e.namespaceURI||"innerHTML"in e)e.innerHTML=t;else{for((ue=ue||document.createElement("div")).innerHTML="<svg>"+t.valueOf().toString()+"</svg>",t=ue.firstChild;e.firstChild;)e.removeChild(e.firstChild);for(;t.firstChild;)e.appendChild(t.firstChild)}},"undefined"!==typeof MSApp&&MSApp.execUnsafeLocalFunction?function(e,t,n,r){MSApp.execUnsafeLocalFunction((function(){return ce(e,t)}))}:ce);function fe(e,t){if(t){var n=e.firstChild;if(n&&n===e.lastChild&&3===n.nodeType)return void(n.nodeValue=t)}e.textContent=t}var pe={animationIterationCount:!0,aspectRatio:!0,borderImageOutset:!0,borderImageSlice:!0,borderImageWidth:!0,boxFlex:!0,boxFlexGroup:!0,boxOrdinalGroup:!0,columnCount:!0,columns:!0,flex:!0,flexGrow:!0,flexPositive:!0,flexShrink:!0,flexNegative:!0,flexOrder:!0,gridArea:!0,gridRow:!0,gridRowEnd:!0,gridRowSpan:!0,gridRowStart:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnSpan:!0,gridColumnStart:!0,fontWeight:!0,lineClamp:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,tabSize:!0,widows:!0,zIndex:!0,zoom:!0,fillOpacity:!0,floodOpacity:!0,stopOpacity:!0,strokeDasharray:!0,strokeDashoffset:!0,strokeMiterlimit:!0,strokeOpacity:!0,strokeWidth:!0},me=["Webkit","ms","Moz","O"];function he(e,t,n){return null==t||"boolean"===typeof t||""===t?"":n||"number"!==typeof t||0===t||pe.hasOwnProperty(e)&&pe[e]?(""+t).trim():t+"px"}function ve(e,t){for(var n in e=e.style,t)if(t.hasOwnProperty(n)){var r=0===n.indexOf("--"),a=he(n,t[n],r);"float"===n&&(n="cssFloat"),r?e.setProperty(n,a):e[n]=a}}Object.keys(pe).forEach((function(e){me.forEach((function(t){t=t+e.charAt(0).toUpperCase()+e.substring(1),pe[t]=pe[e]}))}));var be=I({menuitem:!0},{area:!0,base:!0,br:!0,col:!0,embed:!0,hr:!0,img:!0,input:!0,keygen:!0,link:!0,meta:!0,param:!0,source:!0,track:!0,wbr:!0});function ye(e,t){if(t){if(be[e]&&(null!=t.children||null!=t.dangerouslySetInnerHTML))throw Error(o(137,e));if(null!=t.dangerouslySetInnerHTML){if(null!=t.children)throw Error(o(60));if("object"!==typeof t.dangerouslySetInnerHTML||!("__html"in t.dangerouslySetInnerHTML))throw Error(o(61))}if(null!=t.style&&"object"!==typeof t.style)throw Error(o(62))}}function ge(e,t){if(-1===e.indexOf("-"))return"string"===typeof t.is;switch(e){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var _e=null;function we(e){return(e=e.target||e.srcElement||window).correspondingUseElement&&(e=e.correspondingUseElement),3===e.nodeType?e.parentNode:e}var ke=null,Se=null,Te=null;function Ce(e){if(e=ga(e)){if("function"!==typeof ke)throw Error(o(280));var t=e.stateNode;t&&(t=wa(t),ke(e.stateNode,e.type,t))}}function xe(e){Se?Te?Te.push(e):Te=[e]:Se=e}function Ae(){if(Se){var e=Se,t=Te;if(Te=Se=null,Ce(e),t)for(e=0;e<t.length;e++)Ce(t[e])}}function Fe(e,t){return e(t)}function Ee(){}var Pe=!1;function Oe(e,t,n){if(Pe)return e(t,n);Pe=!0;try{return Fe(e,t,n)}finally{Pe=!1,(null!==Se||null!==Te)&&(Ee(),Ae())}}function Ne(e,t){var n=e.stateNode;if(null===n)return null;var r=wa(n);if(null===r)return null;n=r[t];e:switch(t){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(r=!r.disabled)||(r=!("button"===(e=e.type)||"input"===e||"select"===e||"textarea"===e)),e=!r;break e;default:e=!1}if(e)return null;if(n&&"function"!==typeof n)throw Error(o(231,t,typeof n));return n}var Me=!1;if(c)try{var Re={};Object.defineProperty(Re,"passive",{get:function(){Me=!0}}),window.addEventListener("test",Re,Re),window.removeEventListener("test",Re,Re)}catch(ce){Me=!1}function De(e,t,n,r,a,o,i,s,l){var u=Array.prototype.slice.call(arguments,3);try{t.apply(n,u)}catch(c){this.onError(c)}}var Le=!1,Ie=null,ze=!1,je=null,Ze={onError:function(e){Le=!0,Ie=e}};function Be(e,t,n,r,a,o,i,s,l){Le=!1,Ie=null,De.apply(Ze,arguments)}function Ve(e){var t=e,n=e;if(e.alternate)for(;t.return;)t=t.return;else{e=t;do{0!==(4098&(t=e).flags)&&(n=t.return),e=t.return}while(e)}return 3===t.tag?n:null}function We(e){if(13===e.tag){var t=e.memoizedState;if(null===t&&(null!==(e=e.alternate)&&(t=e.memoizedState)),null!==t)return t.dehydrated}return null}function Ge(e){if(Ve(e)!==e)throw Error(o(188))}function Ue(e){return null!==(e=function(e){var t=e.alternate;if(!t){if(null===(t=Ve(e)))throw Error(o(188));return t!==e?null:e}for(var n=e,r=t;;){var a=n.return;if(null===a)break;var i=a.alternate;if(null===i){if(null!==(r=a.return)){n=r;continue}break}if(a.child===i.child){for(i=a.child;i;){if(i===n)return Ge(a),e;if(i===r)return Ge(a),t;i=i.sibling}throw Error(o(188))}if(n.return!==r.return)n=a,r=i;else{for(var s=!1,l=a.child;l;){if(l===n){s=!0,n=a,r=i;break}if(l===r){s=!0,r=a,n=i;break}l=l.sibling}if(!s){for(l=i.child;l;){if(l===n){s=!0,n=i,r=a;break}if(l===r){s=!0,r=i,n=a;break}l=l.sibling}if(!s)throw Error(o(189))}}if(n.alternate!==r)throw Error(o(190))}if(3!==n.tag)throw Error(o(188));return n.stateNode.current===n?e:t}(e))?He(e):null}function He(e){if(5===e.tag||6===e.tag)return e;for(e=e.child;null!==e;){var t=He(e);if(null!==t)return t;e=e.sibling}return null}var $e=a.unstable_scheduleCallback,Je=a.unstable_cancelCallback,qe=a.unstable_shouldYield,Qe=a.unstable_requestPaint,Ke=a.unstable_now,Ye=a.unstable_getCurrentPriorityLevel,Xe=a.unstable_ImmediatePriority,et=a.unstable_UserBlockingPriority,tt=a.unstable_NormalPriority,nt=a.unstable_LowPriority,rt=a.unstable_IdlePriority,at=null,ot=null;var it=Math.clz32?Math.clz32:function(e){return 0===(e>>>=0)?32:31-(st(e)/lt|0)|0},st=Math.log,lt=Math.LN2;var ut=64,ct=4194304;function dt(e){switch(e&-e){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return 4194240&e;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return 130023424&e;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 1073741824;default:return e}}function ft(e,t){var n=e.pendingLanes;if(0===n)return 0;var r=0,a=e.suspendedLanes,o=e.pingedLanes,i=268435455&n;if(0!==i){var s=i&~a;0!==s?r=dt(s):0!==(o&=i)&&(r=dt(o))}else 0!==(i=n&~a)?r=dt(i):0!==o&&(r=dt(o));if(0===r)return 0;if(0!==t&&t!==r&&0===(t&a)&&((a=r&-r)>=(o=t&-t)||16===a&&0!==(4194240&o)))return t;if(0!==(4&r)&&(r|=16&n),0!==(t=e.entangledLanes))for(e=e.entanglements,t&=r;0<t;)a=1<<(n=31-it(t)),r|=e[n],t&=~a;return r}function pt(e,t){switch(e){case 1:case 2:case 4:return t+250;case 8:case 16:case 32:case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return t+5e3;default:return-1}}function mt(e){return 0!==(e=-1073741825&e.pendingLanes)?e:1073741824&e?1073741824:0}function ht(){var e=ut;return 0===(4194240&(ut<<=1))&&(ut=64),e}function vt(e){for(var t=[],n=0;31>n;n++)t.push(e);return t}function bt(e,t,n){e.pendingLanes|=t,536870912!==t&&(e.suspendedLanes=0,e.pingedLanes=0),(e=e.eventTimes)[t=31-it(t)]=n}function yt(e,t){var n=e.entangledLanes|=t;for(e=e.entanglements;n;){var r=31-it(n),a=1<<r;a&t|e[r]&t&&(e[r]|=t),n&=~a}}var gt=0;function _t(e){return 1<(e&=-e)?4<e?0!==(268435455&e)?16:536870912:4:1}var wt,kt,St,Tt,Ct,xt=!1,At=[],Ft=null,Et=null,Pt=null,Ot=new Map,Nt=new Map,Mt=[],Rt="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset submit".split(" ");function Dt(e,t){switch(e){case"focusin":case"focusout":Ft=null;break;case"dragenter":case"dragleave":Et=null;break;case"mouseover":case"mouseout":Pt=null;break;case"pointerover":case"pointerout":Ot.delete(t.pointerId);break;case"gotpointercapture":case"lostpointercapture":Nt.delete(t.pointerId)}}function Lt(e,t,n,r,a,o){return null===e||e.nativeEvent!==o?(e={blockedOn:t,domEventName:n,eventSystemFlags:r,nativeEvent:o,targetContainers:[a]},null!==t&&(null!==(t=ga(t))&&kt(t)),e):(e.eventSystemFlags|=r,t=e.targetContainers,null!==a&&-1===t.indexOf(a)&&t.push(a),e)}function It(e){var t=ya(e.target);if(null!==t){var n=Ve(t);if(null!==n)if(13===(t=n.tag)){if(null!==(t=We(n)))return e.blockedOn=t,void Ct(e.priority,(function(){St(n)}))}else if(3===t&&n.stateNode.current.memoizedState.isDehydrated)return void(e.blockedOn=3===n.tag?n.stateNode.containerInfo:null)}e.blockedOn=null}function zt(e){if(null!==e.blockedOn)return!1;for(var t=e.targetContainers;0<t.length;){var n=qt(e.domEventName,e.eventSystemFlags,t[0],e.nativeEvent);if(null!==n)return null!==(t=ga(n))&&kt(t),e.blockedOn=n,!1;var r=new(n=e.nativeEvent).constructor(n.type,n);_e=r,n.target.dispatchEvent(r),_e=null,t.shift()}return!0}function jt(e,t,n){zt(e)&&n.delete(t)}function Zt(){xt=!1,null!==Ft&&zt(Ft)&&(Ft=null),null!==Et&&zt(Et)&&(Et=null),null!==Pt&&zt(Pt)&&(Pt=null),Ot.forEach(jt),Nt.forEach(jt)}function Bt(e,t){e.blockedOn===t&&(e.blockedOn=null,xt||(xt=!0,a.unstable_scheduleCallback(a.unstable_NormalPriority,Zt)))}function Vt(e){function t(t){return Bt(t,e)}if(0<At.length){Bt(At[0],e);for(var n=1;n<At.length;n++){var r=At[n];r.blockedOn===e&&(r.blockedOn=null)}}for(null!==Ft&&Bt(Ft,e),null!==Et&&Bt(Et,e),null!==Pt&&Bt(Pt,e),Ot.forEach(t),Nt.forEach(t),n=0;n<Mt.length;n++)(r=Mt[n]).blockedOn===e&&(r.blockedOn=null);for(;0<Mt.length&&null===(n=Mt[0]).blockedOn;)It(n),null===n.blockedOn&&Mt.shift()}var Wt=_.ReactCurrentBatchConfig,Gt=!0;function Ut(e,t,n,r){var a=gt,o=Wt.transition;Wt.transition=null;try{gt=1,$t(e,t,n,r)}finally{gt=a,Wt.transition=o}}function Ht(e,t,n,r){var a=gt,o=Wt.transition;Wt.transition=null;try{gt=4,$t(e,t,n,r)}finally{gt=a,Wt.transition=o}}function $t(e,t,n,r){if(Gt){var a=qt(e,t,n,r);if(null===a)Gr(e,t,r,Jt,n),Dt(e,r);else if(function(e,t,n,r,a){switch(t){case"focusin":return Ft=Lt(Ft,e,t,n,r,a),!0;case"dragenter":return Et=Lt(Et,e,t,n,r,a),!0;case"mouseover":return Pt=Lt(Pt,e,t,n,r,a),!0;case"pointerover":var o=a.pointerId;return Ot.set(o,Lt(Ot.get(o)||null,e,t,n,r,a)),!0;case"gotpointercapture":return o=a.pointerId,Nt.set(o,Lt(Nt.get(o)||null,e,t,n,r,a)),!0}return!1}(a,e,t,n,r))r.stopPropagation();else if(Dt(e,r),4&t&&-1<Rt.indexOf(e)){for(;null!==a;){var o=ga(a);if(null!==o&&wt(o),null===(o=qt(e,t,n,r))&&Gr(e,t,r,Jt,n),o===a)break;a=o}null!==a&&r.stopPropagation()}else Gr(e,t,r,null,n)}}var Jt=null;function qt(e,t,n,r){if(Jt=null,null!==(e=ya(e=we(r))))if(null===(t=Ve(e)))e=null;else if(13===(n=t.tag)){if(null!==(e=We(t)))return e;e=null}else if(3===n){if(t.stateNode.current.memoizedState.isDehydrated)return 3===t.tag?t.stateNode.containerInfo:null;e=null}else t!==e&&(e=null);return Jt=e,null}function Qt(e){switch(e){case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 1;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"toggle":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 4;case"message":switch(Ye()){case Xe:return 1;case et:return 4;case tt:case nt:return 16;case rt:return 536870912;default:return 16}default:return 16}}var Kt=null,Yt=null,Xt=null;function en(){if(Xt)return Xt;var e,t,n=Yt,r=n.length,a="value"in Kt?Kt.value:Kt.textContent,o=a.length;for(e=0;e<r&&n[e]===a[e];e++);var i=r-e;for(t=1;t<=i&&n[r-t]===a[o-t];t++);return Xt=a.slice(e,1<t?1-t:void 0)}function tn(e){var t=e.keyCode;return"charCode"in e?0===(e=e.charCode)&&13===t&&(e=13):e=t,10===e&&(e=13),32<=e||13===e?e:0}function nn(){return!0}function rn(){return!1}function an(e){function t(t,n,r,a,o){for(var i in this._reactName=t,this._targetInst=r,this.type=n,this.nativeEvent=a,this.target=o,this.currentTarget=null,e)e.hasOwnProperty(i)&&(t=e[i],this[i]=t?t(a):a[i]);return this.isDefaultPrevented=(null!=a.defaultPrevented?a.defaultPrevented:!1===a.returnValue)?nn:rn,this.isPropagationStopped=rn,this}return I(t.prototype,{preventDefault:function(){this.defaultPrevented=!0;var e=this.nativeEvent;e&&(e.preventDefault?e.preventDefault():"unknown"!==typeof e.returnValue&&(e.returnValue=!1),this.isDefaultPrevented=nn)},stopPropagation:function(){var e=this.nativeEvent;e&&(e.stopPropagation?e.stopPropagation():"unknown"!==typeof e.cancelBubble&&(e.cancelBubble=!0),this.isPropagationStopped=nn)},persist:function(){},isPersistent:nn}),t}var on,sn,ln,un={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(e){return e.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},cn=an(un),dn=I({},un,{view:0,detail:0}),fn=an(dn),pn=I({},dn,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:Cn,button:0,buttons:0,relatedTarget:function(e){return void 0===e.relatedTarget?e.fromElement===e.srcElement?e.toElement:e.fromElement:e.relatedTarget},movementX:function(e){return"movementX"in e?e.movementX:(e!==ln&&(ln&&"mousemove"===e.type?(on=e.screenX-ln.screenX,sn=e.screenY-ln.screenY):sn=on=0,ln=e),on)},movementY:function(e){return"movementY"in e?e.movementY:sn}}),mn=an(pn),hn=an(I({},pn,{dataTransfer:0})),vn=an(I({},dn,{relatedTarget:0})),bn=an(I({},un,{animationName:0,elapsedTime:0,pseudoElement:0})),yn=I({},un,{clipboardData:function(e){return"clipboardData"in e?e.clipboardData:window.clipboardData}}),gn=an(yn),_n=an(I({},un,{data:0})),wn={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},kn={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},Sn={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function Tn(e){var t=this.nativeEvent;return t.getModifierState?t.getModifierState(e):!!(e=Sn[e])&&!!t[e]}function Cn(){return Tn}var xn=I({},dn,{key:function(e){if(e.key){var t=wn[e.key]||e.key;if("Unidentified"!==t)return t}return"keypress"===e.type?13===(e=tn(e))?"Enter":String.fromCharCode(e):"keydown"===e.type||"keyup"===e.type?kn[e.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:Cn,charCode:function(e){return"keypress"===e.type?tn(e):0},keyCode:function(e){return"keydown"===e.type||"keyup"===e.type?e.keyCode:0},which:function(e){return"keypress"===e.type?tn(e):"keydown"===e.type||"keyup"===e.type?e.keyCode:0}}),An=an(xn),Fn=an(I({},pn,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0})),En=an(I({},dn,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:Cn})),Pn=an(I({},un,{propertyName:0,elapsedTime:0,pseudoElement:0})),On=I({},pn,{deltaX:function(e){return"deltaX"in e?e.deltaX:"wheelDeltaX"in e?-e.wheelDeltaX:0},deltaY:function(e){return"deltaY"in e?e.deltaY:"wheelDeltaY"in e?-e.wheelDeltaY:"wheelDelta"in e?-e.wheelDelta:0},deltaZ:0,deltaMode:0}),Nn=an(On),Mn=[9,13,27,32],Rn=c&&"CompositionEvent"in window,Dn=null;c&&"documentMode"in document&&(Dn=document.documentMode);var Ln=c&&"TextEvent"in window&&!Dn,In=c&&(!Rn||Dn&&8<Dn&&11>=Dn),zn=String.fromCharCode(32),jn=!1;function Zn(e,t){switch(e){case"keyup":return-1!==Mn.indexOf(t.keyCode);case"keydown":return 229!==t.keyCode;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function Bn(e){return"object"===typeof(e=e.detail)&&"data"in e?e.data:null}var Vn=!1;var Wn={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function Gn(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return"input"===t?!!Wn[e.type]:"textarea"===t}function Un(e,t,n,r){xe(r),0<(t=Hr(t,"onChange")).length&&(n=new cn("onChange","change",null,n,r),e.push({event:n,listeners:t}))}var Hn=null,$n=null;function Jn(e){zr(e,0)}function qn(e){if($(_a(e)))return e}function Qn(e,t){if("change"===e)return t}var Kn=!1;if(c){var Yn;if(c){var Xn="oninput"in document;if(!Xn){var er=document.createElement("div");er.setAttribute("oninput","return;"),Xn="function"===typeof er.oninput}Yn=Xn}else Yn=!1;Kn=Yn&&(!document.documentMode||9<document.documentMode)}function tr(){Hn&&(Hn.detachEvent("onpropertychange",nr),$n=Hn=null)}function nr(e){if("value"===e.propertyName&&qn($n)){var t=[];Un(t,$n,e,we(e)),Oe(Jn,t)}}function rr(e,t,n){"focusin"===e?(tr(),$n=n,(Hn=t).attachEvent("onpropertychange",nr)):"focusout"===e&&tr()}function ar(e){if("selectionchange"===e||"keyup"===e||"keydown"===e)return qn($n)}function or(e,t){if("click"===e)return qn(t)}function ir(e,t){if("input"===e||"change"===e)return qn(t)}var sr="function"===typeof Object.is?Object.is:function(e,t){return e===t&&(0!==e||1/e===1/t)||e!==e&&t!==t};function lr(e,t){if(sr(e,t))return!0;if("object"!==typeof e||null===e||"object"!==typeof t||null===t)return!1;var n=Object.keys(e),r=Object.keys(t);if(n.length!==r.length)return!1;for(r=0;r<n.length;r++){var a=n[r];if(!d.call(t,a)||!sr(e[a],t[a]))return!1}return!0}function ur(e){for(;e&&e.firstChild;)e=e.firstChild;return e}function cr(e,t){var n,r=ur(e);for(e=0;r;){if(3===r.nodeType){if(n=e+r.textContent.length,e<=t&&n>=t)return{node:r,offset:t-e};e=n}e:{for(;r;){if(r.nextSibling){r=r.nextSibling;break e}r=r.parentNode}r=void 0}r=ur(r)}}function dr(e,t){return!(!e||!t)&&(e===t||(!e||3!==e.nodeType)&&(t&&3===t.nodeType?dr(e,t.parentNode):"contains"in e?e.contains(t):!!e.compareDocumentPosition&&!!(16&e.compareDocumentPosition(t))))}function fr(){for(var e=window,t=J();t instanceof e.HTMLIFrameElement;){try{var n="string"===typeof t.contentWindow.location.href}catch(r){n=!1}if(!n)break;t=J((e=t.contentWindow).document)}return t}function pr(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return t&&("input"===t&&("text"===e.type||"search"===e.type||"tel"===e.type||"url"===e.type||"password"===e.type)||"textarea"===t||"true"===e.contentEditable)}function mr(e){var t=fr(),n=e.focusedElem,r=e.selectionRange;if(t!==n&&n&&n.ownerDocument&&dr(n.ownerDocument.documentElement,n)){if(null!==r&&pr(n))if(t=r.start,void 0===(e=r.end)&&(e=t),"selectionStart"in n)n.selectionStart=t,n.selectionEnd=Math.min(e,n.value.length);else if((e=(t=n.ownerDocument||document)&&t.defaultView||window).getSelection){e=e.getSelection();var a=n.textContent.length,o=Math.min(r.start,a);r=void 0===r.end?o:Math.min(r.end,a),!e.extend&&o>r&&(a=r,r=o,o=a),a=cr(n,o);var i=cr(n,r);a&&i&&(1!==e.rangeCount||e.anchorNode!==a.node||e.anchorOffset!==a.offset||e.focusNode!==i.node||e.focusOffset!==i.offset)&&((t=t.createRange()).setStart(a.node,a.offset),e.removeAllRanges(),o>r?(e.addRange(t),e.extend(i.node,i.offset)):(t.setEnd(i.node,i.offset),e.addRange(t)))}for(t=[],e=n;e=e.parentNode;)1===e.nodeType&&t.push({element:e,left:e.scrollLeft,top:e.scrollTop});for("function"===typeof n.focus&&n.focus(),n=0;n<t.length;n++)(e=t[n]).element.scrollLeft=e.left,e.element.scrollTop=e.top}}var hr=c&&"documentMode"in document&&11>=document.documentMode,vr=null,br=null,yr=null,gr=!1;function _r(e,t,n){var r=n.window===n?n.document:9===n.nodeType?n:n.ownerDocument;gr||null==vr||vr!==J(r)||("selectionStart"in(r=vr)&&pr(r)?r={start:r.selectionStart,end:r.selectionEnd}:r={anchorNode:(r=(r.ownerDocument&&r.ownerDocument.defaultView||window).getSelection()).anchorNode,anchorOffset:r.anchorOffset,focusNode:r.focusNode,focusOffset:r.focusOffset},yr&&lr(yr,r)||(yr=r,0<(r=Hr(br,"onSelect")).length&&(t=new cn("onSelect","select",null,t,n),e.push({event:t,listeners:r}),t.target=vr)))}function wr(e,t){var n={};return n[e.toLowerCase()]=t.toLowerCase(),n["Webkit"+e]="webkit"+t,n["Moz"+e]="moz"+t,n}var kr={animationend:wr("Animation","AnimationEnd"),animationiteration:wr("Animation","AnimationIteration"),animationstart:wr("Animation","AnimationStart"),transitionend:wr("Transition","TransitionEnd")},Sr={},Tr={};function Cr(e){if(Sr[e])return Sr[e];if(!kr[e])return e;var t,n=kr[e];for(t in n)if(n.hasOwnProperty(t)&&t in Tr)return Sr[e]=n[t];return e}c&&(Tr=document.createElement("div").style,"AnimationEvent"in window||(delete kr.animationend.animation,delete kr.animationiteration.animation,delete kr.animationstart.animation),"TransitionEvent"in window||delete kr.transitionend.transition);var xr=Cr("animationend"),Ar=Cr("animationiteration"),Fr=Cr("animationstart"),Er=Cr("transitionend"),Pr=new Map,Or="abort auxClick cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");function Nr(e,t){Pr.set(e,t),l(t,[e])}for(var Mr=0;Mr<Or.length;Mr++){var Rr=Or[Mr];Nr(Rr.toLowerCase(),"on"+(Rr[0].toUpperCase()+Rr.slice(1)))}Nr(xr,"onAnimationEnd"),Nr(Ar,"onAnimationIteration"),Nr(Fr,"onAnimationStart"),Nr("dblclick","onDoubleClick"),Nr("focusin","onFocus"),Nr("focusout","onBlur"),Nr(Er,"onTransitionEnd"),u("onMouseEnter",["mouseout","mouseover"]),u("onMouseLeave",["mouseout","mouseover"]),u("onPointerEnter",["pointerout","pointerover"]),u("onPointerLeave",["pointerout","pointerover"]),l("onChange","change click focusin focusout input keydown keyup selectionchange".split(" ")),l("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" ")),l("onBeforeInput",["compositionend","keypress","textInput","paste"]),l("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" ")),l("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" ")),l("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var Dr="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),Lr=new Set("cancel close invalid load scroll toggle".split(" ").concat(Dr));function Ir(e,t,n){var r=e.type||"unknown-event";e.currentTarget=n,function(e,t,n,r,a,i,s,l,u){if(Be.apply(this,arguments),Le){if(!Le)throw Error(o(198));var c=Ie;Le=!1,Ie=null,ze||(ze=!0,je=c)}}(r,t,void 0,e),e.currentTarget=null}function zr(e,t){t=0!==(4&t);for(var n=0;n<e.length;n++){var r=e[n],a=r.event;r=r.listeners;e:{var o=void 0;if(t)for(var i=r.length-1;0<=i;i--){var s=r[i],l=s.instance,u=s.currentTarget;if(s=s.listener,l!==o&&a.isPropagationStopped())break e;Ir(a,s,u),o=l}else for(i=0;i<r.length;i++){if(l=(s=r[i]).instance,u=s.currentTarget,s=s.listener,l!==o&&a.isPropagationStopped())break e;Ir(a,s,u),o=l}}}if(ze)throw e=je,ze=!1,je=null,e}function jr(e,t){var n=t[ha];void 0===n&&(n=t[ha]=new Set);var r=e+"__bubble";n.has(r)||(Wr(t,e,2,!1),n.add(r))}function Zr(e,t,n){var r=0;t&&(r|=4),Wr(n,e,r,t)}var Br="_reactListening"+Math.random().toString(36).slice(2);function Vr(e){if(!e[Br]){e[Br]=!0,i.forEach((function(t){"selectionchange"!==t&&(Lr.has(t)||Zr(t,!1,e),Zr(t,!0,e))}));var t=9===e.nodeType?e:e.ownerDocument;null===t||t[Br]||(t[Br]=!0,Zr("selectionchange",!1,t))}}function Wr(e,t,n,r){switch(Qt(t)){case 1:var a=Ut;break;case 4:a=Ht;break;default:a=$t}n=a.bind(null,t,n,e),a=void 0,!Me||"touchstart"!==t&&"touchmove"!==t&&"wheel"!==t||(a=!0),r?void 0!==a?e.addEventListener(t,n,{capture:!0,passive:a}):e.addEventListener(t,n,!0):void 0!==a?e.addEventListener(t,n,{passive:a}):e.addEventListener(t,n,!1)}function Gr(e,t,n,r,a){var o=r;if(0===(1&t)&&0===(2&t)&&null!==r)e:for(;;){if(null===r)return;var i=r.tag;if(3===i||4===i){var s=r.stateNode.containerInfo;if(s===a||8===s.nodeType&&s.parentNode===a)break;if(4===i)for(i=r.return;null!==i;){var l=i.tag;if((3===l||4===l)&&((l=i.stateNode.containerInfo)===a||8===l.nodeType&&l.parentNode===a))return;i=i.return}for(;null!==s;){if(null===(i=ya(s)))return;if(5===(l=i.tag)||6===l){r=o=i;continue e}s=s.parentNode}}r=r.return}Oe((function(){var r=o,a=we(n),i=[];e:{var s=Pr.get(e);if(void 0!==s){var l=cn,u=e;switch(e){case"keypress":if(0===tn(n))break e;case"keydown":case"keyup":l=An;break;case"focusin":u="focus",l=vn;break;case"focusout":u="blur",l=vn;break;case"beforeblur":case"afterblur":l=vn;break;case"click":if(2===n.button)break e;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":l=mn;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":l=hn;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":l=En;break;case xr:case Ar:case Fr:l=bn;break;case Er:l=Pn;break;case"scroll":l=fn;break;case"wheel":l=Nn;break;case"copy":case"cut":case"paste":l=gn;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":l=Fn}var c=0!==(4&t),d=!c&&"scroll"===e,f=c?null!==s?s+"Capture":null:s;c=[];for(var p,m=r;null!==m;){var h=(p=m).stateNode;if(5===p.tag&&null!==h&&(p=h,null!==f&&(null!=(h=Ne(m,f))&&c.push(Ur(m,h,p)))),d)break;m=m.return}0<c.length&&(s=new l(s,u,null,n,a),i.push({event:s,listeners:c}))}}if(0===(7&t)){if(l="mouseout"===e||"pointerout"===e,(!(s="mouseover"===e||"pointerover"===e)||n===_e||!(u=n.relatedTarget||n.fromElement)||!ya(u)&&!u[ma])&&(l||s)&&(s=a.window===a?a:(s=a.ownerDocument)?s.defaultView||s.parentWindow:window,l?(l=r,null!==(u=(u=n.relatedTarget||n.toElement)?ya(u):null)&&(u!==(d=Ve(u))||5!==u.tag&&6!==u.tag)&&(u=null)):(l=null,u=r),l!==u)){if(c=mn,h="onMouseLeave",f="onMouseEnter",m="mouse","pointerout"!==e&&"pointerover"!==e||(c=Fn,h="onPointerLeave",f="onPointerEnter",m="pointer"),d=null==l?s:_a(l),p=null==u?s:_a(u),(s=new c(h,m+"leave",l,n,a)).target=d,s.relatedTarget=p,h=null,ya(a)===r&&((c=new c(f,m+"enter",u,n,a)).target=p,c.relatedTarget=d,h=c),d=h,l&&u)e:{for(f=u,m=0,p=c=l;p;p=$r(p))m++;for(p=0,h=f;h;h=$r(h))p++;for(;0<m-p;)c=$r(c),m--;for(;0<p-m;)f=$r(f),p--;for(;m--;){if(c===f||null!==f&&c===f.alternate)break e;c=$r(c),f=$r(f)}c=null}else c=null;null!==l&&Jr(i,s,l,c,!1),null!==u&&null!==d&&Jr(i,d,u,c,!0)}if("select"===(l=(s=r?_a(r):window).nodeName&&s.nodeName.toLowerCase())||"input"===l&&"file"===s.type)var v=Qn;else if(Gn(s))if(Kn)v=ir;else{v=ar;var b=rr}else(l=s.nodeName)&&"input"===l.toLowerCase()&&("checkbox"===s.type||"radio"===s.type)&&(v=or);switch(v&&(v=v(e,r))?Un(i,v,n,a):(b&&b(e,s,r),"focusout"===e&&(b=s._wrapperState)&&b.controlled&&"number"===s.type&&ee(s,"number",s.value)),b=r?_a(r):window,e){case"focusin":(Gn(b)||"true"===b.contentEditable)&&(vr=b,br=r,yr=null);break;case"focusout":yr=br=vr=null;break;case"mousedown":gr=!0;break;case"contextmenu":case"mouseup":case"dragend":gr=!1,_r(i,n,a);break;case"selectionchange":if(hr)break;case"keydown":case"keyup":_r(i,n,a)}var y;if(Rn)e:{switch(e){case"compositionstart":var g="onCompositionStart";break e;case"compositionend":g="onCompositionEnd";break e;case"compositionupdate":g="onCompositionUpdate";break e}g=void 0}else Vn?Zn(e,n)&&(g="onCompositionEnd"):"keydown"===e&&229===n.keyCode&&(g="onCompositionStart");g&&(In&&"ko"!==n.locale&&(Vn||"onCompositionStart"!==g?"onCompositionEnd"===g&&Vn&&(y=en()):(Yt="value"in(Kt=a)?Kt.value:Kt.textContent,Vn=!0)),0<(b=Hr(r,g)).length&&(g=new _n(g,e,null,n,a),i.push({event:g,listeners:b}),y?g.data=y:null!==(y=Bn(n))&&(g.data=y))),(y=Ln?function(e,t){switch(e){case"compositionend":return Bn(t);case"keypress":return 32!==t.which?null:(jn=!0,zn);case"textInput":return(e=t.data)===zn&&jn?null:e;default:return null}}(e,n):function(e,t){if(Vn)return"compositionend"===e||!Rn&&Zn(e,t)?(e=en(),Xt=Yt=Kt=null,Vn=!1,e):null;switch(e){case"paste":default:return null;case"keypress":if(!(t.ctrlKey||t.altKey||t.metaKey)||t.ctrlKey&&t.altKey){if(t.char&&1<t.char.length)return t.char;if(t.which)return String.fromCharCode(t.which)}return null;case"compositionend":return In&&"ko"!==t.locale?null:t.data}}(e,n))&&(0<(r=Hr(r,"onBeforeInput")).length&&(a=new _n("onBeforeInput","beforeinput",null,n,a),i.push({event:a,listeners:r}),a.data=y))}zr(i,t)}))}function Ur(e,t,n){return{instance:e,listener:t,currentTarget:n}}function Hr(e,t){for(var n=t+"Capture",r=[];null!==e;){var a=e,o=a.stateNode;5===a.tag&&null!==o&&(a=o,null!=(o=Ne(e,n))&&r.unshift(Ur(e,o,a)),null!=(o=Ne(e,t))&&r.push(Ur(e,o,a))),e=e.return}return r}function $r(e){if(null===e)return null;do{e=e.return}while(e&&5!==e.tag);return e||null}function Jr(e,t,n,r,a){for(var o=t._reactName,i=[];null!==n&&n!==r;){var s=n,l=s.alternate,u=s.stateNode;if(null!==l&&l===r)break;5===s.tag&&null!==u&&(s=u,a?null!=(l=Ne(n,o))&&i.unshift(Ur(n,l,s)):a||null!=(l=Ne(n,o))&&i.push(Ur(n,l,s))),n=n.return}0!==i.length&&e.push({event:t,listeners:i})}var qr=/\r\n?/g,Qr=/\u0000|\uFFFD/g;function Kr(e){return("string"===typeof e?e:""+e).replace(qr,"\n").replace(Qr,"")}function Yr(e,t,n){if(t=Kr(t),Kr(e)!==t&&n)throw Error(o(425))}function Xr(){}var ea=null,ta=null;function na(e,t){return"textarea"===e||"noscript"===e||"string"===typeof t.children||"number"===typeof t.children||"object"===typeof t.dangerouslySetInnerHTML&&null!==t.dangerouslySetInnerHTML&&null!=t.dangerouslySetInnerHTML.__html}var ra="function"===typeof setTimeout?setTimeout:void 0,aa="function"===typeof clearTimeout?clearTimeout:void 0,oa="function"===typeof Promise?Promise:void 0,ia="function"===typeof queueMicrotask?queueMicrotask:"undefined"!==typeof oa?function(e){return oa.resolve(null).then(e).catch(sa)}:ra;function sa(e){setTimeout((function(){throw e}))}function la(e,t){var n=t,r=0;do{var a=n.nextSibling;if(e.removeChild(n),a&&8===a.nodeType)if("/$"===(n=a.data)){if(0===r)return e.removeChild(a),void Vt(t);r--}else"$"!==n&&"$?"!==n&&"$!"!==n||r++;n=a}while(n);Vt(t)}function ua(e){for(;null!=e;e=e.nextSibling){var t=e.nodeType;if(1===t||3===t)break;if(8===t){if("$"===(t=e.data)||"$!"===t||"$?"===t)break;if("/$"===t)return null}}return e}function ca(e){e=e.previousSibling;for(var t=0;e;){if(8===e.nodeType){var n=e.data;if("$"===n||"$!"===n||"$?"===n){if(0===t)return e;t--}else"/$"===n&&t++}e=e.previousSibling}return null}var da=Math.random().toString(36).slice(2),fa="__reactFiber$"+da,pa="__reactProps$"+da,ma="__reactContainer$"+da,ha="__reactEvents$"+da,va="__reactListeners$"+da,ba="__reactHandles$"+da;function ya(e){var t=e[fa];if(t)return t;for(var n=e.parentNode;n;){if(t=n[ma]||n[fa]){if(n=t.alternate,null!==t.child||null!==n&&null!==n.child)for(e=ca(e);null!==e;){if(n=e[fa])return n;e=ca(e)}return t}n=(e=n).parentNode}return null}function ga(e){return!(e=e[fa]||e[ma])||5!==e.tag&&6!==e.tag&&13!==e.tag&&3!==e.tag?null:e}function _a(e){if(5===e.tag||6===e.tag)return e.stateNode;throw Error(o(33))}function wa(e){return e[pa]||null}var ka=[],Sa=-1;function Ta(e){return{current:e}}function Ca(e){0>Sa||(e.current=ka[Sa],ka[Sa]=null,Sa--)}function xa(e,t){Sa++,ka[Sa]=e.current,e.current=t}var Aa={},Fa=Ta(Aa),Ea=Ta(!1),Pa=Aa;function Oa(e,t){var n=e.type.contextTypes;if(!n)return Aa;var r=e.stateNode;if(r&&r.__reactInternalMemoizedUnmaskedChildContext===t)return r.__reactInternalMemoizedMaskedChildContext;var a,o={};for(a in n)o[a]=t[a];return r&&((e=e.stateNode).__reactInternalMemoizedUnmaskedChildContext=t,e.__reactInternalMemoizedMaskedChildContext=o),o}function Na(e){return null!==(e=e.childContextTypes)&&void 0!==e}function Ma(){Ca(Ea),Ca(Fa)}function Ra(e,t,n){if(Fa.current!==Aa)throw Error(o(168));xa(Fa,t),xa(Ea,n)}function Da(e,t,n){var r=e.stateNode;if(t=t.childContextTypes,"function"!==typeof r.getChildContext)return n;for(var a in r=r.getChildContext())if(!(a in t))throw Error(o(108,W(e)||"Unknown",a));return I({},n,r)}function La(e){return e=(e=e.stateNode)&&e.__reactInternalMemoizedMergedChildContext||Aa,Pa=Fa.current,xa(Fa,e),xa(Ea,Ea.current),!0}function Ia(e,t,n){var r=e.stateNode;if(!r)throw Error(o(169));n?(e=Da(e,t,Pa),r.__reactInternalMemoizedMergedChildContext=e,Ca(Ea),Ca(Fa),xa(Fa,e)):Ca(Ea),xa(Ea,n)}var za=null,ja=!1,Za=!1;function Ba(e){null===za?za=[e]:za.push(e)}function Va(){if(!Za&&null!==za){Za=!0;var e=0,t=gt;try{var n=za;for(gt=1;e<n.length;e++){var r=n[e];do{r=r(!0)}while(null!==r)}za=null,ja=!1}catch(a){throw null!==za&&(za=za.slice(e+1)),$e(Xe,Va),a}finally{gt=t,Za=!1}}return null}var Wa=[],Ga=0,Ua=null,Ha=0,$a=[],Ja=0,qa=null,Qa=1,Ka="";function Ya(e,t){Wa[Ga++]=Ha,Wa[Ga++]=Ua,Ua=e,Ha=t}function Xa(e,t,n){$a[Ja++]=Qa,$a[Ja++]=Ka,$a[Ja++]=qa,qa=e;var r=Qa;e=Ka;var a=32-it(r)-1;r&=~(1<<a),n+=1;var o=32-it(t)+a;if(30<o){var i=a-a%5;o=(r&(1<<i)-1).toString(32),r>>=i,a-=i,Qa=1<<32-it(t)+a|n<<a|r,Ka=o+e}else Qa=1<<o|n<<a|r,Ka=e}function eo(e){null!==e.return&&(Ya(e,1),Xa(e,1,0))}function to(e){for(;e===Ua;)Ua=Wa[--Ga],Wa[Ga]=null,Ha=Wa[--Ga],Wa[Ga]=null;for(;e===qa;)qa=$a[--Ja],$a[Ja]=null,Ka=$a[--Ja],$a[Ja]=null,Qa=$a[--Ja],$a[Ja]=null}var no=null,ro=null,ao=!1,oo=null;function io(e,t){var n=Ou(5,null,null,0);n.elementType="DELETED",n.stateNode=t,n.return=e,null===(t=e.deletions)?(e.deletions=[n],e.flags|=16):t.push(n)}function so(e,t){switch(e.tag){case 5:var n=e.type;return null!==(t=1!==t.nodeType||n.toLowerCase()!==t.nodeName.toLowerCase()?null:t)&&(e.stateNode=t,no=e,ro=ua(t.firstChild),!0);case 6:return null!==(t=""===e.pendingProps||3!==t.nodeType?null:t)&&(e.stateNode=t,no=e,ro=null,!0);case 13:return null!==(t=8!==t.nodeType?null:t)&&(n=null!==qa?{id:Qa,overflow:Ka}:null,e.memoizedState={dehydrated:t,treeContext:n,retryLane:1073741824},(n=Ou(18,null,null,0)).stateNode=t,n.return=e,e.child=n,no=e,ro=null,!0);default:return!1}}function lo(e){return 0!==(1&e.mode)&&0===(128&e.flags)}function uo(e){if(ao){var t=ro;if(t){var n=t;if(!so(e,t)){if(lo(e))throw Error(o(418));t=ua(n.nextSibling);var r=no;t&&so(e,t)?io(r,n):(e.flags=-4097&e.flags|2,ao=!1,no=e)}}else{if(lo(e))throw Error(o(418));e.flags=-4097&e.flags|2,ao=!1,no=e}}}function co(e){for(e=e.return;null!==e&&5!==e.tag&&3!==e.tag&&13!==e.tag;)e=e.return;no=e}function fo(e){if(e!==no)return!1;if(!ao)return co(e),ao=!0,!1;var t;if((t=3!==e.tag)&&!(t=5!==e.tag)&&(t="head"!==(t=e.type)&&"body"!==t&&!na(e.type,e.memoizedProps)),t&&(t=ro)){if(lo(e))throw po(),Error(o(418));for(;t;)io(e,t),t=ua(t.nextSibling)}if(co(e),13===e.tag){if(!(e=null!==(e=e.memoizedState)?e.dehydrated:null))throw Error(o(317));e:{for(e=e.nextSibling,t=0;e;){if(8===e.nodeType){var n=e.data;if("/$"===n){if(0===t){ro=ua(e.nextSibling);break e}t--}else"$"!==n&&"$!"!==n&&"$?"!==n||t++}e=e.nextSibling}ro=null}}else ro=no?ua(e.stateNode.nextSibling):null;return!0}function po(){for(var e=ro;e;)e=ua(e.nextSibling)}function mo(){ro=no=null,ao=!1}function ho(e){null===oo?oo=[e]:oo.push(e)}var vo=_.ReactCurrentBatchConfig;function bo(e,t){if(e&&e.defaultProps){for(var n in t=I({},t),e=e.defaultProps)void 0===t[n]&&(t[n]=e[n]);return t}return t}var yo=Ta(null),go=null,_o=null,wo=null;function ko(){wo=_o=go=null}function So(e){var t=yo.current;Ca(yo),e._currentValue=t}function To(e,t,n){for(;null!==e;){var r=e.alternate;if((e.childLanes&t)!==t?(e.childLanes|=t,null!==r&&(r.childLanes|=t)):null!==r&&(r.childLanes&t)!==t&&(r.childLanes|=t),e===n)break;e=e.return}}function Co(e,t){go=e,wo=_o=null,null!==(e=e.dependencies)&&null!==e.firstContext&&(0!==(e.lanes&t)&&(_s=!0),e.firstContext=null)}function xo(e){var t=e._currentValue;if(wo!==e)if(e={context:e,memoizedValue:t,next:null},null===_o){if(null===go)throw Error(o(308));_o=e,go.dependencies={lanes:0,firstContext:e}}else _o=_o.next=e;return t}var Ao=null;function Fo(e){null===Ao?Ao=[e]:Ao.push(e)}function Eo(e,t,n,r){var a=t.interleaved;return null===a?(n.next=n,Fo(t)):(n.next=a.next,a.next=n),t.interleaved=n,Po(e,r)}function Po(e,t){e.lanes|=t;var n=e.alternate;for(null!==n&&(n.lanes|=t),n=e,e=e.return;null!==e;)e.childLanes|=t,null!==(n=e.alternate)&&(n.childLanes|=t),n=e,e=e.return;return 3===n.tag?n.stateNode:null}var Oo=!1;function No(e){e.updateQueue={baseState:e.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,interleaved:null,lanes:0},effects:null}}function Mo(e,t){e=e.updateQueue,t.updateQueue===e&&(t.updateQueue={baseState:e.baseState,firstBaseUpdate:e.firstBaseUpdate,lastBaseUpdate:e.lastBaseUpdate,shared:e.shared,effects:e.effects})}function Ro(e,t){return{eventTime:e,lane:t,tag:0,payload:null,callback:null,next:null}}function Do(e,t,n){var r=e.updateQueue;if(null===r)return null;if(r=r.shared,0!==(2&Fl)){var a=r.pending;return null===a?t.next=t:(t.next=a.next,a.next=t),r.pending=t,Po(e,n)}return null===(a=r.interleaved)?(t.next=t,Fo(r)):(t.next=a.next,a.next=t),r.interleaved=t,Po(e,n)}function Lo(e,t,n){if(null!==(t=t.updateQueue)&&(t=t.shared,0!==(4194240&n))){var r=t.lanes;n|=r&=e.pendingLanes,t.lanes=n,yt(e,n)}}function Io(e,t){var n=e.updateQueue,r=e.alternate;if(null!==r&&n===(r=r.updateQueue)){var a=null,o=null;if(null!==(n=n.firstBaseUpdate)){do{var i={eventTime:n.eventTime,lane:n.lane,tag:n.tag,payload:n.payload,callback:n.callback,next:null};null===o?a=o=i:o=o.next=i,n=n.next}while(null!==n);null===o?a=o=t:o=o.next=t}else a=o=t;return n={baseState:r.baseState,firstBaseUpdate:a,lastBaseUpdate:o,shared:r.shared,effects:r.effects},void(e.updateQueue=n)}null===(e=n.lastBaseUpdate)?n.firstBaseUpdate=t:e.next=t,n.lastBaseUpdate=t}function zo(e,t,n,r){var a=e.updateQueue;Oo=!1;var o=a.firstBaseUpdate,i=a.lastBaseUpdate,s=a.shared.pending;if(null!==s){a.shared.pending=null;var l=s,u=l.next;l.next=null,null===i?o=u:i.next=u,i=l;var c=e.alternate;null!==c&&((s=(c=c.updateQueue).lastBaseUpdate)!==i&&(null===s?c.firstBaseUpdate=u:s.next=u,c.lastBaseUpdate=l))}if(null!==o){var d=a.baseState;for(i=0,c=u=l=null,s=o;;){var f=s.lane,p=s.eventTime;if((r&f)===f){null!==c&&(c=c.next={eventTime:p,lane:0,tag:s.tag,payload:s.payload,callback:s.callback,next:null});e:{var m=e,h=s;switch(f=t,p=n,h.tag){case 1:if("function"===typeof(m=h.payload)){d=m.call(p,d,f);break e}d=m;break e;case 3:m.flags=-65537&m.flags|128;case 0:if(null===(f="function"===typeof(m=h.payload)?m.call(p,d,f):m)||void 0===f)break e;d=I({},d,f);break e;case 2:Oo=!0}}null!==s.callback&&0!==s.lane&&(e.flags|=64,null===(f=a.effects)?a.effects=[s]:f.push(s))}else p={eventTime:p,lane:f,tag:s.tag,payload:s.payload,callback:s.callback,next:null},null===c?(u=c=p,l=d):c=c.next=p,i|=f;if(null===(s=s.next)){if(null===(s=a.shared.pending))break;s=(f=s).next,f.next=null,a.lastBaseUpdate=f,a.shared.pending=null}}if(null===c&&(l=d),a.baseState=l,a.firstBaseUpdate=u,a.lastBaseUpdate=c,null!==(t=a.shared.interleaved)){a=t;do{i|=a.lane,a=a.next}while(a!==t)}else null===o&&(a.shared.lanes=0);Ll|=i,e.lanes=i,e.memoizedState=d}}function jo(e,t,n){if(e=t.effects,t.effects=null,null!==e)for(t=0;t<e.length;t++){var r=e[t],a=r.callback;if(null!==a){if(r.callback=null,r=n,"function"!==typeof a)throw Error(o(191,a));a.call(r)}}}var Zo=(new r.Component).refs;function Bo(e,t,n,r){n=null===(n=n(r,t=e.memoizedState))||void 0===n?t:I({},t,n),e.memoizedState=n,0===e.lanes&&(e.updateQueue.baseState=n)}var Vo={isMounted:function(e){return!!(e=e._reactInternals)&&Ve(e)===e},enqueueSetState:function(e,t,n){e=e._reactInternals;var r=eu(),a=tu(e),o=Ro(r,a);o.payload=t,void 0!==n&&null!==n&&(o.callback=n),null!==(t=Do(e,o,a))&&(nu(t,e,a,r),Lo(t,e,a))},enqueueReplaceState:function(e,t,n){e=e._reactInternals;var r=eu(),a=tu(e),o=Ro(r,a);o.tag=1,o.payload=t,void 0!==n&&null!==n&&(o.callback=n),null!==(t=Do(e,o,a))&&(nu(t,e,a,r),Lo(t,e,a))},enqueueForceUpdate:function(e,t){e=e._reactInternals;var n=eu(),r=tu(e),a=Ro(n,r);a.tag=2,void 0!==t&&null!==t&&(a.callback=t),null!==(t=Do(e,a,r))&&(nu(t,e,r,n),Lo(t,e,r))}};function Wo(e,t,n,r,a,o,i){return"function"===typeof(e=e.stateNode).shouldComponentUpdate?e.shouldComponentUpdate(r,o,i):!t.prototype||!t.prototype.isPureReactComponent||(!lr(n,r)||!lr(a,o))}function Go(e,t,n){var r=!1,a=Aa,o=t.contextType;return"object"===typeof o&&null!==o?o=xo(o):(a=Na(t)?Pa:Fa.current,o=(r=null!==(r=t.contextTypes)&&void 0!==r)?Oa(e,a):Aa),t=new t(n,o),e.memoizedState=null!==t.state&&void 0!==t.state?t.state:null,t.updater=Vo,e.stateNode=t,t._reactInternals=e,r&&((e=e.stateNode).__reactInternalMemoizedUnmaskedChildContext=a,e.__reactInternalMemoizedMaskedChildContext=o),t}function Uo(e,t,n,r){e=t.state,"function"===typeof t.componentWillReceiveProps&&t.componentWillReceiveProps(n,r),"function"===typeof t.UNSAFE_componentWillReceiveProps&&t.UNSAFE_componentWillReceiveProps(n,r),t.state!==e&&Vo.enqueueReplaceState(t,t.state,null)}function Ho(e,t,n,r){var a=e.stateNode;a.props=n,a.state=e.memoizedState,a.refs=Zo,No(e);var o=t.contextType;"object"===typeof o&&null!==o?a.context=xo(o):(o=Na(t)?Pa:Fa.current,a.context=Oa(e,o)),a.state=e.memoizedState,"function"===typeof(o=t.getDerivedStateFromProps)&&(Bo(e,t,o,n),a.state=e.memoizedState),"function"===typeof t.getDerivedStateFromProps||"function"===typeof a.getSnapshotBeforeUpdate||"function"!==typeof a.UNSAFE_componentWillMount&&"function"!==typeof a.componentWillMount||(t=a.state,"function"===typeof a.componentWillMount&&a.componentWillMount(),"function"===typeof a.UNSAFE_componentWillMount&&a.UNSAFE_componentWillMount(),t!==a.state&&Vo.enqueueReplaceState(a,a.state,null),zo(e,n,a,r),a.state=e.memoizedState),"function"===typeof a.componentDidMount&&(e.flags|=4194308)}function $o(e,t,n){if(null!==(e=n.ref)&&"function"!==typeof e&&"object"!==typeof e){if(n._owner){if(n=n._owner){if(1!==n.tag)throw Error(o(309));var r=n.stateNode}if(!r)throw Error(o(147,e));var a=r,i=""+e;return null!==t&&null!==t.ref&&"function"===typeof t.ref&&t.ref._stringRef===i?t.ref:(t=function(e){var t=a.refs;t===Zo&&(t=a.refs={}),null===e?delete t[i]:t[i]=e},t._stringRef=i,t)}if("string"!==typeof e)throw Error(o(284));if(!n._owner)throw Error(o(290,e))}return e}function Jo(e,t){throw e=Object.prototype.toString.call(t),Error(o(31,"[object Object]"===e?"object with keys {"+Object.keys(t).join(", ")+"}":e))}function qo(e){return(0,e._init)(e._payload)}function Qo(e){function t(t,n){if(e){var r=t.deletions;null===r?(t.deletions=[n],t.flags|=16):r.push(n)}}function n(n,r){if(!e)return null;for(;null!==r;)t(n,r),r=r.sibling;return null}function r(e,t){for(e=new Map;null!==t;)null!==t.key?e.set(t.key,t):e.set(t.index,t),t=t.sibling;return e}function a(e,t){return(e=Mu(e,t)).index=0,e.sibling=null,e}function i(t,n,r){return t.index=r,e?null!==(r=t.alternate)?(r=r.index)<n?(t.flags|=2,n):r:(t.flags|=2,n):(t.flags|=1048576,n)}function s(t){return e&&null===t.alternate&&(t.flags|=2),t}function l(e,t,n,r){return null===t||6!==t.tag?((t=Iu(n,e.mode,r)).return=e,t):((t=a(t,n)).return=e,t)}function u(e,t,n,r){var o=n.type;return o===S?d(e,t,n.props.children,r,n.key):null!==t&&(t.elementType===o||"object"===typeof o&&null!==o&&o.$$typeof===N&&qo(o)===t.type)?((r=a(t,n.props)).ref=$o(e,t,n),r.return=e,r):((r=Ru(n.type,n.key,n.props,null,e.mode,r)).ref=$o(e,t,n),r.return=e,r)}function c(e,t,n,r){return null===t||4!==t.tag||t.stateNode.containerInfo!==n.containerInfo||t.stateNode.implementation!==n.implementation?((t=zu(n,e.mode,r)).return=e,t):((t=a(t,n.children||[])).return=e,t)}function d(e,t,n,r,o){return null===t||7!==t.tag?((t=Du(n,e.mode,r,o)).return=e,t):((t=a(t,n)).return=e,t)}function f(e,t,n){if("string"===typeof t&&""!==t||"number"===typeof t)return(t=Iu(""+t,e.mode,n)).return=e,t;if("object"===typeof t&&null!==t){switch(t.$$typeof){case w:return(n=Ru(t.type,t.key,t.props,null,e.mode,n)).ref=$o(e,null,t),n.return=e,n;case k:return(t=zu(t,e.mode,n)).return=e,t;case N:return f(e,(0,t._init)(t._payload),n)}if(te(t)||D(t))return(t=Du(t,e.mode,n,null)).return=e,t;Jo(e,t)}return null}function p(e,t,n,r){var a=null!==t?t.key:null;if("string"===typeof n&&""!==n||"number"===typeof n)return null!==a?null:l(e,t,""+n,r);if("object"===typeof n&&null!==n){switch(n.$$typeof){case w:return n.key===a?u(e,t,n,r):null;case k:return n.key===a?c(e,t,n,r):null;case N:return p(e,t,(a=n._init)(n._payload),r)}if(te(n)||D(n))return null!==a?null:d(e,t,n,r,null);Jo(e,n)}return null}function m(e,t,n,r,a){if("string"===typeof r&&""!==r||"number"===typeof r)return l(t,e=e.get(n)||null,""+r,a);if("object"===typeof r&&null!==r){switch(r.$$typeof){case w:return u(t,e=e.get(null===r.key?n:r.key)||null,r,a);case k:return c(t,e=e.get(null===r.key?n:r.key)||null,r,a);case N:return m(e,t,n,(0,r._init)(r._payload),a)}if(te(r)||D(r))return d(t,e=e.get(n)||null,r,a,null);Jo(t,r)}return null}function h(a,o,s,l){for(var u=null,c=null,d=o,h=o=0,v=null;null!==d&&h<s.length;h++){d.index>h?(v=d,d=null):v=d.sibling;var b=p(a,d,s[h],l);if(null===b){null===d&&(d=v);break}e&&d&&null===b.alternate&&t(a,d),o=i(b,o,h),null===c?u=b:c.sibling=b,c=b,d=v}if(h===s.length)return n(a,d),ao&&Ya(a,h),u;if(null===d){for(;h<s.length;h++)null!==(d=f(a,s[h],l))&&(o=i(d,o,h),null===c?u=d:c.sibling=d,c=d);return ao&&Ya(a,h),u}for(d=r(a,d);h<s.length;h++)null!==(v=m(d,a,h,s[h],l))&&(e&&null!==v.alternate&&d.delete(null===v.key?h:v.key),o=i(v,o,h),null===c?u=v:c.sibling=v,c=v);return e&&d.forEach((function(e){return t(a,e)})),ao&&Ya(a,h),u}function v(a,s,l,u){var c=D(l);if("function"!==typeof c)throw Error(o(150));if(null==(l=c.call(l)))throw Error(o(151));for(var d=c=null,h=s,v=s=0,b=null,y=l.next();null!==h&&!y.done;v++,y=l.next()){h.index>v?(b=h,h=null):b=h.sibling;var g=p(a,h,y.value,u);if(null===g){null===h&&(h=b);break}e&&h&&null===g.alternate&&t(a,h),s=i(g,s,v),null===d?c=g:d.sibling=g,d=g,h=b}if(y.done)return n(a,h),ao&&Ya(a,v),c;if(null===h){for(;!y.done;v++,y=l.next())null!==(y=f(a,y.value,u))&&(s=i(y,s,v),null===d?c=y:d.sibling=y,d=y);return ao&&Ya(a,v),c}for(h=r(a,h);!y.done;v++,y=l.next())null!==(y=m(h,a,v,y.value,u))&&(e&&null!==y.alternate&&h.delete(null===y.key?v:y.key),s=i(y,s,v),null===d?c=y:d.sibling=y,d=y);return e&&h.forEach((function(e){return t(a,e)})),ao&&Ya(a,v),c}return function e(r,o,i,l){if("object"===typeof i&&null!==i&&i.type===S&&null===i.key&&(i=i.props.children),"object"===typeof i&&null!==i){switch(i.$$typeof){case w:e:{for(var u=i.key,c=o;null!==c;){if(c.key===u){if((u=i.type)===S){if(7===c.tag){n(r,c.sibling),(o=a(c,i.props.children)).return=r,r=o;break e}}else if(c.elementType===u||"object"===typeof u&&null!==u&&u.$$typeof===N&&qo(u)===c.type){n(r,c.sibling),(o=a(c,i.props)).ref=$o(r,c,i),o.return=r,r=o;break e}n(r,c);break}t(r,c),c=c.sibling}i.type===S?((o=Du(i.props.children,r.mode,l,i.key)).return=r,r=o):((l=Ru(i.type,i.key,i.props,null,r.mode,l)).ref=$o(r,o,i),l.return=r,r=l)}return s(r);case k:e:{for(c=i.key;null!==o;){if(o.key===c){if(4===o.tag&&o.stateNode.containerInfo===i.containerInfo&&o.stateNode.implementation===i.implementation){n(r,o.sibling),(o=a(o,i.children||[])).return=r,r=o;break e}n(r,o);break}t(r,o),o=o.sibling}(o=zu(i,r.mode,l)).return=r,r=o}return s(r);case N:return e(r,o,(c=i._init)(i._payload),l)}if(te(i))return h(r,o,i,l);if(D(i))return v(r,o,i,l);Jo(r,i)}return"string"===typeof i&&""!==i||"number"===typeof i?(i=""+i,null!==o&&6===o.tag?(n(r,o.sibling),(o=a(o,i)).return=r,r=o):(n(r,o),(o=Iu(i,r.mode,l)).return=r,r=o),s(r)):n(r,o)}}var Ko=Qo(!0),Yo=Qo(!1),Xo={},ei=Ta(Xo),ti=Ta(Xo),ni=Ta(Xo);function ri(e){if(e===Xo)throw Error(o(174));return e}function ai(e,t){switch(xa(ni,t),xa(ti,e),xa(ei,Xo),e=t.nodeType){case 9:case 11:t=(t=t.documentElement)?t.namespaceURI:le(null,"");break;default:t=le(t=(e=8===e?t.parentNode:t).namespaceURI||null,e=e.tagName)}Ca(ei),xa(ei,t)}function oi(){Ca(ei),Ca(ti),Ca(ni)}function ii(e){ri(ni.current);var t=ri(ei.current),n=le(t,e.type);t!==n&&(xa(ti,e),xa(ei,n))}function si(e){ti.current===e&&(Ca(ei),Ca(ti))}var li=Ta(0);function ui(e){for(var t=e;null!==t;){if(13===t.tag){var n=t.memoizedState;if(null!==n&&(null===(n=n.dehydrated)||"$?"===n.data||"$!"===n.data))return t}else if(19===t.tag&&void 0!==t.memoizedProps.revealOrder){if(0!==(128&t.flags))return t}else if(null!==t.child){t.child.return=t,t=t.child;continue}if(t===e)break;for(;null===t.sibling;){if(null===t.return||t.return===e)return null;t=t.return}t.sibling.return=t.return,t=t.sibling}return null}var ci=[];function di(){for(var e=0;e<ci.length;e++)ci[e]._workInProgressVersionPrimary=null;ci.length=0}var fi=_.ReactCurrentDispatcher,pi=_.ReactCurrentBatchConfig,mi=0,hi=null,vi=null,bi=null,yi=!1,gi=!1,_i=0,wi=0;function ki(){throw Error(o(321))}function Si(e,t){if(null===t)return!1;for(var n=0;n<t.length&&n<e.length;n++)if(!sr(e[n],t[n]))return!1;return!0}function Ti(e,t,n,r,a,i){if(mi=i,hi=t,t.memoizedState=null,t.updateQueue=null,t.lanes=0,fi.current=null===e||null===e.memoizedState?ss:ls,e=n(r,a),gi){i=0;do{if(gi=!1,_i=0,25<=i)throw Error(o(301));i+=1,bi=vi=null,t.updateQueue=null,fi.current=us,e=n(r,a)}while(gi)}if(fi.current=is,t=null!==vi&&null!==vi.next,mi=0,bi=vi=hi=null,yi=!1,t)throw Error(o(300));return e}function Ci(){var e=0!==_i;return _i=0,e}function xi(){var e={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return null===bi?hi.memoizedState=bi=e:bi=bi.next=e,bi}function Ai(){if(null===vi){var e=hi.alternate;e=null!==e?e.memoizedState:null}else e=vi.next;var t=null===bi?hi.memoizedState:bi.next;if(null!==t)bi=t,vi=e;else{if(null===e)throw Error(o(310));e={memoizedState:(vi=e).memoizedState,baseState:vi.baseState,baseQueue:vi.baseQueue,queue:vi.queue,next:null},null===bi?hi.memoizedState=bi=e:bi=bi.next=e}return bi}function Fi(e,t){return"function"===typeof t?t(e):t}function Ei(e){var t=Ai(),n=t.queue;if(null===n)throw Error(o(311));n.lastRenderedReducer=e;var r=vi,a=r.baseQueue,i=n.pending;if(null!==i){if(null!==a){var s=a.next;a.next=i.next,i.next=s}r.baseQueue=a=i,n.pending=null}if(null!==a){i=a.next,r=r.baseState;var l=s=null,u=null,c=i;do{var d=c.lane;if((mi&d)===d)null!==u&&(u=u.next={lane:0,action:c.action,hasEagerState:c.hasEagerState,eagerState:c.eagerState,next:null}),r=c.hasEagerState?c.eagerState:e(r,c.action);else{var f={lane:d,action:c.action,hasEagerState:c.hasEagerState,eagerState:c.eagerState,next:null};null===u?(l=u=f,s=r):u=u.next=f,hi.lanes|=d,Ll|=d}c=c.next}while(null!==c&&c!==i);null===u?s=r:u.next=l,sr(r,t.memoizedState)||(_s=!0),t.memoizedState=r,t.baseState=s,t.baseQueue=u,n.lastRenderedState=r}if(null!==(e=n.interleaved)){a=e;do{i=a.lane,hi.lanes|=i,Ll|=i,a=a.next}while(a!==e)}else null===a&&(n.lanes=0);return[t.memoizedState,n.dispatch]}function Pi(e){var t=Ai(),n=t.queue;if(null===n)throw Error(o(311));n.lastRenderedReducer=e;var r=n.dispatch,a=n.pending,i=t.memoizedState;if(null!==a){n.pending=null;var s=a=a.next;do{i=e(i,s.action),s=s.next}while(s!==a);sr(i,t.memoizedState)||(_s=!0),t.memoizedState=i,null===t.baseQueue&&(t.baseState=i),n.lastRenderedState=i}return[i,r]}function Oi(){}function Ni(e,t){var n=hi,r=Ai(),a=t(),i=!sr(r.memoizedState,a);if(i&&(r.memoizedState=a,_s=!0),r=r.queue,Gi(Di.bind(null,n,r,e),[e]),r.getSnapshot!==t||i||null!==bi&&1&bi.memoizedState.tag){if(n.flags|=2048,ji(9,Ri.bind(null,n,r,a,t),void 0,null),null===El)throw Error(o(349));0!==(30&mi)||Mi(n,t,a)}return a}function Mi(e,t,n){e.flags|=16384,e={getSnapshot:t,value:n},null===(t=hi.updateQueue)?(t={lastEffect:null,stores:null},hi.updateQueue=t,t.stores=[e]):null===(n=t.stores)?t.stores=[e]:n.push(e)}function Ri(e,t,n,r){t.value=n,t.getSnapshot=r,Li(t)&&Ii(e)}function Di(e,t,n){return n((function(){Li(t)&&Ii(e)}))}function Li(e){var t=e.getSnapshot;e=e.value;try{var n=t();return!sr(e,n)}catch(r){return!0}}function Ii(e){var t=Po(e,1);null!==t&&nu(t,e,1,-1)}function zi(e){var t=xi();return"function"===typeof e&&(e=e()),t.memoizedState=t.baseState=e,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:Fi,lastRenderedState:e},t.queue=e,e=e.dispatch=ns.bind(null,hi,e),[t.memoizedState,e]}function ji(e,t,n,r){return e={tag:e,create:t,destroy:n,deps:r,next:null},null===(t=hi.updateQueue)?(t={lastEffect:null,stores:null},hi.updateQueue=t,t.lastEffect=e.next=e):null===(n=t.lastEffect)?t.lastEffect=e.next=e:(r=n.next,n.next=e,e.next=r,t.lastEffect=e),e}function Zi(){return Ai().memoizedState}function Bi(e,t,n,r){var a=xi();hi.flags|=e,a.memoizedState=ji(1|t,n,void 0,void 0===r?null:r)}function Vi(e,t,n,r){var a=Ai();r=void 0===r?null:r;var o=void 0;if(null!==vi){var i=vi.memoizedState;if(o=i.destroy,null!==r&&Si(r,i.deps))return void(a.memoizedState=ji(t,n,o,r))}hi.flags|=e,a.memoizedState=ji(1|t,n,o,r)}function Wi(e,t){return Bi(8390656,8,e,t)}function Gi(e,t){return Vi(2048,8,e,t)}function Ui(e,t){return Vi(4,2,e,t)}function Hi(e,t){return Vi(4,4,e,t)}function $i(e,t){return"function"===typeof t?(e=e(),t(e),function(){t(null)}):null!==t&&void 0!==t?(e=e(),t.current=e,function(){t.current=null}):void 0}function Ji(e,t,n){return n=null!==n&&void 0!==n?n.concat([e]):null,Vi(4,4,$i.bind(null,t,e),n)}function qi(){}function Qi(e,t){var n=Ai();t=void 0===t?null:t;var r=n.memoizedState;return null!==r&&null!==t&&Si(t,r[1])?r[0]:(n.memoizedState=[e,t],e)}function Ki(e,t){var n=Ai();t=void 0===t?null:t;var r=n.memoizedState;return null!==r&&null!==t&&Si(t,r[1])?r[0]:(e=e(),n.memoizedState=[e,t],e)}function Yi(e,t,n){return 0===(21&mi)?(e.baseState&&(e.baseState=!1,_s=!0),e.memoizedState=n):(sr(n,t)||(n=ht(),hi.lanes|=n,Ll|=n,e.baseState=!0),t)}function Xi(e,t){var n=gt;gt=0!==n&&4>n?n:4,e(!0);var r=pi.transition;pi.transition={};try{e(!1),t()}finally{gt=n,pi.transition=r}}function es(){return Ai().memoizedState}function ts(e,t,n){var r=tu(e);if(n={lane:r,action:n,hasEagerState:!1,eagerState:null,next:null},rs(e))as(t,n);else if(null!==(n=Eo(e,t,n,r))){nu(n,e,r,eu()),os(n,t,r)}}function ns(e,t,n){var r=tu(e),a={lane:r,action:n,hasEagerState:!1,eagerState:null,next:null};if(rs(e))as(t,a);else{var o=e.alternate;if(0===e.lanes&&(null===o||0===o.lanes)&&null!==(o=t.lastRenderedReducer))try{var i=t.lastRenderedState,s=o(i,n);if(a.hasEagerState=!0,a.eagerState=s,sr(s,i)){var l=t.interleaved;return null===l?(a.next=a,Fo(t)):(a.next=l.next,l.next=a),void(t.interleaved=a)}}catch(u){}null!==(n=Eo(e,t,a,r))&&(nu(n,e,r,a=eu()),os(n,t,r))}}function rs(e){var t=e.alternate;return e===hi||null!==t&&t===hi}function as(e,t){gi=yi=!0;var n=e.pending;null===n?t.next=t:(t.next=n.next,n.next=t),e.pending=t}function os(e,t,n){if(0!==(4194240&n)){var r=t.lanes;n|=r&=e.pendingLanes,t.lanes=n,yt(e,n)}}var is={readContext:xo,useCallback:ki,useContext:ki,useEffect:ki,useImperativeHandle:ki,useInsertionEffect:ki,useLayoutEffect:ki,useMemo:ki,useReducer:ki,useRef:ki,useState:ki,useDebugValue:ki,useDeferredValue:ki,useTransition:ki,useMutableSource:ki,useSyncExternalStore:ki,useId:ki,unstable_isNewReconciler:!1},ss={readContext:xo,useCallback:function(e,t){return xi().memoizedState=[e,void 0===t?null:t],e},useContext:xo,useEffect:Wi,useImperativeHandle:function(e,t,n){return n=null!==n&&void 0!==n?n.concat([e]):null,Bi(4194308,4,$i.bind(null,t,e),n)},useLayoutEffect:function(e,t){return Bi(4194308,4,e,t)},useInsertionEffect:function(e,t){return Bi(4,2,e,t)},useMemo:function(e,t){var n=xi();return t=void 0===t?null:t,e=e(),n.memoizedState=[e,t],e},useReducer:function(e,t,n){var r=xi();return t=void 0!==n?n(t):t,r.memoizedState=r.baseState=t,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:e,lastRenderedState:t},r.queue=e,e=e.dispatch=ts.bind(null,hi,e),[r.memoizedState,e]},useRef:function(e){return e={current:e},xi().memoizedState=e},useState:zi,useDebugValue:qi,useDeferredValue:function(e){return xi().memoizedState=e},useTransition:function(){var e=zi(!1),t=e[0];return e=Xi.bind(null,e[1]),xi().memoizedState=e,[t,e]},useMutableSource:function(){},useSyncExternalStore:function(e,t,n){var r=hi,a=xi();if(ao){if(void 0===n)throw Error(o(407));n=n()}else{if(n=t(),null===El)throw Error(o(349));0!==(30&mi)||Mi(r,t,n)}a.memoizedState=n;var i={value:n,getSnapshot:t};return a.queue=i,Wi(Di.bind(null,r,i,e),[e]),r.flags|=2048,ji(9,Ri.bind(null,r,i,n,t),void 0,null),n},useId:function(){var e=xi(),t=El.identifierPrefix;if(ao){var n=Ka;t=":"+t+"R"+(n=(Qa&~(1<<32-it(Qa)-1)).toString(32)+n),0<(n=_i++)&&(t+="H"+n.toString(32)),t+=":"}else t=":"+t+"r"+(n=wi++).toString(32)+":";return e.memoizedState=t},unstable_isNewReconciler:!1},ls={readContext:xo,useCallback:Qi,useContext:xo,useEffect:Gi,useImperativeHandle:Ji,useInsertionEffect:Ui,useLayoutEffect:Hi,useMemo:Ki,useReducer:Ei,useRef:Zi,useState:function(){return Ei(Fi)},useDebugValue:qi,useDeferredValue:function(e){return Yi(Ai(),vi.memoizedState,e)},useTransition:function(){return[Ei(Fi)[0],Ai().memoizedState]},useMutableSource:Oi,useSyncExternalStore:Ni,useId:es,unstable_isNewReconciler:!1},us={readContext:xo,useCallback:Qi,useContext:xo,useEffect:Gi,useImperativeHandle:Ji,useInsertionEffect:Ui,useLayoutEffect:Hi,useMemo:Ki,useReducer:Pi,useRef:Zi,useState:function(){return Pi(Fi)},useDebugValue:qi,useDeferredValue:function(e){var t=Ai();return null===vi?t.memoizedState=e:Yi(t,vi.memoizedState,e)},useTransition:function(){return[Pi(Fi)[0],Ai().memoizedState]},useMutableSource:Oi,useSyncExternalStore:Ni,useId:es,unstable_isNewReconciler:!1};function cs(e,t){try{var n="",r=t;do{n+=B(r),r=r.return}while(r);var a=n}catch(o){a="\nError generating stack: "+o.message+"\n"+o.stack}return{value:e,source:t,stack:a,digest:null}}function ds(e,t,n){return{value:e,source:null,stack:null!=n?n:null,digest:null!=t?t:null}}function fs(e,t){try{console.error(t.value)}catch(n){setTimeout((function(){throw n}))}}var ps="function"===typeof WeakMap?WeakMap:Map;function ms(e,t,n){(n=Ro(-1,n)).tag=3,n.payload={element:null};var r=t.value;return n.callback=function(){Gl||(Gl=!0,Ul=r),fs(0,t)},n}function hs(e,t,n){(n=Ro(-1,n)).tag=3;var r=e.type.getDerivedStateFromError;if("function"===typeof r){var a=t.value;n.payload=function(){return r(a)},n.callback=function(){fs(0,t)}}var o=e.stateNode;return null!==o&&"function"===typeof o.componentDidCatch&&(n.callback=function(){fs(0,t),"function"!==typeof r&&(null===Hl?Hl=new Set([this]):Hl.add(this));var e=t.stack;this.componentDidCatch(t.value,{componentStack:null!==e?e:""})}),n}function vs(e,t,n){var r=e.pingCache;if(null===r){r=e.pingCache=new ps;var a=new Set;r.set(t,a)}else void 0===(a=r.get(t))&&(a=new Set,r.set(t,a));a.has(n)||(a.add(n),e=Cu.bind(null,e,t,n),t.then(e,e))}function bs(e){do{var t;if((t=13===e.tag)&&(t=null===(t=e.memoizedState)||null!==t.dehydrated),t)return e;e=e.return}while(null!==e);return null}function ys(e,t,n,r,a){return 0===(1&e.mode)?(e===t?e.flags|=65536:(e.flags|=128,n.flags|=131072,n.flags&=-52805,1===n.tag&&(null===n.alternate?n.tag=17:((t=Ro(-1,1)).tag=2,Do(n,t,1))),n.lanes|=1),e):(e.flags|=65536,e.lanes=a,e)}var gs=_.ReactCurrentOwner,_s=!1;function ws(e,t,n,r){t.child=null===e?Yo(t,null,n,r):Ko(t,e.child,n,r)}function ks(e,t,n,r,a){n=n.render;var o=t.ref;return Co(t,a),r=Ti(e,t,n,r,o,a),n=Ci(),null===e||_s?(ao&&n&&eo(t),t.flags|=1,ws(e,t,r,a),t.child):(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Gs(e,t,a))}function Ss(e,t,n,r,a){if(null===e){var o=n.type;return"function"!==typeof o||Nu(o)||void 0!==o.defaultProps||null!==n.compare||void 0!==n.defaultProps?((e=Ru(n.type,null,r,t,t.mode,a)).ref=t.ref,e.return=t,t.child=e):(t.tag=15,t.type=o,Ts(e,t,o,r,a))}if(o=e.child,0===(e.lanes&a)){var i=o.memoizedProps;if((n=null!==(n=n.compare)?n:lr)(i,r)&&e.ref===t.ref)return Gs(e,t,a)}return t.flags|=1,(e=Mu(o,r)).ref=t.ref,e.return=t,t.child=e}function Ts(e,t,n,r,a){if(null!==e){var o=e.memoizedProps;if(lr(o,r)&&e.ref===t.ref){if(_s=!1,t.pendingProps=r=o,0===(e.lanes&a))return t.lanes=e.lanes,Gs(e,t,a);0!==(131072&e.flags)&&(_s=!0)}}return As(e,t,n,r,a)}function Cs(e,t,n){var r=t.pendingProps,a=r.children,o=null!==e?e.memoizedState:null;if("hidden"===r.mode)if(0===(1&t.mode))t.memoizedState={baseLanes:0,cachePool:null,transitions:null},xa(Ml,Nl),Nl|=n;else{if(0===(1073741824&n))return e=null!==o?o.baseLanes|n:n,t.lanes=t.childLanes=1073741824,t.memoizedState={baseLanes:e,cachePool:null,transitions:null},t.updateQueue=null,xa(Ml,Nl),Nl|=e,null;t.memoizedState={baseLanes:0,cachePool:null,transitions:null},r=null!==o?o.baseLanes:n,xa(Ml,Nl),Nl|=r}else null!==o?(r=o.baseLanes|n,t.memoizedState=null):r=n,xa(Ml,Nl),Nl|=r;return ws(e,t,a,n),t.child}function xs(e,t){var n=t.ref;(null===e&&null!==n||null!==e&&e.ref!==n)&&(t.flags|=512,t.flags|=2097152)}function As(e,t,n,r,a){var o=Na(n)?Pa:Fa.current;return o=Oa(t,o),Co(t,a),n=Ti(e,t,n,r,o,a),r=Ci(),null===e||_s?(ao&&r&&eo(t),t.flags|=1,ws(e,t,n,a),t.child):(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Gs(e,t,a))}function Fs(e,t,n,r,a){if(Na(n)){var o=!0;La(t)}else o=!1;if(Co(t,a),null===t.stateNode)Ws(e,t),Go(t,n,r),Ho(t,n,r,a),r=!0;else if(null===e){var i=t.stateNode,s=t.memoizedProps;i.props=s;var l=i.context,u=n.contextType;"object"===typeof u&&null!==u?u=xo(u):u=Oa(t,u=Na(n)?Pa:Fa.current);var c=n.getDerivedStateFromProps,d="function"===typeof c||"function"===typeof i.getSnapshotBeforeUpdate;d||"function"!==typeof i.UNSAFE_componentWillReceiveProps&&"function"!==typeof i.componentWillReceiveProps||(s!==r||l!==u)&&Uo(t,i,r,u),Oo=!1;var f=t.memoizedState;i.state=f,zo(t,r,i,a),l=t.memoizedState,s!==r||f!==l||Ea.current||Oo?("function"===typeof c&&(Bo(t,n,c,r),l=t.memoizedState),(s=Oo||Wo(t,n,s,r,f,l,u))?(d||"function"!==typeof i.UNSAFE_componentWillMount&&"function"!==typeof i.componentWillMount||("function"===typeof i.componentWillMount&&i.componentWillMount(),"function"===typeof i.UNSAFE_componentWillMount&&i.UNSAFE_componentWillMount()),"function"===typeof i.componentDidMount&&(t.flags|=4194308)):("function"===typeof i.componentDidMount&&(t.flags|=4194308),t.memoizedProps=r,t.memoizedState=l),i.props=r,i.state=l,i.context=u,r=s):("function"===typeof i.componentDidMount&&(t.flags|=4194308),r=!1)}else{i=t.stateNode,Mo(e,t),s=t.memoizedProps,u=t.type===t.elementType?s:bo(t.type,s),i.props=u,d=t.pendingProps,f=i.context,"object"===typeof(l=n.contextType)&&null!==l?l=xo(l):l=Oa(t,l=Na(n)?Pa:Fa.current);var p=n.getDerivedStateFromProps;(c="function"===typeof p||"function"===typeof i.getSnapshotBeforeUpdate)||"function"!==typeof i.UNSAFE_componentWillReceiveProps&&"function"!==typeof i.componentWillReceiveProps||(s!==d||f!==l)&&Uo(t,i,r,l),Oo=!1,f=t.memoizedState,i.state=f,zo(t,r,i,a);var m=t.memoizedState;s!==d||f!==m||Ea.current||Oo?("function"===typeof p&&(Bo(t,n,p,r),m=t.memoizedState),(u=Oo||Wo(t,n,u,r,f,m,l)||!1)?(c||"function"!==typeof i.UNSAFE_componentWillUpdate&&"function"!==typeof i.componentWillUpdate||("function"===typeof i.componentWillUpdate&&i.componentWillUpdate(r,m,l),"function"===typeof i.UNSAFE_componentWillUpdate&&i.UNSAFE_componentWillUpdate(r,m,l)),"function"===typeof i.componentDidUpdate&&(t.flags|=4),"function"===typeof i.getSnapshotBeforeUpdate&&(t.flags|=1024)):("function"!==typeof i.componentDidUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=4),"function"!==typeof i.getSnapshotBeforeUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=1024),t.memoizedProps=r,t.memoizedState=m),i.props=r,i.state=m,i.context=l,r=u):("function"!==typeof i.componentDidUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=4),"function"!==typeof i.getSnapshotBeforeUpdate||s===e.memoizedProps&&f===e.memoizedState||(t.flags|=1024),r=!1)}return Es(e,t,n,r,o,a)}function Es(e,t,n,r,a,o){xs(e,t);var i=0!==(128&t.flags);if(!r&&!i)return a&&Ia(t,n,!1),Gs(e,t,o);r=t.stateNode,gs.current=t;var s=i&&"function"!==typeof n.getDerivedStateFromError?null:r.render();return t.flags|=1,null!==e&&i?(t.child=Ko(t,e.child,null,o),t.child=Ko(t,null,s,o)):ws(e,t,s,o),t.memoizedState=r.state,a&&Ia(t,n,!0),t.child}function Ps(e){var t=e.stateNode;t.pendingContext?Ra(0,t.pendingContext,t.pendingContext!==t.context):t.context&&Ra(0,t.context,!1),ai(e,t.containerInfo)}function Os(e,t,n,r,a){return mo(),ho(a),t.flags|=256,ws(e,t,n,r),t.child}var Ns,Ms,Rs,Ds={dehydrated:null,treeContext:null,retryLane:0};function Ls(e){return{baseLanes:e,cachePool:null,transitions:null}}function Is(e,t,n){var r,a=t.pendingProps,i=li.current,s=!1,l=0!==(128&t.flags);if((r=l)||(r=(null===e||null!==e.memoizedState)&&0!==(2&i)),r?(s=!0,t.flags&=-129):null!==e&&null===e.memoizedState||(i|=1),xa(li,1&i),null===e)return uo(t),null!==(e=t.memoizedState)&&null!==(e=e.dehydrated)?(0===(1&t.mode)?t.lanes=1:"$!"===e.data?t.lanes=8:t.lanes=1073741824,null):(l=a.children,e=a.fallback,s?(a=t.mode,s=t.child,l={mode:"hidden",children:l},0===(1&a)&&null!==s?(s.childLanes=0,s.pendingProps=l):s=Lu(l,a,0,null),e=Du(e,a,n,null),s.return=t,e.return=t,s.sibling=e,t.child=s,t.child.memoizedState=Ls(n),t.memoizedState=Ds,e):zs(t,l));if(null!==(i=e.memoizedState)&&null!==(r=i.dehydrated))return function(e,t,n,r,a,i,s){if(n)return 256&t.flags?(t.flags&=-257,js(e,t,s,r=ds(Error(o(422))))):null!==t.memoizedState?(t.child=e.child,t.flags|=128,null):(i=r.fallback,a=t.mode,r=Lu({mode:"visible",children:r.children},a,0,null),(i=Du(i,a,s,null)).flags|=2,r.return=t,i.return=t,r.sibling=i,t.child=r,0!==(1&t.mode)&&Ko(t,e.child,null,s),t.child.memoizedState=Ls(s),t.memoizedState=Ds,i);if(0===(1&t.mode))return js(e,t,s,null);if("$!"===a.data){if(r=a.nextSibling&&a.nextSibling.dataset)var l=r.dgst;return r=l,js(e,t,s,r=ds(i=Error(o(419)),r,void 0))}if(l=0!==(s&e.childLanes),_s||l){if(null!==(r=El)){switch(s&-s){case 4:a=2;break;case 16:a=8;break;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:a=32;break;case 536870912:a=268435456;break;default:a=0}0!==(a=0!==(a&(r.suspendedLanes|s))?0:a)&&a!==i.retryLane&&(i.retryLane=a,Po(e,a),nu(r,e,a,-1))}return hu(),js(e,t,s,r=ds(Error(o(421))))}return"$?"===a.data?(t.flags|=128,t.child=e.child,t=Au.bind(null,e),a._reactRetry=t,null):(e=i.treeContext,ro=ua(a.nextSibling),no=t,ao=!0,oo=null,null!==e&&($a[Ja++]=Qa,$a[Ja++]=Ka,$a[Ja++]=qa,Qa=e.id,Ka=e.overflow,qa=t),(t=zs(t,r.children)).flags|=4096,t)}(e,t,l,a,r,i,n);if(s){s=a.fallback,l=t.mode,r=(i=e.child).sibling;var u={mode:"hidden",children:a.children};return 0===(1&l)&&t.child!==i?((a=t.child).childLanes=0,a.pendingProps=u,t.deletions=null):(a=Mu(i,u)).subtreeFlags=14680064&i.subtreeFlags,null!==r?s=Mu(r,s):(s=Du(s,l,n,null)).flags|=2,s.return=t,a.return=t,a.sibling=s,t.child=a,a=s,s=t.child,l=null===(l=e.child.memoizedState)?Ls(n):{baseLanes:l.baseLanes|n,cachePool:null,transitions:l.transitions},s.memoizedState=l,s.childLanes=e.childLanes&~n,t.memoizedState=Ds,a}return e=(s=e.child).sibling,a=Mu(s,{mode:"visible",children:a.children}),0===(1&t.mode)&&(a.lanes=n),a.return=t,a.sibling=null,null!==e&&(null===(n=t.deletions)?(t.deletions=[e],t.flags|=16):n.push(e)),t.child=a,t.memoizedState=null,a}function zs(e,t){return(t=Lu({mode:"visible",children:t},e.mode,0,null)).return=e,e.child=t}function js(e,t,n,r){return null!==r&&ho(r),Ko(t,e.child,null,n),(e=zs(t,t.pendingProps.children)).flags|=2,t.memoizedState=null,e}function Zs(e,t,n){e.lanes|=t;var r=e.alternate;null!==r&&(r.lanes|=t),To(e.return,t,n)}function Bs(e,t,n,r,a){var o=e.memoizedState;null===o?e.memoizedState={isBackwards:t,rendering:null,renderingStartTime:0,last:r,tail:n,tailMode:a}:(o.isBackwards=t,o.rendering=null,o.renderingStartTime=0,o.last=r,o.tail=n,o.tailMode=a)}function Vs(e,t,n){var r=t.pendingProps,a=r.revealOrder,o=r.tail;if(ws(e,t,r.children,n),0!==(2&(r=li.current)))r=1&r|2,t.flags|=128;else{if(null!==e&&0!==(128&e.flags))e:for(e=t.child;null!==e;){if(13===e.tag)null!==e.memoizedState&&Zs(e,n,t);else if(19===e.tag)Zs(e,n,t);else if(null!==e.child){e.child.return=e,e=e.child;continue}if(e===t)break e;for(;null===e.sibling;){if(null===e.return||e.return===t)break e;e=e.return}e.sibling.return=e.return,e=e.sibling}r&=1}if(xa(li,r),0===(1&t.mode))t.memoizedState=null;else switch(a){case"forwards":for(n=t.child,a=null;null!==n;)null!==(e=n.alternate)&&null===ui(e)&&(a=n),n=n.sibling;null===(n=a)?(a=t.child,t.child=null):(a=n.sibling,n.sibling=null),Bs(t,!1,a,n,o);break;case"backwards":for(n=null,a=t.child,t.child=null;null!==a;){if(null!==(e=a.alternate)&&null===ui(e)){t.child=a;break}e=a.sibling,a.sibling=n,n=a,a=e}Bs(t,!0,n,null,o);break;case"together":Bs(t,!1,null,null,void 0);break;default:t.memoizedState=null}return t.child}function Ws(e,t){0===(1&t.mode)&&null!==e&&(e.alternate=null,t.alternate=null,t.flags|=2)}function Gs(e,t,n){if(null!==e&&(t.dependencies=e.dependencies),Ll|=t.lanes,0===(n&t.childLanes))return null;if(null!==e&&t.child!==e.child)throw Error(o(153));if(null!==t.child){for(n=Mu(e=t.child,e.pendingProps),t.child=n,n.return=t;null!==e.sibling;)e=e.sibling,(n=n.sibling=Mu(e,e.pendingProps)).return=t;n.sibling=null}return t.child}function Us(e,t){if(!ao)switch(e.tailMode){case"hidden":t=e.tail;for(var n=null;null!==t;)null!==t.alternate&&(n=t),t=t.sibling;null===n?e.tail=null:n.sibling=null;break;case"collapsed":n=e.tail;for(var r=null;null!==n;)null!==n.alternate&&(r=n),n=n.sibling;null===r?t||null===e.tail?e.tail=null:e.tail.sibling=null:r.sibling=null}}function Hs(e){var t=null!==e.alternate&&e.alternate.child===e.child,n=0,r=0;if(t)for(var a=e.child;null!==a;)n|=a.lanes|a.childLanes,r|=14680064&a.subtreeFlags,r|=14680064&a.flags,a.return=e,a=a.sibling;else for(a=e.child;null!==a;)n|=a.lanes|a.childLanes,r|=a.subtreeFlags,r|=a.flags,a.return=e,a=a.sibling;return e.subtreeFlags|=r,e.childLanes=n,t}function $s(e,t,n){var r=t.pendingProps;switch(to(t),t.tag){case 2:case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return Hs(t),null;case 1:case 17:return Na(t.type)&&Ma(),Hs(t),null;case 3:return r=t.stateNode,oi(),Ca(Ea),Ca(Fa),di(),r.pendingContext&&(r.context=r.pendingContext,r.pendingContext=null),null!==e&&null!==e.child||(fo(t)?t.flags|=4:null===e||e.memoizedState.isDehydrated&&0===(256&t.flags)||(t.flags|=1024,null!==oo&&(iu(oo),oo=null))),Hs(t),null;case 5:si(t);var a=ri(ni.current);if(n=t.type,null!==e&&null!=t.stateNode)Ms(e,t,n,r),e.ref!==t.ref&&(t.flags|=512,t.flags|=2097152);else{if(!r){if(null===t.stateNode)throw Error(o(166));return Hs(t),null}if(e=ri(ei.current),fo(t)){r=t.stateNode,n=t.type;var i=t.memoizedProps;switch(r[fa]=t,r[pa]=i,e=0!==(1&t.mode),n){case"dialog":jr("cancel",r),jr("close",r);break;case"iframe":case"object":case"embed":jr("load",r);break;case"video":case"audio":for(a=0;a<Dr.length;a++)jr(Dr[a],r);break;case"source":jr("error",r);break;case"img":case"image":case"link":jr("error",r),jr("load",r);break;case"details":jr("toggle",r);break;case"input":Q(r,i),jr("invalid",r);break;case"select":r._wrapperState={wasMultiple:!!i.multiple},jr("invalid",r);break;case"textarea":ae(r,i),jr("invalid",r)}for(var l in ye(n,i),a=null,i)if(i.hasOwnProperty(l)){var u=i[l];"children"===l?"string"===typeof u?r.textContent!==u&&(!0!==i.suppressHydrationWarning&&Yr(r.textContent,u,e),a=["children",u]):"number"===typeof u&&r.textContent!==""+u&&(!0!==i.suppressHydrationWarning&&Yr(r.textContent,u,e),a=["children",""+u]):s.hasOwnProperty(l)&&null!=u&&"onScroll"===l&&jr("scroll",r)}switch(n){case"input":H(r),X(r,i,!0);break;case"textarea":H(r),ie(r);break;case"select":case"option":break;default:"function"===typeof i.onClick&&(r.onclick=Xr)}r=a,t.updateQueue=r,null!==r&&(t.flags|=4)}else{l=9===a.nodeType?a:a.ownerDocument,"http://www.w3.org/1999/xhtml"===e&&(e=se(n)),"http://www.w3.org/1999/xhtml"===e?"script"===n?((e=l.createElement("div")).innerHTML="<script><\/script>",e=e.removeChild(e.firstChild)):"string"===typeof r.is?e=l.createElement(n,{is:r.is}):(e=l.createElement(n),"select"===n&&(l=e,r.multiple?l.multiple=!0:r.size&&(l.size=r.size))):e=l.createElementNS(e,n),e[fa]=t,e[pa]=r,Ns(e,t),t.stateNode=e;e:{switch(l=ge(n,r),n){case"dialog":jr("cancel",e),jr("close",e),a=r;break;case"iframe":case"object":case"embed":jr("load",e),a=r;break;case"video":case"audio":for(a=0;a<Dr.length;a++)jr(Dr[a],e);a=r;break;case"source":jr("error",e),a=r;break;case"img":case"image":case"link":jr("error",e),jr("load",e),a=r;break;case"details":jr("toggle",e),a=r;break;case"input":Q(e,r),a=q(e,r),jr("invalid",e);break;case"option":default:a=r;break;case"select":e._wrapperState={wasMultiple:!!r.multiple},a=I({},r,{value:void 0}),jr("invalid",e);break;case"textarea":ae(e,r),a=re(e,r),jr("invalid",e)}for(i in ye(n,a),u=a)if(u.hasOwnProperty(i)){var c=u[i];"style"===i?ve(e,c):"dangerouslySetInnerHTML"===i?null!=(c=c?c.__html:void 0)&&de(e,c):"children"===i?"string"===typeof c?("textarea"!==n||""!==c)&&fe(e,c):"number"===typeof c&&fe(e,""+c):"suppressContentEditableWarning"!==i&&"suppressHydrationWarning"!==i&&"autoFocus"!==i&&(s.hasOwnProperty(i)?null!=c&&"onScroll"===i&&jr("scroll",e):null!=c&&g(e,i,c,l))}switch(n){case"input":H(e),X(e,r,!1);break;case"textarea":H(e),ie(e);break;case"option":null!=r.value&&e.setAttribute("value",""+G(r.value));break;case"select":e.multiple=!!r.multiple,null!=(i=r.value)?ne(e,!!r.multiple,i,!1):null!=r.defaultValue&&ne(e,!!r.multiple,r.defaultValue,!0);break;default:"function"===typeof a.onClick&&(e.onclick=Xr)}switch(n){case"button":case"input":case"select":case"textarea":r=!!r.autoFocus;break e;case"img":r=!0;break e;default:r=!1}}r&&(t.flags|=4)}null!==t.ref&&(t.flags|=512,t.flags|=2097152)}return Hs(t),null;case 6:if(e&&null!=t.stateNode)Rs(0,t,e.memoizedProps,r);else{if("string"!==typeof r&&null===t.stateNode)throw Error(o(166));if(n=ri(ni.current),ri(ei.current),fo(t)){if(r=t.stateNode,n=t.memoizedProps,r[fa]=t,(i=r.nodeValue!==n)&&null!==(e=no))switch(e.tag){case 3:Yr(r.nodeValue,n,0!==(1&e.mode));break;case 5:!0!==e.memoizedProps.suppressHydrationWarning&&Yr(r.nodeValue,n,0!==(1&e.mode))}i&&(t.flags|=4)}else(r=(9===n.nodeType?n:n.ownerDocument).createTextNode(r))[fa]=t,t.stateNode=r}return Hs(t),null;case 13:if(Ca(li),r=t.memoizedState,null===e||null!==e.memoizedState&&null!==e.memoizedState.dehydrated){if(ao&&null!==ro&&0!==(1&t.mode)&&0===(128&t.flags))po(),mo(),t.flags|=98560,i=!1;else if(i=fo(t),null!==r&&null!==r.dehydrated){if(null===e){if(!i)throw Error(o(318));if(!(i=null!==(i=t.memoizedState)?i.dehydrated:null))throw Error(o(317));i[fa]=t}else mo(),0===(128&t.flags)&&(t.memoizedState=null),t.flags|=4;Hs(t),i=!1}else null!==oo&&(iu(oo),oo=null),i=!0;if(!i)return 65536&t.flags?t:null}return 0!==(128&t.flags)?(t.lanes=n,t):((r=null!==r)!==(null!==e&&null!==e.memoizedState)&&r&&(t.child.flags|=8192,0!==(1&t.mode)&&(null===e||0!==(1&li.current)?0===Rl&&(Rl=3):hu())),null!==t.updateQueue&&(t.flags|=4),Hs(t),null);case 4:return oi(),null===e&&Vr(t.stateNode.containerInfo),Hs(t),null;case 10:return So(t.type._context),Hs(t),null;case 19:if(Ca(li),null===(i=t.memoizedState))return Hs(t),null;if(r=0!==(128&t.flags),null===(l=i.rendering))if(r)Us(i,!1);else{if(0!==Rl||null!==e&&0!==(128&e.flags))for(e=t.child;null!==e;){if(null!==(l=ui(e))){for(t.flags|=128,Us(i,!1),null!==(r=l.updateQueue)&&(t.updateQueue=r,t.flags|=4),t.subtreeFlags=0,r=n,n=t.child;null!==n;)e=r,(i=n).flags&=14680066,null===(l=i.alternate)?(i.childLanes=0,i.lanes=e,i.child=null,i.subtreeFlags=0,i.memoizedProps=null,i.memoizedState=null,i.updateQueue=null,i.dependencies=null,i.stateNode=null):(i.childLanes=l.childLanes,i.lanes=l.lanes,i.child=l.child,i.subtreeFlags=0,i.deletions=null,i.memoizedProps=l.memoizedProps,i.memoizedState=l.memoizedState,i.updateQueue=l.updateQueue,i.type=l.type,e=l.dependencies,i.dependencies=null===e?null:{lanes:e.lanes,firstContext:e.firstContext}),n=n.sibling;return xa(li,1&li.current|2),t.child}e=e.sibling}null!==i.tail&&Ke()>Vl&&(t.flags|=128,r=!0,Us(i,!1),t.lanes=4194304)}else{if(!r)if(null!==(e=ui(l))){if(t.flags|=128,r=!0,null!==(n=e.updateQueue)&&(t.updateQueue=n,t.flags|=4),Us(i,!0),null===i.tail&&"hidden"===i.tailMode&&!l.alternate&&!ao)return Hs(t),null}else 2*Ke()-i.renderingStartTime>Vl&&1073741824!==n&&(t.flags|=128,r=!0,Us(i,!1),t.lanes=4194304);i.isBackwards?(l.sibling=t.child,t.child=l):(null!==(n=i.last)?n.sibling=l:t.child=l,i.last=l)}return null!==i.tail?(t=i.tail,i.rendering=t,i.tail=t.sibling,i.renderingStartTime=Ke(),t.sibling=null,n=li.current,xa(li,r?1&n|2:1&n),t):(Hs(t),null);case 22:case 23:return du(),r=null!==t.memoizedState,null!==e&&null!==e.memoizedState!==r&&(t.flags|=8192),r&&0!==(1&t.mode)?0!==(1073741824&Nl)&&(Hs(t),6&t.subtreeFlags&&(t.flags|=8192)):Hs(t),null;case 24:case 25:return null}throw Error(o(156,t.tag))}function Js(e,t){switch(to(t),t.tag){case 1:return Na(t.type)&&Ma(),65536&(e=t.flags)?(t.flags=-65537&e|128,t):null;case 3:return oi(),Ca(Ea),Ca(Fa),di(),0!==(65536&(e=t.flags))&&0===(128&e)?(t.flags=-65537&e|128,t):null;case 5:return si(t),null;case 13:if(Ca(li),null!==(e=t.memoizedState)&&null!==e.dehydrated){if(null===t.alternate)throw Error(o(340));mo()}return 65536&(e=t.flags)?(t.flags=-65537&e|128,t):null;case 19:return Ca(li),null;case 4:return oi(),null;case 10:return So(t.type._context),null;case 22:case 23:return du(),null;default:return null}}Ns=function(e,t){for(var n=t.child;null!==n;){if(5===n.tag||6===n.tag)e.appendChild(n.stateNode);else if(4!==n.tag&&null!==n.child){n.child.return=n,n=n.child;continue}if(n===t)break;for(;null===n.sibling;){if(null===n.return||n.return===t)return;n=n.return}n.sibling.return=n.return,n=n.sibling}},Ms=function(e,t,n,r){var a=e.memoizedProps;if(a!==r){e=t.stateNode,ri(ei.current);var o,i=null;switch(n){case"input":a=q(e,a),r=q(e,r),i=[];break;case"select":a=I({},a,{value:void 0}),r=I({},r,{value:void 0}),i=[];break;case"textarea":a=re(e,a),r=re(e,r),i=[];break;default:"function"!==typeof a.onClick&&"function"===typeof r.onClick&&(e.onclick=Xr)}for(c in ye(n,r),n=null,a)if(!r.hasOwnProperty(c)&&a.hasOwnProperty(c)&&null!=a[c])if("style"===c){var l=a[c];for(o in l)l.hasOwnProperty(o)&&(n||(n={}),n[o]="")}else"dangerouslySetInnerHTML"!==c&&"children"!==c&&"suppressContentEditableWarning"!==c&&"suppressHydrationWarning"!==c&&"autoFocus"!==c&&(s.hasOwnProperty(c)?i||(i=[]):(i=i||[]).push(c,null));for(c in r){var u=r[c];if(l=null!=a?a[c]:void 0,r.hasOwnProperty(c)&&u!==l&&(null!=u||null!=l))if("style"===c)if(l){for(o in l)!l.hasOwnProperty(o)||u&&u.hasOwnProperty(o)||(n||(n={}),n[o]="");for(o in u)u.hasOwnProperty(o)&&l[o]!==u[o]&&(n||(n={}),n[o]=u[o])}else n||(i||(i=[]),i.push(c,n)),n=u;else"dangerouslySetInnerHTML"===c?(u=u?u.__html:void 0,l=l?l.__html:void 0,null!=u&&l!==u&&(i=i||[]).push(c,u)):"children"===c?"string"!==typeof u&&"number"!==typeof u||(i=i||[]).push(c,""+u):"suppressContentEditableWarning"!==c&&"suppressHydrationWarning"!==c&&(s.hasOwnProperty(c)?(null!=u&&"onScroll"===c&&jr("scroll",e),i||l===u||(i=[])):(i=i||[]).push(c,u))}n&&(i=i||[]).push("style",n);var c=i;(t.updateQueue=c)&&(t.flags|=4)}},Rs=function(e,t,n,r){n!==r&&(t.flags|=4)};var qs=!1,Qs=!1,Ks="function"===typeof WeakSet?WeakSet:Set,Ys=null;function Xs(e,t){var n=e.ref;if(null!==n)if("function"===typeof n)try{n(null)}catch(r){Tu(e,t,r)}else n.current=null}function el(e,t,n){try{n()}catch(r){Tu(e,t,r)}}var tl=!1;function nl(e,t,n){var r=t.updateQueue;if(null!==(r=null!==r?r.lastEffect:null)){var a=r=r.next;do{if((a.tag&e)===e){var o=a.destroy;a.destroy=void 0,void 0!==o&&el(t,n,o)}a=a.next}while(a!==r)}}function rl(e,t){if(null!==(t=null!==(t=t.updateQueue)?t.lastEffect:null)){var n=t=t.next;do{if((n.tag&e)===e){var r=n.create;n.destroy=r()}n=n.next}while(n!==t)}}function al(e){var t=e.ref;if(null!==t){var n=e.stateNode;e.tag,e=n,"function"===typeof t?t(e):t.current=e}}function ol(e){var t=e.alternate;null!==t&&(e.alternate=null,ol(t)),e.child=null,e.deletions=null,e.sibling=null,5===e.tag&&(null!==(t=e.stateNode)&&(delete t[fa],delete t[pa],delete t[ha],delete t[va],delete t[ba])),e.stateNode=null,e.return=null,e.dependencies=null,e.memoizedProps=null,e.memoizedState=null,e.pendingProps=null,e.stateNode=null,e.updateQueue=null}function il(e){return 5===e.tag||3===e.tag||4===e.tag}function sl(e){e:for(;;){for(;null===e.sibling;){if(null===e.return||il(e.return))return null;e=e.return}for(e.sibling.return=e.return,e=e.sibling;5!==e.tag&&6!==e.tag&&18!==e.tag;){if(2&e.flags)continue e;if(null===e.child||4===e.tag)continue e;e.child.return=e,e=e.child}if(!(2&e.flags))return e.stateNode}}function ll(e,t,n){var r=e.tag;if(5===r||6===r)e=e.stateNode,t?8===n.nodeType?n.parentNode.insertBefore(e,t):n.insertBefore(e,t):(8===n.nodeType?(t=n.parentNode).insertBefore(e,n):(t=n).appendChild(e),null!==(n=n._reactRootContainer)&&void 0!==n||null!==t.onclick||(t.onclick=Xr));else if(4!==r&&null!==(e=e.child))for(ll(e,t,n),e=e.sibling;null!==e;)ll(e,t,n),e=e.sibling}function ul(e,t,n){var r=e.tag;if(5===r||6===r)e=e.stateNode,t?n.insertBefore(e,t):n.appendChild(e);else if(4!==r&&null!==(e=e.child))for(ul(e,t,n),e=e.sibling;null!==e;)ul(e,t,n),e=e.sibling}var cl=null,dl=!1;function fl(e,t,n){for(n=n.child;null!==n;)pl(e,t,n),n=n.sibling}function pl(e,t,n){if(ot&&"function"===typeof ot.onCommitFiberUnmount)try{ot.onCommitFiberUnmount(at,n)}catch(s){}switch(n.tag){case 5:Qs||Xs(n,t);case 6:var r=cl,a=dl;cl=null,fl(e,t,n),dl=a,null!==(cl=r)&&(dl?(e=cl,n=n.stateNode,8===e.nodeType?e.parentNode.removeChild(n):e.removeChild(n)):cl.removeChild(n.stateNode));break;case 18:null!==cl&&(dl?(e=cl,n=n.stateNode,8===e.nodeType?la(e.parentNode,n):1===e.nodeType&&la(e,n),Vt(e)):la(cl,n.stateNode));break;case 4:r=cl,a=dl,cl=n.stateNode.containerInfo,dl=!0,fl(e,t,n),cl=r,dl=a;break;case 0:case 11:case 14:case 15:if(!Qs&&(null!==(r=n.updateQueue)&&null!==(r=r.lastEffect))){a=r=r.next;do{var o=a,i=o.destroy;o=o.tag,void 0!==i&&(0!==(2&o)||0!==(4&o))&&el(n,t,i),a=a.next}while(a!==r)}fl(e,t,n);break;case 1:if(!Qs&&(Xs(n,t),"function"===typeof(r=n.stateNode).componentWillUnmount))try{r.props=n.memoizedProps,r.state=n.memoizedState,r.componentWillUnmount()}catch(s){Tu(n,t,s)}fl(e,t,n);break;case 21:fl(e,t,n);break;case 22:1&n.mode?(Qs=(r=Qs)||null!==n.memoizedState,fl(e,t,n),Qs=r):fl(e,t,n);break;default:fl(e,t,n)}}function ml(e){var t=e.updateQueue;if(null!==t){e.updateQueue=null;var n=e.stateNode;null===n&&(n=e.stateNode=new Ks),t.forEach((function(t){var r=Fu.bind(null,e,t);n.has(t)||(n.add(t),t.then(r,r))}))}}function hl(e,t){var n=t.deletions;if(null!==n)for(var r=0;r<n.length;r++){var a=n[r];try{var i=e,s=t,l=s;e:for(;null!==l;){switch(l.tag){case 5:cl=l.stateNode,dl=!1;break e;case 3:case 4:cl=l.stateNode.containerInfo,dl=!0;break e}l=l.return}if(null===cl)throw Error(o(160));pl(i,s,a),cl=null,dl=!1;var u=a.alternate;null!==u&&(u.return=null),a.return=null}catch(c){Tu(a,t,c)}}if(12854&t.subtreeFlags)for(t=t.child;null!==t;)vl(t,e),t=t.sibling}function vl(e,t){var n=e.alternate,r=e.flags;switch(e.tag){case 0:case 11:case 14:case 15:if(hl(t,e),bl(e),4&r){try{nl(3,e,e.return),rl(3,e)}catch(v){Tu(e,e.return,v)}try{nl(5,e,e.return)}catch(v){Tu(e,e.return,v)}}break;case 1:hl(t,e),bl(e),512&r&&null!==n&&Xs(n,n.return);break;case 5:if(hl(t,e),bl(e),512&r&&null!==n&&Xs(n,n.return),32&e.flags){var a=e.stateNode;try{fe(a,"")}catch(v){Tu(e,e.return,v)}}if(4&r&&null!=(a=e.stateNode)){var i=e.memoizedProps,s=null!==n?n.memoizedProps:i,l=e.type,u=e.updateQueue;if(e.updateQueue=null,null!==u)try{"input"===l&&"radio"===i.type&&null!=i.name&&K(a,i),ge(l,s);var c=ge(l,i);for(s=0;s<u.length;s+=2){var d=u[s],f=u[s+1];"style"===d?ve(a,f):"dangerouslySetInnerHTML"===d?de(a,f):"children"===d?fe(a,f):g(a,d,f,c)}switch(l){case"input":Y(a,i);break;case"textarea":oe(a,i);break;case"select":var p=a._wrapperState.wasMultiple;a._wrapperState.wasMultiple=!!i.multiple;var m=i.value;null!=m?ne(a,!!i.multiple,m,!1):p!==!!i.multiple&&(null!=i.defaultValue?ne(a,!!i.multiple,i.defaultValue,!0):ne(a,!!i.multiple,i.multiple?[]:"",!1))}a[pa]=i}catch(v){Tu(e,e.return,v)}}break;case 6:if(hl(t,e),bl(e),4&r){if(null===e.stateNode)throw Error(o(162));a=e.stateNode,i=e.memoizedProps;try{a.nodeValue=i}catch(v){Tu(e,e.return,v)}}break;case 3:if(hl(t,e),bl(e),4&r&&null!==n&&n.memoizedState.isDehydrated)try{Vt(t.containerInfo)}catch(v){Tu(e,e.return,v)}break;case 4:default:hl(t,e),bl(e);break;case 13:hl(t,e),bl(e),8192&(a=e.child).flags&&(i=null!==a.memoizedState,a.stateNode.isHidden=i,!i||null!==a.alternate&&null!==a.alternate.memoizedState||(Bl=Ke())),4&r&&ml(e);break;case 22:if(d=null!==n&&null!==n.memoizedState,1&e.mode?(Qs=(c=Qs)||d,hl(t,e),Qs=c):hl(t,e),bl(e),8192&r){if(c=null!==e.memoizedState,(e.stateNode.isHidden=c)&&!d&&0!==(1&e.mode))for(Ys=e,d=e.child;null!==d;){for(f=Ys=d;null!==Ys;){switch(m=(p=Ys).child,p.tag){case 0:case 11:case 14:case 15:nl(4,p,p.return);break;case 1:Xs(p,p.return);var h=p.stateNode;if("function"===typeof h.componentWillUnmount){r=p,n=p.return;try{t=r,h.props=t.memoizedProps,h.state=t.memoizedState,h.componentWillUnmount()}catch(v){Tu(r,n,v)}}break;case 5:Xs(p,p.return);break;case 22:if(null!==p.memoizedState){wl(f);continue}}null!==m?(m.return=p,Ys=m):wl(f)}d=d.sibling}e:for(d=null,f=e;;){if(5===f.tag){if(null===d){d=f;try{a=f.stateNode,c?"function"===typeof(i=a.style).setProperty?i.setProperty("display","none","important"):i.display="none":(l=f.stateNode,s=void 0!==(u=f.memoizedProps.style)&&null!==u&&u.hasOwnProperty("display")?u.display:null,l.style.display=he("display",s))}catch(v){Tu(e,e.return,v)}}}else if(6===f.tag){if(null===d)try{f.stateNode.nodeValue=c?"":f.memoizedProps}catch(v){Tu(e,e.return,v)}}else if((22!==f.tag&&23!==f.tag||null===f.memoizedState||f===e)&&null!==f.child){f.child.return=f,f=f.child;continue}if(f===e)break e;for(;null===f.sibling;){if(null===f.return||f.return===e)break e;d===f&&(d=null),f=f.return}d===f&&(d=null),f.sibling.return=f.return,f=f.sibling}}break;case 19:hl(t,e),bl(e),4&r&&ml(e);case 21:}}function bl(e){var t=e.flags;if(2&t){try{e:{for(var n=e.return;null!==n;){if(il(n)){var r=n;break e}n=n.return}throw Error(o(160))}switch(r.tag){case 5:var a=r.stateNode;32&r.flags&&(fe(a,""),r.flags&=-33),ul(e,sl(e),a);break;case 3:case 4:var i=r.stateNode.containerInfo;ll(e,sl(e),i);break;default:throw Error(o(161))}}catch(s){Tu(e,e.return,s)}e.flags&=-3}4096&t&&(e.flags&=-4097)}function yl(e,t,n){Ys=e,gl(e,t,n)}function gl(e,t,n){for(var r=0!==(1&e.mode);null!==Ys;){var a=Ys,o=a.child;if(22===a.tag&&r){var i=null!==a.memoizedState||qs;if(!i){var s=a.alternate,l=null!==s&&null!==s.memoizedState||Qs;s=qs;var u=Qs;if(qs=i,(Qs=l)&&!u)for(Ys=a;null!==Ys;)l=(i=Ys).child,22===i.tag&&null!==i.memoizedState?kl(a):null!==l?(l.return=i,Ys=l):kl(a);for(;null!==o;)Ys=o,gl(o,t,n),o=o.sibling;Ys=a,qs=s,Qs=u}_l(e)}else 0!==(8772&a.subtreeFlags)&&null!==o?(o.return=a,Ys=o):_l(e)}}function _l(e){for(;null!==Ys;){var t=Ys;if(0!==(8772&t.flags)){var n=t.alternate;try{if(0!==(8772&t.flags))switch(t.tag){case 0:case 11:case 15:Qs||rl(5,t);break;case 1:var r=t.stateNode;if(4&t.flags&&!Qs)if(null===n)r.componentDidMount();else{var a=t.elementType===t.type?n.memoizedProps:bo(t.type,n.memoizedProps);r.componentDidUpdate(a,n.memoizedState,r.__reactInternalSnapshotBeforeUpdate)}var i=t.updateQueue;null!==i&&jo(t,i,r);break;case 3:var s=t.updateQueue;if(null!==s){if(n=null,null!==t.child)switch(t.child.tag){case 5:case 1:n=t.child.stateNode}jo(t,s,n)}break;case 5:var l=t.stateNode;if(null===n&&4&t.flags){n=l;var u=t.memoizedProps;switch(t.type){case"button":case"input":case"select":case"textarea":u.autoFocus&&n.focus();break;case"img":u.src&&(n.src=u.src)}}break;case 6:case 4:case 12:case 19:case 17:case 21:case 22:case 23:case 25:break;case 13:if(null===t.memoizedState){var c=t.alternate;if(null!==c){var d=c.memoizedState;if(null!==d){var f=d.dehydrated;null!==f&&Vt(f)}}}break;default:throw Error(o(163))}Qs||512&t.flags&&al(t)}catch(p){Tu(t,t.return,p)}}if(t===e){Ys=null;break}if(null!==(n=t.sibling)){n.return=t.return,Ys=n;break}Ys=t.return}}function wl(e){for(;null!==Ys;){var t=Ys;if(t===e){Ys=null;break}var n=t.sibling;if(null!==n){n.return=t.return,Ys=n;break}Ys=t.return}}function kl(e){for(;null!==Ys;){var t=Ys;try{switch(t.tag){case 0:case 11:case 15:var n=t.return;try{rl(4,t)}catch(l){Tu(t,n,l)}break;case 1:var r=t.stateNode;if("function"===typeof r.componentDidMount){var a=t.return;try{r.componentDidMount()}catch(l){Tu(t,a,l)}}var o=t.return;try{al(t)}catch(l){Tu(t,o,l)}break;case 5:var i=t.return;try{al(t)}catch(l){Tu(t,i,l)}}}catch(l){Tu(t,t.return,l)}if(t===e){Ys=null;break}var s=t.sibling;if(null!==s){s.return=t.return,Ys=s;break}Ys=t.return}}var Sl,Tl=Math.ceil,Cl=_.ReactCurrentDispatcher,xl=_.ReactCurrentOwner,Al=_.ReactCurrentBatchConfig,Fl=0,El=null,Pl=null,Ol=0,Nl=0,Ml=Ta(0),Rl=0,Dl=null,Ll=0,Il=0,zl=0,jl=null,Zl=null,Bl=0,Vl=1/0,Wl=null,Gl=!1,Ul=null,Hl=null,$l=!1,Jl=null,ql=0,Ql=0,Kl=null,Yl=-1,Xl=0;function eu(){return 0!==(6&Fl)?Ke():-1!==Yl?Yl:Yl=Ke()}function tu(e){return 0===(1&e.mode)?1:0!==(2&Fl)&&0!==Ol?Ol&-Ol:null!==vo.transition?(0===Xl&&(Xl=ht()),Xl):0!==(e=gt)?e:e=void 0===(e=window.event)?16:Qt(e.type)}function nu(e,t,n,r){if(50<Ql)throw Ql=0,Kl=null,Error(o(185));bt(e,n,r),0!==(2&Fl)&&e===El||(e===El&&(0===(2&Fl)&&(Il|=n),4===Rl&&su(e,Ol)),ru(e,r),1===n&&0===Fl&&0===(1&t.mode)&&(Vl=Ke()+500,ja&&Va()))}function ru(e,t){var n=e.callbackNode;!function(e,t){for(var n=e.suspendedLanes,r=e.pingedLanes,a=e.expirationTimes,o=e.pendingLanes;0<o;){var i=31-it(o),s=1<<i,l=a[i];-1===l?0!==(s&n)&&0===(s&r)||(a[i]=pt(s,t)):l<=t&&(e.expiredLanes|=s),o&=~s}}(e,t);var r=ft(e,e===El?Ol:0);if(0===r)null!==n&&Je(n),e.callbackNode=null,e.callbackPriority=0;else if(t=r&-r,e.callbackPriority!==t){if(null!=n&&Je(n),1===t)0===e.tag?function(e){ja=!0,Ba(e)}(lu.bind(null,e)):Ba(lu.bind(null,e)),ia((function(){0===(6&Fl)&&Va()})),n=null;else{switch(_t(r)){case 1:n=Xe;break;case 4:n=et;break;case 16:default:n=tt;break;case 536870912:n=rt}n=Eu(n,au.bind(null,e))}e.callbackPriority=t,e.callbackNode=n}}function au(e,t){if(Yl=-1,Xl=0,0!==(6&Fl))throw Error(o(327));var n=e.callbackNode;if(ku()&&e.callbackNode!==n)return null;var r=ft(e,e===El?Ol:0);if(0===r)return null;if(0!==(30&r)||0!==(r&e.expiredLanes)||t)t=vu(e,r);else{t=r;var a=Fl;Fl|=2;var i=mu();for(El===e&&Ol===t||(Wl=null,Vl=Ke()+500,fu(e,t));;)try{yu();break}catch(l){pu(e,l)}ko(),Cl.current=i,Fl=a,null!==Pl?t=0:(El=null,Ol=0,t=Rl)}if(0!==t){if(2===t&&(0!==(a=mt(e))&&(r=a,t=ou(e,a))),1===t)throw n=Dl,fu(e,0),su(e,r),ru(e,Ke()),n;if(6===t)su(e,r);else{if(a=e.current.alternate,0===(30&r)&&!function(e){for(var t=e;;){if(16384&t.flags){var n=t.updateQueue;if(null!==n&&null!==(n=n.stores))for(var r=0;r<n.length;r++){var a=n[r],o=a.getSnapshot;a=a.value;try{if(!sr(o(),a))return!1}catch(s){return!1}}}if(n=t.child,16384&t.subtreeFlags&&null!==n)n.return=t,t=n;else{if(t===e)break;for(;null===t.sibling;){if(null===t.return||t.return===e)return!0;t=t.return}t.sibling.return=t.return,t=t.sibling}}return!0}(a)&&(2===(t=vu(e,r))&&(0!==(i=mt(e))&&(r=i,t=ou(e,i))),1===t))throw n=Dl,fu(e,0),su(e,r),ru(e,Ke()),n;switch(e.finishedWork=a,e.finishedLanes=r,t){case 0:case 1:throw Error(o(345));case 2:case 5:wu(e,Zl,Wl);break;case 3:if(su(e,r),(130023424&r)===r&&10<(t=Bl+500-Ke())){if(0!==ft(e,0))break;if(((a=e.suspendedLanes)&r)!==r){eu(),e.pingedLanes|=e.suspendedLanes&a;break}e.timeoutHandle=ra(wu.bind(null,e,Zl,Wl),t);break}wu(e,Zl,Wl);break;case 4:if(su(e,r),(4194240&r)===r)break;for(t=e.eventTimes,a=-1;0<r;){var s=31-it(r);i=1<<s,(s=t[s])>a&&(a=s),r&=~i}if(r=a,10<(r=(120>(r=Ke()-r)?120:480>r?480:1080>r?1080:1920>r?1920:3e3>r?3e3:4320>r?4320:1960*Tl(r/1960))-r)){e.timeoutHandle=ra(wu.bind(null,e,Zl,Wl),r);break}wu(e,Zl,Wl);break;default:throw Error(o(329))}}}return ru(e,Ke()),e.callbackNode===n?au.bind(null,e):null}function ou(e,t){var n=jl;return e.current.memoizedState.isDehydrated&&(fu(e,t).flags|=256),2!==(e=vu(e,t))&&(t=Zl,Zl=n,null!==t&&iu(t)),e}function iu(e){null===Zl?Zl=e:Zl.push.apply(Zl,e)}function su(e,t){for(t&=~zl,t&=~Il,e.suspendedLanes|=t,e.pingedLanes&=~t,e=e.expirationTimes;0<t;){var n=31-it(t),r=1<<n;e[n]=-1,t&=~r}}function lu(e){if(0!==(6&Fl))throw Error(o(327));ku();var t=ft(e,0);if(0===(1&t))return ru(e,Ke()),null;var n=vu(e,t);if(0!==e.tag&&2===n){var r=mt(e);0!==r&&(t=r,n=ou(e,r))}if(1===n)throw n=Dl,fu(e,0),su(e,t),ru(e,Ke()),n;if(6===n)throw Error(o(345));return e.finishedWork=e.current.alternate,e.finishedLanes=t,wu(e,Zl,Wl),ru(e,Ke()),null}function uu(e,t){var n=Fl;Fl|=1;try{return e(t)}finally{0===(Fl=n)&&(Vl=Ke()+500,ja&&Va())}}function cu(e){null!==Jl&&0===Jl.tag&&0===(6&Fl)&&ku();var t=Fl;Fl|=1;var n=Al.transition,r=gt;try{if(Al.transition=null,gt=1,e)return e()}finally{gt=r,Al.transition=n,0===(6&(Fl=t))&&Va()}}function du(){Nl=Ml.current,Ca(Ml)}function fu(e,t){e.finishedWork=null,e.finishedLanes=0;var n=e.timeoutHandle;if(-1!==n&&(e.timeoutHandle=-1,aa(n)),null!==Pl)for(n=Pl.return;null!==n;){var r=n;switch(to(r),r.tag){case 1:null!==(r=r.type.childContextTypes)&&void 0!==r&&Ma();break;case 3:oi(),Ca(Ea),Ca(Fa),di();break;case 5:si(r);break;case 4:oi();break;case 13:case 19:Ca(li);break;case 10:So(r.type._context);break;case 22:case 23:du()}n=n.return}if(El=e,Pl=e=Mu(e.current,null),Ol=Nl=t,Rl=0,Dl=null,zl=Il=Ll=0,Zl=jl=null,null!==Ao){for(t=0;t<Ao.length;t++)if(null!==(r=(n=Ao[t]).interleaved)){n.interleaved=null;var a=r.next,o=n.pending;if(null!==o){var i=o.next;o.next=a,r.next=i}n.pending=r}Ao=null}return e}function pu(e,t){for(;;){var n=Pl;try{if(ko(),fi.current=is,yi){for(var r=hi.memoizedState;null!==r;){var a=r.queue;null!==a&&(a.pending=null),r=r.next}yi=!1}if(mi=0,bi=vi=hi=null,gi=!1,_i=0,xl.current=null,null===n||null===n.return){Rl=1,Dl=t,Pl=null;break}e:{var i=e,s=n.return,l=n,u=t;if(t=Ol,l.flags|=32768,null!==u&&"object"===typeof u&&"function"===typeof u.then){var c=u,d=l,f=d.tag;if(0===(1&d.mode)&&(0===f||11===f||15===f)){var p=d.alternate;p?(d.updateQueue=p.updateQueue,d.memoizedState=p.memoizedState,d.lanes=p.lanes):(d.updateQueue=null,d.memoizedState=null)}var m=bs(s);if(null!==m){m.flags&=-257,ys(m,s,l,0,t),1&m.mode&&vs(i,c,t),u=c;var h=(t=m).updateQueue;if(null===h){var v=new Set;v.add(u),t.updateQueue=v}else h.add(u);break e}if(0===(1&t)){vs(i,c,t),hu();break e}u=Error(o(426))}else if(ao&&1&l.mode){var b=bs(s);if(null!==b){0===(65536&b.flags)&&(b.flags|=256),ys(b,s,l,0,t),ho(cs(u,l));break e}}i=u=cs(u,l),4!==Rl&&(Rl=2),null===jl?jl=[i]:jl.push(i),i=s;do{switch(i.tag){case 3:i.flags|=65536,t&=-t,i.lanes|=t,Io(i,ms(0,u,t));break e;case 1:l=u;var y=i.type,g=i.stateNode;if(0===(128&i.flags)&&("function"===typeof y.getDerivedStateFromError||null!==g&&"function"===typeof g.componentDidCatch&&(null===Hl||!Hl.has(g)))){i.flags|=65536,t&=-t,i.lanes|=t,Io(i,hs(i,l,t));break e}}i=i.return}while(null!==i)}_u(n)}catch(_){t=_,Pl===n&&null!==n&&(Pl=n=n.return);continue}break}}function mu(){var e=Cl.current;return Cl.current=is,null===e?is:e}function hu(){0!==Rl&&3!==Rl&&2!==Rl||(Rl=4),null===El||0===(268435455&Ll)&&0===(268435455&Il)||su(El,Ol)}function vu(e,t){var n=Fl;Fl|=2;var r=mu();for(El===e&&Ol===t||(Wl=null,fu(e,t));;)try{bu();break}catch(a){pu(e,a)}if(ko(),Fl=n,Cl.current=r,null!==Pl)throw Error(o(261));return El=null,Ol=0,Rl}function bu(){for(;null!==Pl;)gu(Pl)}function yu(){for(;null!==Pl&&!qe();)gu(Pl)}function gu(e){var t=Sl(e.alternate,e,Nl);e.memoizedProps=e.pendingProps,null===t?_u(e):Pl=t,xl.current=null}function _u(e){var t=e;do{var n=t.alternate;if(e=t.return,0===(32768&t.flags)){if(null!==(n=$s(n,t,Nl)))return void(Pl=n)}else{if(null!==(n=Js(n,t)))return n.flags&=32767,void(Pl=n);if(null===e)return Rl=6,void(Pl=null);e.flags|=32768,e.subtreeFlags=0,e.deletions=null}if(null!==(t=t.sibling))return void(Pl=t);Pl=t=e}while(null!==t);0===Rl&&(Rl=5)}function wu(e,t,n){var r=gt,a=Al.transition;try{Al.transition=null,gt=1,function(e,t,n,r){do{ku()}while(null!==Jl);if(0!==(6&Fl))throw Error(o(327));n=e.finishedWork;var a=e.finishedLanes;if(null===n)return null;if(e.finishedWork=null,e.finishedLanes=0,n===e.current)throw Error(o(177));e.callbackNode=null,e.callbackPriority=0;var i=n.lanes|n.childLanes;if(function(e,t){var n=e.pendingLanes&~t;e.pendingLanes=t,e.suspendedLanes=0,e.pingedLanes=0,e.expiredLanes&=t,e.mutableReadLanes&=t,e.entangledLanes&=t,t=e.entanglements;var r=e.eventTimes;for(e=e.expirationTimes;0<n;){var a=31-it(n),o=1<<a;t[a]=0,r[a]=-1,e[a]=-1,n&=~o}}(e,i),e===El&&(Pl=El=null,Ol=0),0===(2064&n.subtreeFlags)&&0===(2064&n.flags)||$l||($l=!0,Eu(tt,(function(){return ku(),null}))),i=0!==(15990&n.flags),0!==(15990&n.subtreeFlags)||i){i=Al.transition,Al.transition=null;var s=gt;gt=1;var l=Fl;Fl|=4,xl.current=null,function(e,t){if(ea=Gt,pr(e=fr())){if("selectionStart"in e)var n={start:e.selectionStart,end:e.selectionEnd};else e:{var r=(n=(n=e.ownerDocument)&&n.defaultView||window).getSelection&&n.getSelection();if(r&&0!==r.rangeCount){n=r.anchorNode;var a=r.anchorOffset,i=r.focusNode;r=r.focusOffset;try{n.nodeType,i.nodeType}catch(w){n=null;break e}var s=0,l=-1,u=-1,c=0,d=0,f=e,p=null;t:for(;;){for(var m;f!==n||0!==a&&3!==f.nodeType||(l=s+a),f!==i||0!==r&&3!==f.nodeType||(u=s+r),3===f.nodeType&&(s+=f.nodeValue.length),null!==(m=f.firstChild);)p=f,f=m;for(;;){if(f===e)break t;if(p===n&&++c===a&&(l=s),p===i&&++d===r&&(u=s),null!==(m=f.nextSibling))break;p=(f=p).parentNode}f=m}n=-1===l||-1===u?null:{start:l,end:u}}else n=null}n=n||{start:0,end:0}}else n=null;for(ta={focusedElem:e,selectionRange:n},Gt=!1,Ys=t;null!==Ys;)if(e=(t=Ys).child,0!==(1028&t.subtreeFlags)&&null!==e)e.return=t,Ys=e;else for(;null!==Ys;){t=Ys;try{var h=t.alternate;if(0!==(1024&t.flags))switch(t.tag){case 0:case 11:case 15:case 5:case 6:case 4:case 17:break;case 1:if(null!==h){var v=h.memoizedProps,b=h.memoizedState,y=t.stateNode,g=y.getSnapshotBeforeUpdate(t.elementType===t.type?v:bo(t.type,v),b);y.__reactInternalSnapshotBeforeUpdate=g}break;case 3:var _=t.stateNode.containerInfo;1===_.nodeType?_.textContent="":9===_.nodeType&&_.documentElement&&_.removeChild(_.documentElement);break;default:throw Error(o(163))}}catch(w){Tu(t,t.return,w)}if(null!==(e=t.sibling)){e.return=t.return,Ys=e;break}Ys=t.return}h=tl,tl=!1}(e,n),vl(n,e),mr(ta),Gt=!!ea,ta=ea=null,e.current=n,yl(n,e,a),Qe(),Fl=l,gt=s,Al.transition=i}else e.current=n;if($l&&($l=!1,Jl=e,ql=a),0===(i=e.pendingLanes)&&(Hl=null),function(e){if(ot&&"function"===typeof ot.onCommitFiberRoot)try{ot.onCommitFiberRoot(at,e,void 0,128===(128&e.current.flags))}catch(t){}}(n.stateNode),ru(e,Ke()),null!==t)for(r=e.onRecoverableError,n=0;n<t.length;n++)r((a=t[n]).value,{componentStack:a.stack,digest:a.digest});if(Gl)throw Gl=!1,e=Ul,Ul=null,e;0!==(1&ql)&&0!==e.tag&&ku(),0!==(1&(i=e.pendingLanes))?e===Kl?Ql++:(Ql=0,Kl=e):Ql=0,Va()}(e,t,n,r)}finally{Al.transition=a,gt=r}return null}function ku(){if(null!==Jl){var e=_t(ql),t=Al.transition,n=gt;try{if(Al.transition=null,gt=16>e?16:e,null===Jl)var r=!1;else{if(e=Jl,Jl=null,ql=0,0!==(6&Fl))throw Error(o(331));var a=Fl;for(Fl|=4,Ys=e.current;null!==Ys;){var i=Ys,s=i.child;if(0!==(16&Ys.flags)){var l=i.deletions;if(null!==l){for(var u=0;u<l.length;u++){var c=l[u];for(Ys=c;null!==Ys;){var d=Ys;switch(d.tag){case 0:case 11:case 15:nl(8,d,i)}var f=d.child;if(null!==f)f.return=d,Ys=f;else for(;null!==Ys;){var p=(d=Ys).sibling,m=d.return;if(ol(d),d===c){Ys=null;break}if(null!==p){p.return=m,Ys=p;break}Ys=m}}}var h=i.alternate;if(null!==h){var v=h.child;if(null!==v){h.child=null;do{var b=v.sibling;v.sibling=null,v=b}while(null!==v)}}Ys=i}}if(0!==(2064&i.subtreeFlags)&&null!==s)s.return=i,Ys=s;else e:for(;null!==Ys;){if(0!==(2048&(i=Ys).flags))switch(i.tag){case 0:case 11:case 15:nl(9,i,i.return)}var y=i.sibling;if(null!==y){y.return=i.return,Ys=y;break e}Ys=i.return}}var g=e.current;for(Ys=g;null!==Ys;){var _=(s=Ys).child;if(0!==(2064&s.subtreeFlags)&&null!==_)_.return=s,Ys=_;else e:for(s=g;null!==Ys;){if(0!==(2048&(l=Ys).flags))try{switch(l.tag){case 0:case 11:case 15:rl(9,l)}}catch(k){Tu(l,l.return,k)}if(l===s){Ys=null;break e}var w=l.sibling;if(null!==w){w.return=l.return,Ys=w;break e}Ys=l.return}}if(Fl=a,Va(),ot&&"function"===typeof ot.onPostCommitFiberRoot)try{ot.onPostCommitFiberRoot(at,e)}catch(k){}r=!0}return r}finally{gt=n,Al.transition=t}}return!1}function Su(e,t,n){e=Do(e,t=ms(0,t=cs(n,t),1),1),t=eu(),null!==e&&(bt(e,1,t),ru(e,t))}function Tu(e,t,n){if(3===e.tag)Su(e,e,n);else for(;null!==t;){if(3===t.tag){Su(t,e,n);break}if(1===t.tag){var r=t.stateNode;if("function"===typeof t.type.getDerivedStateFromError||"function"===typeof r.componentDidCatch&&(null===Hl||!Hl.has(r))){t=Do(t,e=hs(t,e=cs(n,e),1),1),e=eu(),null!==t&&(bt(t,1,e),ru(t,e));break}}t=t.return}}function Cu(e,t,n){var r=e.pingCache;null!==r&&r.delete(t),t=eu(),e.pingedLanes|=e.suspendedLanes&n,El===e&&(Ol&n)===n&&(4===Rl||3===Rl&&(130023424&Ol)===Ol&&500>Ke()-Bl?fu(e,0):zl|=n),ru(e,t)}function xu(e,t){0===t&&(0===(1&e.mode)?t=1:(t=ct,0===(130023424&(ct<<=1))&&(ct=4194304)));var n=eu();null!==(e=Po(e,t))&&(bt(e,t,n),ru(e,n))}function Au(e){var t=e.memoizedState,n=0;null!==t&&(n=t.retryLane),xu(e,n)}function Fu(e,t){var n=0;switch(e.tag){case 13:var r=e.stateNode,a=e.memoizedState;null!==a&&(n=a.retryLane);break;case 19:r=e.stateNode;break;default:throw Error(o(314))}null!==r&&r.delete(t),xu(e,n)}function Eu(e,t){return $e(e,t)}function Pu(e,t,n,r){this.tag=e,this.key=n,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.ref=null,this.pendingProps=t,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=r,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function Ou(e,t,n,r){return new Pu(e,t,n,r)}function Nu(e){return!(!(e=e.prototype)||!e.isReactComponent)}function Mu(e,t){var n=e.alternate;return null===n?((n=Ou(e.tag,t,e.key,e.mode)).elementType=e.elementType,n.type=e.type,n.stateNode=e.stateNode,n.alternate=e,e.alternate=n):(n.pendingProps=t,n.type=e.type,n.flags=0,n.subtreeFlags=0,n.deletions=null),n.flags=14680064&e.flags,n.childLanes=e.childLanes,n.lanes=e.lanes,n.child=e.child,n.memoizedProps=e.memoizedProps,n.memoizedState=e.memoizedState,n.updateQueue=e.updateQueue,t=e.dependencies,n.dependencies=null===t?null:{lanes:t.lanes,firstContext:t.firstContext},n.sibling=e.sibling,n.index=e.index,n.ref=e.ref,n}function Ru(e,t,n,r,a,i){var s=2;if(r=e,"function"===typeof e)Nu(e)&&(s=1);else if("string"===typeof e)s=5;else e:switch(e){case S:return Du(n.children,a,i,t);case T:s=8,a|=8;break;case C:return(e=Ou(12,n,t,2|a)).elementType=C,e.lanes=i,e;case E:return(e=Ou(13,n,t,a)).elementType=E,e.lanes=i,e;case P:return(e=Ou(19,n,t,a)).elementType=P,e.lanes=i,e;case M:return Lu(n,a,i,t);default:if("object"===typeof e&&null!==e)switch(e.$$typeof){case x:s=10;break e;case A:s=9;break e;case F:s=11;break e;case O:s=14;break e;case N:s=16,r=null;break e}throw Error(o(130,null==e?e:typeof e,""))}return(t=Ou(s,n,t,a)).elementType=e,t.type=r,t.lanes=i,t}function Du(e,t,n,r){return(e=Ou(7,e,r,t)).lanes=n,e}function Lu(e,t,n,r){return(e=Ou(22,e,r,t)).elementType=M,e.lanes=n,e.stateNode={isHidden:!1},e}function Iu(e,t,n){return(e=Ou(6,e,null,t)).lanes=n,e}function zu(e,t,n){return(t=Ou(4,null!==e.children?e.children:[],e.key,t)).lanes=n,t.stateNode={containerInfo:e.containerInfo,pendingChildren:null,implementation:e.implementation},t}function ju(e,t,n,r,a){this.tag=t,this.containerInfo=e,this.finishedWork=this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.pendingContext=this.context=null,this.callbackPriority=0,this.eventTimes=vt(0),this.expirationTimes=vt(-1),this.entangledLanes=this.finishedLanes=this.mutableReadLanes=this.expiredLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=vt(0),this.identifierPrefix=r,this.onRecoverableError=a,this.mutableSourceEagerHydrationData=null}function Zu(e,t,n,r,a,o,i,s,l){return e=new ju(e,t,n,s,l),1===t?(t=1,!0===o&&(t|=8)):t=0,o=Ou(3,null,null,t),e.current=o,o.stateNode=e,o.memoizedState={element:r,isDehydrated:n,cache:null,transitions:null,pendingSuspenseBoundaries:null},No(o),e}function Bu(e,t,n){var r=3<arguments.length&&void 0!==arguments[3]?arguments[3]:null;return{$$typeof:k,key:null==r?null:""+r,children:e,containerInfo:t,implementation:n}}function Vu(e){if(!e)return Aa;e:{if(Ve(e=e._reactInternals)!==e||1!==e.tag)throw Error(o(170));var t=e;do{switch(t.tag){case 3:t=t.stateNode.context;break e;case 1:if(Na(t.type)){t=t.stateNode.__reactInternalMemoizedMergedChildContext;break e}}t=t.return}while(null!==t);throw Error(o(171))}if(1===e.tag){var n=e.type;if(Na(n))return Da(e,n,t)}return t}function Wu(e,t,n,r,a,o,i,s,l){return(e=Zu(n,r,!0,e,0,o,0,s,l)).context=Vu(null),n=e.current,(o=Ro(r=eu(),a=tu(n))).callback=void 0!==t&&null!==t?t:null,Do(n,o,a),e.current.lanes=a,bt(e,a,r),ru(e,r),e}function Gu(e,t,n,r){var a=t.current,o=eu(),i=tu(a);return n=Vu(n),null===t.context?t.context=n:t.pendingContext=n,(t=Ro(o,i)).payload={element:e},null!==(r=void 0===r?null:r)&&(t.callback=r),null!==(e=Do(a,t,i))&&(nu(e,a,i,o),Lo(e,a,i)),i}function Uu(e){return(e=e.current).child?(e.child.tag,e.child.stateNode):null}function Hu(e,t){if(null!==(e=e.memoizedState)&&null!==e.dehydrated){var n=e.retryLane;e.retryLane=0!==n&&n<t?n:t}}function $u(e,t){Hu(e,t),(e=e.alternate)&&Hu(e,t)}Sl=function(e,t,n){if(null!==e)if(e.memoizedProps!==t.pendingProps||Ea.current)_s=!0;else{if(0===(e.lanes&n)&&0===(128&t.flags))return _s=!1,function(e,t,n){switch(t.tag){case 3:Ps(t),mo();break;case 5:ii(t);break;case 1:Na(t.type)&&La(t);break;case 4:ai(t,t.stateNode.containerInfo);break;case 10:var r=t.type._context,a=t.memoizedProps.value;xa(yo,r._currentValue),r._currentValue=a;break;case 13:if(null!==(r=t.memoizedState))return null!==r.dehydrated?(xa(li,1&li.current),t.flags|=128,null):0!==(n&t.child.childLanes)?Is(e,t,n):(xa(li,1&li.current),null!==(e=Gs(e,t,n))?e.sibling:null);xa(li,1&li.current);break;case 19:if(r=0!==(n&t.childLanes),0!==(128&e.flags)){if(r)return Vs(e,t,n);t.flags|=128}if(null!==(a=t.memoizedState)&&(a.rendering=null,a.tail=null,a.lastEffect=null),xa(li,li.current),r)break;return null;case 22:case 23:return t.lanes=0,Cs(e,t,n)}return Gs(e,t,n)}(e,t,n);_s=0!==(131072&e.flags)}else _s=!1,ao&&0!==(1048576&t.flags)&&Xa(t,Ha,t.index);switch(t.lanes=0,t.tag){case 2:var r=t.type;Ws(e,t),e=t.pendingProps;var a=Oa(t,Fa.current);Co(t,n),a=Ti(null,t,r,e,a,n);var i=Ci();return t.flags|=1,"object"===typeof a&&null!==a&&"function"===typeof a.render&&void 0===a.$$typeof?(t.tag=1,t.memoizedState=null,t.updateQueue=null,Na(r)?(i=!0,La(t)):i=!1,t.memoizedState=null!==a.state&&void 0!==a.state?a.state:null,No(t),a.updater=Vo,t.stateNode=a,a._reactInternals=t,Ho(t,r,e,n),t=Es(null,t,r,!0,i,n)):(t.tag=0,ao&&i&&eo(t),ws(null,t,a,n),t=t.child),t;case 16:r=t.elementType;e:{switch(Ws(e,t),e=t.pendingProps,r=(a=r._init)(r._payload),t.type=r,a=t.tag=function(e){if("function"===typeof e)return Nu(e)?1:0;if(void 0!==e&&null!==e){if((e=e.$$typeof)===F)return 11;if(e===O)return 14}return 2}(r),e=bo(r,e),a){case 0:t=As(null,t,r,e,n);break e;case 1:t=Fs(null,t,r,e,n);break e;case 11:t=ks(null,t,r,e,n);break e;case 14:t=Ss(null,t,r,bo(r.type,e),n);break e}throw Error(o(306,r,""))}return t;case 0:return r=t.type,a=t.pendingProps,As(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 1:return r=t.type,a=t.pendingProps,Fs(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 3:e:{if(Ps(t),null===e)throw Error(o(387));r=t.pendingProps,a=(i=t.memoizedState).element,Mo(e,t),zo(t,r,null,n);var s=t.memoizedState;if(r=s.element,i.isDehydrated){if(i={element:r,isDehydrated:!1,cache:s.cache,pendingSuspenseBoundaries:s.pendingSuspenseBoundaries,transitions:s.transitions},t.updateQueue.baseState=i,t.memoizedState=i,256&t.flags){t=Os(e,t,r,n,a=cs(Error(o(423)),t));break e}if(r!==a){t=Os(e,t,r,n,a=cs(Error(o(424)),t));break e}for(ro=ua(t.stateNode.containerInfo.firstChild),no=t,ao=!0,oo=null,n=Yo(t,null,r,n),t.child=n;n;)n.flags=-3&n.flags|4096,n=n.sibling}else{if(mo(),r===a){t=Gs(e,t,n);break e}ws(e,t,r,n)}t=t.child}return t;case 5:return ii(t),null===e&&uo(t),r=t.type,a=t.pendingProps,i=null!==e?e.memoizedProps:null,s=a.children,na(r,a)?s=null:null!==i&&na(r,i)&&(t.flags|=32),xs(e,t),ws(e,t,s,n),t.child;case 6:return null===e&&uo(t),null;case 13:return Is(e,t,n);case 4:return ai(t,t.stateNode.containerInfo),r=t.pendingProps,null===e?t.child=Ko(t,null,r,n):ws(e,t,r,n),t.child;case 11:return r=t.type,a=t.pendingProps,ks(e,t,r,a=t.elementType===r?a:bo(r,a),n);case 7:return ws(e,t,t.pendingProps,n),t.child;case 8:case 12:return ws(e,t,t.pendingProps.children,n),t.child;case 10:e:{if(r=t.type._context,a=t.pendingProps,i=t.memoizedProps,s=a.value,xa(yo,r._currentValue),r._currentValue=s,null!==i)if(sr(i.value,s)){if(i.children===a.children&&!Ea.current){t=Gs(e,t,n);break e}}else for(null!==(i=t.child)&&(i.return=t);null!==i;){var l=i.dependencies;if(null!==l){s=i.child;for(var u=l.firstContext;null!==u;){if(u.context===r){if(1===i.tag){(u=Ro(-1,n&-n)).tag=2;var c=i.updateQueue;if(null!==c){var d=(c=c.shared).pending;null===d?u.next=u:(u.next=d.next,d.next=u),c.pending=u}}i.lanes|=n,null!==(u=i.alternate)&&(u.lanes|=n),To(i.return,n,t),l.lanes|=n;break}u=u.next}}else if(10===i.tag)s=i.type===t.type?null:i.child;else if(18===i.tag){if(null===(s=i.return))throw Error(o(341));s.lanes|=n,null!==(l=s.alternate)&&(l.lanes|=n),To(s,n,t),s=i.sibling}else s=i.child;if(null!==s)s.return=i;else for(s=i;null!==s;){if(s===t){s=null;break}if(null!==(i=s.sibling)){i.return=s.return,s=i;break}s=s.return}i=s}ws(e,t,a.children,n),t=t.child}return t;case 9:return a=t.type,r=t.pendingProps.children,Co(t,n),r=r(a=xo(a)),t.flags|=1,ws(e,t,r,n),t.child;case 14:return a=bo(r=t.type,t.pendingProps),Ss(e,t,r,a=bo(r.type,a),n);case 15:return Ts(e,t,t.type,t.pendingProps,n);case 17:return r=t.type,a=t.pendingProps,a=t.elementType===r?a:bo(r,a),Ws(e,t),t.tag=1,Na(r)?(e=!0,La(t)):e=!1,Co(t,n),Go(t,r,a),Ho(t,r,a,n),Es(null,t,r,!0,e,n);case 19:return Vs(e,t,n);case 22:return Cs(e,t,n)}throw Error(o(156,t.tag))};var Ju="function"===typeof reportError?reportError:function(e){console.error(e)};function qu(e){this._internalRoot=e}function Qu(e){this._internalRoot=e}function Ku(e){return!(!e||1!==e.nodeType&&9!==e.nodeType&&11!==e.nodeType)}function Yu(e){return!(!e||1!==e.nodeType&&9!==e.nodeType&&11!==e.nodeType&&(8!==e.nodeType||" react-mount-point-unstable "!==e.nodeValue))}function Xu(){}function ec(e,t,n,r,a){var o=n._reactRootContainer;if(o){var i=o;if("function"===typeof a){var s=a;a=function(){var e=Uu(i);s.call(e)}}Gu(t,i,e,a)}else i=function(e,t,n,r,a){if(a){if("function"===typeof r){var o=r;r=function(){var e=Uu(i);o.call(e)}}var i=Wu(t,r,e,0,null,!1,0,"",Xu);return e._reactRootContainer=i,e[ma]=i.current,Vr(8===e.nodeType?e.parentNode:e),cu(),i}for(;a=e.lastChild;)e.removeChild(a);if("function"===typeof r){var s=r;r=function(){var e=Uu(l);s.call(e)}}var l=Zu(e,0,!1,null,0,!1,0,"",Xu);return e._reactRootContainer=l,e[ma]=l.current,Vr(8===e.nodeType?e.parentNode:e),cu((function(){Gu(t,l,n,r)})),l}(n,t,e,a,r);return Uu(i)}Qu.prototype.render=qu.prototype.render=function(e){var t=this._internalRoot;if(null===t)throw Error(o(409));Gu(e,t,null,null)},Qu.prototype.unmount=qu.prototype.unmount=function(){var e=this._internalRoot;if(null!==e){this._internalRoot=null;var t=e.containerInfo;cu((function(){Gu(null,e,null,null)})),t[ma]=null}},Qu.prototype.unstable_scheduleHydration=function(e){if(e){var t=Tt();e={blockedOn:null,target:e,priority:t};for(var n=0;n<Mt.length&&0!==t&&t<Mt[n].priority;n++);Mt.splice(n,0,e),0===n&&It(e)}},wt=function(e){switch(e.tag){case 3:var t=e.stateNode;if(t.current.memoizedState.isDehydrated){var n=dt(t.pendingLanes);0!==n&&(yt(t,1|n),ru(t,Ke()),0===(6&Fl)&&(Vl=Ke()+500,Va()))}break;case 13:cu((function(){var t=Po(e,1);if(null!==t){var n=eu();nu(t,e,1,n)}})),$u(e,1)}},kt=function(e){if(13===e.tag){var t=Po(e,134217728);if(null!==t)nu(t,e,134217728,eu());$u(e,134217728)}},St=function(e){if(13===e.tag){var t=tu(e),n=Po(e,t);if(null!==n)nu(n,e,t,eu());$u(e,t)}},Tt=function(){return gt},Ct=function(e,t){var n=gt;try{return gt=e,t()}finally{gt=n}},ke=function(e,t,n){switch(t){case"input":if(Y(e,n),t=n.name,"radio"===n.type&&null!=t){for(n=e;n.parentNode;)n=n.parentNode;for(n=n.querySelectorAll("input[name="+JSON.stringify(""+t)+'][type="radio"]'),t=0;t<n.length;t++){var r=n[t];if(r!==e&&r.form===e.form){var a=wa(r);if(!a)throw Error(o(90));$(r),Y(r,a)}}}break;case"textarea":oe(e,n);break;case"select":null!=(t=n.value)&&ne(e,!!n.multiple,t,!1)}},Fe=uu,Ee=cu;var tc={usingClientEntryPoint:!1,Events:[ga,_a,wa,xe,Ae,uu]},nc={findFiberByHostInstance:ya,bundleType:0,version:"18.2.0",rendererPackageName:"react-dom"},rc={bundleType:nc.bundleType,version:nc.version,rendererPackageName:nc.rendererPackageName,rendererConfig:nc.rendererConfig,overrideHookState:null,overrideHookStateDeletePath:null,overrideHookStateRenamePath:null,overrideProps:null,overridePropsDeletePath:null,overridePropsRenamePath:null,setErrorHandler:null,setSuspenseHandler:null,scheduleUpdate:null,currentDispatcherRef:_.ReactCurrentDispatcher,findHostInstanceByFiber:function(e){return null===(e=Ue(e))?null:e.stateNode},findFiberByHostInstance:nc.findFiberByHostInstance||function(){return null},findHostInstancesForRefresh:null,scheduleRefresh:null,scheduleRoot:null,setRefreshHandler:null,getCurrentFiber:null,reconcilerVersion:"18.2.0-next-9e3b772b8-20220608"};if("undefined"!==typeof __REACT_DEVTOOLS_GLOBAL_HOOK__){var ac=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!ac.isDisabled&&ac.supportsFiber)try{at=ac.inject(rc),ot=ac}catch(ce){}}t.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=tc,t.createPortal=function(e,t){var n=2<arguments.length&&void 0!==arguments[2]?arguments[2]:null;if(!Ku(t))throw Error(o(200));return Bu(e,t,null,n)},t.createRoot=function(e,t){if(!Ku(e))throw Error(o(299));var n=!1,r="",a=Ju;return null!==t&&void 0!==t&&(!0===t.unstable_strictMode&&(n=!0),void 0!==t.identifierPrefix&&(r=t.identifierPrefix),void 0!==t.onRecoverableError&&(a=t.onRecoverableError)),t=Zu(e,1,!1,null,0,n,0,r,a),e[ma]=t.current,Vr(8===e.nodeType?e.parentNode:e),new qu(t)},t.findDOMNode=function(e){if(null==e)return null;if(1===e.nodeType)return e;var t=e._reactInternals;if(void 0===t){if("function"===typeof e.render)throw Error(o(188));throw e=Object.keys(e).join(","),Error(o(268,e))}return e=null===(e=Ue(t))?null:e.stateNode},t.flushSync=function(e){return cu(e)},t.hydrate=function(e,t,n){if(!Yu(t))throw Error(o(200));return ec(null,e,t,!0,n)},t.hydrateRoot=function(e,t,n){if(!Ku(e))throw Error(o(405));var r=null!=n&&n.hydratedSources||null,a=!1,i="",s=Ju;if(null!==n&&void 0!==n&&(!0===n.unstable_strictMode&&(a=!0),void 0!==n.identifierPrefix&&(i=n.identifierPrefix),void 0!==n.onRecoverableError&&(s=n.onRecoverableError)),t=Wu(t,null,e,1,null!=n?n:null,a,0,i,s),e[ma]=t.current,Vr(e),r)for(e=0;e<r.length;e++)a=(a=(n=r[e])._getVersion)(n._source),null==t.mutableSourceEagerHydrationData?t.mutableSourceEagerHydrationData=[n,a]:t.mutableSourceEagerHydrationData.push(n,a);return new Qu(t)},t.render=function(e,t,n){if(!Yu(t))throw Error(o(200));return ec(null,e,t,!1,n)},t.unmountComponentAtNode=function(e){if(!Yu(e))throw Error(o(40));return!!e._reactRootContainer&&(cu((function(){ec(null,null,e,!1,(function(){e._reactRootContainer=null,e[ma]=null}))})),!0)},t.unstable_batchedUpdates=uu,t.unstable_renderSubtreeIntoContainer=function(e,t,n,r){if(!Yu(n))throw Error(o(200));if(null==e||void 0===e._reactInternals)throw Error(o(38));return ec(e,t,n,!1,r)},t.version="18.2.0-next-9e3b772b8-20220608"},1250:function(e,t,n){"use strict";var r=n(4164);t.createRoot=r.createRoot,t.hydrateRoot=r.hydrateRoot},4164:function(e,t,n){"use strict";!function e(){if("undefined"!==typeof __REACT_DEVTOOLS_GLOBAL_HOOK__&&"function"===typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE)try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(e)}catch(t){console.error(t)}}(),e.exports=n(4463)},6374:function(e,t,n){"use strict";var r=n(2791),a=Symbol.for("react.element"),o=Symbol.for("react.fragment"),i=Object.prototype.hasOwnProperty,s=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED.ReactCurrentOwner,l={key:!0,ref:!0,__self:!0,__source:!0};function u(e,t,n){var r,o={},u=null,c=null;for(r in void 0!==n&&(u=""+n),void 0!==t.key&&(u=""+t.key),void 0!==t.ref&&(c=t.ref),t)i.call(t,r)&&!l.hasOwnProperty(r)&&(o[r]=t[r]);if(e&&e.defaultProps)for(r in t=e.defaultProps)void 0===o[r]&&(o[r]=t[r]);return{$$typeof:a,type:e,key:u,ref:c,props:o,_owner:s.current}}t.Fragment=o,t.jsx=u,t.jsxs=u},9117:function(e,t){"use strict";var n=Symbol.for("react.element"),r=Symbol.for("react.portal"),a=Symbol.for("react.fragment"),o=Symbol.for("react.strict_mode"),i=Symbol.for("react.profiler"),s=Symbol.for("react.provider"),l=Symbol.for("react.context"),u=Symbol.for("react.forward_ref"),c=Symbol.for("react.suspense"),d=Symbol.for("react.memo"),f=Symbol.for("react.lazy"),p=Symbol.iterator;var m={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},h=Object.assign,v={};function b(e,t,n){this.props=e,this.context=t,this.refs=v,this.updater=n||m}function y(){}function g(e,t,n){this.props=e,this.context=t,this.refs=v,this.updater=n||m}b.prototype.isReactComponent={},b.prototype.setState=function(e,t){if("object"!==typeof e&&"function"!==typeof e&&null!=e)throw Error("setState(...): takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,e,t,"setState")},b.prototype.forceUpdate=function(e){this.updater.enqueueForceUpdate(this,e,"forceUpdate")},y.prototype=b.prototype;var _=g.prototype=new y;_.constructor=g,h(_,b.prototype),_.isPureReactComponent=!0;var w=Array.isArray,k=Object.prototype.hasOwnProperty,S={current:null},T={key:!0,ref:!0,__self:!0,__source:!0};function C(e,t,r){var a,o={},i=null,s=null;if(null!=t)for(a in void 0!==t.ref&&(s=t.ref),void 0!==t.key&&(i=""+t.key),t)k.call(t,a)&&!T.hasOwnProperty(a)&&(o[a]=t[a]);var l=arguments.length-2;if(1===l)o.children=r;else if(1<l){for(var u=Array(l),c=0;c<l;c++)u[c]=arguments[c+2];o.children=u}if(e&&e.defaultProps)for(a in l=e.defaultProps)void 0===o[a]&&(o[a]=l[a]);return{$$typeof:n,type:e,key:i,ref:s,props:o,_owner:S.current}}function x(e){return"object"===typeof e&&null!==e&&e.$$typeof===n}var A=/\/+/g;function F(e,t){return"object"===typeof e&&null!==e&&null!=e.key?function(e){var t={"=":"=0",":":"=2"};return"$"+e.replace(/[=:]/g,(function(e){return t[e]}))}(""+e.key):t.toString(36)}function E(e,t,a,o,i){var s=typeof e;"undefined"!==s&&"boolean"!==s||(e=null);var l=!1;if(null===e)l=!0;else switch(s){case"string":case"number":l=!0;break;case"object":switch(e.$$typeof){case n:case r:l=!0}}if(l)return i=i(l=e),e=""===o?"."+F(l,0):o,w(i)?(a="",null!=e&&(a=e.replace(A,"$&/")+"/"),E(i,t,a,"",(function(e){return e}))):null!=i&&(x(i)&&(i=function(e,t){return{$$typeof:n,type:e.type,key:t,ref:e.ref,props:e.props,_owner:e._owner}}(i,a+(!i.key||l&&l.key===i.key?"":(""+i.key).replace(A,"$&/")+"/")+e)),t.push(i)),1;if(l=0,o=""===o?".":o+":",w(e))for(var u=0;u<e.length;u++){var c=o+F(s=e[u],u);l+=E(s,t,a,c,i)}else if(c=function(e){return null===e||"object"!==typeof e?null:"function"===typeof(e=p&&e[p]||e["@@iterator"])?e:null}(e),"function"===typeof c)for(e=c.call(e),u=0;!(s=e.next()).done;)l+=E(s=s.value,t,a,c=o+F(s,u++),i);else if("object"===s)throw t=String(e),Error("Objects are not valid as a React child (found: "+("[object Object]"===t?"object with keys {"+Object.keys(e).join(", ")+"}":t)+"). If you meant to render a collection of children, use an array instead.");return l}function P(e,t,n){if(null==e)return e;var r=[],a=0;return E(e,r,"","",(function(e){return t.call(n,e,a++)})),r}function O(e){if(-1===e._status){var t=e._result;(t=t()).then((function(t){0!==e._status&&-1!==e._status||(e._status=1,e._result=t)}),(function(t){0!==e._status&&-1!==e._status||(e._status=2,e._result=t)})),-1===e._status&&(e._status=0,e._result=t)}if(1===e._status)return e._result.default;throw e._result}var N={current:null},M={transition:null},R={ReactCurrentDispatcher:N,ReactCurrentBatchConfig:M,ReactCurrentOwner:S};t.Children={map:P,forEach:function(e,t,n){P(e,(function(){t.apply(this,arguments)}),n)},count:function(e){var t=0;return P(e,(function(){t++})),t},toArray:function(e){return P(e,(function(e){return e}))||[]},only:function(e){if(!x(e))throw Error("React.Children.only expected to receive a single React element child.");return e}},t.Component=b,t.Fragment=a,t.Profiler=i,t.PureComponent=g,t.StrictMode=o,t.Suspense=c,t.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=R,t.cloneElement=function(e,t,r){if(null===e||void 0===e)throw Error("React.cloneElement(...): The argument must be a React element, but you passed "+e+".");var a=h({},e.props),o=e.key,i=e.ref,s=e._owner;if(null!=t){if(void 0!==t.ref&&(i=t.ref,s=S.current),void 0!==t.key&&(o=""+t.key),e.type&&e.type.defaultProps)var l=e.type.defaultProps;for(u in t)k.call(t,u)&&!T.hasOwnProperty(u)&&(a[u]=void 0===t[u]&&void 0!==l?l[u]:t[u])}var u=arguments.length-2;if(1===u)a.children=r;else if(1<u){l=Array(u);for(var c=0;c<u;c++)l[c]=arguments[c+2];a.children=l}return{$$typeof:n,type:e.type,key:o,ref:i,props:a,_owner:s}},t.createContext=function(e){return(e={$$typeof:l,_currentValue:e,_currentValue2:e,_threadCount:0,Provider:null,Consumer:null,_defaultValue:null,_globalName:null}).Provider={$$typeof:s,_context:e},e.Consumer=e},t.createElement=C,t.createFactory=function(e){var t=C.bind(null,e);return t.type=e,t},t.createRef=function(){return{current:null}},t.forwardRef=function(e){return{$$typeof:u,render:e}},t.isValidElement=x,t.lazy=function(e){return{$$typeof:f,_payload:{_status:-1,_result:e},_init:O}},t.memo=function(e,t){return{$$typeof:d,type:e,compare:void 0===t?null:t}},t.startTransition=function(e){var t=M.transition;M.transition={};try{e()}finally{M.transition=t}},t.unstable_act=function(){throw Error("act(...) is not supported in production builds of React.")},t.useCallback=function(e,t){return N.current.useCallback(e,t)},t.useContext=function(e){return N.current.useContext(e)},t.useDebugValue=function(){},t.useDeferredValue=function(e){return N.current.useDeferredValue(e)},t.useEffect=function(e,t){return N.current.useEffect(e,t)},t.useId=function(){return N.current.useId()},t.useImperativeHandle=function(e,t,n){return N.current.useImperativeHandle(e,t,n)},t.useInsertionEffect=function(e,t){return N.current.useInsertionEffect(e,t)},t.useLayoutEffect=function(e,t){return N.current.useLayoutEffect(e,t)},t.useMemo=function(e,t){return N.current.useMemo(e,t)},t.useReducer=function(e,t,n){return N.current.useReducer(e,t,n)},t.useRef=function(e){return N.current.useRef(e)},t.useState=function(e){return N.current.useState(e)},t.useSyncExternalStore=function(e,t,n){return N.current.useSyncExternalStore(e,t,n)},t.useTransition=function(){return N.current.useTransition()},t.version="18.2.0"},2791:function(e,t,n){"use strict";e.exports=n(9117)},184:function(e,t,n){"use strict";e.exports=n(6374)},6813:function(e,t){"use strict";function n(e,t){var n=e.length;e.push(t);e:for(;0<n;){var r=n-1>>>1,a=e[r];if(!(0<o(a,t)))break e;e[r]=t,e[n]=a,n=r}}function r(e){return 0===e.length?null:e[0]}function a(e){if(0===e.length)return null;var t=e[0],n=e.pop();if(n!==t){e[0]=n;e:for(var r=0,a=e.length,i=a>>>1;r<i;){var s=2*(r+1)-1,l=e[s],u=s+1,c=e[u];if(0>o(l,n))u<a&&0>o(c,l)?(e[r]=c,e[u]=n,r=u):(e[r]=l,e[s]=n,r=s);else{if(!(u<a&&0>o(c,n)))break e;e[r]=c,e[u]=n,r=u}}}return t}function o(e,t){var n=e.sortIndex-t.sortIndex;return 0!==n?n:e.id-t.id}if("object"===typeof performance&&"function"===typeof performance.now){var i=performance;t.unstable_now=function(){return i.now()}}else{var s=Date,l=s.now();t.unstable_now=function(){return s.now()-l}}var u=[],c=[],d=1,f=null,p=3,m=!1,h=!1,v=!1,b="function"===typeof setTimeout?setTimeout:null,y="function"===typeof clearTimeout?clearTimeout:null,g="undefined"!==typeof setImmediate?setImmediate:null;function _(e){for(var t=r(c);null!==t;){if(null===t.callback)a(c);else{if(!(t.startTime<=e))break;a(c),t.sortIndex=t.expirationTime,n(u,t)}t=r(c)}}function w(e){if(v=!1,_(e),!h)if(null!==r(u))h=!0,M(k);else{var t=r(c);null!==t&&R(w,t.startTime-e)}}function k(e,n){h=!1,v&&(v=!1,y(x),x=-1),m=!0;var o=p;try{for(_(n),f=r(u);null!==f&&(!(f.expirationTime>n)||e&&!E());){var i=f.callback;if("function"===typeof i){f.callback=null,p=f.priorityLevel;var s=i(f.expirationTime<=n);n=t.unstable_now(),"function"===typeof s?f.callback=s:f===r(u)&&a(u),_(n)}else a(u);f=r(u)}if(null!==f)var l=!0;else{var d=r(c);null!==d&&R(w,d.startTime-n),l=!1}return l}finally{f=null,p=o,m=!1}}"undefined"!==typeof navigator&&void 0!==navigator.scheduling&&void 0!==navigator.scheduling.isInputPending&&navigator.scheduling.isInputPending.bind(navigator.scheduling);var S,T=!1,C=null,x=-1,A=5,F=-1;function E(){return!(t.unstable_now()-F<A)}function P(){if(null!==C){var e=t.unstable_now();F=e;var n=!0;try{n=C(!0,e)}finally{n?S():(T=!1,C=null)}}else T=!1}if("function"===typeof g)S=function(){g(P)};else if("undefined"!==typeof MessageChannel){var O=new MessageChannel,N=O.port2;O.port1.onmessage=P,S=function(){N.postMessage(null)}}else S=function(){b(P,0)};function M(e){C=e,T||(T=!0,S())}function R(e,n){x=b((function(){e(t.unstable_now())}),n)}t.unstable_IdlePriority=5,t.unstable_ImmediatePriority=1,t.unstable_LowPriority=4,t.unstable_NormalPriority=3,t.unstable_Profiling=null,t.unstable_UserBlockingPriority=2,t.unstable_cancelCallback=function(e){e.callback=null},t.unstable_continueExecution=function(){h||m||(h=!0,M(k))},t.unstable_forceFrameRate=function(e){0>e||125<e?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):A=0<e?Math.floor(1e3/e):5},t.unstable_getCurrentPriorityLevel=function(){return p},t.unstable_getFirstCallbackNode=function(){return r(u)},t.unstable_next=function(e){switch(p){case 1:case 2:case 3:var t=3;break;default:t=p}var n=p;p=t;try{return e()}finally{p=n}},t.unstable_pauseExecution=function(){},t.unstable_requestPaint=function(){},t.unstable_runWithPriority=function(e,t){switch(e){case 1:case 2:case 3:case 4:case 5:break;default:e=3}var n=p;p=e;try{return t()}finally{p=n}},t.unstable_scheduleCallback=function(e,a,o){var i=t.unstable_now();switch("object"===typeof o&&null!==o?o="number"===typeof(o=o.delay)&&0<o?i+o:i:o=i,e){case 1:var s=-1;break;case 2:s=250;break;case 5:s=1073741823;break;case 4:s=1e4;break;default:s=5e3}return e={id:d++,callback:a,priorityLevel:e,startTime:o,expirationTime:s=o+s,sortIndex:-1},o>i?(e.sortIndex=o,n(c,e),null===r(u)&&e===r(c)&&(v?(y(x),x=-1):v=!0,R(w,o-i))):(e.sortIndex=s,n(u,e),h||m||(h=!0,M(k))),e},t.unstable_shouldYield=E,t.unstable_wrapCallback=function(e){var t=p;return function(){var n=p;p=t;try{return e.apply(this,arguments)}finally{p=n}}}},5296:function(e,t,n){"use strict";e.exports=n(6813)},4836:function(e){e.exports=function(e){return e&&e.__esModule?e:{default:e}},e.exports.__esModule=!0,e.exports.default=e.exports},907:function(e,t,n){"use strict";function r(e,t){(null==t||t>e.length)&&(t=e.length);for(var n=0,r=new Array(t);n<t;n++)r[n]=e[n];return r}n.d(t,{Z:function(){return r}})},4942:function(e,t,n){"use strict";function r(e,t,n){return t in e?Object.defineProperty(e,t,{value:n,enumerable:!0,configurable:!0,writable:!0}):e[t]=n,e}n.d(t,{Z:function(){return r}})},7462:function(e,t,n){"use strict";function r(){return r=Object.assign?Object.assign.bind():function(e){for(var t=1;t<arguments.length;t++){var n=arguments[t];for(var r in n)Object.prototype.hasOwnProperty.call(n,r)&&(e[r]=n[r])}return e},r.apply(this,arguments)}n.d(t,{Z:function(){return r}})},3366:function(e,t,n){"use strict";function r(e,t){if(null==e)return{};var n,r,a={},o=Object.keys(e);for(r=0;r<o.length;r++)n=o[r],t.indexOf(n)>=0||(a[n]=e[n]);return a}n.d(t,{Z:function(){return r}})},885:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(181);function a(e,t){return function(e){if(Array.isArray(e))return e}(e)||function(e,t){var n=null==e?null:"undefined"!==typeof Symbol&&e[Symbol.iterator]||e["@@iterator"];if(null!=n){var r,a,o=[],i=!0,s=!1;try{for(n=n.call(e);!(i=(r=n.next()).done)&&(o.push(r.value),!t||o.length!==t);i=!0);}catch(l){s=!0,a=l}finally{try{i||null==n.return||n.return()}finally{if(s)throw a}}return o}}(e,t)||(0,r.Z)(e,t)||function(){throw new TypeError("Invalid attempt to destructure non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()}},2982:function(e,t,n){"use strict";n.d(t,{Z:function(){return o}});var r=n(907);var a=n(181);function o(e){return function(e){if(Array.isArray(e))return(0,r.Z)(e)}(e)||function(e){if("undefined"!==typeof Symbol&&null!=e[Symbol.iterator]||null!=e["@@iterator"])return Array.from(e)}(e)||(0,a.Z)(e)||function(){throw new TypeError("Invalid attempt to spread non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()}},181:function(e,t,n){"use strict";n.d(t,{Z:function(){return a}});var r=n(907);function a(e,t){if(e){if("string"===typeof e)return(0,r.Z)(e,t);var n=Object.prototype.toString.call(e).slice(8,-1);return"Object"===n&&e.constructor&&(n=e.constructor.name),"Map"===n||"Set"===n?Array.from(e):"Arguments"===n||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(n)?(0,r.Z)(e,t):void 0}}}},t={};function n(r){var a=t[r];if(void 0!==a)return a.exports;var o=t[r]={exports:{}};return e[r].call(o.exports,o,o.exports,n),o.exports}n.n=function(e){var t=e&&e.__esModule?function(){return e.default}:function(){return e};return n.d(t,{a:t}),t},function(){var e,t=Object.getPrototypeOf?function(e){return Object.getPrototypeOf(e)}:function(e){return e.__proto__};n.t=function(r,a){if(1&a&&(r=this(r)),8&a)return r;if("object"===typeof r&&r){if(4&a&&r.__esModule)return r;if(16&a&&"function"===typeof r.then)return r}var o=Object.create(null);n.r(o);var i={};e=e||[null,t({}),t([]),t(t)];for(var s=2&a&&r;"object"==typeof s&&!~e.indexOf(s);s=t(s))Object.getOwnPropertyNames(s).forEach((function(e){i[e]=function(){return r[e]}}));return i.default=function(){return r},n.d(o,i),o}}(),n.d=function(e,t){for(var r in t)n.o(t,r)&&!n.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},n.o=function(e,t){return Object.prototype.hasOwnProperty.call(e,t)},n.r=function(e){"undefined"!==typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},function(){"use strict";var e=n(2791),t=n(1250),r=n(7462),a=n(5513),o=(n(76),n(9886)),i=(n(2110),n(5438)),s=n(9140),l=n(2561),u=(0,o.w)((function(t,n){var r=t.styles,a=(0,s.O)([r],void 0,(0,e.useContext)(o.T)),u=(0,e.useRef)();return(0,l.j)((function(){var e=n.key+"-global",t=new n.sheet.constructor({key:e,nonce:n.sheet.nonce,container:n.sheet.container,speedy:n.sheet.isSpeedy}),r=!1,o=document.querySelector('style[data-emotion="'+e+" "+a.name+'"]');return n.sheet.tags.length&&(t.before=n.sheet.tags[0]),null!==o&&(r=!0,o.setAttribute("data-emotion",e),t.hydrate([o])),u.current=[t,r],function(){t.flush()}}),[n]),(0,l.j)((function(){var e=u.current,t=e[0];if(e[1])e[1]=!1;else{if(void 0!==a.next&&(0,i.My)(n,a.next,!0),t.tags.length){var r=t.tags[t.tags.length-1].nextElementSibling;t.before=r,t.flush()}n.insert("",a,t,!1)}}),[n,a.name]),null}));function c(){for(var e=arguments.length,t=new Array(e),n=0;n<e;n++)t[n]=arguments[n];return(0,s.O)(t)}var d=function(){var e=c.apply(void 0,arguments),t="animation-"+e.name;return{name:t,styles:"@keyframes "+t+"{"+e.styles+"}",anim:1,toString:function(){return"_EMO_"+this.name+"_"+this.styles+"_EMO_"}}};var f=n(184);function p(e){var t=e.styles,n=e.defaultTheme,r=void 0===n?{}:n,a="function"===typeof t?function(e){return t(void 0===(n=e)||null===n||0===Object.keys(n).length?r:e);var n}:t;return(0,f.jsx)(u,{styles:a})}var m=n(4205);var h=function(e){return(0,f.jsx)(p,(0,r.Z)({},e,{defaultTheme:m.Z}))},v=function(e,t){return(0,r.Z)({WebkitFontSmoothing:"antialiased",MozOsxFontSmoothing:"grayscale",boxSizing:"border-box",WebkitTextSizeAdjust:"100%"},t&&{colorScheme:e.palette.mode})},b=function(e){return(0,r.Z)({color:(e.vars||e).palette.text.primary},e.typography.body1,{backgroundColor:(e.vars||e).palette.background.default,"@media print":{backgroundColor:(e.vars||e).palette.common.white}})};var y=function(t){var n=(0,a.Z)({props:t,name:"MuiCssBaseline"}),o=n.children,i=n.enableColorScheme,s=void 0!==i&&i;return(0,f.jsxs)(e.Fragment,{children:[(0,f.jsx)(h,{styles:function(e){return function(e){var t,n,a={html:v(e,arguments.length>1&&void 0!==arguments[1]&&arguments[1]),"*, *::before, *::after":{boxSizing:"inherit"},"strong, b":{fontWeight:e.typography.fontWeightBold},body:(0,r.Z)({margin:0},b(e),{"&::backdrop":{backgroundColor:(e.vars||e).palette.background.default}})},o=null==(t=e.components)||null==(n=t.MuiCssBaseline)?void 0:n.styleOverrides;return o&&(a=[a,o]),a}(e,s)}}),o]})},g=n(885),_=n(4942),w=n(3366),k=n(8182),S=n(7312),T=n(1217),C=n(4419),x=n(8691),A=(0,n(4046).ZP)(),F=n(5080),E=["className","component","disableGutters","fixed","maxWidth","classes"],P=(0,F.Z)(),O=A("div",{name:"MuiContainer",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["maxWidth".concat((0,S.Z)(String(n.maxWidth)))],n.fixed&&t.fixed,n.disableGutters&&t.disableGutters]}}),N=function(e){return(0,x.Z)({props:e,name:"MuiContainer",defaultTheme:P})},M=function(e,t){var n=e.classes,r=e.fixed,a=e.disableGutters,o=e.maxWidth,i={root:["root",o&&"maxWidth".concat((0,S.Z)(String(o))),r&&"fixed",a&&"disableGutters"]};return(0,C.Z)(i,(function(e){return(0,T.Z)(t,e)}),n)};var R=n(9853),D=n(277),L=function(){var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=t.createStyledComponent,a=void 0===n?O:n,o=t.useThemeProps,i=void 0===o?N:o,s=t.componentName,l=void 0===s?"MuiContainer":s,u=a((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({width:"100%",marginLeft:"auto",boxSizing:"border-box",marginRight:"auto",display:"block"},!n.disableGutters&&(0,_.Z)({paddingLeft:t.spacing(2),paddingRight:t.spacing(2)},t.breakpoints.up("sm"),{paddingLeft:t.spacing(3),paddingRight:t.spacing(3)}))}),(function(e){var t=e.theme;return e.ownerState.fixed&&Object.keys(t.breakpoints.values).reduce((function(e,n){var r=n,a=t.breakpoints.values[r];return 0!==a&&(e[t.breakpoints.up(r)]={maxWidth:"".concat(a).concat(t.breakpoints.unit)}),e}),{})}),(function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({},"xs"===n.maxWidth&&(0,_.Z)({},t.breakpoints.up("xs"),{maxWidth:Math.max(t.breakpoints.values.xs,444)}),n.maxWidth&&"xs"!==n.maxWidth&&(0,_.Z)({},t.breakpoints.up(n.maxWidth),{maxWidth:"".concat(t.breakpoints.values[n.maxWidth]).concat(t.breakpoints.unit)}))})),c=e.forwardRef((function(e,t){var n=i(e),a=n.className,o=n.component,s=void 0===o?"div":o,c=n.disableGutters,d=void 0!==c&&c,p=n.fixed,m=void 0!==p&&p,h=n.maxWidth,v=void 0===h?"lg":h,b=(0,w.Z)(n,E),y=(0,r.Z)({},n,{component:s,disableGutters:d,fixed:m,maxWidth:v}),g=M(y,l);return(0,f.jsx)(u,(0,r.Z)({as:s,ownerState:y,className:(0,k.Z)(g.root,a),ref:t},b))}));return c}({createStyledComponent:(0,D.ZP)("div",{name:"MuiContainer",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["maxWidth".concat((0,R.Z)(String(n.maxWidth)))],n.fixed&&t.fixed,n.disableGutters&&t.disableGutters]}}),useThemeProps:function(e){return(0,a.Z)({props:e,name:"MuiContainer"})}}),I=L,z=n(2421),j=n(104),Z=n(2982),B=n(2466),V=n(114),W=["sx"];function G(e){var t,n=e.sx,a=function(e){var t={systemProps:{},otherProps:{}};return Object.keys(e).forEach((function(n){V.Gc[n]?t.systemProps[n]=e[n]:t.otherProps[n]=e[n]})),t}((0,w.Z)(e,W)),o=a.systemProps,i=a.otherProps;return t=Array.isArray(n)?[o].concat((0,Z.Z)(n)):"function"===typeof n?function(){var e=n.apply(void 0,arguments);return(0,B.P)(e)?(0,r.Z)({},o,e):o}:(0,r.Z)({},o,n),(0,r.Z)({},i,{sx:t})}var U=n(886),H=["className","component"];var $=n(5902),J=n(4360),q=function(){var t=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},n=t.defaultTheme,a=t.defaultClassName,o=void 0===a?"MuiBox-root":a,i=t.generateClassName,s=t.styleFunctionSx,l=void 0===s?j.Z:s,u=(0,z.ZP)("div",{shouldForwardProp:function(e){return"theme"!==e&&"sx"!==e&&"as"!==e}})(l),c=e.forwardRef((function(e,t){var a=(0,U.Z)(n),s=G(e),l=s.className,c=s.component,d=void 0===c?"div":c,p=(0,w.Z)(s,H);return(0,f.jsx)(u,(0,r.Z)({as:d,ref:t,className:(0,k.Z)(l,i?i(o):o),theme:a},p))}));return c}({defaultTheme:(0,J.Z)(),defaultClassName:"MuiBox-root",generateClassName:$.Z.generate}),Q=q,K=JSON.parse('{"e":10,"C":[{"nctid":"NCT01190189","version_a":12,"version_b":13,"version_a_date":"2011-09-01","version_b_date":"2011-10-20","pom_a":[{"label":"1.","content":"Occurrence, intensity and causal relationship to vaccination of serious adverse events[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"2.","content":"Occurrence, intensity and causal relationship to vaccination of medically significant conditions[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"3.","content":"Occurrence of pregnancies and pregnancy outcomes throughout the study[ Time Frame: Throughout the study (from Month 0 to 12) ]"}],"pom_b":[{"label":"1.","content":"Occurrence, intensity and causal relationship to vaccination of serious adverse events[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"2.","content":"Occurrence, intensity and causal relationship to vaccination of medically significant conditions (including potential immune-mediated diseases)[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"3.","content":"Occurrence of pregnancies and pregnancy outcomes[ Time Frame: Throughout the study (from Month 0 to 12) ]"}],"start_date":"April 1, 2011","primary_completion_date":"November 23, 2017","completion_date":"November 23, 2017","first_posted":"August 27, 2010","results_first_posted":"December 17, 2018","last_update_posted":"June 19, 2019"},{"nctid":"NCT01190189","version_a":77,"version_b":78,"version_a_date":"2017-12-21","version_b_date":"2018-05-29","pom_a":[{"label":"1.","content":"Occurrence, intensity and causal relationship to vaccination of serious adverse events[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"2.","content":"Occurrence, intensity and causal relationship to vaccination of medically significant conditions (including potential immune-mediated diseases)[ Time Frame: Throughout the study (from Month 0 to 12) ]"},{"label":"3.","content":"Occurrence of pregnancies and pregnancy outcomes[ Time Frame: Throughout the study (from Month 0 to 12) ]"}],"pom_b":[{"label":"1.","content":"Number of subjects reporting any, Grade 3 and related serious adverse events (SAEs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. A related SAE was defined as an event assessed by the investigator as causally related to the study vaccination."},{"label":"2.","content":"Number of subjects reporting any, Grade 3 and related medically significant conditions (MAEs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]Medically significant conditions were defined as: AEs prompting emergency room or physician visits that were not (1) related to common diseases or (2) routine visits for physical examination or vaccination, or SAEs that were not related to common diseases. Common diseases included: upper respiratory infections, sinusitis, pharyngitis, gastroenteritis, urinary tract infections, cervicovaginal yeast infections, menstrual cycle abnormalities and injury."},{"label":"3.","content":"Number of subjects with potentially Immune-Mediated Diseases (pIMDs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]pIMD(s) are a subset of AEs that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology."},{"label":"4.","content":"Number of subjects with pregnancies and their outcomes[ Time Frame: During the entire study period (From Month 0 to Month 12) ]Pregnancy outcomes are live infant, premature live infant, elec-tive termination, ectopic pregnancy, spontaneous abortion, lost to follow-up and pregnancy ongoing. For each category it was specified if the infant presents congenital anomaly (CA) or no apparent congenital anomaly (No ACA)."}],"start_date":"April 1, 2011","primary_completion_date":"November 23, 2017","completion_date":"November 23, 2017","first_posted":"August 27, 2010","results_first_posted":"December 17, 2018","last_update_posted":"June 19, 2019"},{"nctid":"NCT01190189","version_a":79,"version_b":80,"version_a_date":"2018-05-31","version_b_date":"2018-11-22","pom_a":[{"label":"1.","content":"Number of subjects reporting any, Grade 3 and related serious adverse events (SAEs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. A related SAE was defined as an event assessed by the investigator as causally related to the study vaccination."},{"label":"2.","content":"Number of subjects reporting any, Grade 3 and related medically significant conditions (MAEs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]Medically significant conditions were defined as: AEs prompting emergency room or physician visits that were not (1) related to common diseases or (2) routine visits for physical examination or vaccination, or SAEs that were not related to common diseases. Common diseases included: upper respiratory infections, sinusitis, pharyngitis, gastroenteritis, urinary tract infections, cervicovaginal yeast infections, menstrual cycle abnormalities and injury."},{"label":"3.","content":"Number of subjects with potentially Immune-Mediated Diseases (pIMDs)[ Time Frame: During the entire study period (From Month 0 to Month 12) ]pIMD(s) are a subset of AEs that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology."},{"label":"4.","content":"Number of subjects with pregnancies and their outcomes[ Time Frame: During the entire study period (From Month 0 to Month 12) ]Pregnancy outcomes are live infant, premature live infant, elec-tive termination, ectopic pregnancy, spontaneous abortion, lost to follow-up and pregnancy ongoing. For each category it was specified if the infant presents congenital anomaly (CA) or no apparent congenital anomaly (No ACA)."}],"pom_b":[{"label":"1.","content":"Number of Subjects Reporting Any, Grade 3 and Related Serious Adverse Events (SAEs)[ Time Frame: During the entire study period (from Day 0 up to Month 12) ]Assessed SAEs included medical occurrences that resulted in death, were life-threatening, required hospitalization or prolongation of hospitalization, resulted in disability/incapacity or were congenital anomalies/birth defects in the offspring of a study subject. Any SAE = occurrence of the SAE regardless of intensity grade. Grade 3 SAE = an SAE which prevented normal, everyday activities. Related SAE = an SAE assessed by the investigator as causally related to the study vaccination."},{"label":"2.","content":"Number of Subjects Reporting Any, Grade 3 and Related Medically Significant Conditions (MSCs)[ Time Frame: During the entire study period (from Day 0 up to Month 12) ]Medically significant conditions were defined as: AEs prompting emergency room or physician visits that were not (1) related to common diseases, or (2) not related to routine visits for physical examination or vaccination, or as SAEs that were not related to common diseases. Common diseases included: upper respiratory infections, sinusitis, pharyngitis, gastroenteritis, urinary tract infections, cervicovaginal yeast infections, menstrual cycle abnormalities and injury. Any MSC = occurrence of the MSC regardless of intensity grade. Grade 3 MSC = a MSC which prevented normal, everyday activities. Related MSC = MSC assessed by the investigator as related to the study vaccination."},{"label":"3.","content":"Number of Subjects Reporting Any, Grade 3 and Related Potentially Immune-Mediated Diseases (pIMDs)[ Time Frame: During the entire study period (from Day 0 up to Month 12) ]pIMD(s) are a subset of medically significant conditions (MSCs) that included autoimmune diseases and other inflammatory and/or neurological disorders of interest which may or may not have had an autoimmune aetiology. Any pIMD = occurrence of the pIMD regardless of intensity grade. Grade 3 pIMD = a pIMD which prevented normal, everyday activities. Related pIMD = pIMD assessed by the investigator as related to the study vaccination."},{"label":"4.","content":"Number of Subjects Reporting Pregnancies and Outcomes of the Reported Pregnancies[ Time Frame: During the entire study period (from Day 0 up to Month 12) ]Pregnancy is the term used to describe the period in which a fetus develops inside a woman\'s womb or uterus. In this study, the number of subjects with pregnancies was calculated. The subjects with confirmed pregnancies were followed up to determine the outcomes of the reported pregnancies."}],"start_date":"April 1, 2011","primary_completion_date":"November 23, 2017","completion_date":"November 23, 2017","first_posted":"August 27, 2010","results_first_posted":"December 17, 2018","last_update_posted":"June 19, 2019"},{"nctid":"NCT00236002","version_a":6,"version_b":7,"version_a_date":"2007-05-25","version_b_date":"2007-11-05","pom_a":[{"label":"1.","content":"Bone marrow Density and xrays"}],"pom_b":[{"label":"1.","content":"Bone marrow Density and xrays[ Time Frame: ONE YEAR ]"},{"label":"2.","content":"Bone marrow density[ Time Frame: ONE YEAR ]"}],"start_date":"July 2005","primary_completion_date":"November 2007","completion_date":"August 2009","first_posted":"October 12, 2005","last_update_posted":"August 12, 2009"},{"nctid":"NCT00236002","version_a":8,"version_b":9,"version_a_date":"2007-11-30","version_b_date":"2009-08-11","pom_a":[{"label":"1.","content":"Bone marrow Density and xrays[ Time Frame: ONE YEAR ]"},{"label":"2.","content":"Bone marrow density[ Time Frame: ONE YEAR ]"}],"pom_b":[{"label":"1.","content":"Bone mineral density[ Time Frame: ONE YEAR ]"}],"start_date":"July 2005","primary_completion_date":"November 2007","completion_date":"August 2009","first_posted":"October 12, 2005","last_update_posted":"August 12, 2009"},{"nctid":"NCT01827930","version_a":6,"version_b":7,"version_a_date":"2017-11-17","version_b_date":"2020-12-30","pom_a":[{"label":"1.","content":"Compare the effectiveness of a strategy to adapt dosage of Imatinib Mesylate (based on residual plasma IM), the effectiveness of a standard (IM fixed dose of 400 mg / day )[ Time Frame: 07/2013 (up to 12 months) ]Compare the effectiveness of a strategy to adapt dosage of Imatinib Mesylate (based on residual plasma IM), the effectiveness of a standard (IM fixed dose of 400 mg / day )"}],"pom_b":[{"label":"1.","content":"Percentage of Patients Presenting a Decline of the BCR-ABL Transcript Rate at 12 Months From Baseline - Randomised Study[ Time Frame: 12 months ]The BCR-ABL transcript rate was analysed by molecular biology by RQ-PCR at study entry, 3 months, 6 months, 9 months and 12 months.Treatment is considered effective at 12 months if:for patients with an inclusion transcript rate less than 0.1%: the transcript rate at 12 months is less or equal to 0.001% or undetectable.for patients with an inclusion transcript rate greater than 0.1% : the transcript rate at 12 months is less or equal to 0.1% or undetectable.If BCR-ABL transcript level was unavailable at M12, the treatment was considered ineffective."}],"start_date":"July 2009","primary_completion_date":"January 1, 2017","completion_date":"January 1, 2017","first_posted":"April 10, 2013","results_first_posted":"December 31, 2020","last_update_posted":"December 31, 2020"},{"nctid":"NCT00807768","version_a":340,"version_b":341,"version_a_date":"2012-02-03","version_b_date":"2016-03-17","pom_a":[{"label":"1.","content":"Duration of recurrence-free survival"}],"pom_b":[{"label":"1.","content":"Duration of recurrence-free survival[ Time Frame: From study entry until disease recurrence, death, or date of last contact, assessed up to 10 years ]"}],"start_date":"March 23, 2009","primary_completion_date":"December 29, 2014","first_posted":"December 12, 2008","results_first_posted":"April 27, 2018","last_update_posted":"March 20, 2019"},{"nctid":"NCT00807768","version_a":342,"version_b":343,"version_a_date":"2017-05-03","version_b_date":"2018-03-27","pom_a":[{"label":"1.","content":"Duration of recurrence-free survival[ Time Frame: From study entry until disease recurrence, death, or date of last contact, assessed up to 10 years ]"}],"pom_b":[{"label":"1.","content":"Number of Recurrence or Death Events at Primary Analysis[ Time Frame: Within 4 weeks after completing or discontinuing study therapy, then every 6 months for 2 years, then annually for 3 years, then as clinically indicated, assessed up to 10 years ]Recurrence-Free Survival is the period from study entry until disease recurrence, death, or date of last contact"}],"start_date":"March 23, 2009","primary_completion_date":"December 29, 2014","first_posted":"December 12, 2008","results_first_posted":"April 27, 2018","last_update_posted":"March 20, 2019"},{"nctid":"NCT00807768","version_a":343,"version_b":344,"version_a_date":"2018-03-27","version_b_date":"2018-06-28","pom_a":[{"label":"1.","content":"Number of Recurrence or Death Events at Primary Analysis[ Time Frame: Within 4 weeks after completing or discontinuing study therapy, then every 6 months for 2 years, then annually for 3 years, then as clinically indicated, assessed up to 10 years ]Recurrence-Free Survival is the period from study entry until disease recurrence, death, or date of last contact"}],"pom_b":[{"label":"1.","content":"Number of Participants With Recurrence or Death Events at Primary Analysis[ Time Frame: Within 4 weeks after completing or discontinuing study therapy, then every 6 months for 2 years, then annually for 3 years, then as clinically indicated, assessed up to 10 years ]Recurrence-Free Survival is the period from study entry until disease recurrence, death, or date of last contact"}],"start_date":"March 23, 2009","primary_completion_date":"December 29, 2014","first_posted":"December 12, 2008","results_first_posted":"April 27, 2018","last_update_posted":"March 20, 2019"},{"nctid":"NCT04628767","version_a":3,"version_b":4,"version_a_date":"2021-01-09","version_b_date":"2021-01-13","pom_a":[{"label":"1.","content":"Event-free survival (EFS) (Cisplatin eligible cohort)[ Time Frame: From randomization to the earliest of systemic recurrence, disease progression, or death from any cause, assessed up to 5 years ]EFS events in this trial will be defined as disease recurring outside of the bladder, urethra, or contralateral upper tract."},{"label":"2.","content":"Pathologic complete response (pCR) (Cisplatin ineligible cohort)[ Time Frame: At surgery ]Will assess pathologic complete response at surgery (pCR, pT0N0/Nx) by local pathology review. Patients who drop out prior to surgery or who have unknown response status will be considered as non-responders."}],"pom_b":[{"label":"1.","content":"Event-free survival (EFS) (Cisplatin eligible cohort: Arms A and B)[ Time Frame: From randomization to the earliest of systemic recurrence, disease progression, or death from any cause, assessed up to 5 years ]Defined as disease recurring outside of the bladder, urethra, or contralateral upper tract."},{"label":"2.","content":"Pathologic complete response (pCR) (Cisplatin ineligible cohort: Arm C)[ Time Frame: At surgery ]Will assess pathologic complete response at surgery (pCR, pT0N0/Nx) by local pathology review. Patients who drop out prior to surgery or who have unknown response status will be considered as non-responders."}],"start_date":"May 6, 2021","primary_completion_date":"September 30, 2027","completion_date":"September 30, 2027","first_posted":"November 16, 2020","last_update_posted":"September 14, 2022"},{"nctid":"NCT00434057","version_a":2,"version_b":3,"version_a_date":"2007-09-10","version_b_date":"2009-11-10","pom_a":[{"label":"1.","content":"Sensitivity"},{"label":"2.","content":"Specificity"}],"pom_b":[{"label":"1.","content":"Sensitivity and Specificity[ Time Frame: Within 120 days of Data Lock ]Sensitivity is the fraction of correctly identified cases of melanoma. Specificity is the fraction of correctly identified cases of non-melanoma."}],"start_date":"January 2007","primary_completion_date":"July 2008","completion_date":"July 2008","first_posted":"February 12, 2007","results_first_posted":"November 11, 2009","last_update_posted":"February 14, 2012"},{"nctid":"NCT00362986","version_a":5,"version_b":6,"version_a_date":"2006-10-25","version_b_date":"2006-11-09","pom_a":[],"pom_b":[{"label":"1.","content":"Incidence and severity of rash development by Skindex questionnaire"}],"start_date":"October 2006","primary_completion_date":"July 2007","completion_date":"October 2009","first_posted":"August 15, 2006","last_update_posted":"December 13, 2016"},{"nctid":"NCT00362986","version_a":40,"version_b":41,"version_a_date":"2011-09-20","version_b_date":"2015-07-07","pom_a":[{"label":"1.","content":"Incidence and severity of rash development by Skindex questionnaire"}],"pom_b":[{"label":"1.","content":"Incidence and severity of rash development by Skindex questionnaire[ Time Frame: Up to 8 weeks ]"}],"start_date":"October 2006","primary_completion_date":"July 2007","completion_date":"October 2009","first_posted":"August 15, 2006","last_update_posted":"December 13, 2016"},{"nctid":"NCT00078988","version_a":27,"version_b":28,"version_a_date":"2006-05-04","version_b_date":"2007-02-20","pom_a":[],"pom_b":[{"label":"1.","content":"Event-free survival"},{"label":"2.","content":"Toxic death"}],"start_date":"October 2004","primary_completion_date":"September 2006","completion_date":"September 2006","first_posted":"March 9, 2004","last_update_posted":"May 7, 2015"},{"nctid":"NCT00078988","version_a":37,"version_b":38,"version_a_date":"2010-12-30","version_b_date":"2013-03-07","pom_a":[{"label":"1.","content":"Event-free survival"},{"label":"2.","content":"Toxic death"}],"pom_b":[{"label":"1.","content":"Event-free survival[ Time Frame: om study entry to disease progression, disease relapse, occurrence of a second malignant neoplasm, or death from any cause. assessed up to 4 years ]The primary endpoint for the evaluation of treatment efficacy will be event-free survival (EFS)"},{"label":"2.","content":"Toxic death attributable to complications of treatment in the absence of tumor progression as assessed by NCI Common Toxicity Criteria for Adverse Events (CTCAE) version 3.0[ Time Frame: Up to 4 years after completion of study treatment ]Toxic death will be monitored separately in each of the two chemotherapy groups"}],"start_date":"October 2004","primary_completion_date":"September 2006","completion_date":"September 2006","first_posted":"March 9, 2004","last_update_posted":"May 7, 2015"},{"nctid":"NCT00538863","version_a":5,"version_b":6,"version_a_date":"2012-03-23","version_b_date":"2013-08-06","pom_a":[{"label":"1.","content":"The primary objective is to assess the safety of Fentanyl SL Spray in subjects on efficacious doses of Fentanyl SL Spray[ Time Frame: 90 days ]"}],"pom_b":[{"label":"1.","content":"Percentage of Patients That Experienced 1 or More Adverse Events[ Time Frame: Baseline to end of the study (up to 116 days) ]"}],"start_date":"December 2007","primary_completion_date":"October 2010","completion_date":"October 2010","first_posted":"October 3, 2007","results_first_posted":"October 11, 2013","last_update_posted":"October 11, 2013"},{"nctid":"NCT03240523","version_a":12,"version_b":13,"version_a_date":"2018-06-14","version_b_date":"2018-08-01","pom_a":[{"label":"1.","content":"Amenorrhea (yes/no)[ Time Frame: At 3 months (at the end of treatment perid 1) ]Defined as menstrual blood loss (MBL) < 2 mL based on the menstrual pictogram (MP) during last 28 days of the treatment period.For the primary analysis, the amenorrhea rates at the end of Treatment Period 1 and at the end of Treatment Period 3 in Groups A3 and B will be compared.The study will be continued after the date of primary completion. Study results will be updated once the study is completed, after LPLV."},{"label":"2.","content":"Amenorrhea (yes/no)[ Time Frame: At approximately 1 year (end of treatment perid 3, including treatment breaks) ]"}],"pom_b":[{"label":"1.","content":"Amenorrhea (yes/no)[ Time Frame: At 3 months (at the end of treatment perid 1) ]Defined as menstrual blood loss (MBL) < 2 mL based on the menstrual pictogram (MP) during last 28 days.For the primary analysis of the primary variable, the amenorrhea rates after 12 weeks of treatment in Groups A1, A2 and A3 will be compared to the rate from Group B.The study will be continued after the date of primary completion. Study results will be updated once the study is completed, after LPLV."},{"label":"2.","content":"Amenorrhea (yes/no)[ Time Frame: At approximately 1 year (end of treatment perid 3, including treatment breaks) ]"}],"start_date":"July 31, 2017","primary_completion_date":"June 28, 2020","completion_date":"October 25, 2021","first_posted":"August 7, 2017","last_update_posted":"November 1, 2021"},{"nctid":"NCT03240523","version_a":31,"version_b":32,"version_a_date":"2019-12-23","version_b_date":"2020-01-17","pom_a":[{"label":"1.","content":"Amenorrhea (yes/no)[ Time Frame: At 3 months (at the end of treatment perid 1) ]Defined as menstrual blood loss (MBL) < 2 mL based on the menstrual pictogram (MP) during last 28 days.For the primary analysis of the primary variable, the amenorrhea rates after 12 weeks of treatment in Groups A1, A2 and A3 will be compared to the rate from Group B.The study will be continued after the date of primary completion. Study results will be updated once the study is completed, after LPLV."},{"label":"2.","content":"Amenorrhea (yes/no)[ Time Frame: At approximately 1 year (end of treatment perid 3, including treatment breaks) ]"}],"pom_b":[{"label":"1.","content":"Amenorrhea (yes/no)[ Time Frame: At 3 months (at the end of treatment perid 1) ]Defined as menstrual blood loss (MBL) < 2 mL based on the menstrual pictogram (MP) during last 28 days.For the primary analysis of the primary variable, the amenorrhea rates after 12 weeks of treatment in Groups A1, A2 and A3 will be compared to the rate from Group B."}],"start_date":"July 31, 2017","primary_completion_date":"June 28, 2020","completion_date":"October 25, 2021","first_posted":"August 7, 2017","last_update_posted":"November 1, 2021"},{"nctid":"NCT00282386","version_a":5,"version_b":6,"version_a_date":"2006-10-03","version_b_date":"2007-05-02","pom_a":[{"label":"1.","content":"Cumulative colorectal adenoma recurrence during 156 weeks of treatment in patients with an increased risk to develop colorectal cancer."}],"pom_b":[{"label":"1.","content":"Cumulative colorectal adenoma recurrence during treatment in patients with an increased risk to develop colorectal cancer.[ Time Frame: 156 Weeks ]"}],"start_date":"December 23, 1999","primary_completion_date":"September 1, 2004","completion_date":"September 1, 2004","first_posted":"January 26, 2006","last_update_posted":"May 9, 2017"},{"nctid":"NCT04210115","version_a":29,"version_b":30,"version_a_date":"2020-10-08","version_b_date":"2020-11-03","pom_a":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Up to ~72 months ]OS is defined as the time from randomization to death from any cause."},{"label":"2.","content":"Event-free Survival (EFS)[ Time Frame: Up to ~60 months ]EFS is defined as the time from randomization to an event defined as local, regional, or distant recurrence of the treated esophageal cancer or death from any cause."}],"pom_b":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Up to ~72 months ]OS is defined as the time from randomization to death from any cause."},{"label":"2.","content":"Event-free Survival (EFS)[ Time Frame: Up to ~60 months ]EFS is defined as the time from randomization to an event defined as local, regional, or distant recurrence as assessed by blinded independent central review (BICR) based on imaging or biopsy if indicated (if biopsy is accompanied with radiological recurrence of primary disease as evaluated by investigator); or death from any cause."}],"start_date":"February 28, 2020","primary_completion_date":"February 21, 2026","completion_date":"February 21, 2026","first_posted":"December 24, 2019","last_update_posted":"September 6, 2022"},{"nctid":"NCT02234115","version_a":3,"version_b":4,"version_a_date":"2017-07-03","version_b_date":"2018-03-14","pom_a":[{"label":"1.","content":"Efficacy of Leuprolide Mesylate (LMIS 50mg)[ Time Frame: 336 days ]The percentage of subjects with a serum testosterone concentration suppressed to castrate levels (\u2264 50 ng/dL) by Day 28 \xb1 1(day) following the first injection of LMIS 50 mg and the percentage of subjects with serum testosterone suppression (\u2264 50 ng/dL) from Day 28 through Day 336 (remaining duration of the study)."}],"pom_b":[{"label":"1.","content":"Efficacy of Leuprolide Mesylate (LMIS 50mg)[ Time Frame: baseline to 28 days, 28 days to 336 days ]The percentage of subjects with a serum testosterone concentration suppressed to castrate levels (\u2264 50 ng/dL) following the first injection of LMIS 50 mg from Day 28 through Day 336 (remaining duration of the study)."}],"start_date":"August 2014","primary_completion_date":"August 30, 2016","completion_date":"January 5, 2017","first_posted":"September 9, 2014","results_first_posted":"April 13, 2018","last_update_posted":"March 5, 2019"},{"nctid":"NCT02654587","version_a":17,"version_b":18,"version_a_date":"2017-12-07","version_b_date":"2018-06-26","pom_a":[{"label":"1.","content":"Overall Survival time (OS)[ Time Frame: Approximatively 24 months ]"}],"pom_b":[{"label":"1.","content":"Overall Survival time (OS)[ Time Frame: Approx. 24 months ]"}],"start_date":"February 2016","primary_completion_date":"February 2020","completion_date":"December 2021","first_posted":"January 13, 2016","last_update_posted":"March 8, 2021"},{"nctid":"NCT02654587","version_a":20,"version_b":21,"version_a_date":"2018-09-21","version_b_date":"2019-12-10","pom_a":[{"label":"1.","content":"Overall Survival time (OS)[ Time Frame: Approx. 24 months ]"}],"pom_b":[{"label":"1.","content":"Overall Survival time (OS)[ Time Frame: Approx. 24 months ]In Step 1: OS rate at 12 months in experimental Arm A (OSE2101) in 84 evaluable patients exposed to OSE2101In Step 2: comparison of OS between experimental Arm A (OSE2101) and control Arm B (docetaxel or pemetrexed) when 278 events observed"}],"start_date":"February 2016","primary_completion_date":"February 2020","completion_date":"December 2021","first_posted":"January 13, 2016","last_update_posted":"March 8, 2021"},{"nctid":"NCT01387932","version_a":26,"version_b":27,"version_a_date":"2021-05-04","version_b_date":"2021-11-02","pom_a":[{"label":"1.","content":"Median overall survival[ Time Frame: 2 years ]"}],"pom_b":[{"label":"1.","content":"Median Overall Survival[ Time Frame: 2 years ]Median overall survival will be calculated using the Intent-to-Treat (ITT) population in each treatment arm when the last subject has completed two years of follow up after their first study TACE procedure. Per protocol, study subjects were followed for survival until death or deemed lost to follow up. All deaths are reported within safety."}],"start_date":"June 2011","primary_completion_date":"February 2021","completion_date":"February 2021","first_posted":"July 6, 2011","results_first_posted":"November 30, 2021","last_update_posted":"November 30, 2021"},{"nctid":"NCT00505414","version_a":9,"version_b":10,"version_a_date":"2009-12-02","version_b_date":"2010-05-27","pom_a":[{"label":"1.","content":"\u2022 Complete 28 days of the Maintenance phase \u2022 Have a mean pain intensity < 5.0 point on an 11-point NRS during the Maintenance phase \u2022 Do not use more than 2.0 doses of rescue medication/day on average during the Maintenance phase[ Time Frame: End of trial ]"}],"pom_b":[{"label":"1.","content":"Responders[ Time Frame: End of maintenance phase ]Responders were classified as those subjects that meet all 3 criteria in the maintenance phase: completed 28 days; had a mean pain intensity of less than 5 on an 11 point Numeric Rating Scale (where 0 indicates no pain and 10 indicates worst possible pain) and use less than 2 rescue analgesic doses on average per day."},{"label":"2.","content":"Responder[ Time Frame: 28 days ]Responders are participants that met the following criteria:completed 28 days of the maintenance phasehad a numeric rating scale score below 5 on the 11 point scale (where 0 indicates no pain and 10 indicates worst possible pain)did not use more than 30 mg of rescue medication per day on average in the maintenance period"}],"start_date":"June 2007","primary_completion_date":"February 2009","completion_date":"May 2009","first_posted":"July 23, 2007","results_first_posted":"July 2, 2010","last_update_posted":"November 1, 2019"},{"nctid":"NCT00505414","version_a":10,"version_b":11,"version_a_date":"2010-05-27","version_b_date":"2010-07-05","pom_a":[{"label":"1.","content":"Responders[ Time Frame: End of maintenance phase ]Responders were classified as those subjects that meet all 3 criteria in the maintenance phase: completed 28 days; had a mean pain intensity of less than 5 on an 11 point Numeric Rating Scale (where 0 indicates no pain and 10 indicates worst possible pain) and use less than 2 rescue analgesic doses on average per day."},{"label":"2.","content":"Responder[ Time Frame: 28 days ]Responders are participants that met the following criteria:completed 28 days of the maintenance phasehad a numeric rating scale score below 5 on the 11 point scale (where 0 indicates no pain and 10 indicates worst possible pain)did not use more than 30 mg of rescue medication per day on average in the maintenance period"}],"pom_b":[{"label":"1.","content":"Responder[ Time Frame: completed 28 days in the maintenance phase ]A \\"responder\\" is a participant in the study that:completed 28 days of the maintenance phasehad a numeric rating scale score below 5 on the 11 point scale (where 0 indicates no pain and 10 indicates worst possible pain)did not use more than 30 mg of rescue medication per day on average in the 28 day maintenance period.A participant that met all 3 of the above-mentioned criteria is counted as a responder, in other words the participant benefited from the assigned drug treatment. A participant that fails to meet only 1 of the 3 criteria is not counted as a responder."}],"start_date":"June 2007","primary_completion_date":"February 2009","completion_date":"May 2009","first_posted":"July 23, 2007","results_first_posted":"July 2, 2010","last_update_posted":"November 1, 2019"},{"nctid":"NCT00505414","version_a":11,"version_b":12,"version_a_date":"2010-07-05","version_b_date":"2016-05-02","pom_a":[{"label":"1.","content":"Responder[ Time Frame: completed 28 days in the maintenance phase ]A \\"responder\\" is a participant in the study that:completed 28 days of the maintenance phasehad a numeric rating scale score below 5 on the 11 point scale (where 0 indicates no pain and 10 indicates worst possible pain)did not use more than 30 mg of rescue medication per day on average in the 28 day maintenance period.A participant that met all 3 of the above-mentioned criteria is counted as a responder, in other words the participant benefited from the assigned drug treatment. A participant that fails to meet only 1 of the 3 criteria is not counted as a responder."}],"pom_b":[{"label":"1.","content":"Responder Rates in Maintenance Period[ Time Frame: End of the 4 week Maintenance Phase (Day 43) ]A \\"responder\\" is a participant in the study that:completed 28 days of the maintenance phasehad a numeric rating scale score below 5 on the 11 point scale (where 0 indicates no pain and 10 indicates worst possible pain. This twice daily current pain score was averaged over Day 18 to Day 43.did not use more than 30 mg of rescue medication per day on average in the 28 day (excluding the first 3 days) maintenance period (from Day 18 to Day 43).A participant that met all 3 of the above-mentioned criteria is counted as a responder, in other words the participant benefited from the assigned drug treatment. A participant that fails to meet at least 1 of the 3 criteria is not counted as a responder."}],"start_date":"June 2007","primary_completion_date":"February 2009","completion_date":"May 2009","first_posted":"July 23, 2007","results_first_posted":"July 2, 2010","last_update_posted":"November 1, 2019"},{"nctid":"NCT00193908","version_a":3,"version_b":4,"version_a_date":"2006-01-17","version_b_date":"2006-01-26","pom_a":[{"label":"1.","content":"Frequency of moist desquamation (grade3) acute skin reaction scored as worst reaction within allocated skin care area."}],"pom_b":[{"label":"1.","content":"Frequency of moist desquamation (grade 3) acute skin reaction scored as worst reaction within allocated skin care area"}],"start_date":"March 2004","primary_completion_date":"September 2007","completion_date":"October 2008","first_posted":"September 19, 2005","last_update_posted":"May 14, 2009"},{"nctid":"NCT00193908","version_a":6,"version_b":7,"version_a_date":"2006-07-17","version_b_date":"2007-05-13","pom_a":[{"label":"1.","content":"Frequency of moist desquamation (grade 3) acute skin reaction scored as worst reaction within allocated skin care area"}],"pom_b":[{"label":"1.","content":"Frequency of moist desquamation (grade 3) acute skin reaction scored as worst reaction within allocated skin care area[ Time Frame: 12 weeks ]"}],"start_date":"March 2004","primary_completion_date":"September 2007","completion_date":"October 2008","first_posted":"September 19, 2005","last_update_posted":"May 14, 2009"},{"nctid":"NCT03383458","version_a":42,"version_b":43,"version_a_date":"2020-02-21","version_b_date":"2020-03-09","pom_a":[{"label":"1.","content":"Recurrence-free Survival (RFS)[ Time Frame: Up to 49 months ]defined as the time from randomization to the first documented disease recurrence or death (by any cause), whichever occurs first"}],"pom_b":[{"label":"1.","content":"Recurrence-free Survival (RFS)[ Time Frame: Up to 49 months ]"}],"start_date":"April 18, 2018","primary_completion_date":"December 16, 2024","completion_date":"December 16, 2025","first_posted":"December 26, 2017","last_update_posted":"September 2, 2022"},{"nctid":"NCT00601172","version_a":1,"version_b":2,"version_a_date":"2008-01-24","version_b_date":"2008-02-01","pom_a":[{"label":"1.","content":"Subject diary completed during cycle 1 to assess vomiting and the use of rescue medication.[ Time Frame: during cycle 1 ]"}],"pom_b":[{"label":"1.","content":"Subject diary completed during cycle 1 to assess vomiting and the use of rescue medication."}],"start_date":"March 10, 2008","primary_completion_date":"April 13, 2009","completion_date":"April 13, 2009","first_posted":"January 25, 2008","results_first_posted":"January 17, 2018","last_update_posted":"January 17, 2018"},{"nctid":"NCT00601172","version_a":19,"version_b":20,"version_a_date":"2008-11-13","version_b_date":"2009-07-16","pom_a":[{"label":"1.","content":"Subject diary completed during cycle 1 to assess vomiting and the use of rescue medication."}],"pom_b":[{"label":"1.","content":"Complete response (no vomiting and no use of rescue medication) assessed via subject diary completed during cycle 1, that records vomiting and the use of rescue medication.[ Time Frame: First 120 hours in the first cycle of chemotherapy ]"}],"start_date":"March 10, 2008","primary_completion_date":"April 13, 2009","completion_date":"April 13, 2009","first_posted":"January 25, 2008","results_first_posted":"January 17, 2018","last_update_posted":"January 17, 2018"},{"nctid":"NCT00601172","version_a":26,"version_b":27,"version_a_date":"2013-01-04","version_b_date":"2017-12-18","pom_a":[{"label":"1.","content":"Complete response (no vomiting and no use of rescue medication) assessed via subject diary completed during cycle 1, that records vomiting and the use of rescue medication.[ Time Frame: First 120 hours in the first cycle of chemotherapy ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants Who Achieved a Complete Response in the Overall Phase (0-120 Hours) Following Initiation of the First Cycle of an Oxaliplatin Based Moderately Emetogenic Chemotherapy (MEC) Regimen[ Time Frame: 0 to 120 hours in the first cycle of chemotherapy ]Complete response was defined as no vomiting, no retching and no use of anti-emetic rescue medication. Participants who vomited or retched or received rescue medication in the acute phase (0- 24 hours) following administration of oxaliplatin were also considered as complete response failures in the subsequent delayed (24-120 hour) time period, irrespective of actual response in the delayed phase. However, participants who vomited or retched or received rescue medication in the delayed (24-120 hours) phase were not considered as failures in the acute (0-24 hours) phase. The overall phase began at the start of the administration of the oxaliplatin infusion. Percentage of participants who achieved a complete response in the overall phase (0-120 hours) are presented."}],"start_date":"March 10, 2008","primary_completion_date":"April 13, 2009","completion_date":"April 13, 2009","first_posted":"January 25, 2008","results_first_posted":"January 17, 2018","last_update_posted":"January 17, 2018"},{"nctid":"NCT00552279","version_a":1,"version_b":2,"version_a_date":"2007-10-31","version_b_date":"2007-12-20","pom_a":[{"label":"1.","content":"Anti-HPV-16/18 seroconversion rates .[ Time Frame: one month after the third dose of HPV-16/18 L1 VLP AS04 vaccine in both groups ]"},{"label":"2.","content":"Anti-HPV-16/18 antibody titres[ Time Frame: one month after the third dose of HPV-16/18 L1 VLP AS04 vaccine in both groups. ]"}],"pom_b":[{"label":"1.","content":"Anti-HPV-16/18 seroconversion rates[ Time Frame: One month after the third vaccine dose ]"},{"label":"2.","content":"Anti-HPV-16/18 antibody titres[ Time Frame: One month after the third vaccine dose ]"}],"start_date":"November 12, 2007","primary_completion_date":"February 26, 2009","completion_date":"July 20, 2009","first_posted":"November 1, 2007","results_first_posted":"March 5, 2010","last_update_posted":"June 25, 2018"},{"nctid":"NCT00552279","version_a":11,"version_b":12,"version_a_date":"2009-08-19","version_b_date":"2010-02-12","pom_a":[{"label":"1.","content":"Anti-HPV-16/18 seroconversion rates[ Time Frame: One month after the third vaccine dose ]"},{"label":"2.","content":"Anti-HPV-16/18 antibody titres[ Time Frame: One month after the third vaccine dose ]"}],"pom_b":[{"label":"1.","content":"Number of Subjects Seroconverted for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies[ Time Frame: One month after the third vaccine dose ]Seroconversion is defined as the appearance of anti-HPV-16 and/or anti- HPV-18 antibodies (i.e. antibody titer \u2265 cut-off value) in the sera of subjects seronegative before vaccination.Cut-off values were 8 enzyme-linked immunosorbent assay units per milliliter (EL.U/mL) for anti-HPV-16 antibodies and 7 EL.U/mL for anti- HPV-18 antibodies."},{"label":"2.","content":"Titer of Anti-HPV-16 and Anti-HPV-18 Antibodies[ Time Frame: One month after the third vaccine dose ]Titer given as geometric mean titer (GMT)."}],"start_date":"November 12, 2007","primary_completion_date":"February 26, 2009","completion_date":"July 20, 2009","first_posted":"November 1, 2007","results_first_posted":"March 5, 2010","last_update_posted":"June 25, 2018"},{"nctid":"NCT01316874","version_a":1,"version_b":2,"version_a_date":"2011-03-15","version_b_date":"2011-03-16","pom_a":[{"label":"1.","content":"To assess the efficacy of AD 32 (valrubicin) in patients with CIS of the bladder who previously have been treated with BCG for CIS and in whom recurrence or failure had occurred after multiple courses of intravesical treatment.[ Time Frame: 12 weeks ]"}],"pom_b":[{"label":"1.","content":"Assess the efficacy of AD 32 (valrubicin) in patients with CIS of the bladder who previously have been treated with BCG for CIS and in whom recurrence or failure had occurred after multiple courses of intravesical treatment.[ Time Frame: 12 weeks ]"}],"start_date":"November 1993","primary_completion_date":"April 1997","completion_date":"April 1997","first_posted":"March 16, 2011","last_update_posted":"June 12, 2015"},{"nctid":"NCT00945009","version_a":126,"version_b":127,"version_a_date":"2012-11-21","version_b_date":"2013-06-19","pom_a":[{"label":"1.","content":"4-year event-free survival"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor"},{"label":"5.","content":"Percentage of patients with BWT undergoing definitive surgical treatment by week 12"}],"pom_b":[{"label":"1.","content":"Event-free survival[ Time Frame: 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with BWT undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"start_date":"July 13, 2009","primary_completion_date":"December 31, 2016","completion_date":"November 26, 2023","first_posted":"July 23, 2009","results_first_posted":"March 5, 2019","last_update_posted":"March 25, 2022"},{"nctid":"NCT00945009","version_a":131,"version_b":132,"version_a_date":"2014-10-09","version_b_date":"2015-03-24","pom_a":[{"label":"1.","content":"Event-free survival[ Time Frame: 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with BWT undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"pom_b":[{"label":"1.","content":"Event-free survival[ Time Frame: 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with bilateral Wilms tumor (BWT) undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"start_date":"July 13, 2009","primary_completion_date":"December 31, 2016","completion_date":"November 26, 2023","first_posted":"July 23, 2009","results_first_posted":"March 5, 2019","last_update_posted":"March 25, 2022"},{"nctid":"NCT00945009","version_a":135,"version_b":136,"version_a_date":"2017-11-30","version_b_date":"2018-06-19","pom_a":[{"label":"1.","content":"Event-free survival[ Time Frame: 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with bilateral Wilms tumor (BWT) undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"pom_b":[{"label":"1.","content":"Event-free survival[ Time Frame: Time from study enrollment to the first occurrence of progression, relapse after response or death from any cause, assessed up to 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with BWT undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"start_date":"July 13, 2009","primary_completion_date":"December 31, 2016","completion_date":"November 26, 2023","first_posted":"July 23, 2009","results_first_posted":"March 5, 2019","last_update_posted":"March 25, 2022"},{"nctid":"NCT00945009","version_a":137,"version_b":138,"version_a_date":"2018-07-23","version_b_date":"2019-02-11","pom_a":[{"label":"1.","content":"Event-free survival[ Time Frame: Time from study enrollment to the first occurrence of progression, relapse after response or death from any cause, assessed up to 4 years ]"},{"label":"2.","content":"Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"3.","content":"Efficacy of chemotherapy in preserving renal units and preventing Wilms tumor development in patients with diffuse hyperplastic perilobular nephrogenic rests[ Time Frame: Up to 10 years ]"},{"label":"4.","content":"Facilitation of partial nephrectomy in lieu of total nephrectomy in 25% of patients with unilateral Wilms tumor[ Time Frame: Up to 12 weeks ]"},{"label":"5.","content":"Percentage of patients with BWT undergoing definitive surgical treatment by week 12[ Time Frame: 12 weeks ]"}],"pom_b":[{"label":"1.","content":"Event-Free Survival (EFS)[ Time Frame: 4 years from study enrollment ]Probability of no relapse, secondary malignancy, or death whichever occurs first"},{"label":"2.","content":"Kidney Preservation After Preoperative Chemotherapy[ Time Frame: 12 weeks from study entry ]Prevention of complete removal of at least one kidney in 50% of patients with bilateral Wilms tumor (BWT)."},{"label":"3.","content":"Number of Patients Without Complete Removal of at Least One Kidney[ Time Frame: 12 weeks from the study entry ]To evaluate the efficacy of chemotherapy in preserving renal units in children with diffuse hyperplastic perilobar nephroblastomatosis (DHPLN) and preventing Wilms tumor development."},{"label":"4.","content":"Percentage of Patients Who Experienced Partial Nephrectomy After Preoperative Chemotherapy[ Time Frame: 12 weeks from study entry ]Percentage of patients who experienced partial nephrectomy in lieu of nephrectomy in 25% of children with unilateral tumors and aniridia, Beckwith-Wiedemann syndrome (BWS), hemihypertrophy or other overgrowth syndromes, by using prenephrectomy 2-drug chemotherapy induction with vincristine and dactinomycin."},{"label":"5.","content":"Percentage of Patients Who Had Definitive Surgical Treatment[ Time Frame: 12 weeks from study entry ]Percentage of Bilateral Wilms Tumor (BWT) patients who undergo definitive surgery by week 12 after initiation of chemotherapy."}],"start_date":"July 13, 2009","primary_completion_date":"December 31, 2016","completion_date":"November 26, 2023","first_posted":"July 23, 2009","results_first_posted":"March 5, 2019","last_update_posted":"March 25, 2022"},{"nctid":"NCT00295646","version_a":2,"version_b":3,"version_a_date":"2006-02-27","version_b_date":"2006-06-19","pom_a":[{"label":"1.","content":"- To compare overall and recurrence-free survival between tamoxifen and anastrozole"},{"label":"2.","content":"- To compare bone loss reduction/prevention between zoledronic acid and no zoledronic acid"}],"pom_b":[{"label":"1.","content":"To compare overall and recurrence-free survival between tamoxifen and anastrozole"},{"label":"2.","content":"To compare bone loss reduction/prevention between zoledronic acid and no zoledronic acid"}],"start_date":"June 1999","primary_completion_date":"September 29, 2015","completion_date":"June 26, 2018","first_posted":"February 24, 2006","last_update_posted":"May 31, 2022"},{"nctid":"NCT00295646","version_a":4,"version_b":5,"version_a_date":"2006-08-29","version_b_date":"2008-07-03","pom_a":[{"label":"1.","content":"To compare overall and recurrence-free survival between tamoxifen and anastrozole"},{"label":"2.","content":"To compare bone loss reduction/prevention between zoledronic acid and no zoledronic acid"}],"pom_b":[{"label":"1.","content":"Comparison of tamoxifen with anastrozole in premenopausal patients with non-metastatic breast cancer and comparison of a subgroup additionally treated with zoledronate to a control subgroup without receiving zoledronate according to DFS.[ Time Frame: 28.05.2008 ]"}],"start_date":"June 1999","primary_completion_date":"September 29, 2015","completion_date":"June 26, 2018","first_posted":"February 24, 2006","last_update_posted":"May 31, 2022"},{"nctid":"NCT00006083","version_a":15,"version_b":16,"version_a_date":"2009-05-09","version_b_date":"2010-07-26","pom_a":[],"pom_b":[{"label":"1.","content":"To determine if 5000 IU of Fragmin administered daily when compared to placebo will reduce the incidence of clinically relevant CRCs in cancer patients receiving chemotherapy by CVC[ Time Frame: 16 weeks ]"}],"start_date":"April 2000","primary_completion_date":"November 2000","completion_date":"November 2000","first_posted":"May 26, 2004","last_update_posted":"August 3, 2020"},{"nctid":"NCT00921375","version_a":2,"version_b":3,"version_a_date":"2010-02-11","version_b_date":"2014-12-11","pom_a":[{"label":"1.","content":"Percentage of reduction in plasma uric acid at 4 hrs after uric acid-lowering therapy[ Time Frame: At the end of 4 hrs after initiation of uric acid lowering therapy; during 96 hrs of uric acid lowering therapy; Adverse events during the entire study period ]"},{"label":"2.","content":"Plasma uric acid AUC 0-96 hr[ Time Frame: At the end of 4 hrs after initiation of uric acid lowering therapy; during 96 hrs of uric acid lowering therapy; Adverse events during the entire study period ]"},{"label":"3.","content":"Incidence of adverse events[ Time Frame: At the end of 4 hrs after initiation of uric acid lowering therapy; during 96 hrs of uric acid lowering therapy; Adverse events during the entire study period ]"}],"pom_b":[{"label":"1.","content":"Percentage of reduction in plasma uric acid at 4 hrs after uric acid-lowering therapy[ Time Frame: At the end of 4 hrs after initiation of uric acid lowering therapy; during 96 hrs of uric acid lowering therapy; Adverse events during the entire study period ]"}],"start_date":"February 2010","primary_completion_date":"December 2011","completion_date":"January 2012","first_posted":"June 16, 2009","last_update_posted":"December 12, 2014"},{"nctid":"NCT02481830","version_a":65,"version_b":66,"version_a_date":"2019-04-15","version_b_date":"2020-01-06","pom_a":[{"label":"1.","content":"Overall survival (OS) in subjects with relapsed SCLC[ Time Frame: approximately 12 months. Additional survival follow-up may continue for up to 5 years from the completion of the study ]"}],"pom_b":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: OS was followed continuously while participants were on the study drug and every 3 months ,minimum follow up for overall survival was 15.8 months ]The time from randomization to the date of death, data was based on Kaplan-Meier Estimates."}],"start_date":"September 14, 2015","primary_completion_date":"August 17, 2018","completion_date":"May 30, 2022","first_posted":"June 25, 2015","results_first_posted":"January 9, 2020","last_update_posted":"April 11, 2022"},{"nctid":"NCT00879333","version_a":14,"version_b":15,"version_a_date":"2013-11-19","version_b_date":"2015-04-02","pom_a":[{"label":"1.","content":"Compare Overall Survival in RAD vs. Placebo group[ Time Frame: 2.5 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: 2.5 years ]The primary objective of this study was to compare OS between everolimus + best supportive care (BSC) and placebo + BSC. OS, was defined as the time from date of randomization to the date of death due to any cause. If at the analysis cut-off date a patient was not known to have died, survival was censored at the date of the last contact. OS was analyzed using the Kaplan Meier estimates method."}],"start_date":"July 2009","primary_completion_date":"January 2014","completion_date":"January 2014","first_posted":"April 10, 2009","results_first_posted":"April 6, 2015","last_update_posted":"November 3, 2015"},{"nctid":"NCT01006980","version_a":19,"version_b":20,"version_a_date":"2010-12-27","version_b_date":"2011-04-12","pom_a":[{"label":"1.","content":"Overall survival[ Time Frame: event-driven, assessed approximately 2 years after first patient is randomized ]"}],"pom_b":[{"label":"1.","content":"Overall survival[ Time Frame: approximately 3 years ]"},{"label":"2.","content":"Progression-free survival (tumour assessments according to RECIST criteria)[ Time Frame: approximately 3 years ]"}],"start_date":"January 2010","primary_completion_date":"December 2010","completion_date":"July 2015","first_posted":"November 3, 2009","results_first_posted":"November 16, 2011","last_update_posted":"September 28, 2016"},{"nctid":"NCT01006980","version_a":22,"version_b":23,"version_a_date":"2011-05-25","version_b_date":"2011-10-10","pom_a":[{"label":"1.","content":"Overall survival[ Time Frame: approximately 3 years ]"},{"label":"2.","content":"Progression-free survival (tumour assessments according to RECIST criteria)[ Time Frame: approximately 3 years ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: From randomization (initiated January 2010) to December 30 2010. Median follow-up time in the vemurafenib group was 3.75 months (range 0.3 to 10.8) and in the dacarbazine group was 2.33 months (range <0.1 to 10.3). ]An Overall survival event was defined as death due to any cause. The number of participants with overall survival events is reported."},{"label":"2.","content":"Progression-free Survival[ Time Frame: From randomization (initiated January 2010) to December 30 2010. ]A progression-free survival (PFS) event was defined as disease progression or death due to any cause. Tumor response (progression) was assessed according to the Response Evaluation Criteria In Solid Tumors (RECIST) version 1.1 criteria using computed tomography (CT) scans or magnetic resonance imaging (MRI)."}],"start_date":"January 2010","primary_completion_date":"December 2010","completion_date":"July 2015","first_posted":"November 3, 2009","results_first_posted":"November 16, 2011","last_update_posted":"September 28, 2016"},{"nctid":"NCT01067365","version_a":1,"version_b":2,"version_a_date":"2010-02-10","version_b_date":"2014-06-26","pom_a":[{"label":"1.","content":"Evaluate the safety of Androxal\u2122 administered in men with secondary hypogonadism[ Time Frame: Six months ]"}],"pom_b":[{"label":"1.","content":"Evaluate the safety of Androxal\u2122 administered in men with secondary hypogonadism[ Time Frame: One year ]"}],"start_date":"March 2006","primary_completion_date":"May 2007","completion_date":"May 2007","first_posted":"February 11, 2010","last_update_posted":"June 27, 2014"},{"nctid":"NCT01365182","version_a":1,"version_b":2,"version_a_date":"2011-06-01","version_b_date":"2015-02-16","pom_a":[{"label":"1.","content":"Urinary incontinence[ Time Frame: Change from baseline in urinary incontinence at 6 months ]Urinary incontinence is measured in the amount and frequency of urinary leakage"},{"label":"2.","content":"Quality of life[ Time Frame: Change from baseline in quality of life at 6 months ]Quality of life is measured by standard instrument (SF36 etc.) as an continuous variable"},{"label":"3.","content":"Mood[ Time Frame: Change from baseline in mood at 6 months ]Mood is measured by POMS as a continuous variable"}],"pom_b":[{"label":"1.","content":"Urinary incontinence[ Time Frame: 6 months ]Frequency of daily leakage measured on 3-day diary Amount of leakage measured on 1-hour pad test"},{"label":"2.","content":"Quality of Life (QOL)[ Time Frame: 6 months ]The International Prostate Symptom Score (IPSS) University of California-Los Angeles Prostate Cancer Index (UCLA-PCI) Visual Analogue Scale (VAS)Health-related QOL:SF36 EQ-5D Index"},{"label":"3.","content":"Mood[ Time Frame: 6 months ]The Profile of Mood States (POMS): subscales of tension, depression and hostility."}],"start_date":"January 2009","primary_completion_date":"December 2013","completion_date":"June 2014","first_posted":"June 3, 2011","last_update_posted":"February 18, 2015"},{"nctid":"NCT02678572","version_a":14,"version_b":15,"version_a_date":"2018-01-30","version_b_date":"2018-09-05","pom_a":[{"label":"1.","content":"Overall Survival (OS)[ Time Frame: Patients will be assessed for their survival status from randomization through end of treatment and contacted every 6 months for the first 2 years and yearly thereafter until death. ]Patients will be followed until death"}],"pom_b":[{"label":"1.","content":"Objective Response Rate (ORR) as determined by Independent Central Review Committee[ Time Frame: Patients will be assessed for ORR from baseline through completion of treatment. [assessed up to 36 months] ]ORR (complete or partial response)"}],"start_date":"February 1, 2016","primary_completion_date":"June 30, 2022","completion_date":"May 18, 2023","first_posted":"February 10, 2016","last_update_posted":"March 24, 2022"},{"nctid":"NCT01034163","version_a":1,"version_b":2,"version_a_date":"2009-12-16","version_b_date":"2009-12-18","pom_a":[{"label":"1.","content":"To compare the disease free survival (DFS) in patients with HL after achieving a complete response following AHSCT with HDT who are treated with panobinostat versus those who receive placebo based on investigator\'s review of radiological images.[ Time Frame: 60 months ]"}],"pom_b":[{"label":"1.","content":"Compare Disease Free Survival in Pts. with Hodgkin\'s Lymphoma after achieving a complete response following Autologous stem cell transplant who are treated with panobinostat vs placebo based on investigator\'s review of radiological images[ Time Frame: 60 months ]"}],"start_date":"June 2010","primary_completion_date":"May 2012","completion_date":"May 2012","first_posted":"December 17, 2009","results_first_posted":"July 7, 2016","last_update_posted":"July 7, 2016"},{"nctid":"NCT01034163","version_a":13,"version_b":14,"version_a_date":"2013-05-07","version_b_date":"2016-05-27","pom_a":[{"label":"1.","content":"Compare Disease Free Survival in Pts. with Hodgkin\'s Lymphoma after achieving a complete response following Autologous stem cell transplant who are treated with panobinostat vs placebo based on investigator\'s review of radiological images[ Time Frame: 60 months ]"}],"pom_b":[{"label":"1.","content":"Number of Participants With Adverse Events[ Time Frame: 23 months ]Safety monitoring was conducted throughout the study."}],"start_date":"June 2010","primary_completion_date":"May 2012","completion_date":"May 2012","first_posted":"December 17, 2009","results_first_posted":"July 7, 2016","last_update_posted":"July 7, 2016"},{"nctid":"NCT02504489","version_a":1,"version_b":2,"version_a_date":"2015-07-21","version_b_date":"2015-08-24","pom_a":[{"label":"1.","content":"Overall Survival (all cause mortality)[ Time Frame: Approximately 16 months after study initiation ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]"}],"start_date":"December 2015","primary_completion_date":"March 23, 2021","completion_date":"May 23, 2021","first_posted":"July 22, 2015","last_update_posted":"September 10, 2022"},{"nctid":"NCT02504489","version_a":7,"version_b":8,"version_a_date":"2017-03-17","version_b_date":"2018-05-21","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]To compare the overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy with docetaxel + plinabulin (DP Arm) to patients treated with docetaxel + placebo (D5W) (D Arm) for advanced or metastatic disease."}],"start_date":"December 2015","primary_completion_date":"March 23, 2021","completion_date":"May 23, 2021","first_posted":"July 22, 2015","last_update_posted":"September 10, 2022"},{"nctid":"NCT02504489","version_a":8,"version_b":9,"version_a_date":"2018-05-21","version_b_date":"2019-02-26","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]To compare the overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy with docetaxel + plinabulin (DP Arm) to patients treated with docetaxel + placebo (D5W) (D Arm) for advanced or metastatic disease."}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]Overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy"}],"start_date":"December 2015","primary_completion_date":"March 23, 2021","completion_date":"May 23, 2021","first_posted":"July 22, 2015","last_update_posted":"September 10, 2022"},{"nctid":"NCT02504489","version_a":13,"version_b":14,"version_a_date":"2020-07-07","version_b_date":"2021-01-27","pom_a":[{"label":"1.","content":"Overall Survival[ Time Frame: Approximately 2 years after study initiation ]Overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy"}],"pom_b":[{"label":"1.","content":"Overall Survival[ Time Frame: Mid-February 2021 (Approximately 2 years after study initiation) ]Overall survival of NSCLC patients receiving 2nd- or 3rd-line systemic therapy"}],"start_date":"December 2015","primary_completion_date":"March 23, 2021","completion_date":"May 23, 2021","first_posted":"July 22, 2015","last_update_posted":"September 10, 2022"},{"nctid":"NCT02549352","version_a":1,"version_b":2,"version_a_date":"2015-09-14","version_b_date":"2016-01-11","pom_a":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK)[ Time Frame: 8 weeks ]"}],"pom_b":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK) defined as no clinically visible AKs in the treatment area[ Time Frame: 8 weeks ]"}],"start_date":"November 2015","primary_completion_date":"September 22, 2016","completion_date":"August 2017","first_posted":"September 15, 2015","results_first_posted":"December 26, 2018","last_update_posted":"December 26, 2018"},{"nctid":"NCT02549352","version_a":6,"version_b":7,"version_a_date":"2017-12-19","version_b_date":"2018-12-04","pom_a":[{"label":"1.","content":"Complete clearance of actinic keratosis (AK) defined as no clinically visible AKs in the treatment area[ Time Frame: 8 weeks ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants With Complete Clearance of Actinic Keratosis (AK)[ Time Frame: At Week 8 ]The number of clinically visible actinic keratosis lesions (AKs) identified in the treatment area was recorded at Day 1 (baseline), Weeks 4, and 8.Complete clearance was defined as no clinically visible AKs in the treatment area.The table shows the percentage of mean number of participants across imputations with complete clearance at Week 8."}],"start_date":"November 2015","primary_completion_date":"September 22, 2016","completion_date":"August 2017","first_posted":"September 15, 2015","results_first_posted":"December 26, 2018","last_update_posted":"December 26, 2018"},{"nctid":"NCT02311907","version_a":4,"version_b":5,"version_a_date":"2015-05-22","version_b_date":"2017-01-05","pom_a":[{"label":"1.","content":"Paclitaxel/carboplatin (PC) induced peripheral neuropathy as assessed by EORTC QLQ-CIPN20[ Time Frame: Up to 6 courses of therapy ]The CIPN sensory subscale will be calculated by standard scoring algorithm and converted to 0-100 scale. Generalized linear models (repeated measures analysis of variance [ANOVA] if data are complete) will be used to compare the CIPN between GSH and placebo arms."}],"pom_b":[{"label":"1.","content":"Paclitaxel/Carboplatin (PC) Induced Peripheral Neuropathy as Assessed by EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer (EORTC), Quality of Life (QLQ), Chemotherapy Induced Peripheral Neuropathy 20 (CIPN20)).[ Time Frame: Every 28 day cycle, up to 6 cycles. ]The CIPN sensory subscale will be calculated by standard scoring algorithm and converted to 0-100 scale (higher scores indicated less symptoms and better quality of life). Generalized linear models (repeated measures analysis of variance [ANOVA] if data are complete) will be used to compare the CIPN between Glutathione (GSH) and placebo arms."}],"start_date":"December 2009","primary_completion_date":"August 2012","completion_date":"August 2012","first_posted":"December 9, 2014","results_first_posted":"February 23, 2017","last_update_posted":"February 23, 2017"},{"nctid":"NCT01013649","version_a":317,"version_b":318,"version_a_date":"2012-11-28","version_b_date":"2012-11-30","pom_a":[{"label":"1.","content":"Overall survival of patients treated with gemcitabine hydrochloride with vs without erlotinib hydrochloride (first randomization)"},{"label":"2.","content":"Overall survival of patients treated with chemotherapy with vs without radiotherapy (second randomization)"}],"pom_b":[{"label":"1.","content":"Overall survival (first randomization)[ Time Frame: From the date of first randomization (gemcitabine vs. gemcitabine/erlotinib) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."},{"label":"2.","content":"Overall survival (second randomization)[ Time Frame: From the date of second randomization (chemotherapy vs. chemotherapy followed by chemoradiation) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."}],"start_date":"November 17, 2009","primary_completion_date":"December 31, 2022","completion_date":"December 31, 2022","first_posted":"November 16, 2009","last_update_posted":"September 19, 2022"},{"nctid":"NCT01013649","version_a":320,"version_b":321,"version_a_date":"2013-10-07","version_b_date":"2014-04-09","pom_a":[{"label":"1.","content":"Overall survival (first randomization)[ Time Frame: From the date of first randomization (gemcitabine vs. gemcitabine/erlotinib) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."},{"label":"2.","content":"Overall survival (second randomization)[ Time Frame: From the date of second randomization (chemotherapy vs. chemotherapy followed by chemoradiation) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."}],"pom_b":[{"label":"1.","content":"Overall survival (Phase II)[ Time Frame: From the date of first randomization (gemcitabine vs. gemcitabine/erlotinib) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."},{"label":"2.","content":"Overall survival (Phase III)[ Time Frame: From the date of second randomization (chemotherapy vs. chemotherapy followed by chemoradiation) to the date of death or last follow-up, assessed up to 11 years ]Overall survival will be estimated by the Kaplan-Meier method. The distribution of overall survival estimates between the two arms for both primary endpoint questions will be compared using the log rank test. The Cox proportional hazard regression model will be used to analyze the effects of factors, in addition to treatment, that may be associated with overall survival."}],"start_date":"November 17, 2009","primary_completion_date":"December 31, 2022","completion_date":"December 31, 2022","first_posted":"November 16, 2009","last_update_posted":"September 19, 2022"},{"nctid":"NCT01701232","version_a":10,"version_b":11,"version_a_date":"2016-09-01","version_b_date":"2017-11-02","pom_a":[{"label":"1.","content":"CD20-positive cells count[ Time Frame: day 50 ]Comparison of peripheral blood B-cell depletion and repletion after BCD-020 and MabThera intravenous administration"},{"label":"2.","content":"Overall response rate[ Time Frame: day 50 (cycle 4) ]Estimation of the overall response rate in each treatment arm at the end of treatment"}],"pom_b":[{"label":"1.","content":"Overall response rate[ Time Frame: day 50 (cycle 4) ]Estimation of the overall response rate in each treatment arm at the end of treatment"},{"label":"2.","content":"CD20-positive cells count[ Time Frame: day 50 ]Comparison of peripheral blood B-cell depletion and repletion after BCD-020 and MabThera intravenous administration"}],"start_date":"September 2011","primary_completion_date":"January 2017","completion_date":"January 2017","first_posted":"October 5, 2012","last_update_posted":"November 6, 2017"},{"nctid":"NCT01689519","version_a":98,"version_b":99,"version_a_date":"2015-05-11","version_b_date":"2015-10-01","pom_a":[{"label":"1.","content":"Progression-free survival according to Response Evaluation Criteria in Solid Tumors v1.1[ Time Frame: Approximately 5 years ]"}],"pom_b":[{"label":"1.","content":"Progression-free Survival[ Time Frame: Baseline to the 09 May 2014 data cut-off (up to 1 year, 4 months) ]Progression-free survival was defined as the time from randomization to the first occurrence of disease progression, as determined by the investigator using Response Evaluation Criteria in Solid Tumors v1.1, or death from any cause, whichever came first. Disease progression was defined as: (1) at least a 20% increase in the sum (the increase in the sum must be at least 5 mm) of diameters of target lesions, taking as reference the smallest sum during the study; (2) unequivocal progression of existing non-target lesions; or (3) the appearance of 1 or more new lesions."}],"start_date":"January 8, 2013","primary_completion_date":"May 9, 2014","completion_date":"July 21, 2019","first_posted":"September 21, 2012","results_first_posted":"October 30, 2015","last_update_posted":"May 2, 2022"},{"nctid":"NCT01689519","version_a":111,"version_b":112,"version_a_date":"2020-05-07","version_b_date":"2020-09-14","pom_a":[{"label":"1.","content":"Progression-free Survival[ Time Frame: Baseline to the 09 May 2014 data cut-off (up to 1 year, 4 months) ]Progression-free survival was defined as the time from randomization to the first occurrence of disease progression, as determined by the investigator using Response Evaluation Criteria in Solid Tumors v1.1, or death from any cause, whichever came first. Disease progression was defined as: (1) at least a 20% increase in the sum (the increase in the sum must be at least 5 mm) of diameters of target lesions, taking as reference the smallest sum during the study; (2) unequivocal progression of existing non-target lesions; or (3) the appearance of 1 or more new lesions."}],"pom_b":[{"label":"1.","content":"Progression-free Survival[ Time Frame: Baseline to the 21 July 2019 data cut-off (up to 7 years, 6 months) ]Progression-free survival was defined as the time from randomization to the first occurrence of disease progression, as determined by the investigator using Response Evaluation Criteria in Solid Tumors v1.1, or death from any cause, whichever came first. Disease progression was defined as: (1) at least a 20% increase in the sum (the increase in the sum must be at least 5 mm) of diameters of target lesions, taking as reference the smallest sum during the study; (2) unequivocal progression of existing non-target lesions; or (3) the appearance of 1 or more new lesions."}],"start_date":"January 8, 2013","primary_completion_date":"May 9, 2014","completion_date":"July 21, 2019","first_posted":"September 21, 2012","results_first_posted":"October 30, 2015","last_update_posted":"May 2, 2022"},{"nctid":"NCT01663441","version_a":1,"version_b":2,"version_a_date":"2012-08-10","version_b_date":"2015-03-23","pom_a":[{"label":"1.","content":"Comparison of average platelet counts between mIL-11 and rhIL-11 at day 21 after the initiation of chemotherapy[ Time Frame: day 21 after the initiation of chemotherapy ]"}],"pom_b":[{"label":"1.","content":"Recovery time of platelet counts from below 100x10^9/L raise to more than 100 x10^9/L.[ Time Frame: During 21 days of chemotherapy cycles ]"}],"start_date":"March 2015","primary_completion_date":"August 2017","completion_date":"August 2017","first_posted":"August 13, 2012","last_update_posted":"September 16, 2020"},{"nctid":"NCT03236636","version_a":1,"version_b":2,"version_a_date":"2017-07-28","version_b_date":"2021-01-05","pom_a":[{"label":"1.","content":"Overall survival (OS)[ Time Frame: 1-2 years ]OS is defined as the time from randomization to died from any cause. For the subjects who failed to visit, deletion is performed on the final date of knowing the survival of the subjects, for subjects who still survive, deletion is performed on the data expiration date."}],"pom_b":[{"label":"1.","content":"Overall survival (OS)[ Time Frame: 2-4 years ]OS is defined as the time from randomization to died from any cause. For the subjects who failed to visit, deletion is performed on the final date of knowing the survival of the subjects, for subjects who still survive, deletion is performed on the data expiration date."}],"start_date":"September 8, 2017","primary_completion_date":"December 30, 2022","completion_date":"December 30, 2022","first_posted":"August 2, 2017","last_update_posted":"January 27, 2021"},{"nctid":"NCT00098475","version_a":25,"version_b":26,"version_a_date":"2006-05-04","version_b_date":"2007-02-05","pom_a":[],"pom_b":[{"label":"1.","content":"Comparison of treatment regimens"}],"start_date":"October 26, 2004","primary_completion_date":"November 30, 2008","first_posted":"December 8, 2004","results_first_posted":"January 22, 2014","last_update_posted":"September 19, 2022"},{"nctid":"NCT00098475","version_a":42,"version_b":43,"version_a_date":"2012-11-27","version_b_date":"2013-01-09","pom_a":[{"label":"1.","content":"Comparison of treatment regimens"}],"pom_b":[{"label":"1.","content":"Response rate based on IBMTR/ABMTR[ Time Frame: Up to 7 years ]"},{"label":"2.","content":"Toxicity profile as assessed by CTCAE version 4.0[ Time Frame: Up to 7 years ]At each interim analysis a 1-sided 95% repeated confidence interval (RCI) based on an O\\"Brien-Fleming type boundary (48) on toxicity difference between the arms will be computed."}],"start_date":"October 26, 2004","primary_completion_date":"November 30, 2008","first_posted":"December 8, 2004","results_first_posted":"January 22, 2014","last_update_posted":"September 19, 2022"},{"nctid":"NCT00098475","version_a":43,"version_b":44,"version_a_date":"2013-01-09","version_b_date":"2013-12-05","pom_a":[{"label":"1.","content":"Response rate based on IBMTR/ABMTR[ Time Frame: Up to 7 years ]"},{"label":"2.","content":"Toxicity profile as assessed by CTCAE version 4.0[ Time Frame: Up to 7 years ]At each interim analysis a 1-sided 95% repeated confidence interval (RCI) based on an O\\"Brien-Fleming type boundary (48) on toxicity difference between the arms will be computed."}],"pom_b":[{"label":"1.","content":"Proportion of Patients With Objective Response (First Phase, Step 1)[ Time Frame: Assessed every 4 weeks for 16 weeks during Step 1 ]Objective response is defined as either complete response (CR) or partial response (PR). Patients who have complete disappearance of an M-protein and no evidence of myeloma in the bone marrow are considered to have CR. PR requires all the following: (1) \u226550% reduction in the level of the serum monoclonal paraprotein. (2) Reduction in 24-hour urinary light chain excretion either by \u226590% or to <200 mg. (3)For patients with non-secretory (or oligosecretory) myeloma only, a \u226550% reduction in plasma cells in a bone marrow aspirate and on trephine biopsy must be documented. (4)50% reduction in size of soft tissue plasmacytoma (by radiography or clinical examination). (5) No increase in the number or size of lytic bone lesions (development of a compression fracture does not exclude response).As the expansion phase was a substudy terminated early with only 7 patients enrolled, the clinical results presented are mainly for the first phase only."}],"start_date":"October 26, 2004","primary_completion_date":"November 30, 2008","first_posted":"December 8, 2004","results_first_posted":"January 22, 2014","last_update_posted":"September 19, 2022"},{"nctid":"NCT00260832","version_a":6,"version_b":7,"version_a_date":"2006-09-19","version_b_date":"2006-09-25","pom_a":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML."}],"pom_b":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML"}],"start_date":"November 2005","primary_completion_date":"October 2009","completion_date":"December 2010","first_posted":"December 2, 2005","results_first_posted":"September 21, 2011","last_update_posted":"September 11, 2019"},{"nctid":"NCT00260832","version_a":9,"version_b":10,"version_a_date":"2007-01-19","version_b_date":"2008-01-02","pom_a":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML"}],"pom_b":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML[ Time Frame: survival; 6 months ]"}],"start_date":"November 2005","primary_completion_date":"October 2009","completion_date":"December 2010","first_posted":"December 2, 2005","results_first_posted":"September 21, 2011","last_update_posted":"September 11, 2019"},{"nctid":"NCT00260832","version_a":11,"version_b":12,"version_a_date":"2008-09-22","version_b_date":"2008-10-31","pom_a":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML[ Time Frame: survival; 6 months ]"}],"pom_b":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML.[ Time Frame: Survival; 6 months ]"}],"start_date":"November 2005","primary_completion_date":"October 2009","completion_date":"December 2010","first_posted":"December 2, 2005","results_first_posted":"September 21, 2011","last_update_posted":"September 11, 2019"},{"nctid":"NCT00260832","version_a":14,"version_b":15,"version_a_date":"2009-06-01","version_b_date":"2009-06-17","pom_a":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML.[ Time Frame: Survival; 6 months ]"}],"pom_b":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML.[ Time Frame: From randomization to the date of death from any cause. ]"}],"start_date":"November 2005","primary_completion_date":"October 2009","completion_date":"December 2010","first_posted":"December 2, 2005","results_first_posted":"September 21, 2011","last_update_posted":"September 11, 2019"},{"nctid":"NCT00260832","version_a":18,"version_b":19,"version_a_date":"2010-07-27","version_b_date":"2011-08-16","pom_a":[{"label":"1.","content":"Overall survival in patients 65 years or older who have newly diagnosed de novo or secondary AML.[ Time Frame: From randomization to the date of death from any cause. ]"}],"pom_b":[{"label":"1.","content":"Overall Survival in Patients 65 Years or Older Who Have Newly Diagnosed de Novo or Secondary AML.[ Time Frame: The interval from date of randomization to the date of death from any cause or the last date the subject was known to be alive or 5 years whichever occurs first. ]The interval from date of randomization to the date of death from any cause or the last date the subject was known to be alive or 5 years whichever occurs first."}],"start_date":"November 2005","primary_completion_date":"October 2009","completion_date":"December 2010","first_posted":"December 2, 2005","results_first_posted":"September 21, 2011","last_update_posted":"September 11, 2019"},{"nctid":"NCT04870333","version_a":1,"version_b":2,"version_a_date":"2021-04-28","version_b_date":"2022-02-20","pom_a":[{"label":"1.","content":"Confirmed symptomatic COVID-19 infection during treatment[ Time Frame: 6-9 months ]The primary outcome for PROTECT is confirmed symptomatic COVID-19 infection during treatment.The primary outcome event is defined as the presence of bothPCR confirmed SARS-CoV2 andOne or more symptoms in keeping with COVID-19, including:Respiratory (Cough +/- sputum and shortness of breath)Constitutional (Pyrexia/chills, myalgia/arthralgia, fatigue, rash, headache, confusion)Gastrointestinal (nausea/vomiting, diarrhoea, abdominal pain, loss of appetite) The date (time) of the primary outcome event is defined as the date of the confirmed COVID-19 test."}],"pom_b":[{"label":"1.","content":"Confirmed symptomatic COVID-19 infection during treatment[ Time Frame: 6-9 months. Reported at 24 weeks for niclosamide and ciclesonide arms and 16 weeks for sotrovimab arm ]The primary outcome for PROTECT is confirmed symptomatic COVID-19 infection during treatment.The primary outcome event is defined as the presence of bothPCR confirmed SARS-CoV2 andOne or more symptoms in keeping with COVID-19, including:Respiratory (Cough +/- sputum and shortness of breath)Constitutional (Pyrexia/chills, myalgia/arthralgia, fatigue, rash, headache, confusion)Gastrointestinal (nausea/vomiting, diarrhoea, abdominal pain, loss of appetite) The date (time) of the primary outcome event is defined as the date of the confirmed COVID-19 test."}],"start_date":"February 19, 2021","primary_completion_date":"July 2023","completion_date":"October 2024","first_posted":"May 3, 2021","last_update_posted":"March 8, 2022"},{"nctid":"NCT04546607","version_a":1,"version_b":2,"version_a_date":"2020-09-05","version_b_date":"2020-09-13","pom_a":[{"label":"1.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at baseline (Visit 2) (week 2) ]FACIT-F scale as primary endpoint"},{"label":"2.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 3 (week 3) ]FACIT-F scale as primary endpoint"},{"label":"3.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 6 (week 6) ]FACIT-F scale as primary endpoint"},{"label":"4.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 9 (week 9) ]FACIT-F scale as primary endpoint"},{"label":"5.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at baseline (Visit 2) (week 2) ]Visual Analogue fatigue scale (VAFS) as primary endpoint"},{"label":"6.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 3 (week 3) ]Visual Analogue fatigue scale (VAFS) as primary endpoint"},{"label":"7.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 6 (week 6) ]Visual Analogue fatigue scale (VAFS) as primary endpoint"},{"label":"8.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 9 (week 9) ]Visual Analogue fatigue scale (VAFS) as primary endpoint"}],"pom_b":[{"label":"1.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at baseline (Visit 2) (week 2) ]Functional Assessment of Chronic Illness Therapy Fatigue FACIT-F scale as primary endpoint. FACIT-Fatigue Scale: (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much)"},{"label":"2.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 3 (week 3) ]Functional Assessment of Chronic Illness Therapy Fatigue FACIT-F scale as primary endpoint. FACIT-Fatigue Scale: (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much)"},{"label":"3.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 6 (week 6) ]Functional Assessment of Chronic Illness Therapy Fatigue FACIT-F scale as primary endpoint. FACIT-Fatigue Scale: (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much)"},{"label":"4.","content":"To evaluate efficacy of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Improving Fatigue in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 9 (week 9) ]Functional Assessment of Chronic Illness Therapy Fatigue FACIT-F scale as primary endpoint. FACIT-Fatigue Scale: (0 = not at all; 1 = a little bit; 2 = somewhat; 3 = quite a bit; and 4 = very much)"},{"label":"5.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at baseline (Visit 2) (week 2) ]Visual Analogue fatigue scale (VAFS) as primary endpoint. Fatigue with 0 being worst and 10 being normal."},{"label":"6.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 3 (week 3) ]Visual Analogue fatigue scale (VAFS) as primary endpoint. Fatigue with 0 being worst and 10 being normal."},{"label":"7.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 6 (week 6) ]Visual Analogue fatigue scale (VAFS) as primary endpoint. Fatigue with 0 being worst and 10 being normal."},{"label":"8.","content":"To evaluate the safety and tolerability of CANSSUFIVE\xae Nuvastatic (C5OSEW5050ESA) in Patients with Solid Stage I - IV Tumors.[ Time Frame: Measured at Visit 9 (week 9) ]Visual Analogue fatigue scale (VAFS) as primary endpoint. Fatigue with 0 being worst and 10 being normal."}],"start_date":"September 2, 2017","primary_completion_date":"October 28, 2019","completion_date":"October 31, 2019","first_posted":"September 14, 2020","last_update_posted":"September 16, 2020"},{"nctid":"NCT01363479","version_a":8,"version_b":9,"version_a_date":"2013-09-23","version_b_date":"2014-11-06","pom_a":[{"label":"1.","content":"Proportion of patients with complete response (CR) defined as no emesis, no rescue medication[ Time Frame: 0-24 hours ]"}],"pom_b":[{"label":"1.","content":"Proportion of Patients With Complete Response (CR) Defined as no Emesis, no Rescue Medication[ Time Frame: 0-24 hours ]"}],"start_date":"July 2011","primary_completion_date":"November 2012","completion_date":"November 2012","first_posted":"June 1, 2011","results_first_posted":"November 17, 2014","last_update_posted":"September 22, 2021"},{"nctid":"NCT01363479","version_a":9,"version_b":10,"version_a_date":"2014-11-06","version_b_date":"2021-08-30","pom_a":[{"label":"1.","content":"Proportion of Patients With Complete Response (CR) Defined as no Emesis, no Rescue Medication[ Time Frame: 0-24 hours ]"}],"pom_b":[{"label":"1.","content":"Percentage of Patients With Complete Response (CR) Defined as no Emesis, no Rescue Medication[ Time Frame: 0-24 hours ]"}],"start_date":"July 2011","primary_completion_date":"November 2012","completion_date":"November 2012","first_posted":"June 1, 2011","results_first_posted":"November 17, 2014","last_update_posted":"September 22, 2021"},{"nctid":"NCT02787239","version_a":3,"version_b":4,"version_a_date":"2018-09-27","version_b_date":"2019-05-06","pom_a":[{"label":"1.","content":"Percentage of Participants With Objective Response Rate (ORR)[ Time Frame: 18 weeks ]"}],"pom_b":[{"label":"1.","content":"Percentage of Participants With Overall Response Rate (ORR)[ Time Frame: 18 weeks ]"}],"start_date":"October 2015","primary_completion_date":"May 2018","completion_date":"May 2018","first_posted":"June 1, 2016","last_update_posted":"May 9, 2022"},{"nctid":"NCT02822573","version_a":7,"version_b":8,"version_a_date":"2018-07-12","version_b_date":"2019-05-14","pom_a":[{"label":"1.","content":"Memory Question[ Time Frame: Pre-Screening ]Prospective participants will first be asked, \\"How would you rate the change in your ability to think including remembering, organizing your thoughts and speaking since you were first diagnosed with cancer?\\" Response choices will be \'No change or better\', \'mildly worse\', \'moderately worse\', \'much worse\'. Only if a woman responds with \\"moderately worse\\" or \\"much worse\\" will she proceed."},{"label":"2.","content":"HVLT- R Form C 1st learning trial[ Time Frame: Pre-Screening ]An entry level score of < 7 words recalled is required. This will provide information on ineligible patients and patients that are eligible and choose not to participate."},{"label":"3.","content":"Changes in Hopkins Verbal Learning Test-Revised (HVLT-R) Results[ Time Frame: Baseline and Week 12 ]The HVLT-R measures verbal learning and memory. It consists of a 12-item word list which is read to subjects on three successive learning trials. Free recall scores are recorded for each learning trial. Scores for immediate recall (total of three trials), delayed recall (total number of words recalled after 20 minutes), and recognition (total number of words correctly identified) will be the variables derived from the HVLT-R."},{"label":"4.","content":"Changes in Controlled Oral Word Association Test (COWA) Results[ Time Frame: Baseline and Week 12 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"5.","content":"Changes in Trail Making Test, Parts A & B (TMT-A, TMT-B) Results[ Time Frame: Baseline and Week 12 ]Part A of the TMT measures attention and visual motor skills and processing speed and requires subjects to connect 25 numbered circles in the proper sequence (1-2-3-\u2026) as quickly as possible. TMT-B is similar except subjects are required to connect dots in an alternating numerical and alphabetical sequence (1-A-2-B-\u2026). TMT-B with its added complexity and set shifting requirements is a widely used measure of executive function. The score for TMT-A and TMT-B is the total time in seconds required to complete the task. Scores can also be generated for number of errors and number of circles correctly connected."},{"label":"6.","content":"Shipley Institute of Living Scale-Version 2 Vocabulary[ Time Frame: Baseline ]Provides an assessment of premorbid intellectual functioning comparable to a verbal IQ and thus is a proxy for cognitive reserve. This vocabulary test requires respondents to read a target word and select one of four words that most closely means the same thing. Score it total correct of 40 items."},{"label":"7.","content":"Changes in PROMIS 7-item Fatigue Scale Results[ Time Frame: Baseline and Week 12 ]This self-report scale assesses fatigue."},{"label":"8.","content":"PROMIS 8-item Sleep Disturbance Scale[ Time Frame: Baseline ]Self-reported sleep disturbance will be measured with the PROMIS Sleep Disturbance scale."},{"label":"9.","content":"Changes in Personal Health Questionnaire-9 Depression Scale Results[ Time Frame: Baseline, Week 12, Week 24, Week 36 ]The PHQ-9 is a widely used self-report scale for assessing depression severity. It has 9 items assessing cardinal features of major depression which are rated from zero (\\"Not at all\\") to 5 (\\"nearly every day\\")."},{"label":"10.","content":"Digit Span Test-Backwards (DST-B)[ Time Frame: Baseline ]The DST-B assesses attention and working memory. It requires respondents to repeat back in reverse order spans of numbers. Seven pairs of spans of increasing lengths are presented and repeated. A total score is the number of correctly repeated spans."},{"label":"11.","content":"Changes in Hopkins Verbal Learning Test-Revised (HVLT-R) Results[ Time Frame: Baseline, Week 12 and Week 24 ]The HVLT-R measures verbal learning and memory. It consists of a 12-item word list which is read to subjects on three successive learning trials. Free recall scores are recorded for each learning trial. Scores for immediate recall (total of three trials), delayed recall (total number of words recalled after 20 minutes), and recognition (total number of words correctly identified) will be the variables derived from the HVLT-R."},{"label":"12.","content":"Changes in Hopkins Verbal Learning Test-Revised (HVLT-R) Results[ Time Frame: Baseline, Week 12, Week 24 and Week 36 ]The HVLT-R measures verbal learning and memory. It consists of a 12-item word list which is read to subjects on three successive learning trials. Free recall scores are recorded for each learning trial. Scores for immediate recall (total of three trials), delayed recall (total number of words recalled after 20 minutes), and recognition (total number of words correctly identified) will be the variables derived from the HVLT-R."},{"label":"13.","content":"Changes in Controlled Oral Word Association Test (COWA) Results[ Time Frame: Baseline, Week 12 and Week 24 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"14.","content":"Changes in Controlled Oral Word Association Test (COWA) Results[ Time Frame: Baseline, and Week 12, Week 24 and Week 36 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"15.","content":"Changes in Trail Making Test, Parts A & B (TMT-A, TMT-B) Results[ Time Frame: Baseline, Week 12 and Week 24 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"16.","content":"Changes in Trail Making Test, Parts A & B (TMT-A, TMT-B) Results[ Time Frame: Baseline, Week 12, Week 24 and Week 36 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"17.","content":"Changes in Shipley Institute of Living Scale-Version 2 Vocabulary Results[ Time Frame: Baseline and Week 12 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"18.","content":"Changes in Shipley Institute of Living Scale-Version 2 Vocabulary Results[ Time Frame: Baseline, Week 12, and Week 24 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"19.","content":"Changes in Shipley Institute of Living Scale-Version 2 Vocabulary Results[ Time Frame: Baseline, Week 12, Week 24, and Week 36 ]The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions."},{"label":"20.","content":"Changes in PROMIS 7-item Fatigue Scale Results[ Time Frame: Baseline, Week 12 and Week 24 ]This self-report scale assesses fatigue."},{"label":"21.","content":"Changes in PROMIS 7-item Fatigue Scale Results[ Time Frame: Baseline, Week 12, Week 24 and Week 36 ]This self-report scale assesses fatigue."},{"label":"22.","content":"Changes in PROMIS 8-item Sleep Disturbance Scale Results[ Time Frame: Baseline and Week 12 ]Self-reported sleep disturbance will be measured with the PROMIS Sleep Disturbance scale."},{"label":"23.","content":"Changes in PROMIS 8-item Sleep Disturbance Scale Results[ Time Frame: Baseline, Week 12 and Week 24 ]Self-reported sleep disturbance will be measured with the PROMIS Sleep Disturbance scale."},{"label":"24.","content":"Changes in PROMIS 8-item Sleep Disturbance Scale Results[ Time Frame: Baseline, Week 12, Week 24 and Week 36 ]Self-reported sleep disturbance will be measured with the PROMIS Sleep Disturbance scale."},{"label":"25.","content":"Changes in Digit Span Test-Backwards (DST-B) Results[ Time Frame: Baseline and Week 12 ]The DST-B assesses attention and working memory. It requires respondents to repeat back in reverse order spans of numbers. Seven pairs of spans of increasing lengths are presented and repeated. A total score is the number of correctly repeated spans."},{"label":"26.","content":"Changes in Digit Span Test-Backwards (DST-B) Results[ Time Frame: Baseline, Week 12 and Week 24 ]The DST-B assesses attention and working memory. It requires respondents to repeat back in reverse order spans of numbers. Seven pairs of spans of increasing lengths are presented and repeated. A total score is the number of correctly repeated spans."},{"label":"27.","content":"Changes in Digit Span Test-Backwards (DST-B) Results[ Time Frame: Baseline, Week 12, Week 24 and Week 36 ]The DST-B assesses attention and working memory. It requires respondents to repeat back in reverse order spans of numbers. Seven pairs of spans of increasing lengths are presented and repeated. A total score is the number of correctly repeated spans."}],"pom_b":[{"label":"1.","content":"Changes in Hopkins Verbal Learning Test-Revised (HVLT-R) Results[ Time Frame: Baseline and Week 24 ]The HVLT-R measures verbal learning and memory. It consists of a 12-item word list which is read to subjects on three successive learning trials. Free recall scores are recorded for each learning trial. Scores for immediate recall (total of three trials), delayed recall (total number of words recalled after 20 minutes), and recognition (total number of words correctly identified) will be the variables derived from the HVLT-R."}],"start_date":"May 30, 2017","primary_completion_date":"July 29, 2022","completion_date":"July 29, 2022","first_posted":"July 4, 2016","last_update_posted":"August 1, 2022"},{"nctid":"NCT00137111","version_a":12,"version_b":13,"version_a_date":"2007-11-06","version_b_date":"2007-12-20","pom_a":[{"label":"1.","content":"To improve the cure rate of children with non-B-cell acute lymphoblastic leukemia without the use of irradiation"}],"pom_b":[{"label":"1.","content":"To determine if CNS irradiation can be safely omitted in the context of the systemic therapy used in the protocol[ Time Frame: 2 years post week 56 (3 years and one month after the beginning of treatment). ]"}],"start_date":"July 8, 2000","primary_completion_date":"November 2010","completion_date":"April 2014","first_posted":"August 29, 2005","results_first_posted":"April 26, 2011","last_update_posted":"September 11, 2020"},{"nctid":"NCT00137111","version_a":15,"version_b":16,"version_a_date":"2008-09-09","version_b_date":"2011-04-22","pom_a":[{"label":"1.","content":"To determine if CNS irradiation can be safely omitted in the context of the systemic therapy used in the protocol[ Time Frame: 2 years post week 56 (3 years and one month after the beginning of treatment). ]"}],"pom_b":[{"label":"1.","content":"Overall Event-free Survival (EFS)[ Time Frame: Median follow-up time (range) 5.6 (1.3 to 8.9) years ]EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate."},{"label":"2.","content":"Continuous Complete Remission Since Week 56 Therapy.[ Time Frame: Median follow up time (range) 4.5 (1 to 7.8) years ]CCR was measured from end of week 56 therapy to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Measurement was determined by Kaplan-Meyer estimate."}],"start_date":"July 8, 2000","primary_completion_date":"November 2010","completion_date":"April 2014","first_posted":"August 29, 2005","results_first_posted":"April 26, 2011","last_update_posted":"September 11, 2020"},{"nctid":"NCT00513747","version_a":278,"version_b":279,"version_a_date":"2010-04-24","version_b_date":"2011-11-03","pom_a":[{"label":"1.","content":"Time to second treatment (TT2T)"}],"pom_b":[],"start_date":"January 2008","primary_completion_date":"June 2016","completion_date":"June 2016","first_posted":"August 9, 2007","results_first_posted":"April 6, 2020","last_update_posted":"April 22, 2020"},{"nctid":"NCT00513747","version_a":279,"version_b":280,"version_a_date":"2011-11-03","version_b_date":"2015-06-24","pom_a":[],"pom_b":[{"label":"1.","content":"Time to second treatment[ Time Frame: Every 3 months post-treatment until death or relapse ]"}],"start_date":"January 2008","primary_completion_date":"June 2016","completion_date":"June 2016","first_posted":"August 9, 2007","results_first_posted":"April 6, 2020","last_update_posted":"April 22, 2020"},{"nctid":"NCT00513747","version_a":283,"version_b":284,"version_a_date":"2017-09-20","version_b_date":"2020-03-23","pom_a":[{"label":"1.","content":"Time to second treatment[ Time Frame: Every 3 months post-treatment until death or relapse ]"}],"pom_b":[{"label":"1.","content":"Time to Second Treatment in High Risk Patients[ Time Frame: Up to 72 months ]Kaplan-Meier analysis was conducted to estimate the distribution of time from randomization to second treatment or death whichever comes first. Events were defined as the start of second treatment or death. Patients who had not experienced one of these defined events of interest were censored at their last known follow-up."},{"label":"2.","content":"Disease-Free Survival in High Risk Patients[ Time Frame: Up to 72 months ]Kaplan-Meier analysis was conducted to estimate disease free survival defined as:>Arm A: Time from randomization until Second Treatment (first relapse) or death whichever comes first. Events were defined as the start of second treatment or death. Patients who had not experienced one of these defined events of interest were censored at their last known follow-up.>Arm B: Time from randomization until First Treatment (first relapse) or death whichever comes first. Events were defined as the start of first treatment or death. Patients who had not experienced one of these defined events of interest were censored at their last known follow-up."},{"label":"3.","content":"Overall Survival (OS) for High Risk Patients[ Time Frame: Up to 72 months ]Kaplan-Meier analysis was conducted to estimate the distribution of time from randomization to death from any cause. Estimates were not stratified. Patients who did not experience this primary outcome had their survival times censored at their last follow-up."}],"start_date":"January 2008","primary_completion_date":"June 2016","completion_date":"June 2016","first_posted":"August 9, 2007","results_first_posted":"April 6, 2020","last_update_posted":"April 22, 2020"},{"nctid":"NCT01252069","version_a":1,"version_b":2,"version_a_date":"2010-12-01","version_b_date":"2010-12-14","pom_a":[{"label":"1.","content":"Efficacy endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Investigate sustained efficacy of PGL4001 on uterine bleeding (% of subjects in amenorrhea at end of PGL4001 treatment), myoma size (transvaginal ultrasound), pain (short Mc Gill questionnaire) and quality of life (specific UFS-QoL questionnaire and general EQ-5D questionnaire)."},{"label":"2.","content":"Safety endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assess the overall safety of the on-off 3 months administration of PGL4001 for up to a total of four treatment cycles.Number and proportion of subjects experiencing treatment-emergent adverse events observed by physical examination,vital signs, ECG, transvaginal ultrasound and laboratory parameters."},{"label":"3.","content":"Exploratory endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assessment of the strengh of the first menstrual bleed after each PGL4001 treament using the Pictorial Bleeding Assessment Chart (PBAC)."}],"pom_b":[{"label":"1.","content":"Efficacy endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Investigate sustained efficacy of PGL4001 on uterine bleeding (% of subjects in amenorrhea at end of PGL4001 treatment), myoma size (transvaginal ultrasound), pain (short Mc Gill questionnaire) and quality of life (specific Uterine Fibroid Symptom and Quality of Life [UFS-QoL] questionnaire and general EQ-5D questionnaire)."},{"label":"2.","content":"Safety endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assess the overall safety of the on-off 3 months administration of PGL4001 for up to a total of four treatment cycles.Number and proportion of subjects experiencing treatment-emergent adverse events observed by physical examination,vital signs, ECG, transvaginal ultrasound and laboratory parameters."},{"label":"3.","content":"Exploratory endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assessment of the strengh of the first menstrual bleed after each PGL4001 treament using the Pictorial Bleeding Assessment Chart (PBAC)."}],"start_date":"January 2011","primary_completion_date":"August 2013","completion_date":"January 2014","first_posted":"December 2, 2010","last_update_posted":"January 13, 2016"},{"nctid":"NCT01252069","version_a":9,"version_b":10,"version_a_date":"2014-06-02","version_b_date":"2016-01-12","pom_a":[{"label":"1.","content":"Efficacy endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Investigate sustained efficacy of PGL4001 on uterine bleeding (% of subjects in amenorrhea at end of PGL4001 treatment), myoma size (transvaginal ultrasound), pain (short Mc Gill questionnaire) and quality of life (specific Uterine Fibroid Symptom and Quality of Life [UFS-QoL] questionnaire and general EQ-5D questionnaire)."},{"label":"2.","content":"Safety endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assess the overall safety of the on-off 3 months administration of PGL4001 for up to a total of four treatment cycles.Number and proportion of subjects experiencing treatment-emergent adverse events observed by physical examination,vital signs, ECG, transvaginal ultrasound and laboratory parameters."},{"label":"3.","content":"Exploratory endpoints[ Time Frame: From baseline to end of PGL4001 treatment (3months treatment) and to approximately 2 weeks after double blind treatment with progestin/placebo during three successive periods each ended by a drug free period until return of menses. ]Assessment of the strengh of the first menstrual bleed after each PGL4001 treament using the Pictorial Bleeding Assessment Chart (PBAC)."}],"pom_b":[{"label":"1.","content":"percentage of subjects in amennorrhoea at the end of each PGL4001 treatment course received[ Time Frame: From baseline to end of each PGL4001 treatment (3months treatment) ]"}],"start_date":"January 2011","primary_completion_date":"August 2013","completion_date":"January 2014","first_posted":"December 2, 2010","last_update_posted":"January 13, 2016"},{"nctid":"NCT00196781","version_a":3,"version_b":4,"version_a_date":"2008-02-14","version_b_date":"2010-01-11","pom_a":[{"label":"1.","content":"treatment satisfaction, quality of life, prostate cancer knowledge at 1, 6, and 12 months post random assignment"}],"pom_b":[{"label":"1.","content":"treatment satisfaction, quality of life, prostate cancer knowledge at 1, 6, and 12 months post random assignment[ Time Frame: one, six, and one year follow-up assesments ]"}],"start_date":"September 2002","primary_completion_date":"December 2005","completion_date":"December 2005","first_posted":"September 20, 2005","last_update_posted":"January 13, 2010"},{"nctid":"NCT02576977","version_a":9,"version_b":10,"version_a_date":"2016-03-09","version_b_date":"2016-03-15","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to 33 months ]"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to 33 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to 33 months ]"}],"start_date":"October 19, 2015","primary_completion_date":"July 9, 2018","completion_date":"July 16, 2020","first_posted":"October 15, 2015","results_first_posted":"August 2, 2019","last_update_posted":"October 8, 2021"},{"nctid":"NCT02576977","version_a":36,"version_b":37,"version_a_date":"2019-03-11","version_b_date":"2019-07-08","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS)[ Time Frame: Up to 33 months ]"},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to 33 months ]"}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS) Assessed by Clinical Adjudication Committee (CAC) Blinded Central Review According to the International Myeloma Working Group (IMWG) Response Criteria[ Time Frame: Up to approximately 30 months ]Progression free survival was defined as the time from randomization to the first documented disease progression, or death due to any cause, whichever occurred first. PFS was assessed by CAC blinded central review according to the IMWG criteria based on the development of new bone lesions or soft tissue plasmacytomas or on a definite increase in the size of existing bone lesions or soft tissue plasmacytomas. Median PFS was calculated from the product-limit (Kaplan-Meier) method for censored data. The data cutoff date was July 9, 2018."},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 30 months ]Overall survival is defined as the time from randomization to death due to any cause. Participants without documented death at the time of the final analysis were censored at the date of the last follow-up. Median overall survival was calculated from the product-limit (Kaplan-Meier) method for censored data. The data cutoff date was July 9, 2018."}],"start_date":"October 19, 2015","primary_completion_date":"July 9, 2018","completion_date":"July 16, 2020","first_posted":"October 15, 2015","results_first_posted":"August 2, 2019","last_update_posted":"October 8, 2021"},{"nctid":"NCT02576977","version_a":43,"version_b":44,"version_a_date":"2021-02-12","version_b_date":"2021-09-13","pom_a":[{"label":"1.","content":"Progression Free Survival (PFS) Assessed by Clinical Adjudication Committee (CAC) Blinded Central Review According to the International Myeloma Working Group (IMWG) Response Criteria[ Time Frame: Up to approximately 30 months ]Progression free survival was defined as the time from randomization to the first documented disease progression, or death due to any cause, whichever occurred first. PFS was assessed by CAC blinded central review according to the IMWG criteria based on the development of new bone lesions or soft tissue plasmacytomas or on a definite increase in the size of existing bone lesions or soft tissue plasmacytomas. Median PFS was calculated from the product-limit (Kaplan-Meier) method for censored data. The data cutoff date was July 9, 2018."},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 30 months ]Overall survival is defined as the time from randomization to death due to any cause. Participants without documented death at the time of the final analysis were censored at the date of the last follow-up. Median overall survival was calculated from the product-limit (Kaplan-Meier) method for censored data. The data cutoff date was July 9, 2018."}],"pom_b":[{"label":"1.","content":"Progression Free Survival (PFS) Assessed by Clinical Adjudication Committee (CAC) Blinded Central Review According to the International Myeloma Working Group (IMWG) Response Criteria[ Time Frame: Up to approximately 30 months ]Progression free survival was defined as the time from randomization to the first documented disease progression, or death due to any cause, whichever occurred first. PFS was assessed by CAC blinded central review according to the IMWG criteria based on the development of new bone lesions or soft tissue plasmacytomas or on a definite increase in the size of existing bone lesions or soft tissue plasmacytomas. Median PFS was calculated from the product-limit (Kaplan-Meier) method for censored data. The database cutoff date was July 9, 2018."},{"label":"2.","content":"Overall Survival (OS)[ Time Frame: Up to approximately 54 months ]Overall survival is defined as the time from randomization to death due to any cause. Participants without documented death at the time of the final analysis were censored at the date of the last follow-up. Median overall survival was calculated from the product-limit (Kaplan-Meier) method for censored data. The database cutoff date was August 3, 2020."}],"start_date":"October 19, 2015","primary_completion_date":"July 9, 2018","completion_date":"July 16, 2020","first_posted":"October 15, 2015","results_first_posted":"August 2, 2019","last_update_posted":"October 8, 2021"},{"nctid":"NCT00417911","version_a":2,"version_b":3,"version_a_date":"2008-03-13","version_b_date":"2010-06-17","pom_a":[{"label":"1.","content":"Evaluate the effect on EFS (an event is defined as either progression or death of any cause without preceding progression) of consolidation treatment with bortezomib after ASCT compared to no consolidation"}],"pom_b":[{"label":"1.","content":"Evaluate the effect on EFS (an event is defined as either progression or death of any cause without preceding progression) of consolidation treatment with bortezomib after ASCT compared to no consolidation[ Time Frame: 1 year after randomization of the last patient ]"}],"start_date":"December 2005","primary_completion_date":"May 2009","completion_date":"May 2010","first_posted":"January 4, 2007","last_update_posted":"June 22, 2010"},{"nctid":"NCT01231412","version_a":3,"version_b":4,"version_a_date":"2010-11-24","version_b_date":"2011-06-24","pom_a":[{"label":"1.","content":"The rate of acute grade II-IV GHVD[ Time Frame: At day 150 ]"}],"pom_b":[{"label":"1.","content":"Rate of acute grade II-IV GHVD[ Time Frame: At day 150 post-transplant ]Exclusive of GVHD that occurs as a result of alterations to immunosuppressive therapy in response to relapse or progression. An arm will be declared a \'success\' if the observed rate of acute grades II-IV GVHD is 40% or less (i.e. 20 or fewer patients out of 50)."}],"start_date":"November 2010","primary_completion_date":"October 8, 2016","completion_date":"June 30, 2017","first_posted":"November 1, 2010","results_first_posted":"December 4, 2017","last_update_posted":"October 24, 2019"},{"nctid":"NCT01231412","version_a":5,"version_b":6,"version_a_date":"2011-07-14","version_b_date":"2011-11-03","pom_a":[{"label":"1.","content":"Rate of acute grade II-IV GHVD[ Time Frame: At day 150 post-transplant ]Exclusive of GVHD that occurs as a result of alterations to immunosuppressive therapy in response to relapse or progression. An arm will be declared a \'success\' if the observed rate of acute grades II-IV GVHD is 40% or less (i.e. 20 or fewer patients out of 50)."}],"pom_b":[{"label":"1.","content":"Rate of acute grade II-IV GHVD, exclusive of GVHD that occurs as a result of alterations to immunosuppressive therapy in response to relapse or progression[ Time Frame: At day 100 post-transplant ]The actual analysis will be a time-to-event analysis using a log-rank statistic. Patients dying or relapsing within the first 100 days post-transplant will be censored at that time. Skin involvement will be assessed by biopsy with percentage of body surface area involved recorded. Gastrointestinal (GI) symptoms suspicious for GVHD will be evaluated by biopsy as indicated. Acute GVHD will be graded according to established criteria by an independent reviewer blinded to study arm and patient identity."}],"start_date":"November 2010","primary_completion_date":"October 8, 2016","completion_date":"June 30, 2017","first_posted":"November 1, 2010","results_first_posted":"December 4, 2017","last_update_posted":"October 24, 2019"},{"nctid":"NCT01231412","version_a":21,"version_b":22,"version_a_date":"2016-12-08","version_b_date":"2017-11-01","pom_a":[{"label":"1.","content":"Rate of acute grade II-IV GHVD, exclusive of GVHD that occurs as a result of alterations to immunosuppressive therapy in response to relapse or progression[ Time Frame: At day 100 post-transplant ]The actual analysis will be a time-to-event analysis using a log-rank statistic. Patients dying or relapsing within the first 100 days post-transplant will be censored at that time. Skin involvement will be assessed by biopsy with percentage of body surface area involved recorded. Gastrointestinal (GI) symptoms suspicious for GVHD will be evaluated by biopsy as indicated. Acute GVHD will be graded according to established criteria by an independent reviewer blinded to study arm and patient identity."}],"pom_b":[{"label":"1.","content":"Rate of Acute Grade II-IV GVHD, Exclusive of GVHD That Occurs as a Result of Alterations to Immunosuppressive Therapy in Response to Relapse or Progression[ Time Frame: At day 100 post-transplant ]The actual analysis will be a time-to-event analysis using a log-rank statistic. Patients dying or relapsing within the first 100 days post-transplant will be censored at that time. Skin involvement will be assessed by biopsy with percentage of body surface area involved recorded. Gastrointestinal (GI) symptoms suspicious for GVHD will be evaluated by biopsy as indicated. Acute GVHD will be graded according to established criteria by an independent reviewer blinded to study arm and patient identity."}],"start_date":"November 2010","primary_completion_date":"October 8, 2016","completion_date":"June 30, 2017","first_posted":"November 1, 2010","results_first_posted":"December 4, 2017","last_update_posted":"October 24, 2019"},{"nctid":"NCT01231412","version_a":22,"version_b":23,"version_a_date":"2017-11-01","version_b_date":"2018-01-11","pom_a":[{"label":"1.","content":"Rate of Acute Grade II-IV GVHD, Exclusive of GVHD That Occurs as a Result of Alterations to Immunosuppressive Therapy in Response to Relapse or Progression[ Time Frame: At day 100 post-transplant ]The actual analysis will be a time-to-event analysis using a log-rank statistic. Patients dying or relapsing within the first 100 days post-transplant will be censored at that time. Skin involvement will be assessed by biopsy with percentage of body surface area involved recorded. Gastrointestinal (GI) symptoms suspicious for GVHD will be evaluated by biopsy as indicated. Acute GVHD will be graded according to established criteria by an independent reviewer blinded to study arm and patient identity."}],"pom_b":[{"label":"1.","content":"Incidences of Acute Grade II-IV GVHD, Exclusive of GVHD That Occurs as a Result of Alterations to Immunosuppressive Therapy in Response to Relapse or Progression[ Time Frame: At day 100 post-transplant ]Number of patients who developed acute GVHD post-transplant. aGVHD StagesSkin:a maculopapular eruption involving < 25% BSA a maculopapular eruption involving 25 - 50% BSA generalized erythroderma generalized erythroderma with bullous formation and often with desquamationLiver:bilirubin 2.0 - 3.0 mg/100 mL bilirubin 3 - 5.9 mg/100 mL bilirubin 6 - 14.9 mg/100 mL bilirubin > 15 mg/100 mLGut:Diarrhea is graded 1 - 4 in severity. Nausea and vomiting and/or anorexia caused by GVHD is assigned as 1 in severity. The severity of gut involvement is assigned to the most severe involvement noted. Patients with visible bloody diarrhea are at least stage 2 gut and grade 3 overall.aGVHD Grades Grade III: Stage 2 - 4 gut involvement and/or stage 2 - 4 liver involvement Grade IV: Pattern and severity of GVHD similar to grade 3 with extreme constitutional symptoms or death"}],"start_date":"November 2010","primary_completion_date":"October 8, 2016","completion_date":"June 30, 2017","first_posted":"November 1, 2010","results_first_posted":"December 4, 2017","last_update_posted":"October 24, 2019"},{"nctid":"NCT01231412","version_a":25,"version_b":26,"version_a_date":"2019-04-17","version_b_date":"2019-10-10","pom_a":[{"label":"1.","content":"Incidences of Acute Grade II-IV GVHD, Exclusive of GVHD That Occurs as a Result of Alterations to Immunosuppressive Therapy in Response to Relapse or Progression[ Time Frame: At day 100 post-transplant ]Number of patients who developed acute GVHD post-transplant. aGVHD StagesSkin:a maculopapular eruption involving < 25% BSA a maculopapular eruption involving 25 - 50% BSA generalized erythroderma generalized erythroderma with bullous formation and often with desquamationLiver:bilirubin 2.0 - 3.0 mg/100 mL bilirubin 3 - 5.9 mg/100 mL bilirubin 6 - 14.9 mg/100 mL bilirubin > 15 mg/100 mLGut:Diarrhea is graded 1 - 4 in severity. Nausea and vomiting and/or anorexia caused by GVHD is assigned as 1 in severity. The severity of gut involvement is assigned to the most severe involvement noted. Patients with visible bloody diarrhea are at least stage 2 gut and grade 3 overall.aGVHD Grades Grade III: Stage 2 - 4 gut involvement and/or stage 2 - 4 liver involvement Grade IV: Pattern and severity of GVHD similar to grade 3 with extreme constitutional symptoms or death"}],"pom_b":[{"label":"1.","content":"Number of Patients With Grades II-IV Acute GVHD[ Time Frame: At day 100 post-transplant ]Number of patients with grades II-IV acute GVHDaGVHD StagesSkin:a maculopapular eruption involving < 25% BSAa maculopapular eruption involving 25 - 50% BSAgeneralized erythrodermageneralized erythroderma w/ bullous formation and often w/ desquamationLiver:bilirubin 2.0 - 3.0 mg/100 mLbilirubin 3 - 5.9 mg/100 mLbilirubin 6 - 14.9 mg/100 mLbilirubin > 15 mg/100 mLGut:Diarrhea is graded 1 - 4 in severity. Nausea and vomiting and/or anorexia caused by GVHD is assigned as 1 in severity. The severity of gut involvement is assigned to the most severe involvement noted. Patients w/ visible bloody diarrhea are at least stage 2 gut and grade 3 overall.aGVHD Grades Grade II: Stage 1 - 2 skin w/ no gut/liver involvement Grade III: Stage 2 - 4 gut involvement and/or stage 2 - 4 liver involvement Grade IV: Pattern and severity of GVHD similar to grade 3 w/ extreme constitutional symptoms or death"}],"start_date":"November 2010","primary_completion_date":"October 8, 2016","completion_date":"June 30, 2017","first_posted":"November 1, 2010","results_first_posted":"December 4, 2017","last_update_posted":"October 24, 2019"},{"nctid":"NCT00374322","version_a":11,"version_b":12,"version_a_date":"2007-04-24","version_b_date":"2007-05-01","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: 6 Weeks ]"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":12,"version_b":13,"version_a_date":"2007-05-01","version_b_date":"2007-06-14","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: 6 Weeks ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":17,"version_b":18,"version_a_date":"2007-08-20","version_b_date":"2007-11-01","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: Throughout entire study ]"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":19,"version_b":20,"version_a_date":"2007-11-20","version_b_date":"2007-12-07","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: Throughout entire study ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: throughout study ]"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":21,"version_b":22,"version_a_date":"2007-12-17","version_b_date":"2008-01-23","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: throughout study ]"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":73,"version_b":74,"version_a_date":"2009-09-17","version_b_date":"2009-10-01","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause"}],"pom_b":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: During the 12 month treatment period assessments are done every 3 months. During the 10 year follow-up, assessments are every 3, 6 or 12 months (dependent upon time from initial diagnosis) ]"}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":152,"version_b":153,"version_a_date":"2013-02-21","version_b_date":"2014-07-03","pom_a":[{"label":"1.","content":"Disease-free survival defined as the interval between the date of randomization and the date of objective disease recurrence, a second primary cancer, or death from any cause[ Time Frame: During the 12 month treatment period assessments are done every 3 months. During the 10 year follow-up, assessments are every 3, 6 or 12 months (dependent upon time from initial diagnosis) ]"}],"pom_b":[{"label":"1.","content":"Number of participants (par.) with any recurrence of the initial disease, second primary cancer, contralateral breast cancer, or death (disease-free survival [DFS])[ Time Frame: From randomization until the date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause (assessed up to 6 years; 1 year of treatment and 5 years of follow-up [median of 5.3 years for final analys ]DFS=interval between the date of randomization and the date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause. The date of the event is the earliest date of the occurrence of any of the following: local recurrence (LR) following mastectomy; LR in ipsilateral breast following lumpectomy; regional recurrence; distant recurrence; contralateral breast cancer, including ductal carcinoma in situ; other second primary cancer (excluding squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix, or lobular carcinoma in situ of the breast); death from any cause without a prior event. Par. who started additional anti-cancer adjuvant therapy prior to the recurrence of their disease were to be censored. Par. who did not withdraw from the study and did not experience a specified event or death were to be censored (follow-up ongoing) at the last visit date available at which progression was assessed."}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00374322","version_a":153,"version_b":154,"version_a_date":"2014-07-03","version_b_date":"2014-08-14","pom_a":[{"label":"1.","content":"Number of participants (par.) with any recurrence of the initial disease, second primary cancer, contralateral breast cancer, or death (disease-free survival [DFS])[ Time Frame: From randomization until the date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause (assessed up to 6 years; 1 year of treatment and 5 years of follow-up [median of 5.3 years for final analys ]DFS=interval between the date of randomization and the date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause. The date of the event is the earliest date of the occurrence of any of the following: local recurrence (LR) following mastectomy; LR in ipsilateral breast following lumpectomy; regional recurrence; distant recurrence; contralateral breast cancer, including ductal carcinoma in situ; other second primary cancer (excluding squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix, or lobular carcinoma in situ of the breast); death from any cause without a prior event. Par. who started additional anti-cancer adjuvant therapy prior to the recurrence of their disease were to be censored. Par. who did not withdraw from the study and did not experience a specified event or death were to be censored (follow-up ongoing) at the last visit date available at which progression was assessed."}],"pom_b":[{"label":"1.","content":"Number of Participants (Par.) With Any Recurrence of the Initial Disease, Second Primary Cancer, Contralateral Breast Cancer, or Death (Disease-free Survival [DFS])[ Time Frame: From randomization until date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause (assessed up to 6 years; 1 year of treatment, 5 years of follow-up [median of 5.3 years for final analysis]) ]DFS=interval between the date of randomization and the date of the first occurrence of an objective disease recurrence, a second primary cancer, or death from any cause. The date of the event is the earliest date of the occurrence of any of the following: local recurrence (LR) following mastectomy; LR in ipsilateral breast following lumpectomy; regional recurrence; distant recurrence; contralateral breast cancer, including ductal carcinoma in situ; other second primary cancer (excluding squamous or basal cell carcinoma of the skin, melanoma in situ, carcinoma in situ of the cervix, or lobular carcinoma in situ of the breast); death from any cause without a prior event. Par. who started additional anti-cancer adjuvant therapy prior to the recurrence of their disease were to be censored. Par. who did not withdraw from the study and did not experience a specified event or death were to be censored (follow-up ongoing) at the last visit date available at which progression was assessed."}],"start_date":"August 2006","primary_completion_date":"September 2011","completion_date":"July 2013","first_posted":"September 11, 2006","results_first_posted":"August 18, 2014","last_update_posted":"August 18, 2014"},{"nctid":"NCT00002583","version_a":24,"version_b":25,"version_a_date":"2011-04-04","version_b_date":"2011-04-18","pom_a":[],"pom_b":[{"label":"1.","content":"survival[ Time Frame: At time of death ]"}],"start_date":"July 7, 1994","primary_completion_date":"April 25, 2004","completion_date":"December 21, 2009","first_posted":"April 22, 2004","last_update_posted":"April 3, 2020"},{"nctid":"NCT00384891","version_a":1,"version_b":2,"version_a_date":"2006-10-05","version_b_date":"2008-08-06","pom_a":[{"label":"1.","content":"Recurrence free survival, or"},{"label":"2.","content":"time to complete response in CIS"},{"label":"3.","content":"progression rate (to disease stage>T1) and/or metastatic disease"}],"pom_b":[{"label":"1.","content":"Recurrence free survival, or[ Time Frame: 2 years ]"},{"label":"2.","content":"time to complete response in CIS"},{"label":"3.","content":"progression rate (to disease stage>T1) and/or metastatic disease"}],"start_date":"February 2002","primary_completion_date":"December 2013","completion_date":"December 2013","first_posted":"October 6, 2006","last_update_posted":"October 7, 2014"},{"nctid":"NCT00384891","version_a":2,"version_b":3,"version_a_date":"2008-08-06","version_b_date":"2008-09-23","pom_a":[{"label":"1.","content":"Recurrence free survival, or[ Time Frame: 2 years ]"},{"label":"2.","content":"time to complete response in CIS"},{"label":"3.","content":"progression rate (to disease stage>T1) and/or metastatic disease"}],"pom_b":[{"label":"1.","content":"Recurrence free survival, or[ Time Frame: 2 years ]"},{"label":"2.","content":"Time to complete response in CIS"},{"label":"3.","content":"Progression rate (to disease stage>T1) and/or metastatic disease"}],"start_date":"February 2002","primary_completion_date":"December 2013","completion_date":"December 2013","first_posted":"October 6, 2006","last_update_posted":"October 7, 2014"},{"nctid":"NCT00384891","version_a":4,"version_b":5,"version_a_date":"2010-07-19","version_b_date":"2014-10-05","pom_a":[{"label":"1.","content":"Recurrence free survival, or[ Time Frame: 2 years ]"},{"label":"2.","content":"Time to complete response in CIS"},{"label":"3.","content":"Progression rate (to disease stage>T1) and/or metastatic disease"}],"pom_b":[{"label":"1.","content":"Recurrence free survival[ Time Frame: 2 years ]Recurrence free survival probability of STCCB in patients with pure (non-CIS) papillary tumor"}],"start_date":"February 2002","primary_completion_date":"December 2013","completion_date":"December 2013","first_posted":"October 6, 2006","last_update_posted":"October 7, 2014"},{"nctid":"NCT04001010","version_a":3,"version_b":4,"version_a_date":"2019-08-13","version_b_date":"2020-03-09","pom_a":[{"label":"1.","content":"The overall HRQoL (Health related Quality of Life) of patients with uncontrolled symptoms related to advanced cancer will be measured using a patient self rating questionnaire.[ Time Frame: change from baseline in the EORTC-QLQ-C15-PAL overall QoL single-item scale score at Week 4 ]The QoL will be measured using European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire - Core 15 Palliative (EORTC-QLQ-C15-PAL) item 15. Scale range is 1 to 7; 1 (very poor) being the worst rating to the maximal rating of 7 (Excellent)."},{"label":"2.","content":"Uncontrolled cancer pain will be measured using a patient self rating questionnaire.[ Time Frame: change from baseline in the EORTC-QLQ-C15-PAL pain multi-item scale score at Week 4. ]The uncontrolled cancer pain will be measured using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire - Core 15 Palliative (EORTC-QLQ-C15-PAL) item 5 and 12. Scale range is 1 to 4; 1 (not at all) being the worst rating to the maximal rating of 4 (Very Much)."}],"pom_b":[{"label":"1.","content":"physical functioning related to advanced cancer will be measured using a patient self rating questionnaire.[ Time Frame: Change from baseline in EORTC-QLQ-C15-PAL physical functioning in multi-item scales at week 4, 8 and 12 W4 W8 W12 ]EORTC-QLQ-C15-PAL"},{"label":"2.","content":"Cachexia grade will be measured[ Time Frame: Change from baseline in BMI and Cachexia grade as per Weight Loss Grading System at week 4, 8 and 12. Downgrading cachexia grade or grade maintenance will be considered as a drug benefit. ]Weight Loss Grading System"}],"start_date":"July 2022","primary_completion_date":"July 2023","completion_date":"December 2023","first_posted":"June 27, 2019","last_update_posted":"February 5, 2021"},{"nctid":"NCT04001010","version_a":4,"version_b":5,"version_a_date":"2020-03-09","version_b_date":"2020-03-16","pom_a":[{"label":"1.","content":"physical functioning related to advanced cancer will be measured using a patient self rating questionnaire.[ Time Frame: Change from baseline in EORTC-QLQ-C15-PAL physical functioning in multi-item scales at week 4, 8 and 12 W4 W8 W12 ]EORTC-QLQ-C15-PAL"},{"label":"2.","content":"Cachexia grade will be measured[ Time Frame: Change from baseline in BMI and Cachexia grade as per Weight Loss Grading System at week 4, 8 and 12. Downgrading cachexia grade or grade maintenance will be considered as a drug benefit. ]Weight Loss Grading System"}],"pom_b":[{"label":"1.","content":"physical functioning related to advanced cancer will be measured using a patient self rating questionnaire.[ Time Frame: Change from baseline in EORTC-QLQ-C15-PAL physical functioning in multi-item scales at week 4, 8 and 12 W4 W8 W12 ]European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 15 Palliative (EORTC-QLQ-C15-PAL). items are rated on a scale of 1 (not at all) to 4 (very much). high scores on a symptom scale correlate to increased symptom burden"},{"label":"2.","content":"Cachexia grade will be measured as per Weight Loss Grading System[ Time Frame: Change from baseline at week 4, 8 and 12. ]Downgrading cachexia grade or grade maintenance will be considered as a drug benefit."}],"start_date":"July 2022","primary_completion_date":"July 2023","completion_date":"December 2023","first_posted":"June 27, 2019","last_update_posted":"February 5, 2021"}]}'),Y=n(1184);var X=e.createContext(),ee=n(5878);function te(e){return(0,T.Z)("MuiGrid",e)}var ne=["auto",!0,1,2,3,4,5,6,7,8,9,10,11,12],re=(0,ee.Z)("MuiGrid",["root","container","item","zeroMinWidth"].concat((0,Z.Z)([0,1,2,3,4,5,6,7,8,9,10].map((function(e){return"spacing-xs-".concat(e)}))),(0,Z.Z)(["column-reverse","column","row-reverse","row"].map((function(e){return"direction-xs-".concat(e)}))),(0,Z.Z)(["nowrap","wrap-reverse","wrap"].map((function(e){return"wrap-xs-".concat(e)}))),(0,Z.Z)(ne.map((function(e){return"grid-xs-".concat(e)}))),(0,Z.Z)(ne.map((function(e){return"grid-sm-".concat(e)}))),(0,Z.Z)(ne.map((function(e){return"grid-md-".concat(e)}))),(0,Z.Z)(ne.map((function(e){return"grid-lg-".concat(e)}))),(0,Z.Z)(ne.map((function(e){return"grid-xl-".concat(e)}))))),ae=re,oe=["className","columns","columnSpacing","component","container","direction","item","rowSpacing","spacing","wrap","zeroMinWidth"];function ie(e){var t=parseFloat(e);return"".concat(t).concat(String(e).replace(String(t),"")||"px")}function se(e){var t=e.breakpoints,n=e.values,r="";Object.keys(n).forEach((function(e){""===r&&0!==n[e]&&(r=e)}));var a=Object.keys(t).sort((function(e,n){return t[e]-t[n]}));return a.slice(0,a.indexOf(r))}var le=(0,D.ZP)("div",{name:"MuiGrid",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState,r=n.container,a=n.direction,o=n.item,i=n.spacing,s=n.wrap,l=n.zeroMinWidth,u=n.breakpoints,c=[];r&&(c=function(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:{};if(!e||e<=0)return[];if("string"===typeof e&&!Number.isNaN(Number(e))||"number"===typeof e)return[n["spacing-xs-".concat(String(e))]];var r=[];return t.forEach((function(t){var a=e[t];Number(a)>0&&r.push(n["spacing-".concat(t,"-").concat(String(a))])})),r}(i,u,t));var d=[];return u.forEach((function(e){var r=n[e];r&&d.push(t["grid-".concat(e,"-").concat(String(r))])})),[t.root,r&&t.container,o&&t.item,l&&t.zeroMinWidth].concat((0,Z.Z)(c),["row"!==a&&t["direction-xs-".concat(String(a))],"wrap"!==s&&t["wrap-xs-".concat(String(s))]],d)}})((function(e){var t=e.ownerState;return(0,r.Z)({boxSizing:"border-box"},t.container&&{display:"flex",flexWrap:"wrap",width:"100%"},t.item&&{margin:0},t.zeroMinWidth&&{minWidth:0},"wrap"!==t.wrap&&{flexWrap:t.wrap})}),(function(e){var t=e.theme,n=e.ownerState,r=(0,Y.P$)({values:n.direction,breakpoints:t.breakpoints.values});return(0,Y.k9)({theme:t},r,(function(e){var t={flexDirection:e};return 0===e.indexOf("column")&&(t["& > .".concat(ae.item)]={maxWidth:"none"}),t}))}),(function(e){var t=e.theme,n=e.ownerState,r=n.container,a=n.rowSpacing,o={};if(r&&0!==a){var i,s=(0,Y.P$)({values:a,breakpoints:t.breakpoints.values});"object"===typeof s&&(i=se({breakpoints:t.breakpoints.values,values:s})),o=(0,Y.k9)({theme:t},s,(function(e,n){var r,a=t.spacing(e);return"0px"!==a?(0,_.Z)({marginTop:"-".concat(ie(a))},"& > .".concat(ae.item),{paddingTop:ie(a)}):null!=(r=i)&&r.includes(n)?{}:(0,_.Z)({marginTop:0},"& > .".concat(ae.item),{paddingTop:0})}))}return o}),(function(e){var t=e.theme,n=e.ownerState,r=n.container,a=n.columnSpacing,o={};if(r&&0!==a){var i,s=(0,Y.P$)({values:a,breakpoints:t.breakpoints.values});"object"===typeof s&&(i=se({breakpoints:t.breakpoints.values,values:s})),o=(0,Y.k9)({theme:t},s,(function(e,n){var r,a=t.spacing(e);return"0px"!==a?(0,_.Z)({width:"calc(100% + ".concat(ie(a),")"),marginLeft:"-".concat(ie(a))},"& > .".concat(ae.item),{paddingLeft:ie(a)}):null!=(r=i)&&r.includes(n)?{}:(0,_.Z)({width:"100%",marginLeft:0},"& > .".concat(ae.item),{paddingLeft:0})}))}return o}),(function(e){var t,n=e.theme,a=e.ownerState;return n.breakpoints.keys.reduce((function(e,o){var i={};if(a[o]&&(t=a[o]),!t)return e;if(!0===t)i={flexBasis:0,flexGrow:1,maxWidth:"100%"};else if("auto"===t)i={flexBasis:"auto",flexGrow:0,flexShrink:0,maxWidth:"none",width:"auto"};else{var s=(0,Y.P$)({values:a.columns,breakpoints:n.breakpoints.values}),l="object"===typeof s?s[o]:s;if(void 0===l||null===l)return e;var u="".concat(Math.round(t/l*1e8)/1e6,"%"),c={};if(a.container&&a.item&&0!==a.columnSpacing){var d=n.spacing(a.columnSpacing);if("0px"!==d){var f="calc(".concat(u," + ").concat(ie(d),")");c={flexBasis:f,maxWidth:f}}}i=(0,r.Z)({flexBasis:u,flexGrow:0,maxWidth:u},c)}return 0===n.breakpoints.values[o]?Object.assign(e,i):e[n.breakpoints.up(o)]=i,e}),{})}));var ue=function(e){var t=e.classes,n=e.container,r=e.direction,a=e.item,o=e.spacing,i=e.wrap,s=e.zeroMinWidth,l=e.breakpoints,u=[];n&&(u=function(e,t){if(!e||e<=0)return[];if("string"===typeof e&&!Number.isNaN(Number(e))||"number"===typeof e)return["spacing-xs-".concat(String(e))];var n=[];return t.forEach((function(t){var r=e[t];if(Number(r)>0){var a="spacing-".concat(t,"-").concat(String(r));n.push(a)}})),n}(o,l));var c=[];l.forEach((function(t){var n=e[t];n&&c.push("grid-".concat(t,"-").concat(String(n)))}));var d={root:["root",n&&"container",a&&"item",s&&"zeroMinWidth"].concat((0,Z.Z)(u),["row"!==r&&"direction-xs-".concat(String(r)),"wrap"!==i&&"wrap-xs-".concat(String(i))],c)};return(0,C.Z)(d,te,t)},ce=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiGrid"}),i=(0,U.Z)(m.Z).breakpoints,s=G(o),l=s.className,u=s.columns,c=s.columnSpacing,d=s.component,p=void 0===d?"div":d,h=s.container,v=void 0!==h&&h,b=s.direction,y=void 0===b?"row":b,g=s.item,_=void 0!==g&&g,S=s.rowSpacing,T=s.spacing,C=void 0===T?0:T,x=s.wrap,A=void 0===x?"wrap":x,F=s.zeroMinWidth,E=void 0!==F&&F,P=(0,w.Z)(s,oe),O=S||C,N=c||C,M=e.useContext(X),R=v?u||12:M,D={},L=(0,r.Z)({},P);i.keys.forEach((function(e){null!=P[e]&&(D[e]=P[e],delete L[e])}));var I=(0,r.Z)({},s,{columns:R,container:v,direction:y,item:_,rowSpacing:O,columnSpacing:N,wrap:A,zeroMinWidth:E,spacing:C},D,{breakpoints:i.keys}),z=ue(I);return(0,f.jsx)(X.Provider,{value:R,children:(0,f.jsx)(le,(0,r.Z)({ownerState:I,className:(0,k.Z)(z.root,l),as:p,ref:n},L))})})),de=ce,fe=n(2065);function pe(e){return(0,T.Z)("MuiPaper",e)}(0,ee.Z)("MuiPaper",["root","rounded","outlined","elevation","elevation0","elevation1","elevation2","elevation3","elevation4","elevation5","elevation6","elevation7","elevation8","elevation9","elevation10","elevation11","elevation12","elevation13","elevation14","elevation15","elevation16","elevation17","elevation18","elevation19","elevation20","elevation21","elevation22","elevation23","elevation24"]);var me=["className","component","elevation","square","variant"],he=function(e){return((e<1?5.11916*Math.pow(e,2):4.5*Math.log(e+1)+2)/100).toFixed(2)},ve=(0,D.ZP)("div",{name:"MuiPaper",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t[n.variant],!n.square&&t.rounded,"elevation"===n.variant&&t["elevation".concat(n.elevation)]]}})((function(e){var t,n=e.theme,a=e.ownerState;return(0,r.Z)({backgroundColor:(n.vars||n).palette.background.paper,color:(n.vars||n).palette.text.primary,transition:n.transitions.create("box-shadow")},!a.square&&{borderRadius:n.shape.borderRadius},"outlined"===a.variant&&{border:"1px solid ".concat((n.vars||n).palette.divider)},"elevation"===a.variant&&(0,r.Z)({boxShadow:(n.vars||n).shadows[a.elevation]},!n.vars&&"dark"===n.palette.mode&&{backgroundImage:"linear-gradient(".concat((0,fe.Fq)("#fff",he(a.elevation)),", ").concat((0,fe.Fq)("#fff",he(a.elevation)),")")},n.vars&&{backgroundImage:null==(t=n.vars.overlays)?void 0:t[a.elevation]}))})),be=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiPaper"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=n.elevation,u=void 0===l?1:l,c=n.square,d=void 0!==c&&c,p=n.variant,m=void 0===p?"elevation":p,h=(0,w.Z)(n,me),v=(0,r.Z)({},n,{component:s,elevation:u,square:d,variant:m}),b=function(e){var t=e.square,n=e.elevation,r=e.variant,a=e.classes,o={root:["root",r,!t&&"rounded","elevation"===r&&"elevation".concat(n)]};return(0,C.Z)(o,pe,a)}(v);return(0,f.jsx)(ve,(0,r.Z)({as:s,ownerState:v,className:(0,k.Z)(b.root,o),ref:t},h))}));function ye(e){return(0,T.Z)("MuiCard",e)}(0,ee.Z)("MuiCard",["root"]);var ge=["className","raised"],_e=(0,D.ZP)(be,{name:"MuiCard",slot:"Root",overridesResolver:function(e,t){return t.root}})((function(){return{overflow:"hidden"}})),we=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiCard"}),o=n.className,i=n.raised,s=void 0!==i&&i,l=(0,w.Z)(n,ge),u=(0,r.Z)({},n,{raised:s}),c=function(e){var t=e.classes;return(0,C.Z)({root:["root"]},ye,t)}(u);return(0,f.jsx)(_e,(0,r.Z)({className:(0,k.Z)(c.root,o),elevation:s?8:void 0,ref:t,ownerState:u},l))}));function ke(e){return(0,T.Z)("MuiCardContent",e)}(0,ee.Z)("MuiCardContent",["root"]);var Se=["className","component"],Te=(0,D.ZP)("div",{name:"MuiCardContent",slot:"Root",overridesResolver:function(e,t){return t.root}})((function(){return{padding:16,"&:last-child":{paddingBottom:24}}})),Ce=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiCardContent"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=(0,w.Z)(n,Se),u=(0,r.Z)({},n,{component:s}),c=function(e){var t=e.classes;return(0,C.Z)({root:["root"]},ke,t)}(u);return(0,f.jsx)(Te,(0,r.Z)({as:s,className:(0,k.Z)(c.root,o),ownerState:u,ref:t},l))}));function xe(e){return(0,T.Z)("MuiTypography",e)}(0,ee.Z)("MuiTypography",["root","h1","h2","h3","h4","h5","h6","subtitle1","subtitle2","body1","body2","inherit","button","caption","overline","alignLeft","alignRight","alignCenter","alignJustify","noWrap","gutterBottom","paragraph"]);var Ae=["align","className","component","gutterBottom","noWrap","paragraph","variant","variantMapping"],Fe=(0,D.ZP)("span",{name:"MuiTypography",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,n.variant&&t[n.variant],"inherit"!==n.align&&t["align".concat((0,R.Z)(n.align))],n.noWrap&&t.noWrap,n.gutterBottom&&t.gutterBottom,n.paragraph&&t.paragraph]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({margin:0},n.variant&&t.typography[n.variant],"inherit"!==n.align&&{textAlign:n.align},n.noWrap&&{overflow:"hidden",textOverflow:"ellipsis",whiteSpace:"nowrap"},n.gutterBottom&&{marginBottom:"0.35em"},n.paragraph&&{marginBottom:16})})),Ee={h1:"h1",h2:"h2",h3:"h3",h4:"h4",h5:"h5",h6:"h6",subtitle1:"h6",subtitle2:"h6",body1:"p",body2:"p",inherit:"p"},Pe={primary:"primary.main",textPrimary:"text.primary",secondary:"secondary.main",textSecondary:"text.secondary",error:"error.main"},Oe=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiTypography"}),o=function(e){return Pe[e]||e}(n.color),i=G((0,r.Z)({},n,{color:o})),s=i.align,l=void 0===s?"inherit":s,u=i.className,c=i.component,d=i.gutterBottom,p=void 0!==d&&d,m=i.noWrap,h=void 0!==m&&m,v=i.paragraph,b=void 0!==v&&v,y=i.variant,g=void 0===y?"body1":y,_=i.variantMapping,S=void 0===_?Ee:_,T=(0,w.Z)(i,Ae),x=(0,r.Z)({},i,{align:l,color:o,className:u,component:c,gutterBottom:p,noWrap:h,paragraph:b,variant:g,variantMapping:S}),A=c||(b?"p":S[g]||Ee[g])||"span",F=function(e){var t=e.align,n=e.gutterBottom,r=e.noWrap,a=e.paragraph,o=e.variant,i=e.classes,s={root:["root",o,"inherit"!==e.align&&"align".concat((0,R.Z)(t)),n&&"gutterBottom",r&&"noWrap",a&&"paragraph"]};return(0,C.Z)(s,xe,i)}(x);return(0,f.jsx)(Fe,(0,r.Z)({as:A,ref:t,ownerState:x,className:(0,k.Z)(F.root,u)},T))})),Ne=n(5682),Me=["component","direction","spacing","divider","children"];function Re(t,n){var r=e.Children.toArray(t).filter(Boolean);return r.reduce((function(t,a,o){return t.push(a),o<r.length-1&&t.push(e.cloneElement(n,{key:"separator-".concat(o)})),t}),[])}var De=(0,D.ZP)("div",{name:"MuiStack",slot:"Root",overridesResolver:function(e,t){return[t.root]}})((function(e){var t=e.ownerState,n=e.theme,a=(0,r.Z)({display:"flex",flexDirection:"column"},(0,Y.k9)({theme:n},(0,Y.P$)({values:t.direction,breakpoints:n.breakpoints.values}),(function(e){return{flexDirection:e}})));if(t.spacing){var o=(0,Ne.hB)(n),i=Object.keys(n.breakpoints.values).reduce((function(e,n){return("object"===typeof t.spacing&&null!=t.spacing[n]||"object"===typeof t.direction&&null!=t.direction[n])&&(e[n]=!0),e}),{}),s=(0,Y.P$)({values:t.direction,base:i}),l=(0,Y.P$)({values:t.spacing,base:i});"object"===typeof s&&Object.keys(s).forEach((function(e,t,n){if(!s[e]){var r=t>0?s[n[t-1]]:"column";s[e]=r}}));a=(0,B.Z)(a,(0,Y.k9)({theme:n},l,(function(e,n){return{"& > :not(style) + :not(style)":(0,_.Z)({margin:0},"margin".concat((r=n?s[n]:t.direction,{row:"Left","row-reverse":"Right",column:"Top","column-reverse":"Bottom"}[r])),(0,Ne.NA)(o,e))};var r})))}return a=(0,Y.dt)(n.breakpoints,a)})),Le=e.forwardRef((function(e,t){var n=G((0,a.Z)({props:e,name:"MuiStack"})),o=n.component,i=void 0===o?"div":o,s=n.direction,l=void 0===s?"column":s,u=n.spacing,c=void 0===u?0:u,d=n.divider,p=n.children,m=(0,w.Z)(n,Me),h={direction:l,spacing:c};return(0,f.jsx)(De,(0,r.Z)({as:i,ownerState:h,ref:t},m,{children:d?Re(p,d):p}))})),Ie=Le,ze=n(1774),je=n.n(ze);var Ze=function(e){var t=e.datum,n=e.datumNumber,r=e.results,a=(e.setResults,t.pom_a),o=t.pom_b,i=t.version_a_date,s=t.version_b_date;console.log({datum:t});var l=function(e,t){return e.map((function(e){return(0,f.jsx)(we,{children:(0,f.jsx)(Ce,{children:(0,f.jsxs)(Oe,{children:[(0,f.jsx)("b",{children:e.label})," ",e.content]})})},e.content)}))};return(0,f.jsxs)(de,{container:!0,spacing:2,children:[(0,f.jsx)(de,{item:!0,xs:12,children:(0,f.jsx)(we,{children:(0,f.jsx)(Ce,{children:(0,f.jsxs)(de,{container:!0,children:[(0,f.jsxs)(de,{item:!0,xs:4,children:[(0,f.jsxs)(Oe,{variant:"h6",children:["Comparison Number ",n+1," of ",r.length]}),(0,f.jsxs)(Oe,{variant:"h4",children:["Trial ",t.nctid]})]}),(0,f.jsxs)(de,{item:!0,xs:4,children:[t.first_posted?(0,f.jsxs)(Oe,{children:["First Posted: ",t.first_posted]}):null,t.start_date?(0,f.jsxs)(Oe,{children:["Start Date: ",t.start_date]}):null]}),(0,f.jsxs)(de,{item:!0,xs:4,children:[t.primary_completion_date?(0,f.jsxs)(Oe,{children:["Primary Completion Date: ",t.primary_completion_date]}):null,t.last_update_posted?(0,f.jsxs)(Oe,{children:["Last Update Posted : ",t.last_update_posted]}):null]})]})})})}),(0,f.jsx)(de,{item:!0,xs:6,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Ce,{children:[(0,f.jsxs)(Oe,{variant:"h6",children:["Primary Outcomes for Version ",t.version_a,": ",i]}),(0,f.jsx)(Oe,{variant:"caption"}),(0,f.jsx)(Ie,{spacing:1,children:l(t.pom_a)})]})})}),(0,f.jsx)(de,{item:!0,xs:6,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Ce,{children:[(0,f.jsxs)(Oe,{variant:"h6",children:["Primary Outcomes for Version ",t.version_b,": ",s]}),(0,f.jsx)(Ie,{spacing:1,children:l(t.pom_b)})]})})}),(0,f.jsx)(de,{item:!0,xs:12,children:(0,f.jsx)(we,{children:(0,f.jsxs)(Ce,{children:[(0,f.jsx)(Oe,{variant:"h6",children:"Compare the Raw Text"}),(0,f.jsx)(je(),{oldValue:JSON.stringify(a,void 0,4),newValue:JSON.stringify(o,void 0,4),splitView:!0,compareMethod:ze.DiffMethod.WORDS,styles:{variables:{light:{codeFoldGutterBackground:"#6F767E",codeFoldBackground:"#E2E4E5"}}},leftTitle:"Version ".concat(t.version_a),rightTitle:"Version ".concat(t.version_b)})]})})})]})};function Be(e){return(0,T.Z)("MuiAppBar",e)}(0,ee.Z)("MuiAppBar",["root","positionFixed","positionAbsolute","positionSticky","positionStatic","positionRelative","colorDefault","colorPrimary","colorSecondary","colorInherit","colorTransparent"]);var Ve=["className","color","enableColorOnDark","position"],We=function(e,t){return"".concat(null==e?void 0:e.replace(")",""),", ").concat(t,")")},Ge=(0,D.ZP)(be,{name:"MuiAppBar",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,t["position".concat((0,R.Z)(n.position))],t["color".concat((0,R.Z)(n.color))]]}})((function(e){var t=e.theme,n=e.ownerState,a="light"===t.palette.mode?t.palette.grey[100]:t.palette.grey[900];return(0,r.Z)({display:"flex",flexDirection:"column",width:"100%",boxSizing:"border-box",flexShrink:0},"fixed"===n.position&&{position:"fixed",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0,"@media print":{position:"absolute"}},"absolute"===n.position&&{position:"absolute",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0},"sticky"===n.position&&{position:"sticky",zIndex:(t.vars||t).zIndex.appBar,top:0,left:"auto",right:0},"static"===n.position&&{position:"static"},"relative"===n.position&&{position:"relative"},!t.vars&&(0,r.Z)({},"default"===n.color&&{backgroundColor:a,color:t.palette.getContrastText(a)},n.color&&"default"!==n.color&&"inherit"!==n.color&&"transparent"!==n.color&&{backgroundColor:t.palette[n.color].main,color:t.palette[n.color].contrastText},"inherit"===n.color&&{color:"inherit"},"dark"===t.palette.mode&&!n.enableColorOnDark&&{backgroundColor:null,color:null},"transparent"===n.color&&(0,r.Z)({backgroundColor:"transparent",color:"inherit"},"dark"===t.palette.mode&&{backgroundImage:"none"})),t.vars&&(0,r.Z)({},"default"===n.color&&{"--AppBar-background":n.enableColorOnDark?t.vars.palette.AppBar.defaultBg:We(t.vars.palette.AppBar.darkBg,t.vars.palette.AppBar.defaultBg),"--AppBar-color":n.enableColorOnDark?t.vars.palette.text.primary:We(t.vars.palette.AppBar.darkColor,t.vars.palette.text.primary)},n.color&&!n.color.match(/^(default|inherit|transparent)$/)&&{"--AppBar-background":n.enableColorOnDark?t.vars.palette[n.color].main:We(t.vars.palette.AppBar.darkBg,t.vars.palette[n.color].main),"--AppBar-color":n.enableColorOnDark?t.vars.palette[n.color].contrastText:We(t.vars.palette.AppBar.darkColor,t.vars.palette[n.color].contrastText)},{backgroundColor:"var(--AppBar-background)",color:"inherit"===n.color?"inherit":"var(--AppBar-color)"},"transparent"===n.color&&{backgroundImage:"none",backgroundColor:"transparent",color:"inherit"}))})),Ue=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiAppBar"}),o=n.className,i=n.color,s=void 0===i?"primary":i,l=n.enableColorOnDark,u=void 0!==l&&l,c=n.position,d=void 0===c?"fixed":c,p=(0,w.Z)(n,Ve),m=(0,r.Z)({},n,{color:s,position:d,enableColorOnDark:u}),h=function(e){var t=e.color,n=e.position,r=e.classes,a={root:["root","color".concat((0,R.Z)(t)),"position".concat((0,R.Z)(n))]};return(0,C.Z)(a,Be,r)}(m);return(0,f.jsx)(Ge,(0,r.Z)({square:!0,component:"header",ownerState:m,elevation:4,className:(0,k.Z)(h.root,o,"fixed"===d&&"mui-fixed"),ref:t},p))}));function He(e){return(0,T.Z)("MuiToolbar",e)}(0,ee.Z)("MuiToolbar",["root","gutters","regular","dense"]);var $e=["className","component","disableGutters","variant"],Je=(0,D.ZP)("div",{name:"MuiToolbar",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,!n.disableGutters&&t.gutters,t[n.variant]]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({position:"relative",display:"flex",alignItems:"center"},!n.disableGutters&&(0,_.Z)({paddingLeft:t.spacing(2),paddingRight:t.spacing(2)},t.breakpoints.up("sm"),{paddingLeft:t.spacing(3),paddingRight:t.spacing(3)}),"dense"===n.variant&&{minHeight:48})}),(function(e){var t=e.theme;return"regular"===e.ownerState.variant&&t.mixins.toolbar})),qe=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiToolbar"}),o=n.className,i=n.component,s=void 0===i?"div":i,l=n.disableGutters,u=void 0!==l&&l,c=n.variant,d=void 0===c?"regular":c,p=(0,w.Z)(n,$e),m=(0,r.Z)({},n,{component:s,disableGutters:u,variant:d}),h=function(e){var t=e.classes,n={root:["root",!e.disableGutters&&"gutters",e.variant]};return(0,C.Z)(n,He,t)}(m);return(0,f.jsx)(Je,(0,r.Z)({as:s,className:(0,k.Z)(h.root,o),ref:t,ownerState:m},p))})),Qe=n(792),Ke=n(6702),Ye=n(2763);function Xe(e,t){return t||(t=e.slice(0)),Object.freeze(Object.defineProperties(e,{raw:{value:Object.freeze(t)}}))}function et(e,t){return et=Object.setPrototypeOf?Object.setPrototypeOf.bind():function(e,t){return e.__proto__=t,e},et(e,t)}var tt=e.createContext(null);function nt(t,n){var r=Object.create(null);return t&&e.Children.map(t,(function(e){return e})).forEach((function(t){r[t.key]=function(t){return n&&(0,e.isValidElement)(t)?n(t):t}(t)})),r}function rt(e,t,n){return null!=n[t]?n[t]:e.props[t]}function at(t,n,r){var a=nt(t.children),o=function(e,t){function n(n){return n in t?t[n]:e[n]}e=e||{},t=t||{};var r,a=Object.create(null),o=[];for(var i in e)i in t?o.length&&(a[i]=o,o=[]):o.push(i);var s={};for(var l in t){if(a[l])for(r=0;r<a[l].length;r++){var u=a[l][r];s[a[l][r]]=n(u)}s[l]=n(l)}for(r=0;r<o.length;r++)s[o[r]]=n(o[r]);return s}(n,a);return Object.keys(o).forEach((function(i){var s=o[i];if((0,e.isValidElement)(s)){var l=i in n,u=i in a,c=n[i],d=(0,e.isValidElement)(c)&&!c.props.in;!u||l&&!d?u||!l||d?u&&l&&(0,e.isValidElement)(c)&&(o[i]=(0,e.cloneElement)(s,{onExited:r.bind(null,s),in:c.props.in,exit:rt(s,"exit",t),enter:rt(s,"enter",t)})):o[i]=(0,e.cloneElement)(s,{in:!1}):o[i]=(0,e.cloneElement)(s,{onExited:r.bind(null,s),in:!0,exit:rt(s,"exit",t),enter:rt(s,"enter",t)})}})),o}var ot=Object.values||function(e){return Object.keys(e).map((function(t){return e[t]}))},it=function(t){var n,a;function o(e,n){var r,a=(r=t.call(this,e,n)||this).handleExited.bind(function(e){if(void 0===e)throw new ReferenceError("this hasn't been initialised - super() hasn't been called");return e}(r));return r.state={contextValue:{isMounting:!0},handleExited:a,firstRender:!0},r}a=t,(n=o).prototype=Object.create(a.prototype),n.prototype.constructor=n,et(n,a);var i=o.prototype;return i.componentDidMount=function(){this.mounted=!0,this.setState({contextValue:{isMounting:!1}})},i.componentWillUnmount=function(){this.mounted=!1},o.getDerivedStateFromProps=function(t,n){var r,a,o=n.children,i=n.handleExited;return{children:n.firstRender?(r=t,a=i,nt(r.children,(function(t){return(0,e.cloneElement)(t,{onExited:a.bind(null,t),in:!0,appear:rt(t,"appear",r),enter:rt(t,"enter",r),exit:rt(t,"exit",r)})}))):at(t,o,i),firstRender:!1}},i.handleExited=function(e,t){var n=nt(this.props.children);e.key in n||(e.props.onExited&&e.props.onExited(t),this.mounted&&this.setState((function(t){var n=(0,r.Z)({},t.children);return delete n[e.key],{children:n}})))},i.render=function(){var t=this.props,n=t.component,r=t.childFactory,a=(0,w.Z)(t,["component","childFactory"]),o=this.state.contextValue,i=ot(this.state.children).map(r);return delete a.appear,delete a.enter,delete a.exit,null===n?e.createElement(tt.Provider,{value:o},i):e.createElement(tt.Provider,{value:o},e.createElement(n,a,i))},o}(e.Component);it.propTypes={},it.defaultProps={component:"div",childFactory:function(e){return e}};var st=it;var lt=function(t){var n=t.className,r=t.classes,a=t.pulsate,o=void 0!==a&&a,i=t.rippleX,s=t.rippleY,l=t.rippleSize,u=t.in,c=t.onExited,d=t.timeout,p=e.useState(!1),m=(0,g.Z)(p,2),h=m[0],v=m[1],b=(0,k.Z)(n,r.ripple,r.rippleVisible,o&&r.ripplePulsate),y={width:l,height:l,top:-l/2+s,left:-l/2+i},_=(0,k.Z)(r.child,h&&r.childLeaving,o&&r.childPulsate);return u||h||v(!0),e.useEffect((function(){if(!u&&null!=c){var e=setTimeout(c,d);return function(){clearTimeout(e)}}}),[c,u,d]),(0,f.jsx)("span",{className:b,style:y,children:(0,f.jsx)("span",{className:_})})};var ut,ct,dt,ft,pt,mt,ht,vt,bt=(0,ee.Z)("MuiTouchRipple",["root","ripple","rippleVisible","ripplePulsate","child","childLeaving","childPulsate"]),yt=["center","classes","className"],gt=d(pt||(pt=ut||(ut=Xe(["\n  0% {\n    transform: scale(0);\n    opacity: 0.1;\n  }\n\n  100% {\n    transform: scale(1);\n    opacity: 0.3;\n  }\n"])))),_t=d(mt||(mt=ct||(ct=Xe(["\n  0% {\n    opacity: 1;\n  }\n\n  100% {\n    opacity: 0;\n  }\n"])))),wt=d(ht||(ht=dt||(dt=Xe(["\n  0% {\n    transform: scale(1);\n  }\n\n  50% {\n    transform: scale(0.92);\n  }\n\n  100% {\n    transform: scale(1);\n  }\n"])))),kt=(0,D.ZP)("span",{name:"MuiTouchRipple",slot:"Root"})({overflow:"hidden",pointerEvents:"none",position:"absolute",zIndex:0,top:0,right:0,bottom:0,left:0,borderRadius:"inherit"}),St=(0,D.ZP)(lt,{name:"MuiTouchRipple",slot:"Ripple"})(vt||(vt=ft||(ft=Xe(["\n  opacity: 0;\n  position: absolute;\n\n  &."," {\n    opacity: 0.3;\n    transform: scale(1);\n    animation-name: ",";\n    animation-duration: ","ms;\n    animation-timing-function: ",";\n  }\n\n  &."," {\n    animation-duration: ","ms;\n  }\n\n  & ."," {\n    opacity: 1;\n    display: block;\n    width: 100%;\n    height: 100%;\n    border-radius: 50%;\n    background-color: currentColor;\n  }\n\n  & ."," {\n    opacity: 0;\n    animation-name: ",";\n    animation-duration: ","ms;\n    animation-timing-function: ",";\n  }\n\n  & ."," {\n    position: absolute;\n    /* @noflip */\n    left: 0px;\n    top: 0;\n    animation-name: ",";\n    animation-duration: 2500ms;\n    animation-timing-function: ",";\n    animation-iteration-count: infinite;\n    animation-delay: 200ms;\n  }\n"]))),bt.rippleVisible,gt,550,(function(e){return e.theme.transitions.easing.easeInOut}),bt.ripplePulsate,(function(e){return e.theme.transitions.duration.shorter}),bt.child,bt.childLeaving,_t,550,(function(e){return e.theme.transitions.easing.easeInOut}),bt.childPulsate,wt,(function(e){return e.theme.transitions.easing.easeInOut})),Tt=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiTouchRipple"}),i=o.center,s=void 0!==i&&i,l=o.classes,u=void 0===l?{}:l,c=o.className,d=(0,w.Z)(o,yt),p=e.useState([]),m=(0,g.Z)(p,2),h=m[0],v=m[1],b=e.useRef(0),y=e.useRef(null);e.useEffect((function(){y.current&&(y.current(),y.current=null)}),[h]);var _=e.useRef(!1),S=e.useRef(null),T=e.useRef(null),C=e.useRef(null);e.useEffect((function(){return function(){clearTimeout(S.current)}}),[]);var x=e.useCallback((function(e){var t=e.pulsate,n=e.rippleX,r=e.rippleY,a=e.rippleSize,o=e.cb;v((function(e){return[].concat((0,Z.Z)(e),[(0,f.jsx)(St,{classes:{ripple:(0,k.Z)(u.ripple,bt.ripple),rippleVisible:(0,k.Z)(u.rippleVisible,bt.rippleVisible),ripplePulsate:(0,k.Z)(u.ripplePulsate,bt.ripplePulsate),child:(0,k.Z)(u.child,bt.child),childLeaving:(0,k.Z)(u.childLeaving,bt.childLeaving),childPulsate:(0,k.Z)(u.childPulsate,bt.childPulsate)},timeout:550,pulsate:t,rippleX:n,rippleY:r,rippleSize:a},b.current)])})),b.current+=1,y.current=o}),[u]),A=e.useCallback((function(){var e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{},t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},n=arguments.length>2?arguments[2]:void 0,r=t.pulsate,a=void 0!==r&&r,o=t.center,i=void 0===o?s||t.pulsate:o,l=t.fakeElement,u=void 0!==l&&l;if("mousedown"===(null==e?void 0:e.type)&&_.current)_.current=!1;else{"touchstart"===(null==e?void 0:e.type)&&(_.current=!0);var c,d,f,p=u?null:C.current,m=p?p.getBoundingClientRect():{width:0,height:0,left:0,top:0};if(i||void 0===e||0===e.clientX&&0===e.clientY||!e.clientX&&!e.touches)c=Math.round(m.width/2),d=Math.round(m.height/2);else{var h=e.touches&&e.touches.length>0?e.touches[0]:e,v=h.clientX,b=h.clientY;c=Math.round(v-m.left),d=Math.round(b-m.top)}if(i)(f=Math.sqrt((2*Math.pow(m.width,2)+Math.pow(m.height,2))/3))%2===0&&(f+=1);else{var y=2*Math.max(Math.abs((p?p.clientWidth:0)-c),c)+2,g=2*Math.max(Math.abs((p?p.clientHeight:0)-d),d)+2;f=Math.sqrt(Math.pow(y,2)+Math.pow(g,2))}null!=e&&e.touches?null===T.current&&(T.current=function(){x({pulsate:a,rippleX:c,rippleY:d,rippleSize:f,cb:n})},S.current=setTimeout((function(){T.current&&(T.current(),T.current=null)}),80)):x({pulsate:a,rippleX:c,rippleY:d,rippleSize:f,cb:n})}}),[s,x]),F=e.useCallback((function(){A({},{pulsate:!0})}),[A]),E=e.useCallback((function(e,t){if(clearTimeout(S.current),"touchend"===(null==e?void 0:e.type)&&T.current)return T.current(),T.current=null,void(S.current=setTimeout((function(){E(e,t)})));T.current=null,v((function(e){return e.length>0?e.slice(1):e})),y.current=t}),[]);return e.useImperativeHandle(n,(function(){return{pulsate:F,start:A,stop:E}}),[F,A,E]),(0,f.jsx)(kt,(0,r.Z)({className:(0,k.Z)(bt.root,u.root,c),ref:C},d,{children:(0,f.jsx)(st,{component:null,exit:!0,children:h})}))})),Ct=Tt;function xt(e){return(0,T.Z)("MuiButtonBase",e)}var At,Ft=(0,ee.Z)("MuiButtonBase",["root","disabled","focusVisible"]),Et=["action","centerRipple","children","className","component","disabled","disableRipple","disableTouchRipple","focusRipple","focusVisibleClassName","LinkComponent","onBlur","onClick","onContextMenu","onDragLeave","onFocus","onFocusVisible","onKeyDown","onKeyUp","onMouseDown","onMouseLeave","onMouseUp","onTouchEnd","onTouchMove","onTouchStart","tabIndex","TouchRippleProps","touchRippleRef","type"],Pt=(0,D.ZP)("button",{name:"MuiButtonBase",slot:"Root",overridesResolver:function(e,t){return t.root}})((At={display:"inline-flex",alignItems:"center",justifyContent:"center",position:"relative",boxSizing:"border-box",WebkitTapHighlightColor:"transparent",backgroundColor:"transparent",outline:0,border:0,margin:0,borderRadius:0,padding:0,cursor:"pointer",userSelect:"none",verticalAlign:"middle",MozAppearance:"none",WebkitAppearance:"none",textDecoration:"none",color:"inherit","&::-moz-focus-inner":{borderStyle:"none"}},(0,_.Z)(At,"&.".concat(Ft.disabled),{pointerEvents:"none",cursor:"default"}),(0,_.Z)(At,"@media print",{colorAdjust:"exact"}),At)),Ot=e.forwardRef((function(t,n){var o=(0,a.Z)({props:t,name:"MuiButtonBase"}),i=o.action,s=o.centerRipple,l=void 0!==s&&s,u=o.children,c=o.className,d=o.component,p=void 0===d?"button":d,m=o.disabled,h=void 0!==m&&m,v=o.disableRipple,b=void 0!==v&&v,y=o.disableTouchRipple,_=void 0!==y&&y,S=o.focusRipple,T=void 0!==S&&S,x=o.LinkComponent,A=void 0===x?"a":x,F=o.onBlur,E=o.onClick,P=o.onContextMenu,O=o.onDragLeave,N=o.onFocus,M=o.onFocusVisible,R=o.onKeyDown,D=o.onKeyUp,L=o.onMouseDown,I=o.onMouseLeave,z=o.onMouseUp,j=o.onTouchEnd,Z=o.onTouchMove,B=o.onTouchStart,V=o.tabIndex,W=void 0===V?0:V,G=o.TouchRippleProps,U=o.touchRippleRef,H=o.type,$=(0,w.Z)(o,Et),J=e.useRef(null),q=e.useRef(null),Q=(0,Qe.Z)(q,U),K=(0,Ye.Z)(),Y=K.isFocusVisibleRef,X=K.onFocus,ee=K.onBlur,te=K.ref,ne=e.useState(!1),re=(0,g.Z)(ne,2),ae=re[0],oe=re[1];h&&ae&&oe(!1),e.useImperativeHandle(i,(function(){return{focusVisible:function(){oe(!0),J.current.focus()}}}),[]);var ie=e.useState(!1),se=(0,g.Z)(ie,2),le=se[0],ue=se[1];e.useEffect((function(){ue(!0)}),[]);var ce=le&&!b&&!h;function de(e,t){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:_;return(0,Ke.Z)((function(r){return t&&t(r),!n&&q.current&&q.current[e](r),!0}))}e.useEffect((function(){ae&&T&&!b&&le&&q.current.pulsate()}),[b,T,ae,le]);var fe=de("start",L),pe=de("stop",P),me=de("stop",O),he=de("stop",z),ve=de("stop",(function(e){ae&&e.preventDefault(),I&&I(e)})),be=de("start",B),ye=de("stop",j),ge=de("stop",Z),_e=de("stop",(function(e){ee(e),!1===Y.current&&oe(!1),F&&F(e)}),!1),we=(0,Ke.Z)((function(e){J.current||(J.current=e.currentTarget),X(e),!0===Y.current&&(oe(!0),M&&M(e)),N&&N(e)})),ke=function(){var e=J.current;return p&&"button"!==p&&!("A"===e.tagName&&e.href)},Se=e.useRef(!1),Te=(0,Ke.Z)((function(e){T&&!Se.current&&ae&&q.current&&" "===e.key&&(Se.current=!0,q.current.stop(e,(function(){q.current.start(e)}))),e.target===e.currentTarget&&ke()&&" "===e.key&&e.preventDefault(),R&&R(e),e.target===e.currentTarget&&ke()&&"Enter"===e.key&&!h&&(e.preventDefault(),E&&E(e))})),Ce=(0,Ke.Z)((function(e){T&&" "===e.key&&q.current&&ae&&!e.defaultPrevented&&(Se.current=!1,q.current.stop(e,(function(){q.current.pulsate(e)}))),D&&D(e),E&&e.target===e.currentTarget&&ke()&&" "===e.key&&!e.defaultPrevented&&E(e)})),xe=p;"button"===xe&&($.href||$.to)&&(xe=A);var Ae={};"button"===xe?(Ae.type=void 0===H?"button":H,Ae.disabled=h):($.href||$.to||(Ae.role="button"),h&&(Ae["aria-disabled"]=h));var Fe=(0,Qe.Z)(te,J),Ee=(0,Qe.Z)(n,Fe);var Pe=(0,r.Z)({},o,{centerRipple:l,component:p,disabled:h,disableRipple:b,disableTouchRipple:_,focusRipple:T,tabIndex:W,focusVisible:ae}),Oe=function(e){var t=e.disabled,n=e.focusVisible,r=e.focusVisibleClassName,a=e.classes,o={root:["root",t&&"disabled",n&&"focusVisible"]},i=(0,C.Z)(o,xt,a);return n&&r&&(i.root+=" ".concat(r)),i}(Pe);return(0,f.jsxs)(Pt,(0,r.Z)({as:xe,className:(0,k.Z)(Oe.root,c),ownerState:Pe,onBlur:_e,onClick:E,onContextMenu:pe,onFocus:we,onKeyDown:Te,onKeyUp:Ce,onMouseDown:fe,onMouseLeave:ve,onMouseUp:he,onDragLeave:me,onTouchEnd:ye,onTouchMove:ge,onTouchStart:be,ref:Ee,tabIndex:h?-1:W,type:H},Ae,$,{children:[u,ce?(0,f.jsx)(Ct,(0,r.Z)({ref:Q,center:l},G)):null]}))})),Nt=Ot;function Mt(e){return(0,T.Z)("MuiIconButton",e)}var Rt=(0,ee.Z)("MuiIconButton",["root","disabled","colorInherit","colorPrimary","colorSecondary","edgeStart","edgeEnd","sizeSmall","sizeMedium","sizeLarge"]),Dt=["edge","children","className","color","disabled","disableFocusRipple","size"],Lt=(0,D.ZP)(Nt,{name:"MuiIconButton",slot:"Root",overridesResolver:function(e,t){var n=e.ownerState;return[t.root,"default"!==n.color&&t["color".concat((0,R.Z)(n.color))],n.edge&&t["edge".concat((0,R.Z)(n.edge))],t["size".concat((0,R.Z)(n.size))]]}})((function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({textAlign:"center",flex:"0 0 auto",fontSize:t.typography.pxToRem(24),padding:8,borderRadius:"50%",overflow:"visible",color:(t.vars||t).palette.action.active,transition:t.transitions.create("background-color",{duration:t.transitions.duration.shortest})},!n.disableRipple&&{"&:hover":{backgroundColor:t.vars?"rgba(".concat(t.vars.palette.action.activeChannel," / ").concat(t.vars.palette.action.hoverOpacity,")"):(0,fe.Fq)(t.palette.action.active,t.palette.action.hoverOpacity),"@media (hover: none)":{backgroundColor:"transparent"}}},"start"===n.edge&&{marginLeft:"small"===n.size?-3:-12},"end"===n.edge&&{marginRight:"small"===n.size?-3:-12})}),(function(e){var t=e.theme,n=e.ownerState;return(0,r.Z)({},"inherit"===n.color&&{color:"inherit"},"inherit"!==n.color&&"default"!==n.color&&(0,r.Z)({color:(t.vars||t).palette[n.color].main},!n.disableRipple&&{"&:hover":{backgroundColor:t.vars?"rgba(".concat(t.vars.palette[n.color].mainChannel," / ").concat(t.vars.palette.action.hoverOpacity,")"):(0,fe.Fq)(t.palette[n.color].main,t.palette.action.hoverOpacity),"@media (hover: none)":{backgroundColor:"transparent"}}}),"small"===n.size&&{padding:5,fontSize:t.typography.pxToRem(18)},"large"===n.size&&{padding:12,fontSize:t.typography.pxToRem(28)},(0,_.Z)({},"&.".concat(Rt.disabled),{backgroundColor:"transparent",color:(t.vars||t).palette.action.disabled}))})),It=e.forwardRef((function(e,t){var n=(0,a.Z)({props:e,name:"MuiIconButton"}),o=n.edge,i=void 0!==o&&o,s=n.children,l=n.className,u=n.color,c=void 0===u?"default":u,d=n.disabled,p=void 0!==d&&d,m=n.disableFocusRipple,h=void 0!==m&&m,v=n.size,b=void 0===v?"medium":v,y=(0,w.Z)(n,Dt),g=(0,r.Z)({},n,{edge:i,color:c,disabled:p,disableFocusRipple:h,size:b}),_=function(e){var t=e.classes,n=e.disabled,r=e.color,a=e.edge,o=e.size,i={root:["root",n&&"disabled","default"!==r&&"color".concat((0,R.Z)(r)),a&&"edge".concat((0,R.Z)(a)),"size".concat((0,R.Z)(o))]};return(0,C.Z)(i,Mt,t)}(g);return(0,f.jsx)(Lt,(0,r.Z)({className:(0,k.Z)(_.root,l),centerRipple:!0,focusRipple:!h,disabled:p,ref:t,ownerState:g},y,{children:s}))})),zt=n(2156),jt=n(5129);n(8472),(0,J.Z)({palette:{neutral:{main:"#fff",contrastText:"#000"}}});function Zt(e){var t=e.datumNumber,n=e.setDatumNumber,r=e.numComparisons,a=(e.outputData,e.batchNum),o=function(){n(t-1)},i=function(){n(t+1)};return(0,f.jsx)(Q,{sx:{flexGrow:1},children:(0,f.jsx)(Ue,{position:"static",children:(0,f.jsxs)(qe,{children:[(0,f.jsxs)(Oe,{component:"div",variant:"h6",sx:{flexGrow:1},children:["Compare Trial Versions for Batch ",a]}),(0,f.jsxs)(Oe,{component:"div",children:[t>0?(0,f.jsx)(It,{color:"inherit",variant:"text",onClick:o,children:(0,f.jsx)(zt.Z,{})}):null,t<r-1?(0,f.jsx)(It,{color:"inherit",variant:"text",onClick:i,children:(0,f.jsx)(jt.Z,{})}):null]})]})})})}for(var Bt=JSON.parse('{"1":"Add endpoint to composite endpoint","2":"Add endpoint","3":"Change endpoint","4":"Change endpoint, add endpoint","5":"Change in endpoint in a composite endpoint","6":"Change method of analysis","7":"Change number of events","8":"Change population","9":"Change readers","10":"Change timepoint","11":"Error","12":"From nothing to something","13":"Refine definition","14":"Remove endpoint","15":"Shuffle Endpoints","16":"Syntax","":""}'),Vt=[],Wt=K.e,Gt=K.C,Ut=Gt.length,Ht=0;Ht<Ut;Ht++)Vt.push("");var $t=function(){var t=(0,e.useState)(0),n=(0,g.Z)(t,2),r=n[0],a=n[1],o=(0,e.useState)(Gt[r]),i=(0,g.Z)(o,2),s=i[0],l=i[1],u=(0,e.useState)(Vt),c=(0,g.Z)(u,2),d=c[0],p=c[1],m=(0,e.useState)([]),h=(0,g.Z)(m,2),v=h[0],b=h[1];return(0,e.useEffect)((function(){l(Gt[r])}),[r]),(0,e.useEffect)((function(){for(var e=[],t=0;t<Ut;t++){var n={};n.nctid=Gt[t].nctid,n.version_a=Gt[t].version_a,n.version_b=Gt[t].version_b,n.classification_number=d[t],n.classification_meaning=Bt[d[t]],e.push(n)}b(e)}),[d]),(0,f.jsxs)(e.Fragment,{children:[(0,f.jsx)(Zt,{datumNumber:r,setDatumNumber:a,numComparisons:Ut,outputData:v,batchNum:Wt}),(0,f.jsx)(I,{children:(0,f.jsx)(Q,{sx:{flexGrow:1,m:1},children:(0,f.jsx)(Ze,{datum:s,datumNumber:r,results:d,setResults:p})})})]})};t.createRoot(document.getElementById("root")).render((0,f.jsxs)(e.StrictMode,{children:[(0,f.jsx)(y,{}),(0,f.jsx)($t,{})]}))}()}();
//# sourceMappingURL=main.1e442e01.js.map